<html lang="en-US" class=""><head>
      <meta name="citation_pii" content="S0277953619305908">
<meta name="citation_id" content="112595">
<meta name="citation_issn" content="0277-9536">
<meta name="citation_volume" content="246">
<meta name="citation_publisher" content="Pergamon">
<meta name="citation_firstpage" content="112595">
<meta name="citation_fulltext_world_readable" content="">
<meta name="citation_journal_title" content="Social Science &amp; Medicine">
<meta name="citation_type" content="JOUR">
<meta name="citation_doi" content="10.1016/j.socscimed.2019.112595">
<meta name="dc.identifier" content="10.1016/j.socscimed.2019.112595">
<meta name="citation_article_type" content="Full-length article">
<meta property="og:description" content="Multiple Criteria Decision Analysis (MCDA) has emerged as a methodology for Health Technology Assessment (HTA). However, limited empirical evidence is…">
<meta property="og:image" content="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619X00258-cov150h.gif">
<meta name="citation_title" content="Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework">
<meta property="og:title" content="Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework">
<meta name="citation_publication_date" content="2020/02/01">
<meta name="citation_online_date" content="2019/10/15">
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE,NOCACHE,NOODP,NOYDIR">
      <title>Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework - ScienceDirect</title>
      <link rel="canonical" href="https://www.sciencedirect.com/science/article/pii/S0277953619305908">
      <meta name="tdm-reservation" content="1">
      <meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">
      <meta property="og:type" content="article">
      <meta name="viewport" content="initial-scale=1">
      <meta name="SDTech" content="Proudly brought to you by the SD Technology team">
      <script async="" src="https://cdn.pendo.io/agent/static/d6c1d995-bc7e-4e53-77f1-2ea4ecbb9565/pendo.js"></script><script type="text/javascript">(function newRelicBrowserProSPA() {
  ;
  window.NREUM || (NREUM = {});
  NREUM.init = {
    privacy: {
      cookies_enabled: false
    },
    ajax: {
      deny_list: ["bam-cell.nr-data.net"]
    }
  };
  ;
  NREUM.loader_config = {
    accountID: "2128461",
    trustKey: "2038175",
    agentID: "1118783207",
    licenseKey: "7ac4127487",
    applicationID: "814814845"
  };
  ;
  NREUM.info = {
    beacon: "bam.nr-data.net",
    errorBeacon: "bam.nr-data.net",
    licenseKey: "7ac4127487",
    applicationID: "814814845",
    sa: 1
  };
  ; /*! For license information please see nr-loader-spa-1.238.0.min.js.LICENSE.txt */
  (() => {
    "use strict";

    var e,
      t,
      r = {
        5763: (e, t, r) => {
          r.d(t, {
            P_: () => f,
            Mt: () => p,
            C5: () => s,
            DL: () => v,
            OP: () => T,
            lF: () => D,
            Yu: () => y,
            Dg: () => h,
            CX: () => c,
            GE: () => b,
            sU: () => _
          });
          var n = r(8632),
            i = r(9567);
          const o = {
              beacon: n.ce.beacon,
              errorBeacon: n.ce.errorBeacon,
              licenseKey: void 0,
              applicationID: void 0,
              sa: void 0,
              queueTime: void 0,
              applicationTime: void 0,
              ttGuid: void 0,
              user: void 0,
              account: void 0,
              product: void 0,
              extra: void 0,
              jsAttributes: {},
              userAttributes: void 0,
              atts: void 0,
              transactionName: void 0,
              tNamePlain: void 0
            },
            a = {};
          function s(e) {
            if (!e) throw new Error("All info objects require an agent identifier!");
            if (!a[e]) throw new Error("Info for ".concat(e, " was never set"));
            return a[e];
          }
          function c(e, t) {
            if (!e) throw new Error("All info objects require an agent identifier!");
            a[e] = (0, i.D)(t, o), (0, n.Qy)(e, a[e], "info");
          }
          var u = r(7056);
          const d = () => {
              const e = {
                blockSelector: "[data-nr-block]",
                maskInputOptions: {
                  password: !0
                }
              };
              return {
                allow_bfcache: !0,
                privacy: {
                  cookies_enabled: !0
                },
                ajax: {
                  deny_list: void 0,
                  block_internal: !0,
                  enabled: !0,
                  harvestTimeSeconds: 10
                },
                distributed_tracing: {
                  enabled: void 0,
                  exclude_newrelic_header: void 0,
                  cors_use_newrelic_header: void 0,
                  cors_use_tracecontext_headers: void 0,
                  allowed_origins: void 0
                },
                session: {
                  domain: void 0,
                  expiresMs: u.oD,
                  inactiveMs: u.Hb
                },
                ssl: void 0,
                obfuscate: void 0,
                jserrors: {
                  enabled: !0,
                  harvestTimeSeconds: 10
                },
                metrics: {
                  enabled: !0
                },
                page_action: {
                  enabled: !0,
                  harvestTimeSeconds: 30
                },
                page_view_event: {
                  enabled: !0
                },
                page_view_timing: {
                  enabled: !0,
                  harvestTimeSeconds: 30,
                  long_task: !1
                },
                session_trace: {
                  enabled: !0,
                  harvestTimeSeconds: 10
                },
                harvest: {
                  tooManyRequestsDelay: 60
                },
                session_replay: {
                  enabled: !1,
                  harvestTimeSeconds: 60,
                  sampleRate: .1,
                  errorSampleRate: .1,
                  maskTextSelector: "*",
                  maskAllInputs: !0,
                  get blockClass() {
                    return "nr-block";
                  },
                  get ignoreClass() {
                    return "nr-ignore";
                  },
                  get maskTextClass() {
                    return "nr-mask";
                  },
                  get blockSelector() {
                    return e.blockSelector;
                  },
                  set blockSelector(t) {
                    e.blockSelector += ",".concat(t);
                  },
                  get maskInputOptions() {
                    return e.maskInputOptions;
                  },
                  set maskInputOptions(t) {
                    e.maskInputOptions = {
                      ...t,
                      password: !0
                    };
                  }
                },
                spa: {
                  enabled: !0,
                  harvestTimeSeconds: 10
                }
              };
            },
            l = {};
          function f(e) {
            if (!e) throw new Error("All configuration objects require an agent identifier!");
            if (!l[e]) throw new Error("Configuration for ".concat(e, " was never set"));
            return l[e];
          }
          function h(e, t) {
            if (!e) throw new Error("All configuration objects require an agent identifier!");
            l[e] = (0, i.D)(t, d()), (0, n.Qy)(e, l[e], "config");
          }
          function p(e, t) {
            if (!e) throw new Error("All configuration objects require an agent identifier!");
            var r = f(e);
            if (r) {
              for (var n = t.split("."), i = 0; i < n.length - 1; i++) if ("object" != typeof (r = r[n[i]])) return;
              r = r[n[n.length - 1]];
            }
            return r;
          }
          const g = {
              accountID: void 0,
              trustKey: void 0,
              agentID: void 0,
              licenseKey: void 0,
              applicationID: void 0,
              xpid: void 0
            },
            m = {};
          function v(e) {
            if (!e) throw new Error("All loader-config objects require an agent identifier!");
            if (!m[e]) throw new Error("LoaderConfig for ".concat(e, " was never set"));
            return m[e];
          }
          function b(e, t) {
            if (!e) throw new Error("All loader-config objects require an agent identifier!");
            m[e] = (0, i.D)(t, g), (0, n.Qy)(e, m[e], "loader_config");
          }
          const y = (0, n.mF)().o;
          var w = r(385),
            A = r(6818);
          const x = {
              buildEnv: A.Re,
              bytesSent: {},
              queryBytesSent: {},
              customTransaction: void 0,
              disabled: !1,
              distMethod: A.gF,
              isolatedBacklog: !1,
              loaderType: void 0,
              maxBytes: 3e4,
              offset: Math.floor(w._A?.performance?.timeOrigin || w._A?.performance?.timing?.navigationStart || Date.now()),
              onerror: void 0,
              origin: "" + w._A.location,
              ptid: void 0,
              releaseIds: {},
              session: void 0,
              xhrWrappable: "function" == typeof w._A.XMLHttpRequest?.prototype?.addEventListener,
              version: A.q4,
              denyList: void 0
            },
            E = {};
          function T(e) {
            if (!e) throw new Error("All runtime objects require an agent identifier!");
            if (!E[e]) throw new Error("Runtime for ".concat(e, " was never set"));
            return E[e];
          }
          function _(e, t) {
            if (!e) throw new Error("All runtime objects require an agent identifier!");
            E[e] = (0, i.D)(t, x), (0, n.Qy)(e, E[e], "runtime");
          }
          function D(e) {
            return function (e) {
              try {
                const t = s(e);
                return !!t.licenseKey && !!t.errorBeacon && !!t.applicationID;
              } catch (e) {
                return !1;
              }
            }(e);
          }
        },
        9567: (e, t, r) => {
          r.d(t, {
            D: () => i
          });
          var n = r(50);
          function i(e, t) {
            try {
              if (!e || "object" != typeof e) return (0, n.Z)("Setting a Configurable requires an object as input");
              if (!t || "object" != typeof t) return (0, n.Z)("Setting a Configurable requires a model to set its initial properties");
              const r = Object.create(Object.getPrototypeOf(t), Object.getOwnPropertyDescriptors(t)),
                o = 0 === Object.keys(r).length ? e : r;
              for (let a in o) if (void 0 !== e[a]) try {
                "object" == typeof e[a] && "object" == typeof t[a] ? r[a] = i(e[a], t[a]) : r[a] = e[a];
              } catch (e) {
                (0, n.Z)("An error occurred while setting a property of a Configurable", e);
              }
              return r;
            } catch (e) {
              (0, n.Z)("An error occured while setting a Configurable", e);
            }
          }
        },
        6818: (e, t, r) => {
          r.d(t, {
            Re: () => i,
            gF: () => o,
            q4: () => n
          });
          const n = "1.238.0",
            i = "PROD",
            o = "CDN";
        },
        385: (e, t, r) => {
          r.d(t, {
            FN: () => a,
            IF: () => u,
            Nk: () => l,
            Tt: () => s,
            _A: () => o,
            il: () => n,
            pL: () => c,
            v6: () => i,
            w1: () => d
          });
          const n = "undefined" != typeof window && !!window.document,
            i = "undefined" != typeof WorkerGlobalScope && ("undefined" != typeof self && self instanceof WorkerGlobalScope && self.navigator instanceof WorkerNavigator || "undefined" != typeof globalThis && globalThis instanceof WorkerGlobalScope && globalThis.navigator instanceof WorkerNavigator),
            o = n ? window : "undefined" != typeof WorkerGlobalScope && ("undefined" != typeof self && self instanceof WorkerGlobalScope && self || "undefined" != typeof globalThis && globalThis instanceof WorkerGlobalScope && globalThis),
            a = "" + o?.location,
            s = /iPad|iPhone|iPod/.test(navigator.userAgent),
            c = s && "undefined" == typeof SharedWorker,
            u = (() => {
              const e = navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);
              return Array.isArray(e) && e.length >= 2 ? +e[1] : 0;
            })(),
            d = Boolean(n && window.document.documentMode),
            l = !!navigator.sendBeacon;
        },
        1117: (e, t, r) => {
          r.d(t, {
            w: () => o
          });
          var n = r(50);
          const i = {
            agentIdentifier: "",
            ee: void 0
          };
          class o {
            constructor(e) {
              try {
                if ("object" != typeof e) return (0, n.Z)("shared context requires an object as input");
                this.sharedContext = {}, Object.assign(this.sharedContext, i), Object.entries(e).forEach(e => {
                  let [t, r] = e;
                  Object.keys(i).includes(t) && (this.sharedContext[t] = r);
                });
              } catch (e) {
                (0, n.Z)("An error occured while setting SharedContext", e);
              }
            }
          }
        },
        8e3: (e, t, r) => {
          r.d(t, {
            L: () => d,
            R: () => c
          });
          var n = r(8325),
            i = r(1284),
            o = r(4322),
            a = r(3325);
          const s = {};
          function c(e, t) {
            const r = {
              staged: !1,
              priority: a.p[t] || 0
            };
            u(e), s[e].get(t) || s[e].set(t, r);
          }
          function u(e) {
            e && (s[e] || (s[e] = new Map()));
          }
          function d() {
            let e = arguments.length > 0 && void 0 !== arguments[0] ? arguments[0] : "",
              t = arguments.length > 1 && void 0 !== arguments[1] ? arguments[1] : "feature";
            if (u(e), !e || !s[e].get(t)) return a(t);
            s[e].get(t).staged = !0;
            const r = [...s[e]];
            function a(t) {
              const r = e ? n.ee.get(e) : n.ee,
                a = o.X.handlers;
              if (r.backlog && a) {
                var s = r.backlog[t],
                  c = a[t];
                if (c) {
                  for (var u = 0; s && u < s.length; ++u) l(s[u], c);
                  (0, i.D)(c, function (e, t) {
                    (0, i.D)(t, function (t, r) {
                      r[0].on(e, r[1]);
                    });
                  });
                }
                delete a[t], r.backlog[t] = null, r.emit("drain-" + t, []);
              }
            }
            r.every(e => {
              let [t, r] = e;
              return r.staged;
            }) && (r.sort((e, t) => e[1].priority - t[1].priority), r.forEach(e => {
              let [t] = e;
              a(t);
            }));
          }
          function l(e, t) {
            var r = e[1];
            (0, i.D)(t[r], function (t, r) {
              var n = e[0];
              if (r[0] === n) {
                var i = r[1],
                  o = e[3],
                  a = e[2];
                i.apply(o, a);
              }
            });
          }
        },
        8325: (e, t, r) => {
          r.d(t, {
            A: () => c,
            ee: () => u
          });
          var n = r(8632),
            i = r(2210),
            o = r(5763);
          class a {
            constructor(e) {
              this.contextId = e;
            }
          }
          var s = r(3117);
          const c = "nr@context:".concat(s.a),
            u = function e(t, r) {
              var n = {},
                s = {},
                d = {},
                f = !1;
              try {
                f = 16 === r.length && (0, o.OP)(r).isolatedBacklog;
              } catch (e) {}
              var h = {
                on: g,
                addEventListener: g,
                removeEventListener: function (e, t) {
                  var r = n[e];
                  if (!r) return;
                  for (var i = 0; i < r.length; i++) r[i] === t && r.splice(i, 1);
                },
                emit: function (e, r, n, i, o) {
                  !1 !== o && (o = !0);
                  if (u.aborted && !i) return;
                  t && o && t.emit(e, r, n);
                  for (var a = p(n), c = m(e), d = c.length, l = 0; l < d; l++) c[l].apply(a, r);
                  var f = b()[s[e]];
                  f && f.push([h, e, r, a]);
                  return a;
                },
                get: v,
                listeners: m,
                context: p,
                buffer: function (e, t) {
                  const r = b();
                  if (t = t || "feature", h.aborted) return;
                  Object.entries(e || {}).forEach(e => {
                    let [n, i] = e;
                    s[i] = t, t in r || (r[t] = []);
                  });
                },
                abort: l,
                aborted: !1,
                isBuffering: function (e) {
                  return !!b()[s[e]];
                },
                debugId: r,
                backlog: f ? {} : t && "object" == typeof t.backlog ? t.backlog : {}
              };
              return h;
              function p(e) {
                return e && e instanceof a ? e : e ? (0, i.X)(e, c, () => new a(c)) : new a(c);
              }
              function g(e, t) {
                n[e] = m(e).concat(t);
              }
              function m(e) {
                return n[e] || [];
              }
              function v(t) {
                return d[t] = d[t] || e(h, t);
              }
              function b() {
                return h.backlog;
              }
            }(void 0, "globalEE"),
            d = (0, n.fP)();
          function l() {
            u.aborted = !0, u.backlog = {};
          }
          d.ee || (d.ee = u);
        },
        5546: (e, t, r) => {
          r.d(t, {
            E: () => n,
            p: () => i
          });
          var n = r(8325).ee.get("handle");
          function i(e, t, r, i, o) {
            o ? (o.buffer([e], i), o.emit(e, t, r)) : (n.buffer([e], i), n.emit(e, t, r));
          }
        },
        4322: (e, t, r) => {
          r.d(t, {
            X: () => o
          });
          var n = r(5546);
          o.on = a;
          var i = o.handlers = {};
          function o(e, t, r, o) {
            a(o || n.E, i, e, t, r);
          }
          function a(e, t, r, i, o) {
            o || (o = "feature"), e || (e = n.E);
            var a = t[o] = t[o] || {};
            (a[r] = a[r] || []).push([e, i]);
          }
        },
        3239: (e, t, r) => {
          r.d(t, {
            bP: () => s,
            iz: () => c,
            m$: () => a
          });
          var n = r(385);
          let i = !1,
            o = !1;
          try {
            const e = {
              get passive() {
                return i = !0, !1;
              },
              get signal() {
                return o = !0, !1;
              }
            };
            n._A.addEventListener("test", null, e), n._A.removeEventListener("test", null, e);
          } catch (e) {}
          function a(e, t) {
            return i || o ? {
              capture: !!e,
              passive: i,
              signal: t
            } : !!e;
          }
          function s(e, t) {
            let r = arguments.length > 2 && void 0 !== arguments[2] && arguments[2],
              n = arguments.length > 3 ? arguments[3] : void 0;
            window.addEventListener(e, t, a(r, n));
          }
          function c(e, t) {
            let r = arguments.length > 2 && void 0 !== arguments[2] && arguments[2],
              n = arguments.length > 3 ? arguments[3] : void 0;
            document.addEventListener(e, t, a(r, n));
          }
        },
        3117: (e, t, r) => {
          r.d(t, {
            a: () => n
          });
          const n = (0, r(4402).Rl)();
        },
        4402: (e, t, r) => {
          r.d(t, {
            Ht: () => u,
            M: () => c,
            Rl: () => a,
            ky: () => s
          });
          var n = r(385);
          const i = "xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";
          function o(e, t) {
            return e ? 15 & e[t] : 16 * Math.random() | 0;
          }
          function a() {
            const e = n._A?.crypto || n._A?.msCrypto;
            let t,
              r = 0;
            return e && e.getRandomValues && (t = e.getRandomValues(new Uint8Array(31))), i.split("").map(e => "x" === e ? o(t, ++r).toString(16) : "y" === e ? (3 & o() | 8).toString(16) : e).join("");
          }
          function s(e) {
            const t = n._A?.crypto || n._A?.msCrypto;
            let r,
              i = 0;
            t && t.getRandomValues && (r = t.getRandomValues(new Uint8Array(31)));
            const a = [];
            for (var s = 0; s < e; s++) a.push(o(r, ++i).toString(16));
            return a.join("");
          }
          function c() {
            return s(16);
          }
          function u() {
            return s(32);
          }
        },
        7056: (e, t, r) => {
          r.d(t, {
            Bq: () => n,
            Hb: () => o,
            oD: () => i
          });
          const n = "NRBA",
            i = 144e5,
            o = 18e5;
        },
        7894: (e, t, r) => {
          function n() {
            return Math.round(performance.now());
          }
          r.d(t, {
            z: () => n
          });
        },
        7243: (e, t, r) => {
          r.d(t, {
            e: () => o
          });
          var n = r(385),
            i = {};
          function o(e) {
            if (e in i) return i[e];
            if (0 === (e || "").indexOf("data:")) return {
              protocol: "data"
            };
            let t;
            var r = n._A?.location,
              o = {};
            if (n.il) t = document.createElement("a"), t.href = e;else try {
              t = new URL(e, r.href);
            } catch (e) {
              return o;
            }
            o.port = t.port;
            var a = t.href.split("://");
            !o.port && a[1] && (o.port = a[1].split("/")[0].split("@").pop().split(":")[1]), o.port && "0" !== o.port || (o.port = "https" === a[0] ? "443" : "80"), o.hostname = t.hostname || r.hostname, o.pathname = t.pathname, o.protocol = a[0], "/" !== o.pathname.charAt(0) && (o.pathname = "/" + o.pathname);
            var s = !t.protocol || ":" === t.protocol || t.protocol === r.protocol,
              c = t.hostname === r.hostname && t.port === r.port;
            return o.sameOrigin = s && (!t.hostname || c), "/" === o.pathname && (i[e] = o), o;
          }
        },
        50: (e, t, r) => {
          function n(e, t) {
            "function" == typeof console.warn && (console.warn("New Relic: ".concat(e)), t && console.warn(t));
          }
          r.d(t, {
            Z: () => n
          });
        },
        2587: (e, t, r) => {
          r.d(t, {
            N: () => c,
            T: () => u
          });
          var n = r(8325),
            i = r(5546),
            o = r(8e3),
            a = r(3325);
          const s = {
            stn: [a.D.sessionTrace],
            err: [a.D.jserrors, a.D.metrics],
            ins: [a.D.pageAction],
            spa: [a.D.spa],
            sr: [a.D.sessionReplay, a.D.sessionTrace]
          };
          function c(e, t) {
            const r = n.ee.get(t);
            e && "object" == typeof e && (Object.entries(e).forEach(e => {
              let [t, n] = e;
              void 0 === u[t] && (s[t] ? s[t].forEach(e => {
                n ? (0, i.p)("feat-" + t, [], void 0, e, r) : (0, i.p)("block-" + t, [], void 0, e, r), (0, i.p)("rumresp-" + t, [Boolean(n)], void 0, e, r);
              }) : n && (0, i.p)("feat-" + t, [], void 0, void 0, r), u[t] = Boolean(n));
            }), Object.keys(s).forEach(e => {
              void 0 === u[e] && (s[e]?.forEach(t => (0, i.p)("rumresp-" + e, [!1], void 0, t, r)), u[e] = !1);
            }), (0, o.L)(t, a.D.pageViewEvent));
          }
          const u = {};
        },
        2210: (e, t, r) => {
          r.d(t, {
            X: () => i
          });
          var n = Object.prototype.hasOwnProperty;
          function i(e, t, r) {
            if (n.call(e, t)) return e[t];
            var i = r();
            if (Object.defineProperty && Object.keys) try {
              return Object.defineProperty(e, t, {
                value: i,
                writable: !0,
                enumerable: !1
              }), i;
            } catch (e) {}
            return e[t] = i, i;
          }
        },
        1284: (e, t, r) => {
          r.d(t, {
            D: () => n
          });
          const n = (e, t) => Object.entries(e || {}).map(e => {
            let [r, n] = e;
            return t(r, n);
          });
        },
        4351: (e, t, r) => {
          r.d(t, {
            P: () => o
          });
          var n = r(8325);
          const i = () => {
            const e = new WeakSet();
            return (t, r) => {
              if ("object" == typeof r && null !== r) {
                if (e.has(r)) return;
                e.add(r);
              }
              return r;
            };
          };
          function o(e) {
            try {
              return JSON.stringify(e, i());
            } catch (e) {
              try {
                n.ee.emit("internal-error", [e]);
              } catch (e) {}
            }
          }
        },
        3960: (e, t, r) => {
          r.d(t, {
            K: () => a,
            b: () => o
          });
          var n = r(3239);
          function i() {
            return "undefined" == typeof document || "complete" === document.readyState;
          }
          function o(e, t) {
            if (i()) return e();
            (0, n.bP)("load", e, t);
          }
          function a(e) {
            if (i()) return e();
            (0, n.iz)("DOMContentLoaded", e);
          }
        },
        8632: (e, t, r) => {
          r.d(t, {
            EZ: () => u,
            Qy: () => c,
            ce: () => o,
            fP: () => a,
            gG: () => d,
            mF: () => s
          });
          var n = r(7894),
            i = r(385);
          const o = {
            beacon: "bam.nr-data.net",
            errorBeacon: "bam.nr-data.net"
          };
          function a() {
            return i._A.NREUM || (i._A.NREUM = {}), void 0 === i._A.newrelic && (i._A.newrelic = i._A.NREUM), i._A.NREUM;
          }
          function s() {
            let e = a();
            return e.o || (e.o = {
              ST: i._A.setTimeout,
              SI: i._A.setImmediate,
              CT: i._A.clearTimeout,
              XHR: i._A.XMLHttpRequest,
              REQ: i._A.Request,
              EV: i._A.Event,
              PR: i._A.Promise,
              MO: i._A.MutationObserver,
              FETCH: i._A.fetch
            }), e;
          }
          function c(e, t, r) {
            let i = a();
            const o = i.initializedAgents || {},
              s = o[e] || {};
            return Object.keys(s).length || (s.initializedAt = {
              ms: (0, n.z)(),
              date: new Date()
            }), i.initializedAgents = {
              ...o,
              [e]: {
                ...s,
                [r]: t
              }
            }, i;
          }
          function u(e, t) {
            a()[e] = t;
          }
          function d() {
            return function () {
              let e = a();
              const t = e.info || {};
              e.info = {
                beacon: o.beacon,
                errorBeacon: o.errorBeacon,
                ...t
              };
            }(), function () {
              let e = a();
              const t = e.init || {};
              e.init = {
                ...t
              };
            }(), s(), function () {
              let e = a();
              const t = e.loader_config || {};
              e.loader_config = {
                ...t
              };
            }(), a();
          }
        },
        7956: (e, t, r) => {
          r.d(t, {
            N: () => i
          });
          var n = r(3239);
          function i(e) {
            let t = arguments.length > 1 && void 0 !== arguments[1] && arguments[1],
              r = arguments.length > 2 ? arguments[2] : void 0,
              i = arguments.length > 3 ? arguments[3] : void 0;
            return void (0, n.iz)("visibilitychange", function () {
              if (t) return void ("hidden" == document.visibilityState && e());
              e(document.visibilityState);
            }, r, i);
          }
        },
        1214: (e, t, r) => {
          r.d(t, {
            em: () => b,
            u5: () => j,
            QU: () => O,
            _L: () => I,
            Gm: () => H,
            Lg: () => L,
            BV: () => G,
            Kf: () => K
          });
          var n = r(8325),
            i = r(3117);
          const o = "nr@original:".concat(i.a);
          var a = Object.prototype.hasOwnProperty,
            s = !1;
          function c(e, t) {
            return e || (e = n.ee), r.inPlace = function (e, t, n, i, o) {
              n || (n = "");
              const a = "-" === n.charAt(0);
              for (let s = 0; s < t.length; s++) {
                const c = t[s],
                  u = e[c];
                d(u) || (e[c] = r(u, a ? c + n : n, i, c, o));
              }
            }, r.flag = o, r;
            function r(t, r, n, s, c) {
              return d(t) ? t : (r || (r = ""), nrWrapper[o] = t, function (e, t, r) {
                if (Object.defineProperty && Object.keys) try {
                  return Object.keys(e).forEach(function (r) {
                    Object.defineProperty(t, r, {
                      get: function () {
                        return e[r];
                      },
                      set: function (t) {
                        return e[r] = t, t;
                      }
                    });
                  }), t;
                } catch (e) {
                  u([e], r);
                }
                for (var n in e) a.call(e, n) && (t[n] = e[n]);
              }(t, nrWrapper, e), nrWrapper);
              function nrWrapper() {
                var o, a, d, l;
                try {
                  a = this, o = [...arguments], d = "function" == typeof n ? n(o, a) : n || {};
                } catch (t) {
                  u([t, "", [o, a, s], d], e);
                }
                i(r + "start", [o, a, s], d, c);
                try {
                  return l = t.apply(a, o);
                } catch (e) {
                  throw i(r + "err", [o, a, e], d, c), e;
                } finally {
                  i(r + "end", [o, a, l], d, c);
                }
              }
            }
            function i(r, n, i, o) {
              if (!s || t) {
                var a = s;
                s = !0;
                try {
                  e.emit(r, n, i, t, o);
                } catch (t) {
                  u([t, r, n, i], e);
                }
                s = a;
              }
            }
          }
          function u(e, t) {
            t || (t = n.ee);
            try {
              t.emit("internal-error", e);
            } catch (e) {}
          }
          function d(e) {
            return !(e && e instanceof Function && e.apply && !e[o]);
          }
          var l = r(2210),
            f = r(385);
          const h = {},
            p = f._A.XMLHttpRequest,
            g = "addEventListener",
            m = "removeEventListener",
            v = "nr@wrapped:".concat(n.A);
          function b(e) {
            var t = function (e) {
              return (e || n.ee).get("events");
            }(e);
            if (h[t.debugId]++) return t;
            h[t.debugId] = 1;
            var r = c(t, !0);
            function i(e) {
              r.inPlace(e, [g, m], "-", o);
            }
            function o(e, t) {
              return e[1];
            }
            return "getPrototypeOf" in Object && (f.il && y(document, i), y(f._A, i), y(p.prototype, i)), t.on(g + "-start", function (e, t) {
              var n = e[1];
              if (null !== n && ("function" == typeof n || "object" == typeof n)) {
                var i = (0, l.X)(n, v, function () {
                  var e = {
                    object: function () {
                      if ("function" != typeof n.handleEvent) return;
                      return n.handleEvent.apply(n, arguments);
                    },
                    function: n
                  }[typeof n];
                  return e ? r(e, "fn-", null, e.name || "anonymous") : n;
                });
                this.wrapped = e[1] = i;
              }
            }), t.on(m + "-start", function (e) {
              e[1] = this.wrapped || e[1];
            }), t;
          }
          function y(e, t) {
            let r = e;
            for (; "object" == typeof r && !Object.prototype.hasOwnProperty.call(r, g);) r = Object.getPrototypeOf(r);
            for (var n = arguments.length, i = new Array(n > 2 ? n - 2 : 0), o = 2; o < n; o++) i[o - 2] = arguments[o];
            r && t(r, ...i);
          }
          var w = "fetch-",
            A = w + "body-",
            x = ["arrayBuffer", "blob", "json", "text", "formData"],
            E = f._A.Request,
            T = f._A.Response,
            _ = "prototype";
          const D = {};
          function j(e) {
            const t = function (e) {
              return (e || n.ee).get("fetch");
            }(e);
            if (!(E && T && f._A.fetch)) return t;
            if (D[t.debugId]++) return t;
            function r(e, r, i) {
              var o = e[r];
              "function" == typeof o && (e[r] = function () {
                var e,
                  r = [...arguments],
                  a = {};
                t.emit(i + "before-start", [r], a), a[n.A] && a[n.A].dt && (e = a[n.A].dt);
                var s = o.apply(this, r);
                return t.emit(i + "start", [r, e], s), s.then(function (e) {
                  return t.emit(i + "end", [null, e], s), e;
                }, function (e) {
                  throw t.emit(i + "end", [e], s), e;
                });
              });
            }
            return D[t.debugId] = 1, x.forEach(e => {
              r(E[_], e, A), r(T[_], e, A);
            }), r(f._A, "fetch", w), t.on(w + "end", function (e, r) {
              var n = this;
              if (r) {
                var i = r.headers.get("content-length");
                null !== i && (n.rxSize = i), t.emit(w + "done", [null, r], n);
              } else t.emit(w + "done", [e], n);
            }), t;
          }
          const C = {},
            N = ["pushState", "replaceState"];
          function O(e) {
            const t = function (e) {
              return (e || n.ee).get("history");
            }(e);
            return !f.il || C[t.debugId]++ || (C[t.debugId] = 1, c(t).inPlace(window.history, N, "-")), t;
          }
          var S = r(3239);
          const P = {},
            R = ["appendChild", "insertBefore", "replaceChild"];
          function I(e) {
            const t = function (e) {
              return (e || n.ee).get("jsonp");
            }(e);
            if (!f.il || P[t.debugId]) return t;
            P[t.debugId] = !0;
            var r = c(t),
              i = /[?&](?:callback|cb)=([^&#]+)/,
              o = /(.*)\.([^.]+)/,
              a = /^(\w+)(\.|$)(.*)$/;
            function s(e, t) {
              if (!e) return t;
              const r = e.match(a),
                n = r[1];
              return s(r[3], t[n]);
            }
            return r.inPlace(Node.prototype, R, "dom-"), t.on("dom-start", function (e) {
              !function (e) {
                if (!e || "string" != typeof e.nodeName || "script" !== e.nodeName.toLowerCase()) return;
                if ("function" != typeof e.addEventListener) return;
                var n = (a = e.src, c = a.match(i), c ? c[1] : null);
                var a, c;
                if (!n) return;
                var u = function (e) {
                  var t = e.match(o);
                  if (t && t.length >= 3) return {
                    key: t[2],
                    parent: s(t[1], window)
                  };
                  return {
                    key: e,
                    parent: window
                  };
                }(n);
                if ("function" != typeof u.parent[u.key]) return;
                var d = {};
                function l() {
                  t.emit("jsonp-end", [], d), e.removeEventListener("load", l, (0, S.m$)(!1)), e.removeEventListener("error", f, (0, S.m$)(!1));
                }
                function f() {
                  t.emit("jsonp-error", [], d), t.emit("jsonp-end", [], d), e.removeEventListener("load", l, (0, S.m$)(!1)), e.removeEventListener("error", f, (0, S.m$)(!1));
                }
                r.inPlace(u.parent, [u.key], "cb-", d), e.addEventListener("load", l, (0, S.m$)(!1)), e.addEventListener("error", f, (0, S.m$)(!1)), t.emit("new-jsonp", [e.src], d);
              }(e[0]);
            }), t;
          }
          const k = {};
          function H(e) {
            const t = function (e) {
              return (e || n.ee).get("mutation");
            }(e);
            if (!f.il || k[t.debugId]) return t;
            k[t.debugId] = !0;
            var r = c(t),
              i = f._A.MutationObserver;
            return i && (window.MutationObserver = function (e) {
              return this instanceof i ? new i(r(e, "fn-")) : i.apply(this, arguments);
            }, MutationObserver.prototype = i.prototype), t;
          }
          const z = {};
          function L(e) {
            const t = function (e) {
              return (e || n.ee).get("promise");
            }(e);
            if (z[t.debugId]) return t;
            z[t.debugId] = !0;
            var r = t.context,
              i = c(t),
              a = f._A.Promise;
            return a && function () {
              function e(r) {
                var n = t.context(),
                  o = i(r, "executor-", n, null, !1);
                const s = Reflect.construct(a, [o], e);
                return t.context(s).getCtx = function () {
                  return n;
                }, s;
              }
              f._A.Promise = e, Object.defineProperty(e, "name", {
                value: "Promise"
              }), e.toString = function () {
                return a.toString();
              }, Object.setPrototypeOf(e, a), ["all", "race"].forEach(function (r) {
                const n = a[r];
                e[r] = function (e) {
                  let i = !1;
                  [...(e || [])].forEach(e => {
                    this.resolve(e).then(a("all" === r), a(!1));
                  });
                  const o = n.apply(this, arguments);
                  return o;
                  function a(e) {
                    return function () {
                      t.emit("propagate", [null, !i], o, !1, !1), i = i || !e;
                    };
                  }
                };
              }), ["resolve", "reject"].forEach(function (r) {
                const n = a[r];
                e[r] = function (e) {
                  const r = n.apply(this, arguments);
                  return e !== r && t.emit("propagate", [e, !0], r, !1, !1), r;
                };
              }), e.prototype = a.prototype;
              const n = a.prototype.then;
              a.prototype.then = function () {
                var e = this,
                  o = r(e);
                o.promise = e;
                for (var a = arguments.length, s = new Array(a), c = 0; c < a; c++) s[c] = arguments[c];
                s[0] = i(s[0], "cb-", o, null, !1), s[1] = i(s[1], "cb-", o, null, !1);
                const u = n.apply(this, s);
                return o.nextPromise = u, t.emit("propagate", [e, !0], u, !1, !1), u;
              }, a.prototype.then[o] = n, t.on("executor-start", function (e) {
                e[0] = i(e[0], "resolve-", this, null, !1), e[1] = i(e[1], "resolve-", this, null, !1);
              }), t.on("executor-err", function (e, t, r) {
                e[1](r);
              }), t.on("cb-end", function (e, r, n) {
                t.emit("propagate", [n, !0], this.nextPromise, !1, !1);
              }), t.on("propagate", function (e, r, n) {
                this.getCtx && !r || (this.getCtx = function () {
                  if (e instanceof Promise) var r = t.context(e);
                  return r && r.getCtx ? r.getCtx() : this;
                });
              });
            }(), t;
          }
          const M = {},
            B = "setTimeout",
            F = "setInterval",
            U = "clearTimeout",
            q = "-start",
            Z = "-",
            V = [B, "setImmediate", F, U, "clearImmediate"];
          function G(e) {
            const t = function (e) {
              return (e || n.ee).get("timer");
            }(e);
            if (M[t.debugId]++) return t;
            M[t.debugId] = 1;
            var r = c(t);
            return r.inPlace(f._A, V.slice(0, 2), B + Z), r.inPlace(f._A, V.slice(2, 3), F + Z), r.inPlace(f._A, V.slice(3), U + Z), t.on(F + q, function (e, t, n) {
              e[0] = r(e[0], "fn-", null, n);
            }), t.on(B + q, function (e, t, n) {
              this.method = n, this.timerDuration = isNaN(e[1]) ? 0 : +e[1], e[0] = r(e[0], "fn-", this, n);
            }), t;
          }
          var W = r(50);
          const X = {},
            Q = ["open", "send"];
          function K(e) {
            var t = e || n.ee;
            const r = function (e) {
              return (e || n.ee).get("xhr");
            }(t);
            if (X[r.debugId]++) return r;
            X[r.debugId] = 1, b(t);
            var i = c(r),
              o = f._A.XMLHttpRequest,
              a = f._A.MutationObserver,
              s = f._A.Promise,
              u = f._A.setInterval,
              d = "readystatechange",
              l = ["onload", "onerror", "onabort", "onloadstart", "onloadend", "onprogress", "ontimeout"],
              h = [],
              p = f._A.XMLHttpRequest = function (e) {
                const t = new o(e),
                  n = r.context(t);
                try {
                  r.emit("new-xhr", [t], n), t.addEventListener(d, (a = n, function () {
                    var e = this;
                    e.readyState > 3 && !a.resolved && (a.resolved = !0, r.emit("xhr-resolved", [], e)), i.inPlace(e, l, "fn-", A);
                  }), (0, S.m$)(!1));
                } catch (e) {
                  (0, W.Z)("An error occurred while intercepting XHR", e);
                  try {
                    r.emit("internal-error", [e]);
                  } catch (e) {}
                }
                var a;
                return t;
              };
            function g(e, t) {
              i.inPlace(t, ["onreadystatechange"], "fn-", A);
            }
            if (function (e, t) {
              for (var r in e) t[r] = e[r];
            }(o, p), p.prototype = o.prototype, i.inPlace(p.prototype, Q, "-xhr-", A), r.on("send-xhr-start", function (e, t) {
              g(e, t), function (e) {
                h.push(e), a && (m ? m.then(w) : u ? u(w) : (v = -v, y.data = v));
              }(t);
            }), r.on("open-xhr-start", g), a) {
              var m = s && s.resolve();
              if (!u && !s) {
                var v = 1,
                  y = document.createTextNode(v);
                new a(w).observe(y, {
                  characterData: !0
                });
              }
            } else t.on("fn-end", function (e) {
              e[0] && e[0].type === d || w();
            });
            function w() {
              for (var e = 0; e < h.length; e++) g(0, h[e]);
              h.length && (h = []);
            }
            function A(e, t) {
              return t;
            }
            return r;
          }
        },
        7825: (e, t, r) => {
          r.d(t, {
            t: () => n
          });
          const n = r(3325).D.ajax;
        },
        6660: (e, t, r) => {
          r.d(t, {
            t: () => n
          });
          const n = r(3325).D.jserrors;
        },
        3081: (e, t, r) => {
          r.d(t, {
            gF: () => o,
            mY: () => i,
            t9: () => n,
            vz: () => s,
            xS: () => a
          });
          const n = r(3325).D.metrics,
            i = "sm",
            o = "cm",
            a = "storeSupportabilityMetrics",
            s = "storeEventMetrics";
        },
        4649: (e, t, r) => {
          r.d(t, {
            t: () => n
          });
          const n = r(3325).D.pageAction;
        },
        7633: (e, t, r) => {
          r.d(t, {
            Dz: () => i,
            OJ: () => a,
            qw: () => o,
            t9: () => n
          });
          const n = r(3325).D.pageViewEvent,
            i = "firstbyte",
            o = "domcontent",
            a = "windowload";
        },
        9251: (e, t, r) => {
          r.d(t, {
            t: () => n
          });
          const n = r(3325).D.pageViewTiming;
        },
        3614: (e, t, r) => {
          r.d(t, {
            BST_RESOURCE: () => i,
            END: () => s,
            FEATURE_NAME: () => n,
            FN_END: () => u,
            FN_START: () => c,
            PUSH_STATE: () => d,
            RESOURCE: () => o,
            START: () => a
          });
          const n = r(3325).D.sessionTrace,
            i = "bstResource",
            o = "resource",
            a = "-start",
            s = "-end",
            c = "fn" + a,
            u = "fn" + s,
            d = "pushState";
        },
        7836: (e, t, r) => {
          r.d(t, {
            BODY: () => x,
            CB_END: () => E,
            CB_START: () => u,
            END: () => A,
            FEATURE_NAME: () => i,
            FETCH: () => _,
            FETCH_BODY: () => v,
            FETCH_DONE: () => m,
            FETCH_START: () => g,
            FN_END: () => c,
            FN_START: () => s,
            INTERACTION: () => f,
            INTERACTION_API: () => d,
            INTERACTION_EVENTS: () => o,
            JSONP_END: () => b,
            JSONP_NODE: () => p,
            JS_TIME: () => T,
            MAX_TIMER_BUDGET: () => a,
            REMAINING: () => l,
            SPA_NODE: () => h,
            START: () => w,
            originalSetTimeout: () => y
          });
          var n = r(5763);
          const i = r(3325).D.spa,
            o = ["click", "submit", "keypress", "keydown", "keyup", "change"],
            a = 999,
            s = "fn-start",
            c = "fn-end",
            u = "cb-start",
            d = "api-ixn-",
            l = "remaining",
            f = "interaction",
            h = "spaNode",
            p = "jsonpNode",
            g = "fetch-start",
            m = "fetch-done",
            v = "fetch-body-",
            b = "jsonp-end",
            y = n.Yu.ST,
            w = "-start",
            A = "-end",
            x = "-body",
            E = "cb" + A,
            T = "jsTime",
            _ = "fetch";
        },
        5938: (e, t, r) => {
          r.d(t, {
            W: () => o
          });
          var n = r(5763),
            i = r(8325);
          class o {
            constructor(e, t, r) {
              this.agentIdentifier = e, this.aggregator = t, this.ee = i.ee.get(e, (0, n.OP)(this.agentIdentifier).isolatedBacklog), this.featureName = r, this.blocked = !1;
            }
          }
        },
        9144: (e, t, r) => {
          r.d(t, {
            j: () => m
          });
          var n = r(3325),
            i = r(5763),
            o = r(5546),
            a = r(8325),
            s = r(7894),
            c = r(8e3),
            u = r(3960),
            d = r(385),
            l = r(50),
            f = r(3081),
            h = r(8632);
          function p() {
            const e = (0, h.gG)();
            ["setErrorHandler", "finished", "addToTrace", "inlineHit", "addRelease", "addPageAction", "setCurrentRouteName", "setPageViewName", "setCustomAttribute", "interaction", "noticeError", "setUserId", "setApplicationVersion"].forEach(t => {
              e[t] = function () {
                for (var r = arguments.length, n = new Array(r), i = 0; i < r; i++) n[i] = arguments[i];
                return function (t) {
                  for (var r = arguments.length, n = new Array(r > 1 ? r - 1 : 0), i = 1; i < r; i++) n[i - 1] = arguments[i];
                  let o = [];
                  return Object.values(e.initializedAgents).forEach(e => {
                    e.exposed && e.api[t] && o.push(e.api[t](...n));
                  }), o.length > 1 ? o : o[0];
                }(t, ...n);
              };
            });
          }
          var g = r(2587);
          function m(e) {
            let t = arguments.length > 1 && void 0 !== arguments[1] ? arguments[1] : {},
              m = arguments.length > 2 ? arguments[2] : void 0,
              v = arguments.length > 3 ? arguments[3] : void 0,
              {
                init: b,
                info: y,
                loader_config: w,
                runtime: A = {
                  loaderType: m
                },
                exposed: x = !0
              } = t;
            const E = (0, h.gG)();
            y || (b = E.init, y = E.info, w = E.loader_config), (0, i.Dg)(e, b || {}), (0, i.GE)(e, w || {}), y.jsAttributes ??= {}, d.v6 && (y.jsAttributes.isWorker = !0), (0, i.CX)(e, y);
            const T = (0, i.P_)(e);
            A.denyList = [...(T.ajax?.deny_list || []), ...(T.ajax?.block_internal ? [y.beacon, y.errorBeacon] : [])], (0, i.sU)(e, A), p();
            const _ = function (e, t) {
              t || (0, c.R)(e, "api");
              const h = {};
              var p = a.ee.get(e),
                g = p.get("tracer"),
                m = "api-",
                v = m + "ixn-";
              function b(t, r, n, o) {
                const a = (0, i.C5)(e);
                return null === r ? delete a.jsAttributes[t] : (0, i.CX)(e, {
                  ...a,
                  jsAttributes: {
                    ...a.jsAttributes,
                    [t]: r
                  }
                }), A(m, n, !0, o || null === r ? "session" : void 0)(t, r);
              }
              function y() {}
              ["setErrorHandler", "finished", "addToTrace", "inlineHit", "addRelease"].forEach(e => h[e] = A(m, e, !0, "api")), h.addPageAction = A(m, "addPageAction", !0, n.D.pageAction), h.setCurrentRouteName = A(m, "routeName", !0, n.D.spa), h.setPageViewName = function (t, r) {
                if ("string" == typeof t) return "/" !== t.charAt(0) && (t = "/" + t), (0, i.OP)(e).customTransaction = (r || "http://custom.transaction") + t, A(m, "setPageViewName", !0)();
              }, h.setCustomAttribute = function (e, t) {
                let r = arguments.length > 2 && void 0 !== arguments[2] && arguments[2];
                if ("string" == typeof e) {
                  if (["string", "number"].includes(typeof t) || null === t) return b(e, t, "setCustomAttribute", r);
                  (0, l.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of <".concat(typeof t, "> was provided."));
                } else (0, l.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of <".concat(typeof e, "> was provided."));
              }, h.setUserId = function (e) {
                if ("string" == typeof e || null === e) return b("enduser.id", e, "setUserId", !0);
                (0, l.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of <".concat(typeof e, "> was provided."));
              }, h.setApplicationVersion = function (e) {
                if ("string" == typeof e || null === e) return b("application.version", e, "setApplicationVersion", !1);
                (0, l.Z)("Failed to execute setApplicationVersion. Expected <String | null>, but got <".concat(typeof e, ">."));
              }, h.interaction = function () {
                return new y().get();
              };
              var w = y.prototype = {
                createTracer: function (e, t) {
                  var r = {},
                    i = this,
                    a = "function" == typeof t;
                  return (0, o.p)(v + "tracer", [(0, s.z)(), e, r], i, n.D.spa, p), function () {
                    if (g.emit((a ? "" : "no-") + "fn-start", [(0, s.z)(), i, a], r), a) try {
                      return t.apply(this, arguments);
                    } catch (e) {
                      throw g.emit("fn-err", [arguments, this, e], r), e;
                    } finally {
                      g.emit("fn-end", [(0, s.z)()], r);
                    }
                  };
                }
              };
              function A(e, t, r, i) {
                return function () {
                  return (0, o.p)(f.xS, ["API/" + t + "/called"], void 0, n.D.metrics, p), i && (0, o.p)(e + t, [(0, s.z)(), ...arguments], r ? null : this, i, p), r ? void 0 : this;
                };
              }
              function x() {
                r.e(111).then(r.bind(r, 7438)).then(t => {
                  let {
                    setAPI: r
                  } = t;
                  r(e), (0, c.L)(e, "api");
                }).catch(() => (0, l.Z)("Downloading runtime APIs failed..."));
              }
              return ["actionText", "setName", "setAttribute", "save", "ignore", "onEnd", "getContext", "end", "get"].forEach(e => {
                w[e] = A(v, e, void 0, n.D.spa);
              }), h.noticeError = function (e, t) {
                "string" == typeof e && (e = new Error(e)), (0, o.p)(f.xS, ["API/noticeError/called"], void 0, n.D.metrics, p), (0, o.p)("err", [e, (0, s.z)(), !1, t], void 0, n.D.jserrors, p);
              }, d.il ? (0, u.b)(() => x(), !0) : x(), h;
            }(e, v);
            return (0, h.Qy)(e, _, "api"), (0, h.Qy)(e, x, "exposed"), (0, h.EZ)("activatedFeatures", g.T), _;
          }
        },
        3325: (e, t, r) => {
          r.d(t, {
            D: () => n,
            p: () => i
          });
          const n = {
              ajax: "ajax",
              jserrors: "jserrors",
              metrics: "metrics",
              pageAction: "page_action",
              pageViewEvent: "page_view_event",
              pageViewTiming: "page_view_timing",
              sessionReplay: "session_replay",
              sessionTrace: "session_trace",
              spa: "spa"
            },
            i = {
              [n.pageViewEvent]: 1,
              [n.pageViewTiming]: 2,
              [n.metrics]: 3,
              [n.jserrors]: 4,
              [n.ajax]: 5,
              [n.sessionTrace]: 6,
              [n.pageAction]: 7,
              [n.spa]: 8,
              [n.sessionReplay]: 9
            };
        }
      },
      n = {};
    function i(e) {
      var t = n[e];
      if (void 0 !== t) return t.exports;
      var o = n[e] = {
        exports: {}
      };
      return r[e](o, o.exports, i), o.exports;
    }
    i.m = r, i.d = (e, t) => {
      for (var r in t) i.o(t, r) && !i.o(e, r) && Object.defineProperty(e, r, {
        enumerable: !0,
        get: t[r]
      });
    }, i.f = {}, i.e = e => Promise.all(Object.keys(i.f).reduce((t, r) => (i.f[r](e, t), t), [])), i.u = e => "nr-spa.1097a448-1.238.0.min.js", i.o = (e, t) => Object.prototype.hasOwnProperty.call(e, t), e = {}, t = "NRBA-1.238.0.PROD:", i.l = (r, n, o, a) => {
      if (e[r]) e[r].push(n);else {
        var s, c;
        if (void 0 !== o) for (var u = document.getElementsByTagName("script"), d = 0; d < u.length; d++) {
          var l = u[d];
          if (l.getAttribute("src") == r || l.getAttribute("data-webpack") == t + o) {
            s = l;
            break;
          }
        }
        s || (c = !0, (s = document.createElement("script")).charset = "utf-8", s.timeout = 120, i.nc && s.setAttribute("nonce", i.nc), s.setAttribute("data-webpack", t + o), s.src = r), e[r] = [n];
        var f = (t, n) => {
            s.onerror = s.onload = null, clearTimeout(h);
            var i = e[r];
            if (delete e[r], s.parentNode && s.parentNode.removeChild(s), i && i.forEach(e => e(n)), t) return t(n);
          },
          h = setTimeout(f.bind(null, void 0, {
            type: "timeout",
            target: s
          }), 12e4);
        s.onerror = f.bind(null, s.onerror), s.onload = f.bind(null, s.onload), c && document.head.appendChild(s);
      }
    }, i.r = e => {
      "undefined" != typeof Symbol && Symbol.toStringTag && Object.defineProperty(e, Symbol.toStringTag, {
        value: "Module"
      }), Object.defineProperty(e, "__esModule", {
        value: !0
      });
    }, i.p = "https://js-agent.newrelic.com/", (() => {
      var e = {
        801: 0,
        92: 0
      };
      i.f.j = (t, r) => {
        var n = i.o(e, t) ? e[t] : void 0;
        if (0 !== n) if (n) r.push(n[2]);else {
          var o = new Promise((r, i) => n = e[t] = [r, i]);
          r.push(n[2] = o);
          var a = i.p + i.u(t),
            s = new Error();
          i.l(a, r => {
            if (i.o(e, t) && (0 !== (n = e[t]) && (e[t] = void 0), n)) {
              var o = r && ("load" === r.type ? "missing" : r.type),
                a = r && r.target && r.target.src;
              s.message = "Loading chunk " + t + " failed.\n(" + o + ": " + a + ")", s.name = "ChunkLoadError", s.type = o, s.request = a, n[1](s);
            }
          }, "chunk-" + t, t);
        }
      };
      var t = (t, r) => {
          var n,
            o,
            [a, s, c] = r,
            u = 0;
          if (a.some(t => 0 !== e[t])) {
            for (n in s) i.o(s, n) && (i.m[n] = s[n]);
            if (c) c(i);
          }
          for (t && t(r); u < a.length; u++) o = a[u], i.o(e, o) && e[o] && e[o][0](), e[o] = 0;
        },
        r = self["webpackChunk:NRBA-1.238.0.PROD"] = self["webpackChunk:NRBA-1.238.0.PROD"] || [];
      r.forEach(t.bind(null, 0)), r.push = t.bind(null, r.push.bind(r));
    })(), (() => {
      var e = i(50);
      class t {
        addPageAction(t, r) {
          (0, e.Z)("Call to agent api addPageAction failed. The session trace feature is not currently initialized.");
        }
        setPageViewName(t, r) {
          (0, e.Z)("Call to agent api setPageViewName failed. The page view feature is not currently initialized.");
        }
        setCustomAttribute(t, r, n) {
          (0, e.Z)("Call to agent api setCustomAttribute failed. The js errors feature is not currently initialized.");
        }
        noticeError(t, r) {
          (0, e.Z)("Call to agent api noticeError failed. The js errors feature is not currently initialized.");
        }
        setUserId(t) {
          (0, e.Z)("Call to agent api setUserId failed. The js errors feature is not currently initialized.");
        }
        setApplicationVersion(t) {
          (0, e.Z)("Call to agent api setApplicationVersion failed. The agent is not currently initialized.");
        }
        setErrorHandler(t) {
          (0, e.Z)("Call to agent api setErrorHandler failed. The js errors feature is not currently initialized.");
        }
        finished(t) {
          (0, e.Z)("Call to agent api finished failed. The page action feature is not currently initialized.");
        }
        addRelease(t, r) {
          (0, e.Z)("Call to agent api addRelease failed. The agent is not currently initialized.");
        }
      }
      var r = i(3325),
        n = i(5763);
      const o = Object.values(r.D);
      function a(e) {
        const t = {};
        return o.forEach(r => {
          t[r] = function (e, t) {
            return !1 !== (0, n.Mt)(t, "".concat(e, ".enabled"));
          }(r, e);
        }), t;
      }
      var s = i(9144);
      var c = i(5546),
        u = i(385),
        d = i(8e3),
        l = i(5938),
        f = i(3960);
      class h extends l.W {
        constructor(e, t, r) {
          let n = !(arguments.length > 3 && void 0 !== arguments[3]) || arguments[3];
          super(e, t, r), this.auto = n, this.abortHandler, this.featAggregate, this.onAggregateImported, n && (0, d.R)(e, r);
        }
        importAggregator() {
          let t = arguments.length > 0 && void 0 !== arguments[0] ? arguments[0] : {};
          if (this.featAggregate || !this.auto) return;
          const r = u.il && !0 === (0, n.Mt)(this.agentIdentifier, "privacy.cookies_enabled");
          let o;
          this.onAggregateImported = new Promise(e => {
            o = e;
          });
          const a = async () => {
            let n;
            try {
              if (r) {
                const {
                  setupAgentSession: e
                } = await i.e(111).then(i.bind(i, 3228));
                n = e(this.agentIdentifier);
              }
            } catch (t) {
              (0, e.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.", t);
            }
            try {
              if (!this.shouldImportAgg(this.featureName, n)) return (0, d.L)(this.agentIdentifier, this.featureName), void o(!1);
              const {
                  lazyFeatureLoader: e
                } = await i.e(111).then(i.bind(i, 8582)),
                {
                  Aggregate: r
                } = await e(this.featureName, "aggregate");
              this.featAggregate = new r(this.agentIdentifier, this.aggregator, t), o(!0);
            } catch (t) {
              (0, e.Z)("Downloading and initializing ".concat(this.featureName, " failed..."), t), this.abortHandler?.(), o(!1);
            }
          };
          u.il ? (0, f.b)(() => a(), !0) : a();
        }
        shouldImportAgg(e, t) {
          return e !== r.D.sessionReplay || !!n.Yu.MO && !1 !== (0, n.Mt)(this.agentIdentifier, "session_trace.enabled") && (!!t?.isNew || !!t?.state.sessionReplay);
        }
      }
      var p = i(7633),
        g = i(7894);
      class m extends h {
        static featureName = p.t9;
        constructor(e, t) {
          let i = !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2];
          if (super(e, t, p.t9, i), ("undefined" == typeof PerformanceNavigationTiming || u.Tt) && "undefined" != typeof PerformanceTiming) {
            const t = (0, n.OP)(e);
            t[p.Dz] = Math.max(Date.now() - t.offset, 0), (0, f.K)(() => t[p.qw] = Math.max((0, g.z)() - t[p.Dz], 0)), (0, f.b)(() => {
              const e = (0, g.z)();
              t[p.OJ] = Math.max(e - t[p.Dz], 0), (0, c.p)("timing", ["load", e], void 0, r.D.pageViewTiming, this.ee);
            });
          }
          this.importAggregator();
        }
      }
      var v = i(1117),
        b = i(1284);
      class y extends v.w {
        constructor(e) {
          super(e), this.aggregatedData = {};
        }
        store(e, t, r, n, i) {
          var o = this.getBucket(e, t, r, i);
          return o.metrics = function (e, t) {
            t || (t = {
              count: 0
            });
            return t.count += 1, (0, b.D)(e, function (e, r) {
              t[e] = w(r, t[e]);
            }), t;
          }(n, o.metrics), o;
        }
        merge(e, t, r, n, i) {
          var o = this.getBucket(e, t, n, i);
          if (o.metrics) {
            var a = o.metrics;
            a.count += r.count, (0, b.D)(r, function (e, t) {
              if ("count" !== e) {
                var n = a[e],
                  i = r[e];
                i && !i.c ? a[e] = w(i.t, n) : a[e] = function (e, t) {
                  if (!t) return e;
                  t.c || (t = A(t.t));
                  return t.min = Math.min(e.min, t.min), t.max = Math.max(e.max, t.max), t.t += e.t, t.sos += e.sos, t.c += e.c, t;
                }(i, a[e]);
              }
            });
          } else o.metrics = r;
        }
        storeMetric(e, t, r, n) {
          var i = this.getBucket(e, t, r);
          return i.stats = w(n, i.stats), i;
        }
        getBucket(e, t, r, n) {
          this.aggregatedData[e] || (this.aggregatedData[e] = {});
          var i = this.aggregatedData[e][t];
          return i || (i = this.aggregatedData[e][t] = {
            params: r || {}
          }, n && (i.custom = n)), i;
        }
        get(e, t) {
          return t ? this.aggregatedData[e] && this.aggregatedData[e][t] : this.aggregatedData[e];
        }
        take(e) {
          for (var t = {}, r = "", n = !1, i = 0; i < e.length; i++) t[r = e[i]] = x(this.aggregatedData[r]), t[r].length && (n = !0), delete this.aggregatedData[r];
          return n ? t : null;
        }
      }
      function w(e, t) {
        return null == e ? function (e) {
          e ? e.c++ : e = {
            c: 1
          };
          return e;
        }(t) : t ? (t.c || (t = A(t.t)), t.c += 1, t.t += e, t.sos += e * e, e > t.max && (t.max = e), e < t.min && (t.min = e), t) : {
          t: e
        };
      }
      function A(e) {
        return {
          t: e,
          min: e,
          max: e,
          sos: e * e,
          c: 1
        };
      }
      function x(e) {
        return "object" != typeof e ? [] : (0, b.D)(e, E);
      }
      function E(e, t) {
        return t;
      }
      var T = i(8632),
        _ = i(4402),
        D = i(4351);
      var j = i(7956),
        C = i(3239),
        N = i(9251);
      class O extends h {
        static featureName = N.t;
        constructor(e, t) {
          let r = !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2];
          super(e, t, N.t, r), u.il && ((0, n.OP)(e).initHidden = Boolean("hidden" === document.visibilityState), (0, j.N)(() => (0, c.p)("docHidden", [(0, g.z)()], void 0, N.t, this.ee), !0), (0, C.bP)("pagehide", () => (0, c.p)("winPagehide", [(0, g.z)()], void 0, N.t, this.ee)), this.importAggregator());
        }
      }
      var S = i(3081);
      class P extends h {
        static featureName = S.t9;
        constructor(e, t) {
          let r = !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2];
          super(e, t, S.t9, r), this.importAggregator();
        }
      }
      var R = i(6660);
      class I {
        constructor(e, t, r, n) {
          this.name = "UncaughtError", this.message = e, this.sourceURL = t, this.line = r, this.column = n;
        }
      }
      class k extends h {
        static featureName = R.t;
        #e = new Set();
        constructor(e, t) {
          let n = !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2];
          super(e, t, R.t, n);
          try {
            this.removeOnAbort = new AbortController();
          } catch (e) {}
          this.ee.on("fn-err", (e, t, n) => {
            this.abortHandler && !this.#e.has(n) && (this.#e.add(n), (0, c.p)("err", [this.#t(n), (0, g.z)()], void 0, r.D.jserrors, this.ee));
          }), this.ee.on("internal-error", e => {
            this.abortHandler && (0, c.p)("ierr", [this.#t(e), (0, g.z)(), !0], void 0, r.D.jserrors, this.ee);
          }), u._A.addEventListener("unhandledrejection", e => {
            this.abortHandler && (0, c.p)("err", [this.#r(e), (0, g.z)(), !1, {
              unhandledPromiseRejection: 1
            }], void 0, r.D.jserrors, this.ee);
          }, (0, C.m$)(!1, this.removeOnAbort?.signal)), u._A.addEventListener("error", e => {
            this.abortHandler && (this.#e.has(e.error) ? this.#e.delete(e.error) : (0, c.p)("err", [this.#n(e), (0, g.z)()], void 0, r.D.jserrors, this.ee));
          }, (0, C.m$)(!1, this.removeOnAbort?.signal)), this.abortHandler = this.#i, this.importAggregator();
        }
        #i() {
          this.removeOnAbort?.abort(), this.#e.clear(), this.abortHandler = void 0;
        }
        #t(e) {
          return e instanceof Error ? e : void 0 !== e?.message ? new I(e.message, e.filename || e.sourceURL, e.lineno || e.line, e.colno || e.col) : new I("string" == typeof e ? e : (0, D.P)(e));
        }
        #r(e) {
          let t = "Unhandled Promise Rejection: ";
          if (e?.reason instanceof Error) try {
            return e.reason.message = t + e.reason.message, e.reason;
          } catch (t) {
            return e.reason;
          }
          if (void 0 === e.reason) return new I(t);
          const r = this.#t(e.reason);
          return r.message = t + r.message, r;
        }
        #n(e) {
          return e.error instanceof Error ? e.error : new I(e.message, e.filename, e.lineno, e.colno);
        }
      }
      var H = i(2210);
      let z = 1;
      const L = "nr@id";
      function M(e) {
        const t = typeof e;
        return !e || "object" !== t && "function" !== t ? -1 : e === u._A ? 0 : (0, H.X)(e, L, function () {
          return z++;
        });
      }
      function B(e) {
        if ("string" == typeof e && e.length) return e.length;
        if ("object" == typeof e) {
          if ("undefined" != typeof ArrayBuffer && e instanceof ArrayBuffer && e.byteLength) return e.byteLength;
          if ("undefined" != typeof Blob && e instanceof Blob && e.size) return e.size;
          if (!("undefined" != typeof FormData && e instanceof FormData)) try {
            return (0, D.P)(e).length;
          } catch (e) {
            return;
          }
        }
      }
      var F = i(1214),
        U = i(7243);
      class q {
        constructor(e) {
          this.agentIdentifier = e;
        }
        generateTracePayload(e) {
          if (!this.shouldGenerateTrace(e)) return null;
          var t = (0, n.DL)(this.agentIdentifier);
          if (!t) return null;
          var r = (t.accountID || "").toString() || null,
            i = (t.agentID || "").toString() || null,
            o = (t.trustKey || "").toString() || null;
          if (!r || !i) return null;
          var a = (0, _.M)(),
            s = (0, _.Ht)(),
            c = Date.now(),
            u = {
              spanId: a,
              traceId: s,
              timestamp: c
            };
          return (e.sameOrigin || this.isAllowedOrigin(e) && this.useTraceContextHeadersForCors()) && (u.traceContextParentHeader = this.generateTraceContextParentHeader(a, s), u.traceContextStateHeader = this.generateTraceContextStateHeader(a, c, r, i, o)), (e.sameOrigin && !this.excludeNewrelicHeader() || !e.sameOrigin && this.isAllowedOrigin(e) && this.useNewrelicHeaderForCors()) && (u.newrelicHeader = this.generateTraceHeader(a, s, c, r, i, o)), u;
        }
        generateTraceContextParentHeader(e, t) {
          return "00-" + t + "-" + e + "-01";
        }
        generateTraceContextStateHeader(e, t, r, n, i) {
          return i + "@nr=0-1-" + r + "-" + n + "-" + e + "----" + t;
        }
        generateTraceHeader(e, t, r, n, i, o) {
          if (!("function" == typeof u._A?.btoa)) return null;
          var a = {
            v: [0, 1],
            d: {
              ty: "Browser",
              ac: n,
              ap: i,
              id: e,
              tr: t,
              ti: r
            }
          };
          return o && n !== o && (a.d.tk = o), btoa((0, D.P)(a));
        }
        shouldGenerateTrace(e) {
          return this.isDtEnabled() && this.isAllowedOrigin(e);
        }
        isAllowedOrigin(e) {
          var t = !1,
            r = {};
          if ((0, n.Mt)(this.agentIdentifier, "distributed_tracing") && (r = (0, n.P_)(this.agentIdentifier).distributed_tracing), e.sameOrigin) t = !0;else if (r.allowed_origins instanceof Array) for (var i = 0; i < r.allowed_origins.length; i++) {
            var o = (0, U.e)(r.allowed_origins[i]);
            if (e.hostname === o.hostname && e.protocol === o.protocol && e.port === o.port) {
              t = !0;
              break;
            }
          }
          return t;
        }
        isDtEnabled() {
          var e = (0, n.Mt)(this.agentIdentifier, "distributed_tracing");
          return !!e && !!e.enabled;
        }
        excludeNewrelicHeader() {
          var e = (0, n.Mt)(this.agentIdentifier, "distributed_tracing");
          return !!e && !!e.exclude_newrelic_header;
        }
        useNewrelicHeaderForCors() {
          var e = (0, n.Mt)(this.agentIdentifier, "distributed_tracing");
          return !!e && !1 !== e.cors_use_newrelic_header;
        }
        useTraceContextHeadersForCors() {
          var e = (0, n.Mt)(this.agentIdentifier, "distributed_tracing");
          return !!e && !!e.cors_use_tracecontext_headers;
        }
      }
      var Z = i(7825),
        V = ["load", "error", "abort", "timeout"],
        G = V.length,
        W = n.Yu.REQ,
        X = n.Yu.XHR;
      class Q extends h {
        static featureName = Z.t;
        constructor(e, t) {
          let i = !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2];
          super(e, t, Z.t, i), (0, n.OP)(e).xhrWrappable && (this.dt = new q(e), this.handler = (e, t, r, n) => (0, c.p)(e, t, r, n, this.ee), (0, F.u5)(this.ee), (0, F.Kf)(this.ee), function (e, t, i, o) {
            function a(e) {
              var t = this;
              t.totalCbs = 0, t.called = 0, t.cbTime = 0, t.end = E, t.ended = !1, t.xhrGuids = {}, t.lastSize = null, t.loadCaptureCalled = !1, t.params = this.params || {}, t.metrics = this.metrics || {}, e.addEventListener("load", function (r) {
                _(t, e);
              }, (0, C.m$)(!1)), u.IF || e.addEventListener("progress", function (e) {
                t.lastSize = e.loaded;
              }, (0, C.m$)(!1));
            }
            function s(e) {
              this.params = {
                method: e[0]
              }, T(this, e[1]), this.metrics = {};
            }
            function c(t, r) {
              var i = (0, n.DL)(e);
              i.xpid && this.sameOrigin && r.setRequestHeader("X-NewRelic-ID", i.xpid);
              var a = o.generateTracePayload(this.parsedOrigin);
              if (a) {
                var s = !1;
                a.newrelicHeader && (r.setRequestHeader("newrelic", a.newrelicHeader), s = !0), a.traceContextParentHeader && (r.setRequestHeader("traceparent", a.traceContextParentHeader), a.traceContextStateHeader && r.setRequestHeader("tracestate", a.traceContextStateHeader), s = !0), s && (this.dt = a);
              }
            }
            function d(e, r) {
              var n = this.metrics,
                i = e[0],
                o = this;
              if (n && i) {
                var a = B(i);
                a && (n.txSize = a);
              }
              this.startTime = (0, g.z)(), this.listener = function (e) {
                try {
                  "abort" !== e.type || o.loadCaptureCalled || (o.params.aborted = !0), ("load" !== e.type || o.called === o.totalCbs && (o.onloadCalled || "function" != typeof r.onload) && "function" == typeof o.end) && o.end(r);
                } catch (e) {
                  try {
                    t.emit("internal-error", [e]);
                  } catch (e) {}
                }
              };
              for (var s = 0; s < G; s++) r.addEventListener(V[s], this.listener, (0, C.m$)(!1));
            }
            function l(e, t, r) {
              this.cbTime += e, t ? this.onloadCalled = !0 : this.called += 1, this.called !== this.totalCbs || !this.onloadCalled && "function" == typeof r.onload || "function" != typeof this.end || this.end(r);
            }
            function f(e, t) {
              var r = "" + M(e) + !!t;
              this.xhrGuids && !this.xhrGuids[r] && (this.xhrGuids[r] = !0, this.totalCbs += 1);
            }
            function h(e, t) {
              var r = "" + M(e) + !!t;
              this.xhrGuids && this.xhrGuids[r] && (delete this.xhrGuids[r], this.totalCbs -= 1);
            }
            function p() {
              this.endTime = (0, g.z)();
            }
            function m(e, r) {
              r instanceof X && "load" === e[0] && t.emit("xhr-load-added", [e[1], e[2]], r);
            }
            function v(e, r) {
              r instanceof X && "load" === e[0] && t.emit("xhr-load-removed", [e[1], e[2]], r);
            }
            function b(e, t, r) {
              t instanceof X && ("onload" === r && (this.onload = !0), ("load" === (e[0] && e[0].type) || this.onload) && (this.xhrCbStart = (0, g.z)()));
            }
            function y(e, r) {
              this.xhrCbStart && t.emit("xhr-cb-time", [(0, g.z)() - this.xhrCbStart, this.onload, r], r);
            }
            function w(e) {
              var t,
                r = e[1] || {};
              if ("string" == typeof e[0] ? 0 === (t = e[0]).length && u.il && (t = "" + u._A.location.href) : e[0] && e[0].url ? t = e[0].url : u._A?.URL && e[0] && e[0] instanceof URL ? t = e[0].href : "function" == typeof e[0].toString && (t = e[0].toString()), "string" == typeof t && 0 !== t.length) {
                t && (this.parsedOrigin = (0, U.e)(t), this.sameOrigin = this.parsedOrigin.sameOrigin);
                var n = o.generateTracePayload(this.parsedOrigin);
                if (n && (n.newrelicHeader || n.traceContextParentHeader)) if (e[0] && e[0].headers) s(e[0].headers, n) && (this.dt = n);else {
                  var i = {};
                  for (var a in r) i[a] = r[a];
                  i.headers = new Headers(r.headers || {}), s(i.headers, n) && (this.dt = n), e.length > 1 ? e[1] = i : e.push(i);
                }
              }
              function s(e, t) {
                var r = !1;
                return t.newrelicHeader && (e.set("newrelic", t.newrelicHeader), r = !0), t.traceContextParentHeader && (e.set("traceparent", t.traceContextParentHeader), t.traceContextStateHeader && e.set("tracestate", t.traceContextStateHeader), r = !0), r;
              }
            }
            function A(e, t) {
              this.params = {}, this.metrics = {}, this.startTime = (0, g.z)(), this.dt = t, e.length >= 1 && (this.target = e[0]), e.length >= 2 && (this.opts = e[1]);
              var r,
                n = this.opts || {},
                i = this.target;
              "string" == typeof i ? r = i : "object" == typeof i && i instanceof W ? r = i.url : u._A?.URL && "object" == typeof i && i instanceof URL && (r = i.href), T(this, r);
              var o = ("" + (i && i instanceof W && i.method || n.method || "GET")).toUpperCase();
              this.params.method = o, this.txSize = B(n.body) || 0;
            }
            function x(e, t) {
              var n;
              this.endTime = (0, g.z)(), this.params || (this.params = {}), this.params.status = t ? t.status : 0, "string" == typeof this.rxSize && this.rxSize.length > 0 && (n = +this.rxSize);
              var o = {
                txSize: this.txSize,
                rxSize: n,
                duration: (0, g.z)() - this.startTime
              };
              i("xhr", [this.params, o, this.startTime, this.endTime, "fetch"], this, r.D.ajax);
            }
            function E(e) {
              var t = this.params,
                n = this.metrics;
              if (!this.ended) {
                this.ended = !0;
                for (var o = 0; o < G; o++) e.removeEventListener(V[o], this.listener, !1);
                t.aborted || (n.duration = (0, g.z)() - this.startTime, this.loadCaptureCalled || 4 !== e.readyState ? null == t.status && (t.status = 0) : _(this, e), n.cbTime = this.cbTime, i("xhr", [t, n, this.startTime, this.endTime, "xhr"], this, r.D.ajax));
              }
            }
            function T(e, t) {
              var r = (0, U.e)(t),
                n = e.params;
              n.hostname = r.hostname, n.port = r.port, n.protocol = r.protocol, n.host = r.hostname + ":" + r.port, n.pathname = r.pathname, e.parsedOrigin = r, e.sameOrigin = r.sameOrigin;
            }
            function _(e, t) {
              e.params.status = t.status;
              var r = function (e, t) {
                var r = e.responseType;
                return "json" === r && null !== t ? t : "arraybuffer" === r || "blob" === r || "json" === r ? B(e.response) : "text" === r || "" === r || void 0 === r ? B(e.responseText) : void 0;
              }(t, e.lastSize);
              if (r && (e.metrics.rxSize = r), e.sameOrigin) {
                var n = t.getResponseHeader("X-NewRelic-App-Data");
                n && (e.params.cat = n.split(", ").pop());
              }
              e.loadCaptureCalled = !0;
            }
            t.on("new-xhr", a), t.on("open-xhr-start", s), t.on("open-xhr-end", c), t.on("send-xhr-start", d), t.on("xhr-cb-time", l), t.on("xhr-load-added", f), t.on("xhr-load-removed", h), t.on("xhr-resolved", p), t.on("addEventListener-end", m), t.on("removeEventListener-end", v), t.on("fn-end", y), t.on("fetch-before-start", w), t.on("fetch-start", A), t.on("fn-start", b), t.on("fetch-done", x);
          }(e, this.ee, this.handler, this.dt), this.importAggregator());
        }
      }
      var K = i(3614);
      const {
        BST_RESOURCE: Y,
        RESOURCE: J,
        START: ee,
        END: te,
        FEATURE_NAME: re,
        FN_END: ne,
        FN_START: ie,
        PUSH_STATE: oe
      } = K;
      var ae = i(7836);
      const {
        FEATURE_NAME: se,
        START: ce,
        END: ue,
        BODY: de,
        CB_END: le,
        JS_TIME: fe,
        FETCH: he,
        FN_START: pe,
        CB_START: ge,
        FN_END: me
      } = ae;
      var ve = i(4649);
      class be extends h {
        static featureName = ve.t;
        constructor(e, t) {
          let r = !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2];
          super(e, t, ve.t, r), this.importAggregator();
        }
      }
      new class extends t {
        constructor(t) {
          let r = arguments.length > 1 && void 0 !== arguments[1] ? arguments[1] : (0, _.ky)(16);
          super(), u._A ? (this.agentIdentifier = r, this.sharedAggregator = new y({
            agentIdentifier: this.agentIdentifier
          }), this.features = {}, this.desiredFeatures = new Set(t.features || []), this.desiredFeatures.add(m), Object.assign(this, (0, s.j)(this.agentIdentifier, t, t.loaderType || "agent")), this.start()) : (0, e.Z)("Failed to initial the agent. Could not determine the runtime environment.");
        }
        get config() {
          return {
            info: (0, n.C5)(this.agentIdentifier),
            init: (0, n.P_)(this.agentIdentifier),
            loader_config: (0, n.DL)(this.agentIdentifier),
            runtime: (0, n.OP)(this.agentIdentifier)
          };
        }
        start() {
          const t = "features";
          try {
            const n = a(this.agentIdentifier),
              i = [...this.desiredFeatures];
            i.sort((e, t) => r.p[e.featureName] - r.p[t.featureName]), i.forEach(t => {
              if (n[t.featureName] || t.featureName === r.D.pageViewEvent) {
                const i = function (e) {
                  switch (e) {
                    case r.D.ajax:
                      return [r.D.jserrors];
                    case r.D.sessionTrace:
                      return [r.D.ajax, r.D.pageViewEvent];
                    case r.D.sessionReplay:
                      return [r.D.sessionTrace];
                    case r.D.pageViewTiming:
                      return [r.D.pageViewEvent];
                    default:
                      return [];
                  }
                }(t.featureName);
                i.every(e => n[e]) || (0, e.Z)("".concat(t.featureName, " is enabled but one or more dependent features has been disabled (").concat((0, D.P)(i), "). This may cause unintended consequences or missing data...")), this.features[t.featureName] = new t(this.agentIdentifier, this.sharedAggregator);
              }
            }), (0, T.Qy)(this.agentIdentifier, this.features, t);
          } catch (r) {
            (0, e.Z)("Failed to initialize all enabled instrument classes (agent aborted) -", r);
            for (const e in this.features) this.features[e].abortHandler?.();
            const n = (0, T.fP)();
            return delete n.initializedAgents[this.agentIdentifier]?.api, delete n.initializedAgents[this.agentIdentifier]?.[t], delete this.sharedAggregator, n.ee?.abort(), delete n.ee?.get(this.agentIdentifier), !1;
          }
        }
        addToTrace(t) {
          (0, e.Z)("Call to agent api addToTrace failed. The page action feature is not currently initialized.");
        }
        setCurrentRouteName(t) {
          (0, e.Z)("Call to agent api setCurrentRouteName failed. The spa feature is not currently initialized.");
        }
        interaction() {
          (0, e.Z)("Call to agent api interaction failed. The spa feature is not currently initialized.");
        }
      }({
        features: [Q, m, O, class extends h {
          static featureName = re;
          constructor(e, t) {
            if (super(e, t, re, !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2]), !u.il) return;
            const n = this.ee;
            let i;
            (0, F.QU)(n), this.eventsEE = (0, F.em)(n), this.eventsEE.on(ie, function (e, t) {
              this.bstStart = (0, g.z)();
            }), this.eventsEE.on(ne, function (e, t) {
              (0, c.p)("bst", [e[0], t, this.bstStart, (0, g.z)()], void 0, r.D.sessionTrace, n);
            }), n.on(oe + ee, function (e) {
              this.time = (0, g.z)(), this.startPath = location.pathname + location.hash;
            }), n.on(oe + te, function (e) {
              (0, c.p)("bstHist", [location.pathname + location.hash, this.startPath, this.time], void 0, r.D.sessionTrace, n);
            });
            try {
              i = new PerformanceObserver(e => {
                const t = e.getEntries();
                (0, c.p)(Y, [t], void 0, r.D.sessionTrace, n);
              }), i.observe({
                type: J,
                buffered: !0
              });
            } catch (e) {}
            this.importAggregator({
              resourceObserver: i
            });
          }
        }, P, be, k, class extends h {
          static featureName = se;
          constructor(e, t) {
            if (super(e, t, se, !(arguments.length > 2 && void 0 !== arguments[2]) || arguments[2]), !u.il) return;
            if (!(0, n.OP)(e).xhrWrappable) return;
            try {
              this.removeOnAbort = new AbortController();
            } catch (e) {}
            let r,
              i = 0;
            const o = this.ee.get("tracer"),
              a = (0, F._L)(this.ee),
              s = (0, F.Lg)(this.ee),
              c = (0, F.BV)(this.ee),
              d = (0, F.Kf)(this.ee),
              l = this.ee.get("events"),
              f = (0, F.u5)(this.ee),
              h = (0, F.QU)(this.ee),
              p = (0, F.Gm)(this.ee);
            function m(e, t) {
              h.emit("newURL", ["" + window.location, t]);
            }
            function v() {
              i++, r = window.location.hash, this[pe] = (0, g.z)();
            }
            function b() {
              i--, window.location.hash !== r && m(0, !0);
              var e = (0, g.z)();
              this[fe] = ~~this[fe] + e - this[pe], this[me] = e;
            }
            function y(e, t) {
              e.on(t, function () {
                this[t] = (0, g.z)();
              });
            }
            this.ee.on(pe, v), s.on(ge, v), a.on(ge, v), this.ee.on(me, b), s.on(le, b), a.on(le, b), this.ee.buffer([pe, me, "xhr-resolved"], this.featureName), l.buffer([pe], this.featureName), c.buffer(["setTimeout" + ue, "clearTimeout" + ce, pe], this.featureName), d.buffer([pe, "new-xhr", "send-xhr" + ce], this.featureName), f.buffer([he + ce, he + "-done", he + de + ce, he + de + ue], this.featureName), h.buffer(["newURL"], this.featureName), p.buffer([pe], this.featureName), s.buffer(["propagate", ge, le, "executor-err", "resolve" + ce], this.featureName), o.buffer([pe, "no-" + pe], this.featureName), a.buffer(["new-jsonp", "cb-start", "jsonp-error", "jsonp-end"], this.featureName), y(f, he + ce), y(f, he + "-done"), y(a, "new-jsonp"), y(a, "jsonp-end"), y(a, "cb-start"), h.on("pushState-end", m), h.on("replaceState-end", m), window.addEventListener("hashchange", m, (0, C.m$)(!0, this.removeOnAbort?.signal)), window.addEventListener("load", m, (0, C.m$)(!0, this.removeOnAbort?.signal)), window.addEventListener("popstate", function () {
              m(0, i > 1);
            }, (0, C.m$)(!0, this.removeOnAbort?.signal)), this.abortHandler = this.#i, this.importAggregator();
          }
          #i() {
            this.removeOnAbort?.abort(), this.abortHandler = void 0;
          }
        }],
        loaderType: "spa"
      });
    })();
  })();
})()</script>
      <link rel="shortcut icon" href="https://sdfestaticassets-us-east-1.sciencedirectassets.com/shared-assets/103/images/favSD.ico" type="image/x-icon">
      <link rel="icon" href="https://sdfestaticassets-us-east-1.sciencedirectassets.com/shared-assets/103/images/favSD.ico" type="image/x-icon">
      <link rel="stylesheet" href="https://sdfestaticassets-us-east-1.sciencedirectassets.com/prod/0408e3544c5d8a31f29fd84f48c3b04cd8f090f1/arp.css">
      <link href="//cdn.pendo.io" rel="dns-prefetch">
      <link href="https://cdn.pendo.io" rel="preconnect" crossorigin="anonymous">
      <link rel="dns-prefetch" href="https://smetrics.elsevier.com">
      <script async="" id="reading-assistant-script-tag" src="/feature/assets/ai-components?componentVersion=V14" type="text/javascript"></script>
      <script type="text/javascript">
        
        window.appData = window.appData || [];
        window.pageTargeting = {"region":"us-east-1","platform":"sdtech","entitled":true,"crawler":"","journal":"Social Science & Medicine","auth":"AE"};
        window.arp = {
          config: {"adobeSuite":"elsevier-sd-prod","arsUrl":"https://ars.els-cdn.com","assetRoute":"https://sdfestaticassets-us-east-1.sciencedirectassets.com/prod/0408e3544c5d8a31f29fd84f48c3b04cd8f090f1","recommendationsFeedback":{"enabled":true,"url":"https://feedback.recs.d.elsevier.com/raw/events","timeout":60000},"googleMapsApiKey":"AIzaSyCBYU6I6lrbEU6wQXUEIte3NwGtm3jwHQc","mediaBaseUrl":"https://ars.els-cdn.com/content/image/","xocsMediaPlayerBaseUrl":"https://sdfestaticassets-us-east-1.sciencedirectassets.com/shared-assets/147/js/ableplayer","strictMode":false,"seamlessAccess":{"enableSeamlessAccess":true,"scriptUrl":"https://unpkg.com/@theidentityselector/thiss-ds@1.0.13/dist/thiss-ds.js","persistenceUrl":"https://service.seamlessaccess.org/ps/","persistenceContext":"seamlessaccess.org","scienceDirectUrl":"https://www.sciencedirect.com","shibAuthUrl":"https://auth.elsevier.com/ShibAuth/institutionLogin"},"reaxys":{"apiUrl":"https://reaxys-sdlc.reaxys.com","origin":"sciencedirect","queryBuilderHostPath":"https://www.reaxys.com/reaxys/secured/hopinto.do","url":"https://www.reaxys.com"},"oneTrustCookie":{"enabled":true},"ssrn":{"url":"https://papers.ssrn.com","path":"/sol3/papers.cfm"},"aiNavigation":{"enabled":true,"version":"V1"}},
          subscriptions: [],
          subscribe: function(cb) {
            var self = this;
            var i = this.subscriptions.push(cb) - 1;
            return function unsubscribe() {
              self.subscriptions.splice(i, 1);
            }
          },
        };
        window.addEventListener('beforeprint', () => pendo.onGuideDismissed());
      </script>
    <script data-cfasync="false" src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" data-document-language="true" data-domain-script="865ea198-88cc-4e41-8952-1df75d554d02"></script><meta http-equiv="origin-trial" content="AlK2UR5SkAlj8jjdEc9p3F3xuFYlF6LYjAML3EOqw1g26eCwWPjdmecULvBH5MVPoqKYrOfPhYVL71xAXI1IBQoAAAB8eyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ=="><meta http-equiv="origin-trial" content="Amm8/NmvvQfhwCib6I7ZsmUxiSCfOxWxHayJwyU1r3gRIItzr7bNQid6O8ZYaE1GSQTa69WwhPC9flq/oYkRBwsAAACCeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ=="><meta http-equiv="origin-trial" content="A9wSqI5i0iwGdf6L1CERNdmsTPgVu44ewj8QxTBYgsv1LCPUVF7YmWOvTappqB1139jAymxUW/RO8zmMqo4zlAAAAACNeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiRmxlZGdlQmlkZGluZ0FuZEF1Y3Rpb25TZXJ2ZXIiLCJleHBpcnkiOjE3MzY4MTI4MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9"><meta http-equiv="origin-trial" content="A+d7vJfYtay4OUbdtRPZA3y7bKQLsxaMEPmxgfhBGqKXNrdkCQeJlUwqa6EBbSfjwFtJWTrWIioXeMW+y8bWAgQAAACTeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiRmxlZGdlQmlkZGluZ0FuZEF1Y3Rpb25TZXJ2ZXIiLCJleHBpcnkiOjE3MzY4MTI4MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9"><script src="https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202506050101/pubads_impl.js" async=""></script><link href="https://securepubads.g.doubleclick.net/pagead/managed/dict/m202506100101/gpt" rel="compression-dictionary"><script src="https://unpkg.com/@theidentityselector/thiss-ds@1.0.13/dist/thiss-ds.js" async=""></script><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style><style type="text/css">.MJX_Assistive_MathML {position: absolute!important; top: 0; left: 0; clip: rect(1px, 1px, 1px, 1px); padding: 1px 0 0 0!important; border: 0!important; height: 1px!important; width: 1px!important; overflow: hidden!important; display: block!important; -webkit-touch-callout: none; -webkit-user-select: none; -khtml-user-select: none; -moz-user-select: none; -ms-user-select: none; user-select: none}
.MJX_Assistive_MathML.MJX_Assistive_MathML_Block {width: 100%!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><script src="https://cdn.cookielaw.org/scripttemplates/202504.1.0/otBannerSdk.js" async="" type="text/javascript"></script><style type="text/css">.MJXp-script {font-size: .8em}
.MJXp-right {-webkit-transform-origin: right; -moz-transform-origin: right; -ms-transform-origin: right; -o-transform-origin: right; transform-origin: right}
.MJXp-bold {font-weight: bold}
.MJXp-italic {font-style: italic}
.MJXp-scr {font-family: MathJax_Script,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-frak {font-family: MathJax_Fraktur,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-sf {font-family: MathJax_SansSerif,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-cal {font-family: MathJax_Caligraphic,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-mono {font-family: MathJax_Typewriter,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-largeop {font-size: 150%}
.MJXp-largeop.MJXp-int {vertical-align: -.2em}
.MJXp-math {display: inline-block; line-height: 1.2; text-indent: 0; font-family: 'Times New Roman',Times,STIXGeneral,serif; white-space: nowrap; border-collapse: collapse}
.MJXp-display {display: block; text-align: center; margin: 1em 0}
.MJXp-math span {display: inline-block}
.MJXp-box {display: block!important; text-align: center}
.MJXp-box:after {content: " "}
.MJXp-rule {display: block!important; margin-top: .1em}
.MJXp-char {display: block!important}
.MJXp-mo {margin: 0 .15em}
.MJXp-mfrac {margin: 0 .125em; vertical-align: .25em}
.MJXp-denom {display: inline-table!important; width: 100%}
.MJXp-denom > * {display: table-row!important}
.MJXp-surd {vertical-align: top}
.MJXp-surd > * {display: block!important}
.MJXp-script-box > *  {display: table!important; height: 50%}
.MJXp-script-box > * > * {display: table-cell!important; vertical-align: top}
.MJXp-script-box > *:last-child > * {vertical-align: bottom}
.MJXp-script-box > * > * > * {display: block!important}
.MJXp-mphantom {visibility: hidden}
.MJXp-munderover, .MJXp-munder {display: inline-table!important}
.MJXp-over {display: inline-block!important; text-align: center}
.MJXp-over > * {display: block!important}
.MJXp-munderover > *, .MJXp-munder > * {display: table-row!important}
.MJXp-mtable {vertical-align: .25em; margin: 0 .125em}
.MJXp-mtable > * {display: inline-table!important; vertical-align: middle}
.MJXp-mtr {display: table-row!important}
.MJXp-mtd {display: table-cell!important; text-align: center; padding: .5em 0 0 .5em}
.MJXp-mtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-mlabeledtr {display: table-row!important}
.MJXp-mlabeledtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mlabeledtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-merror {background-color: #FFFF88; color: #CC0000; border: 1px solid #CC0000; padding: 1px 3px; font-style: normal; font-size: 90%}
.MJXp-scale0 {-webkit-transform: scaleX(.0); -moz-transform: scaleX(.0); -ms-transform: scaleX(.0); -o-transform: scaleX(.0); transform: scaleX(.0)}
.MJXp-scale1 {-webkit-transform: scaleX(.1); -moz-transform: scaleX(.1); -ms-transform: scaleX(.1); -o-transform: scaleX(.1); transform: scaleX(.1)}
.MJXp-scale2 {-webkit-transform: scaleX(.2); -moz-transform: scaleX(.2); -ms-transform: scaleX(.2); -o-transform: scaleX(.2); transform: scaleX(.2)}
.MJXp-scale3 {-webkit-transform: scaleX(.3); -moz-transform: scaleX(.3); -ms-transform: scaleX(.3); -o-transform: scaleX(.3); transform: scaleX(.3)}
.MJXp-scale4 {-webkit-transform: scaleX(.4); -moz-transform: scaleX(.4); -ms-transform: scaleX(.4); -o-transform: scaleX(.4); transform: scaleX(.4)}
.MJXp-scale5 {-webkit-transform: scaleX(.5); -moz-transform: scaleX(.5); -ms-transform: scaleX(.5); -o-transform: scaleX(.5); transform: scaleX(.5)}
.MJXp-scale6 {-webkit-transform: scaleX(.6); -moz-transform: scaleX(.6); -ms-transform: scaleX(.6); -o-transform: scaleX(.6); transform: scaleX(.6)}
.MJXp-scale7 {-webkit-transform: scaleX(.7); -moz-transform: scaleX(.7); -ms-transform: scaleX(.7); -o-transform: scaleX(.7); transform: scaleX(.7)}
.MJXp-scale8 {-webkit-transform: scaleX(.8); -moz-transform: scaleX(.8); -ms-transform: scaleX(.8); -o-transform: scaleX(.8); transform: scaleX(.8)}
.MJXp-scale9 {-webkit-transform: scaleX(.9); -moz-transform: scaleX(.9); -ms-transform: scaleX(.9); -o-transform: scaleX(.9); transform: scaleX(.9)}
</style><style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-button-order-0{order:0}#onetrust-banner-sdk .ot-button-order-1{order:1}#onetrust-banner-sdk .ot-button-order-2{order:2}#onetrust-banner-sdk #onetrust-close-btn-container svg{height:10px;width:10px;pointer-events:none}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .pc-logo svg,#onetrust-pc-sdk .ot-pc-logo svg{height:60px;width:180px}#onetrust-pc-sdk #close-pc-btn-handler>svg{margin:auto;display:block;height:12px;width:12px}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo svg,#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.8em;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px}#onetrust-banner-sdk .ot-optout-signal svg.ot-source-sprite,#onetrust-pc-sdk .ot-optout-signal svg.ot-source-sprite{position:relative;bottom:-3px}#onetrust-banner-sdk .ot-optout-signal svg:not(.ot-source-sprite),#onetrust-pc-sdk .ot-optout-signal svg:not(.ot-source-sprite){transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg:not(.ot-source-sprite) path,#onetrust-pc-sdk .ot-optout-signal svg:not(.ot-source-sprite) path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk #onetrust-sprite-svg{display:none}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk img,#onetrust-pc-sdk img,#ot-sdk-cookie-policy img,#ot-sync-ntfy img{overflow:hidden !important}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-group-container{position:relative}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px;margin-right:5px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (max-width: 550px){#onetrust-button-group.ot-button-order-container #onetrust-accept-btn-handler,#onetrust-button-group.ot-button-order-container #onetrust-reject-all-handler,#onetrust-button-group.ot-button-order-container #onetrust-pc-btn-handler{margin-right:0}#onetrust-banner-sdk .has-reject-all-button div#onetrust-button-group.ot-button-order-container #onetrust-accept-btn-handler,#onetrust-banner-sdk .has-reject-all-button div#onetrust-button-group.ot-button-order-container #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button div#onetrust-button-group.ot-button-order-container #onetrust-pc-btn-handler{margin-right:0}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk #onetrust-button-group.ot-button-order-container #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-button-group.ot-button-order-container #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-button-group.ot-button-order-container #onetrust-pc-btn-handler{width:auto}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group.ot-button-order-container{display:inline-flex;flex-wrap:wrap}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group.ot-button-order-container #onetrust-pc-btn-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group.ot-button-order-container #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group.ot-button-order-container #onetrust-accept-btn-handler{float:none}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group.ot-button-order-container *[class*=ot-button-order-]:nth-of-type(1){margin-right:auto !important}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group.ot-button-order-container{width:auto}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:80%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! Extra code to blur out background */
.onetrust-pc-dark-filter{
background:rgba(0,0,0,.5);
z-index:2147483646;
width:100%;
height:100%;
overflow:hidden;
position:fixed;
top:0;
bottom:0;
left:0;
backdrop-filter: initial
}

/*! v6.12.0 2021-01-19 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #eb6500!important;outline:1px solid transparent;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007398!important;border:2px solid #007398!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#eb6500!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007398!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color: #2e2e2e!important;text-decoration-color:#eb6500!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007398!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #eb6500!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:#2e2e2e!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:#2e2e2e!important;text-decoration-color:#eb6500!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #eb6500;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:#2e2e2e;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#eb6500;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#eb6500;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #eb6500!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{width:100%}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk #ot-pc-hdr{margin-left:24px}div#onetrust-pc-sdk .ot-lst-subhdr{width:calc(100% - 24px)}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,div#onetrust-pc-sdk button#filter-apply-handler,div#onetrust-pc-sdk button#filter-cancel-handler{height:2em!important;padding-left:14px!important;padding-right:14px!important}div#onetrust-pc-sdk #ot-fltr-cnt{box-shadow:0 0;border:1px solid #8e8e8e;border-radius:0}div#onetrust-pc-sdk .ot-fltr-scrlcnt{max-height:calc(100% - 80px)}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}div#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:16px}div#onetrust-pc-sdk #ot-lst-cnt{margin-left:24px;width:calc(100% - 48px)}div#onetrust-pc-sdk #ot-anchor{display:none!important}

/* 2023-12-04  Fix for button order in mobile view*/
@media (max-width: 550px) {
  #onetrust-accept-btn-handler {order: 1;  }
  #onetrust-reject-all-handler { order: 2;  }
  #onetrust-pc-btn-handler { order: 3;  }
}


/*! Extra code to blur our background */
.onetrust-pc-dark-filter{
backdrop-filter: blur(3px)
}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;position:relative;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #ot-filter-list-header{margin-top:20px;margin-bottom:10px;float:left;max-width:150px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px 1px 1px 15px;overflow:hidden;text-overflow:ellipsis;white-space:nowrap}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk .ot-btn-container.ot-button-order-container .ot-pc-refuse-all-handler,#onetrust-pc-sdk .ot-btn-container.ot-button-order-container .save-preference-btn-handler,#onetrust-pc-sdk .ot-btn-container.ot-button-order-container #accept-recommended-btn-handler{width:auto;margin-bottom:1rem}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:10px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-accordion-layout .ot-pgph-link{margin-top:5px}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}#onetrust-pc-sdk .ot-btn-container.ot-button-order-container .ot-pc-refuse-all-handler,#onetrust-pc-sdk .ot-btn-container.ot-button-order-container .save-preference-btn-handler,#onetrust-pc-sdk .ot-btn-container.ot-button-order-container #accept-recommended-btn-handler{width:100%}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! Extra code to blur out background */
.onetrust-pc-dark-filter{
background:rgba(0,0,0,.5);
z-index:2147483646;
width:100%;
height:100%;
overflow:hidden;
position:fixed;
top:0;
bottom:0;
left:0;
backdrop-filter: initial
}

/*! v6.12.0 2021-01-19 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #eb6500!important;outline:1px solid transparent;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007398!important;border:2px solid #007398!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#eb6500!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007398!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color: #2e2e2e!important;text-decoration-color:#eb6500!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007398!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #eb6500!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:#2e2e2e!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:#2e2e2e!important;text-decoration-color:#eb6500!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #eb6500;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:#2e2e2e;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#eb6500;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#eb6500;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #eb6500!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{width:100%}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk #ot-pc-hdr{margin-left:24px}div#onetrust-pc-sdk .ot-lst-subhdr{width:calc(100% - 24px)}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,div#onetrust-pc-sdk button#filter-apply-handler,div#onetrust-pc-sdk button#filter-cancel-handler{height:2em!important;padding-left:14px!important;padding-right:14px!important}div#onetrust-pc-sdk #ot-fltr-cnt{box-shadow:0 0;border:1px solid #8e8e8e;border-radius:0}div#onetrust-pc-sdk .ot-fltr-scrlcnt{max-height:calc(100% - 80px)}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}div#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:16px}div#onetrust-pc-sdk #ot-lst-cnt{margin-left:24px;width:calc(100% - 48px)}div#onetrust-pc-sdk #ot-anchor{display:none!important}

/* 2023-12-04  Fix for button order in mobile view*/
@media (max-width: 550px) {
  #onetrust-accept-btn-handler {order: 1;  }
  #onetrust-reject-all-handler { order: 2;  }
  #onetrust-pc-btn-handler { order: 3;  }
}


/*! Extra code to blur our background */
.onetrust-pc-dark-filter{
backdrop-filter: blur(3px)
}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://assets.adobedtm.com/4a848ae9611a/032db4f73473/launch-a6263b31083f.min.js" type="text/javascript" async=""></script><script src="https://assets.adobedtm.com/extensions/EP31dbb9c60e404ba1aa6e746d49be6f29/AppMeasurement.min.js" async=""></script><script src="https://assets.adobedtm.com/extensions/EP31dbb9c60e404ba1aa6e746d49be6f29/AppMeasurement_Module_ActivityMap.min.js" async=""></script><script src="https://assets.adobedtm.com/4a848ae9611a/032db4f73473/93571d51095c/RCa16d232f95a944c0aabdea6621a2ef94-source.min.js" async=""></script><style type="text/css">.MathJax_SVG_Display {text-align: center; margin: 1em 0em; position: relative; display: block!important; text-indent: 0; max-width: none; max-height: none; min-width: 0; min-height: 0; width: 100%}
.MathJax_SVG .MJX-monospace {font-family: monospace}
.MathJax_SVG .MJX-sans-serif {font-family: sans-serif}
#MathJax_SVG_Tooltip {background-color: InfoBackground; color: InfoText; border: 1px solid black; box-shadow: 2px 2px 5px #AAAAAA; -webkit-box-shadow: 2px 2px 5px #AAAAAA; -moz-box-shadow: 2px 2px 5px #AAAAAA; -khtml-box-shadow: 2px 2px 5px #AAAAAA; padding: 3px 4px; z-index: 401; position: absolute; left: 0; top: 0; width: auto; height: auto; display: none}
.MathJax_SVG {display: inline; font-style: normal; font-weight: normal; line-height: normal; font-size: 100%; font-size-adjust: none; text-indent: 0; text-align: left; text-transform: none; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; direction: ltr; max-width: none; max-height: none; min-width: 0; min-height: 0; border: 0; padding: 0; margin: 0}
.MathJax_SVG * {transition: none; -webkit-transition: none; -moz-transition: none; -ms-transition: none; -o-transition: none}
.MathJax_SVG > div {display: inline-block}
.mjx-svg-href {fill: blue; stroke: blue}
.MathJax_SVG_Processing {visibility: hidden; position: absolute; top: 0; left: 0; width: 0; height: 0; overflow: hidden; display: block!important}
.MathJax_SVG_Processed {display: none!important}
.MathJax_SVG_test {font-style: normal; font-weight: normal; font-size: 100%; font-size-adjust: none; text-indent: 0; text-transform: none; letter-spacing: normal; word-spacing: normal; overflow: hidden; height: 1px}
.MathJax_SVG_test.mjx-test-display {display: table!important}
.MathJax_SVG_test.mjx-test-inline {display: inline!important; margin-right: -1px}
.MathJax_SVG_test.mjx-test-default {display: block!important; clear: both}
.MathJax_SVG_ex_box {display: inline-block!important; position: absolute; overflow: hidden; min-height: 0; max-height: none; padding: 0; border: 0; margin: 0; width: 1px; height: 60ex}
.mjx-test-inline .MathJax_SVG_left_box {display: inline-block; width: 0; float: left}
.mjx-test-inline .MathJax_SVG_right_box {display: inline-block; width: 0; float: right}
.mjx-test-display .MathJax_SVG_right_box {display: table-cell!important; width: 10000em!important; min-width: 0; max-width: none; padding: 0; border: 0; margin: 0}
</style><style>
            input[data-pendo-field-valid="false"] {
                border-color: red !important;
                outline-color: red !important;
            }
        </style><style>
            input[data-pendo-field-valid="false"] {
                border-color: red !important;
                outline-color: red !important;
            }
        </style><style>
            input[data-pendo-field-valid="false"] {
                border-color: red !important;
                outline-color: red !important;
            }
        </style></head>
    <body data-sd-ui-layer-boundary="true"><div style="visibility: hidden; overflow: hidden; position: absolute; top: 0px; height: 1px; width: auto; padding: 0px; border: 0px; margin: 0px; text-align: left; text-indent: 0px; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal;"><div id="MathJax_SVG_Hidden"><br></br><br></br></div><svg><defs id="MathJax_SVG_glyphs"><path stroke-width="1" id="MJMATHI-56" d="M52 648Q52 670 65 683H76Q118 680 181 680Q299 680 320 683H330Q336 677 336 674T334 656Q329 641 325 637H304Q282 635 274 635Q245 630 242 620Q242 618 271 369T301 118L374 235Q447 352 520 471T595 594Q599 601 599 609Q599 633 555 637Q537 637 537 648Q537 649 539 661Q542 675 545 679T558 683Q560 683 570 683T604 682T668 681Q737 681 755 683H762Q769 676 769 672Q769 655 760 640Q757 637 743 637Q730 636 719 635T698 630T682 623T670 615T660 608T652 599T645 592L452 282Q272 -9 266 -16Q263 -18 259 -21L241 -22H234Q216 -22 216 -15Q213 -9 177 305Q139 623 138 626Q133 637 76 637H59Q52 642 52 648Z"></path><path stroke-width="1" id="MJMATHI-61" d="M33 157Q33 258 109 349T280 441Q331 441 370 392Q386 422 416 422Q429 422 439 414T449 394Q449 381 412 234T374 68Q374 43 381 35T402 26Q411 27 422 35Q443 55 463 131Q469 151 473 152Q475 153 483 153H487Q506 153 506 144Q506 138 501 117T481 63T449 13Q436 0 417 -8Q409 -10 393 -10Q359 -10 336 5T306 36L300 51Q299 52 296 50Q294 48 292 46Q233 -10 172 -10Q117 -10 75 30T33 157ZM351 328Q351 334 346 350T323 385T277 405Q242 405 210 374T160 293Q131 214 119 129Q119 126 119 118T118 106Q118 61 136 44T179 26Q217 26 254 59T298 110Q300 114 325 217T351 328Z"></path><path stroke-width="1" id="MJMATHI-6C" d="M117 59Q117 26 142 26Q179 26 205 131Q211 151 215 152Q217 153 225 153H229Q238 153 241 153T246 151T248 144Q247 138 245 128T234 90T214 43T183 6T137 -11Q101 -11 70 11T38 85Q38 97 39 102L104 360Q167 615 167 623Q167 626 166 628T162 632T157 634T149 635T141 636T132 637T122 637Q112 637 109 637T101 638T95 641T94 647Q94 649 96 661Q101 680 107 682T179 688Q194 689 213 690T243 693T254 694Q266 694 266 686Q266 675 193 386T118 83Q118 81 118 75T117 65V59Z"></path><path stroke-width="1" id="MJMATHI-75" d="M21 287Q21 295 30 318T55 370T99 420T158 442Q204 442 227 417T250 358Q250 340 216 246T182 105Q182 62 196 45T238 27T291 44T328 78L339 95Q341 99 377 247Q407 367 413 387T427 416Q444 431 463 431Q480 431 488 421T496 402L420 84Q419 79 419 68Q419 43 426 35T447 26Q469 29 482 57T512 145Q514 153 532 153Q551 153 551 144Q550 139 549 130T540 98T523 55T498 17T462 -8Q454 -10 438 -10Q372 -10 347 46Q345 45 336 36T318 21T296 6T267 -6T233 -11Q189 -11 155 7Q103 38 103 113Q103 170 138 262T173 379Q173 380 173 381Q173 390 173 393T169 400T158 404H154Q131 404 112 385T82 344T65 302T57 280Q55 278 41 278H27Q21 284 21 287Z"></path><path stroke-width="1" id="MJMATHI-65" d="M39 168Q39 225 58 272T107 350T174 402T244 433T307 442H310Q355 442 388 420T421 355Q421 265 310 237Q261 224 176 223Q139 223 138 221Q138 219 132 186T125 128Q125 81 146 54T209 26T302 45T394 111Q403 121 406 121Q410 121 419 112T429 98T420 82T390 55T344 24T281 -1T205 -11Q126 -11 83 42T39 168ZM373 353Q367 405 305 405Q272 405 244 391T199 357T170 316T154 280T149 261Q149 260 169 260Q282 260 327 284T373 353Z"></path><path stroke-width="1" id="MJMAIN-3D" d="M56 347Q56 360 70 367H707Q722 359 722 347Q722 336 708 328L390 327H72Q56 332 56 347ZM56 153Q56 168 72 173H708Q722 163 722 153Q722 140 707 133H70Q56 140 56 153Z"></path><path stroke-width="1" id="MJMATHBI-66" d="M584 444Q597 439 597 426Q597 409 586 387Q580 382 505 382H434V380Q432 378 421 314T395 162T368 30Q324 -164 203 -199Q194 -201 175 -201Q123 -201 94 -177T64 -117T88 -58T145 -33Q169 -33 184 -47T200 -84Q200 -122 166 -150L174 -151H185Q202 -148 217 -112Q222 -94 240 9Q246 40 262 132T293 303T307 382H247H210Q190 382 182 385T173 400Q177 436 189 442Q193 444 256 444H318L319 446Q337 565 355 602Q373 640 404 664T458 694T503 701Q569 701 596 676T624 617Q624 581 599 557T544 533Q520 533 504 547T488 585Q488 596 491 606T499 624T508 637T516 646L520 650Q515 650 509 651Q459 651 459 561V554L458 518L452 484Q446 448 445 447V444H584Z"></path><path stroke-width="1" id="MJMAIN-28" d="M94 250Q94 319 104 381T127 488T164 576T202 643T244 695T277 729T302 750H315H319Q333 750 333 741Q333 738 316 720T275 667T226 581T184 443T167 250T184 58T225 -81T274 -167T316 -220T333 -241Q333 -250 318 -250H315H302L274 -226Q180 -141 137 -14T94 250Z"></path><path stroke-width="1" id="MJMATHBI-42" d="M258 624H235Q214 624 209 626T199 639Q203 678 216 684Q220 686 449 686H477H586Q684 686 733 677T817 634Q853 598 853 547Q853 499 826 460T761 401T695 371T654 360H653L662 358Q670 357 683 354T712 344T744 327T774 303T795 269T804 224Q804 148 732 79T533 1Q524 0 288 0H58Q47 5 43 15Q47 54 60 60Q64 62 113 62H162L302 623Q302 624 258 624ZM703 550Q703 571 695 586T675 609T656 619T643 623L545 624H447L417 504Q386 384 386 383T470 382Q554 383 565 385Q632 397 667 447T703 550ZM651 240Q651 265 645 282T626 309T608 322T592 329Q587 330 479 331H373L340 198Q307 65 306 64Q306 62 406 62L507 63L519 65Q565 76 596 107T639 171T651 240Z"></path><path stroke-width="1" id="MJMATHBI-6F" d="M254 -8Q191 -8 146 9T80 54T49 111T39 169Q39 206 53 247T96 329T176 402T292 446Q317 451 336 451L344 452Q353 452 359 452Q457 452 516 408T576 279Q576 169 488 81T254 -8ZM349 400Q321 400 287 385T231 338Q206 301 188 228T170 126Q170 99 178 83Q198 44 260 44Q367 44 409 157Q419 185 432 238T445 317Q445 336 443 348Q435 372 416 384T384 398T349 400Z"></path><path stroke-width="1" id="MJMATHBI-44" d="M258 624H235Q214 624 209 626T199 639Q203 678 216 684Q220 686 437 686Q659 686 668 685Q727 680 772 662T842 621T883 568T905 517T913 475Q914 466 914 434Q914 373 892 307T828 179T712 69T548 7Q517 2 494 2T279 0H58Q47 5 43 15Q47 54 60 60Q64 62 113 62H162L302 623Q302 624 258 624ZM768 475Q768 515 753 544T718 588T666 611T613 622T563 624H538H532H452L382 344Q311 64 311 63T363 62H405Q490 62 545 76T656 142Q696 185 724 265T760 399T768 475Z"></path><path stroke-width="1" id="MJMAIN-2C" d="M78 35T78 60T94 103T137 121Q165 121 187 96T210 8Q210 -27 201 -60T180 -117T154 -158T130 -185T117 -194Q113 -194 104 -185T95 -172Q95 -168 106 -156T131 -126T157 -76T173 -3V9L172 8Q170 7 167 6T161 3T152 1T140 0Q113 0 96 17Z"></path><path stroke-width="1" id="MJMATHBI-54" d="M498 62Q511 58 511 43Q511 10 494 1L490 0Q487 0 482 0T424 1T271 2Q201 2 157 2T94 1T72 0H70Q46 0 46 17Q49 54 62 60L66 62H137Q208 62 209 63L218 98Q227 134 244 203T278 339L347 613H300Q262 612 246 611T198 599T146 564Q128 545 114 512T91 454T79 425Q73 419 52 419Q22 419 22 434Q22 440 41 498T80 611L100 666Q105 673 111 675H434Q758 675 762 673Q772 668 772 657Q772 655 756 549T738 434Q735 419 711 419H707Q690 419 686 421Q677 425 677 434Q676 436 678 449T683 485T686 529Q686 553 679 569T662 594T631 607T593 612T544 613H502L433 340Q418 279 400 207T374 100L365 65L364 62H498Z"></path><path stroke-width="1" id="MJMATHBI-48" d="M258 624H235Q214 624 209 626T199 639Q203 678 216 684Q220 686 239 686Q290 684 403 684Q475 684 512 685T553 686Q576 686 576 668Q572 632 560 626Q555 624 506 624H457L399 389Q399 388 547 388H695L753 623Q753 624 709 624H686Q665 624 660 626T650 639Q653 678 668 684Q672 686 681 686Q685 686 726 685T847 684Q902 684 937 684T986 685T1004 686Q1027 686 1027 668Q1023 632 1011 626Q1006 624 957 624H908L839 344Q768 64 768 63T812 62H839Q871 62 871 44Q867 6 854 2L850 0L808 1Q782 2 675 2Q600 2 560 1T516 0Q499 0 494 15Q498 54 511 60Q515 62 564 62H613L614 66L679 324Q679 326 531 326H383L382 322L317 64Q317 62 361 62H388Q420 62 420 44Q416 6 403 2L399 0L357 1Q331 2 224 2Q149 2 109 1T65 0Q48 0 43 15Q47 54 60 60Q64 62 113 62H162L302 623Q302 624 258 624Z"></path><path stroke-width="1" id="MJMATHBI-45" d="M257 618H231Q198 618 198 636Q202 672 214 678L219 680H811Q817 677 820 673T824 666L825 664Q825 659 814 549T799 433Q793 424 771 424Q752 424 746 427T740 441Q740 445 742 466T744 505Q744 561 722 585T646 616Q639 617 545 618H456Q456 617 427 502T398 385Q398 384 435 384Q461 385 471 385T499 391T526 405T545 433T562 478Q566 494 571 497T595 501H604Q622 501 626 486Q626 482 593 349T557 213Q552 205 530 205Q499 205 499 219Q499 222 503 242T508 281Q508 308 491 314T429 322Q425 322 423 322H382L317 64Q317 62 390 62Q460 62 493 64T569 80T640 124Q665 149 686 187T719 253T733 283Q739 289 760 289Q791 289 791 274Q791 267 763 201T706 71L678 8Q676 4 667 0H58Q47 5 43 15Q47 54 60 60Q64 62 113 62H162L163 66Q163 67 231 341T301 616Q301 618 257 618Z"></path><path stroke-width="1" id="MJMATHBI-53" d="M354 45Q429 45 467 91T506 184Q506 225 477 250Q461 262 384 279T294 300Q238 318 210 362T182 452Q182 493 202 540T257 623Q338 702 449 702Q491 702 501 701Q571 690 610 654Q614 649 617 650Q618 650 650 675T683 702Q685 703 692 703Q714 703 714 690Q714 686 687 578T658 466Q653 458 629 458Q606 458 602 463Q600 465 599 466Q599 467 599 469T598 473Q598 475 599 487T600 511Q600 584 557 614T454 645Q386 645 347 606T308 520Q308 506 311 496T323 477T338 464T360 454T384 446T413 439T441 433Q523 416 549 401Q581 384 602 352Q631 309 631 254Q631 214 615 170T567 83T478 12T347 -16Q322 -16 300 -14T261 -8T230 0T205 10T187 20T172 30L162 37L130 11Q124 7 119 3T110 -4T104 -9T100 -13T96 -15T93 -16T91 -17T88 -17H82Q76 -17 73 -16T69 -14T66 -10T63 -5L90 107Q97 133 106 170Q116 211 120 219T136 228H148Q167 228 173 227T179 218Q179 216 176 200T173 168Q173 102 227 74T354 45Z"></path><path stroke-width="1" id="MJMATHBI-41" d="M65 0Q45 0 45 18Q48 52 61 60Q65 62 81 62Q155 62 165 74Q166 74 265 228T465 539T569 699Q576 707 583 709T611 711T637 710T649 700Q650 697 695 380L741 63L784 62H827Q839 50 839 45L835 29Q831 9 827 5T806 0Q803 0 790 0T743 1T657 2Q585 2 547 1T504 0Q481 0 481 17Q484 54 497 60Q501 62 541 62Q580 62 580 63Q580 68 573 121T564 179V181H308L271 124Q236 69 236 67T283 62H287Q316 62 316 46Q316 26 307 8Q302 3 295 0L262 1Q242 2 168 2Q119 2 93 1T65 0ZM537 372Q533 402 528 435T521 486T518 504V505Q517 505 433 375L348 244L451 243Q555 243 555 244L537 372Z"></path><path stroke-width="1" id="MJMATHBI-46" d="M257 618H231Q198 618 198 636Q202 672 214 678L219 680H795Q801 677 804 673T808 666L809 664Q809 659 798 549T783 433Q777 424 755 424Q736 424 730 427T724 444Q724 448 725 468T727 507V524Q727 541 724 554T713 577T698 594T676 605T653 612T625 616T597 617T566 618T538 618H456L455 614Q455 611 424 491L394 371H429Q454 372 463 372T491 378T517 392T536 419T552 464Q556 481 561 484T586 488Q603 488 607 486Q616 482 616 473Q616 467 584 337T549 201Q542 192 521 192Q503 192 497 195T490 209Q490 212 492 224Q499 251 499 269Q499 288 489 296T465 306T417 308L379 309L348 188Q341 161 334 129T322 80L318 65L317 62H375H409Q430 62 438 59T447 45Q444 8 431 2L426 0L377 1Q347 2 231 2Q152 2 111 1T65 0Q48 0 43 15Q47 54 60 60Q64 62 113 62H162L163 66Q163 67 231 341T301 616Q301 618 257 618Z"></path><path stroke-width="1" id="MJMATHBI-49" d="M247 624Q242 624 233 624T220 623Q186 623 186 640Q186 647 190 664T202 684Q206 686 226 686Q277 684 393 684Q435 684 471 684T528 685T553 686Q573 686 573 670Q573 650 564 632Q556 624 537 624H501H449L380 344Q309 64 309 63T356 62Q361 62 370 62T384 63Q417 63 417 46Q417 26 408 8Q403 3 396 0L352 1Q325 2 216 2T82 1L45 0Q30 7 30 16Q33 51 46 60Q51 62 102 62H154L294 623Q294 624 247 624Z"></path><path stroke-width="1" id="MJMATHBI-4E" d="M258 624H235Q214 624 209 626T199 639Q203 678 216 684Q220 686 344 686H434Q464 686 477 680Q480 677 607 454Q738 227 739 227Q742 227 789 418T836 618Q836 620 835 620L821 622Q811 622 779 624Q755 624 749 625T740 632Q737 635 737 644Q737 656 742 669T754 685Q755 685 757 685T763 686Q768 686 803 685T890 684Q925 684 951 684T990 685T1006 686Q1014 686 1016 684Q1027 679 1027 668Q1023 632 1011 626Q1007 624 978 624Q912 622 907 617Q907 616 831 314T753 8Q749 0 723 0H712Q699 0 692 7Q692 8 671 44T607 155T526 296L361 580L296 323Q234 74 234 68T302 62H307Q334 62 334 44Q330 6 317 2L313 0L280 1Q260 2 181 2Q125 2 96 1T63 0Q48 0 43 15Q43 19 47 35Q52 55 57 58T94 62Q147 64 164 69L233 345Q302 619 302 622Q302 624 258 624Z"></path><path stroke-width="1" id="MJMATHBI-4F" d="M53 245Q53 297 70 356T125 478T216 590T349 671T523 703Q656 703 735 637T815 445Q815 378 791 307Q727 104 527 17Q437 -17 344 -17Q289 -17 242 -5T150 35T79 116T53 245ZM664 489Q664 575 618 611T511 648Q463 648 416 627T334 570Q297 531 270 472T230 355T213 261T208 206Q208 177 215 151T237 98T284 56T358 40Q440 40 510 98T618 270Q664 400 664 489Z"></path><path stroke-width="1" id="MJMATHBI-43" d="M380 -17Q335 -17 293 -10T207 16T130 65T76 144T55 256Q55 306 70 361T122 476T211 582T345 663T525 702H545Q673 702 731 634L777 668Q783 672 789 677T800 685T808 691T814 695T818 698T822 700T825 702T828 703T830 703T833 703Q855 703 855 690Q855 686 823 558T789 426Q786 421 782 420T756 419Q734 420 729 421T724 432Q724 434 725 447T726 472Q726 552 678 604Q640 640 586 640H574Q533 640 494 632T409 604T324 541T260 437Q243 397 227 333T210 219Q210 152 237 117Q255 90 299 68T420 46H429Q506 46 580 100T678 234Q683 249 687 251T712 254H723Q743 254 743 240Q743 232 736 213T710 162T663 100T586 40T477 -5Q433 -17 380 -17Z"></path><path stroke-width="1" id="MJMAIN-29" d="M60 749L64 750Q69 750 74 750H86L114 726Q208 641 251 514T294 250Q294 182 284 119T261 12T224 -76T186 -143T145 -194T113 -227T90 -246Q87 -249 86 -250H74Q66 -250 63 -250T58 -247T55 -238Q56 -237 66 -225Q221 -64 221 250T66 725Q56 737 55 738Q55 746 60 749Z"></path><path stroke-width="1" id="MJSZ1-2211" d="M61 748Q64 750 489 750H913L954 640Q965 609 976 579T993 533T999 516H979L959 517Q936 579 886 621T777 682Q724 700 655 705T436 710H319Q183 710 183 709Q186 706 348 484T511 259Q517 250 513 244L490 216Q466 188 420 134T330 27L149 -187Q149 -188 362 -188Q388 -188 436 -188T506 -189Q679 -189 778 -162T936 -43Q946 -27 959 6H999L913 -249L489 -250Q65 -250 62 -248Q56 -246 56 -239Q56 -234 118 -161Q186 -81 245 -11L428 206Q428 207 242 462L57 717L56 728Q56 744 61 748Z"></path><path stroke-width="1" id="MJMATHI-6D" d="M21 287Q22 293 24 303T36 341T56 388T88 425T132 442T175 435T205 417T221 395T229 376L231 369Q231 367 232 367L243 378Q303 442 384 442Q401 442 415 440T441 433T460 423T475 411T485 398T493 385T497 373T500 364T502 357L510 367Q573 442 659 442Q713 442 746 415T780 336Q780 285 742 178T704 50Q705 36 709 31T724 26Q752 26 776 56T815 138Q818 149 821 151T837 153Q857 153 857 145Q857 144 853 130Q845 101 831 73T785 17T716 -10Q669 -10 648 17T627 73Q627 92 663 193T700 345Q700 404 656 404H651Q565 404 506 303L499 291L466 157Q433 26 428 16Q415 -11 385 -11Q372 -11 364 -4T353 8T350 18Q350 29 384 161L420 307Q423 322 423 345Q423 404 379 404H374Q288 404 229 303L222 291L189 157Q156 26 151 16Q138 -11 108 -11Q95 -11 87 -5T76 7T74 17Q74 30 112 181Q151 335 151 342Q154 357 154 369Q154 405 129 405Q107 405 92 377T69 316T57 280Q55 278 41 278H27Q21 284 21 287Z"></path><path stroke-width="1" id="MJMATHI-69" d="M184 600Q184 624 203 642T247 661Q265 661 277 649T290 619Q290 596 270 577T226 557Q211 557 198 567T184 600ZM21 287Q21 295 30 318T54 369T98 420T158 442Q197 442 223 419T250 357Q250 340 236 301T196 196T154 83Q149 61 149 51Q149 26 166 26Q175 26 185 29T208 43T235 78T260 137Q263 149 265 151T282 153Q302 153 302 143Q302 135 293 112T268 61T223 11T161 -11Q129 -11 102 10T74 74Q74 91 79 106T122 220Q160 321 166 341T173 380Q173 404 156 404H154Q124 404 99 371T61 287Q60 286 59 284T58 281T56 279T53 278T49 278T41 278H27Q21 284 21 287Z"></path><path stroke-width="1" id="MJMAIN-31" d="M213 578L200 573Q186 568 160 563T102 556H83V602H102Q149 604 189 617T245 641T273 663Q275 666 285 666Q294 666 302 660V361L303 61Q310 54 315 52T339 48T401 46H427V0H416Q395 3 257 3Q121 3 100 0H88V46H114Q136 46 152 46T177 47T193 50T201 52T207 57T213 61V578Z"></path><path stroke-width="1" id="MJMATHI-77" d="M580 385Q580 406 599 424T641 443Q659 443 674 425T690 368Q690 339 671 253Q656 197 644 161T609 80T554 12T482 -11Q438 -11 404 5T355 48Q354 47 352 44Q311 -11 252 -11Q226 -11 202 -5T155 14T118 53T104 116Q104 170 138 262T173 379Q173 380 173 381Q173 390 173 393T169 400T158 404H154Q131 404 112 385T82 344T65 302T57 280Q55 278 41 278H27Q21 284 21 287Q21 293 29 315T52 366T96 418T161 441Q204 441 227 416T250 358Q250 340 217 250T184 111Q184 65 205 46T258 26Q301 26 334 87L339 96V119Q339 122 339 128T340 136T341 143T342 152T345 165T348 182T354 206T362 238T373 281Q402 395 406 404Q419 431 449 431Q468 431 475 421T483 402Q483 389 454 274T422 142Q420 131 420 107V100Q420 85 423 71T442 42T487 26Q558 26 600 148Q609 171 620 213T632 273Q632 306 619 325T593 357T580 385Z"></path><path stroke-width="1" id="MJMATHI-76" d="M173 380Q173 405 154 405Q130 405 104 376T61 287Q60 286 59 284T58 281T56 279T53 278T49 278T41 278H27Q21 284 21 287Q21 294 29 316T53 368T97 419T160 441Q202 441 225 417T249 361Q249 344 246 335Q246 329 231 291T200 202T182 113Q182 86 187 69Q200 26 250 26Q287 26 319 60T369 139T398 222T409 277Q409 300 401 317T383 343T365 361T357 383Q357 405 376 424T417 443Q436 443 451 425T467 367Q467 340 455 284T418 159T347 40T241 -11Q177 -11 139 22Q102 54 102 117Q102 148 110 181T151 298Q173 362 173 380Z"></path></defs></svg></div><div id="MathJax_Message" style="display: none;"></div>
      <script type="text/javascript">
        window.__PRELOADED_STATE__ = {"abstracts":{"content":[{"$$":[{"$":{"id":"sectitle0010"},"#name":"section-title","_":"Abstract"},{"$$":[{"$":{"view":"all","id":"abspara0010"},"#name":"simple-para","_":"Multiple Criteria Decision Analysis (MCDA) has emerged as a methodology for Health Technology Assessment (HTA). However, limited empirical evidence is available on its use by decision-makers; where available, it only comes from single-setting exercises, while cross-country comparative studies are unavailable. This study applies the Advance Value Framework (AVF), an MCDA methodology for HTA based on multi-attribute value theory, through a series of case studies with decision-makers in four countries, to explore its feasibility and compare decision-makers' value preferences and results."},{"$":{"view":"all","id":"fspara0045"},"#name":"simple-para","_":"The AVF was applied in the evaluation of three drugs for metastatic, castrate resistant, prostate cancer (abiraterone, cabazitaxel and enzalutamide) in the post-chemotherapy indication. Decision conferences were organised in four European countries in collaboration with their HTA or health insurance organisations by involving relevant assessors and experts: Sweden (TLV), Andalusia/Spain (AETSA), Poland (AOTMiT) and Belgium (INAMI-RIZIV). Participants' value preferences, including performance scoring and criteria weighting, were elicited through a facilitated decision-analysis modelling approach using the MACBETH technique."},{"$":{"view":"all","id":"abspara0015"},"#name":"simple-para","_":"Between 6 and 11 criteria were included in each jurisdiction's value model, allocated across four criteria domains; Therapeutic Benefit criteria consistently ranked first in relative importance across all countries. Consistent drug rankings were observed in all settings, with enzalutamide generating the highest overall weighted preference value (WPV) score, followed by abiraterone and cabazitaxel. Dividing drugs' overall WPV scores by their costs produced the lowest “cost per unit of value” for enzalutamide, followed by abiraterone and cabazitaxel. These results come in contrast with the actual country HTA recommendations and pricing decisions."},{"$":{"view":"all","id":"abspara0020"},"#name":"simple-para","_":"Overall, although some differences in value preferences were observed between countries, drug rankings remained the same. The MCDA methodology employed could act as a decision support tool in HTA, due to the transparency in the construction of value preferences in a collaborative manner."}],"$":{"view":"all","id":"abssec0010"},"#name":"abstract-sec"}],"$":{"view":"all","id":"abs0010","lang":"en","class":"author"},"#name":"abstract"},{"$$":[{"$":{"id":"sectitle0015"},"#name":"section-title","_":"Highlights"},{"$$":[{"$$":[{"$$":[{"$$":[{"#name":"label","_":"•"},{"$":{"view":"all","id":"p0010"},"#name":"para","_":"An MCDA value framework was piloted with HTA decision-makers in four EU countries."}],"$":{"id":"u0010"},"#name":"list-item"},{"$$":[{"#name":"label","_":"•"},{"$":{"view":"all","id":"p0015"},"#name":"para","_":"The value drivers of three prostate cancer drugs and their importance were analysed."}],"$":{"id":"u0015"},"#name":"list-item"},{"$$":[{"#name":"label","_":"•"},{"$":{"view":"all","id":"p0020"},"#name":"para","_":"Decision-maker value preferences were elicited during four decision conferences."}],"$":{"id":"u0020"},"#name":"list-item"},{"$$":[{"#name":"label","_":"•"},{"$":{"view":"all","id":"p0025"},"#name":"para","_":"Value rankings of treatment options were similar and consistent across countries."}],"$":{"id":"u0025"},"#name":"list-item"},{"$$":[{"#name":"label","_":"•"},{"$":{"view":"all","id":"p0030"},"#name":"para","_":"The proposed MCDA methodology has prospects to act as a decision support tool."}],"$":{"id":"u0030"},"#name":"list-item"}],"$":{"id":"ulist0010"},"#name":"list"}],"$":{"view":"all","id":"abspara0025"},"#name":"simple-para"}],"$":{"view":"all","id":"abssec0015"},"#name":"abstract-sec"}],"$":{"view":"all","id":"abs0015","lang":"en","class":"author-highlights"},"#name":"abstract"}],"floats":[],"footnotes":[],"attachments":[]},"accessbarConfig":{"fallback":false,"id":"accessbar","version":"0.0.1","analytics":{"location":"accessbar","eventName":"ctaImpression"},"label":{},"ariaLabel":{"accessbar":"Download options and search","componentsList":"PDF Options"},"banners":[{"id":"BannerSsrn"}],"components":[{"target":"_blank","analytics":[{"ids":["accessbar:fta:single-article"],"eventName":"ctaClick"}],"label":"View&nbsp;**PDF**","ariaLabel":"View PDF. Opens in a new window.","id":"ViewPDF"},{"analytics":[{"ids":["accessbar:fta:full-issue"],"eventName":"ctaClick"}],"label":"Download full issue","id":"DownloadFullIssue"},{"id":"ViewClinicalKeyFullText","analytics":[{"eventName":"ctaClick","ids":["accessbar:fta:clinical-key"]}],"label":"View full text","rel":"noopener noreferrer","target":"_blank","href":"https://www.clinicalkey.com/#!/content/journal/1-s2.0-S0277953619305908"}],"search":{"inputPlaceHolder":"Search ScienceDirect","ariaLabel":{"input":"Search ScienceDirect","submit":"Submit search"},"formAction":"/search#submit","analytics":[{"ids":["accessbar:search"],"eventName":"searchStart"}],"id":"QuickSearch"}},"adobeTarget":{},"article":{"analyticsMetadata":{"accountId":"228598","accountName":"ScienceDirect Guests","loginStatus":"anonymous","userId":"12975512","isLoggedIn":false},"article-number":"112595","cid":"271821","content-family":"serial","copyright-line":"© 2019 The Authors. Published by Elsevier Ltd.","cover-date-years":["2020"],"cover-date-start":"2020-02-01","cover-date-text":"February 2020","document-subtype":"fla","document-type":"article","entitledToken":"F143AACBA53508A69E0036B22D33E533B142D07136AF63FD2DDD295301D6E6978A25023C0530DA20","genAiToken":"eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJnZW5BaUFwcHMiLCJwaWkiOiJTMDI3Nzk1MzYxOTMwNTkwOCIsInN1YiI6IjIyODU5OCIsImlzcyI6ImFycCIsInNlc3Npb25JZCI6IjY4MWIwNmY1NWM3OTgwNDZhYjY5Yjk5MjBmZmY0MDAzODRlYmd4cnFhIiwiZXhwIjoxNzQ5NjA0NzQ0LCJpYXQiOjE3NDk1OTc1NDQsInZlcnNpb24iOjEsImp0aSI6ImU3NGNhNTliLWMzN2QtNGY4ZC1iMzcwLWNmZmY2ZGUyMTkwNSJ9.zJY2t8wnCpd95C1RutkAO-7xqALOCAslUPtdHNoXhzU","eid":"1-s2.0-S0277953619305908","doi":"10.1016/j.socscimed.2019.112595","first-fp":"112595","hub-eid":"1-s2.0-S0277953619X00258","issuePii":"S0277953619X00258","item-weight":"FULL-TEXT","language":"en","last-author":{"#name":"last-author","$":{"xmlns:ce":true,"xmlns:dm":true,"xmlns:sb":true},"$$":[{"#name":"author","$":{"author-id":"S0277953619305908-ae2d09c1d7b6c9b9660a3a41e1db6a0c","id":"au9"},"$$":[{"#name":"given-name","_":"P."},{"#name":"surname","_":"Kanavos"},{"#name":"cross-ref","$":{"id":"crosref0060","refid":"aff1"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"a"}]},{"#name":"cross-ref","$":{"id":"crosref0065","refid":"cor1"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"∗"}]},{"#name":"encoded-e-address","__encoded":"JTdCJTIyJTIzbmFtZSUyMiUzQSUyMmUtYWRkcmVzcyUyMiUyQyUyMiUyNCUyMiUzQSU3QiUyMnhtbG5zJTNBeGxpbmslMjIlM0F0cnVlJTJDJTIyaWQlMjIlM0ElMjJlYWRkMDAxNSUyMiUyQyUyMnR5cGUlMjIlM0ElMjJlbWFpbCUyMiUyQyUyMmhyZWYlMjIlM0ElMjJtYWlsdG8lM0FwLmcua2FuYXZvcyU0MGxzZS5hYy51ayUyMiU3RCUyQyUyMl8lMjIlM0ElMjJwLmcua2FuYXZvcyU0MGxzZS5hYy51ayUyMiU3RA=="}]}]},"normalized-first-auth-initial":"A","normalized-first-auth-surname":"ANGELIS","open-research":{"#name":"open-research","$":{"xmlns:xocs":true},"$$":[{"#name":"or-agreements","$$":[{"#name":"or-agreement","$$":[{"#name":"or-agreement-name","_":"HEFCE"},{"#name":"or-agreement-terms","_":"none"}]}]}]},"pages":[{"first-page":"112595"}],"pii":"S0277953619305908","self-archiving":{"#name":"self-archiving","$":{"xmlns:xocs":true},"$$":[{"#name":"sa-start-date","_":"2020-12-23T00:00:00.000Z"},{"#name":"sa-user-license","_":"http://creativecommons.org/licenses/by-nc-nd/4.0/"}]},"srctitle":"Social Science & Medicine","suppl":"C","timestamp":"2021-01-25T21:18:00.129031Z","title":{"content":[{"#name":"title","$":{"id":"title0010"},"_":"Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework"}],"floats":[],"footnotes":[],"attachments":[]},"vol-first":"246","vol-iss-suppl-text":"Volume 246","userSettings":{"forceAbstract":false,"creditCardPurchaseAllowed":true,"blockFullTextForAnonymousAccess":false,"disableWholeIssueDownload":false,"preventTransactionalAccess":false,"preventDocumentDelivery":true},"contentType":"JL","crossmark":true,"document-references":115,"freeHtmlGiven":false,"ssoUrls":["//acw.clinicalkey.com/SSOCore/update?acw=681b06f55c798046ab69b9920fff400384ebgxrqa%7C%24%7C1C6745D43BCBAF9A06AE3840493E39F5C9B42085E171313B70F03348F0E43FA6250A54675C94FCD9C857DC92233BF31BEB3C9BFFCFB27E583FBA44D1BD4E4F2EB0469A67597464825D387A21AFA2E514&utt=6a64-e24302c57917b71a9c6-c338e6a124245881","//acw.scopus.com/SSOCore/update?acw=681b06f55c798046ab69b9920fff400384ebgxrqa%7C%24%7C1C6745D43BCBAF9A06AE3840493E39F5C9B42085E171313B70F03348F0E43FA6250A54675C94FCD9C857DC92233BF31BEB3C9BFFCFB27E583FBA44D1BD4E4F2EB0469A67597464825D387A21AFA2E514&utt=6a64-e24302c57917b71a9c6-c338e6a124245881","//acw.sciencedirect.com/SSOCore/update?acw=681b06f55c798046ab69b9920fff400384ebgxrqa%7C%24%7C1C6745D43BCBAF9A06AE3840493E39F5C9B42085E171313B70F03348F0E43FA6250A54675C94FCD9C857DC92233BF31BEB3C9BFFCFB27E583FBA44D1BD4E4F2EB0469A67597464825D387A21AFA2E514&utt=6a64-e24302c57917b71a9c6-c338e6a124245881","//acw.elsevier.com/SSOCore/update?acw=681b06f55c798046ab69b9920fff400384ebgxrqa%7C%24%7C1C6745D43BCBAF9A06AE3840493E39F5C9B42085E171313B70F03348F0E43FA6250A54675C94FCD9C857DC92233BF31BEB3C9BFFCFB27E583FBA44D1BD4E4F2EB0469A67597464825D387A21AFA2E514&utt=6a64-e24302c57917b71a9c6-c338e6a124245881"],"userProfile":{"departmentName":"ScienceDirect Guests","accessType":"GUEST","accountId":"228598","webUserId":"12975512","accountName":"ScienceDirect Guests","departmentId":"291352","userType":"NORMAL","hasMultipleOrganizations":false,"accountNumber":"C000228598"},"access":{"openAccess":true,"openArchive":false,"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/"},"accessTypeLabel":"Open access","aipType":"none","articleEntitlement":{"entitled":true,"isCasaUser":false,"usageInfo":"(12975512,U|291352,D|228598,A|3,P|2,PL)(SDFE,CON|681b06f55c798046ab69b9920fff400384ebgxrqa,SSO|ANON_GUEST,ACCESS_TYPE)","entitledByAccount":false,"entitlementOrigin":"SD"},"crawlerInformation":{"canCrawlPDFContent":false,"isCrawler":false},"dates":{"Available online":"15 October 2019","Received":"26 March 2019","Revised":["29 September 2019"],"Accepted":"10 October 2019","Publication date":"1 February 2020","Version of Record":"23 December 2019"},"documentTypeLabel":"Research article","downloadFullIssue":true,"entitlementReason":"openaccess","features":["aamAttachments","keywords","references","preview"],"hasBody":true,"has-large-authors":false,"hasScholarlyAbstract":true,"headerConfig":{"contactUrl":"https://service.elsevier.com/app/contact/supporthub/sciencedirect/","userName":"","userEmail":"","orgName":"ScienceDirect Guests","webUserId":"12975512","libraryBanner":null,"shib_regUrl":"","tick_regUrl":"","recentInstitutions":[],"canActivatePersonalization":false,"hasInstitutionalAssociation":false,"hasMultiOrg":false,"userType":"GUEST","userAnonymity":"ANON_GUEST","allowCart":true,"environment":"prod","cdnAssetsHost":"https://sdfestaticassets-us-east-1.sciencedirectassets.com"},"isCorpReq":false,"isPdfFullText":false,"issn":"02779536","issn-primary-formatted":"0277-9536","issRange":"","isThirdParty":false,"licenseLink":{"prefix":"Under a Creative Commons ","text":"license","url":"http://creativecommons.org/licenses/by-nc-nd/4.0/"},"pageCount":20,"pdfDownload":{"isPdfFullText":false,"urlMetadata":{"queryParams":{"md5":"e88082fe9ad8ac078c8fe972c5265562","pid":"1-s2.0-S0277953619305908-main.pdf"},"pii":"S0277953619305908","pdfExtension":"/pdfft","path":"science/article/pii"}},"publication-content":{"noElsevierLogo":false,"imprintPublisher":{"displayName":"Pergamon","id":"67"},"isSpecialIssue":false,"isSampleIssue":false,"transactionsBlocked":false,"publicationOpenAccess":{"oaStatus":"","oaArticleCount":2499,"openArchiveStatus":false,"openArchiveArticleCount":191,"openAccessStartDate":"","oaAllowsAuthorPaid":true},"issue-cover":{"attachment":[{"attachment-eid":"1-s2.0-S0277953619X00258-cov200h.gif","file-basename":"cov200h","extension":"gif","filename":"cov200h.gif","ucs-locator":["https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0277953619X00258/cover/DOWNSAMPLED200/image/gif/5d381b8fc7ff88fa3d79966d4ee17d11/cov200h.gif"],"attachment-type":"IMAGE-COVER-H200","filesize":"11572","pixel-height":"200","pixel-width":"150"},{"attachment-eid":"1-s2.0-S0277953619X00258-cov150h.gif","file-basename":"cov150h","extension":"gif","filename":"cov150h.gif","ucs-locator":["https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0277953619X00258/cover/DOWNSAMPLED/image/gif/2ae74e68e86d0757770ba3476fb0b824/cov150h.gif"],"attachment-type":"IMAGE-COVER-H150","filesize":"5283","pixel-height":"150","pixel-width":"113"}]},"smallCoverUrl":"https://ars.els-cdn.com/content/image/S02779536.gif","title":"social-science-and-medicine","contentTypeCode":"JL","images":{"coverImage":"https://ars.els-cdn.com/content/image/1-s2.0-S0277953619X00258-cov150h.gif","logo":"https://sdfestaticassets-us-east-1.sciencedirectassets.com/prod/0408e3544c5d8a31f29fd84f48c3b04cd8f090f1/image/elsevier-non-solus.svg","logoAltText":"Elsevier"},"publicationCoverImageUrl":"https://ars.els-cdn.com/content/image/1-s2.0-S0277953619X00258-cov150h.gif"},"rightsLink":"https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&contentID=S0277953619305908&orderBeanReset=true","volRange":"246","titleString":"Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework","ssrn":{},"renderingMode":"Article","isAbstract":false,"isContentVisible":false,"ajaxLinks":{"referenceLinks":true,"references":true,"referredToBy":true,"toc":true,"body":true,"recommendations":true,"citingArticles":true,"authorMetadata":true},"pdfEmbed":false,"displayViewFullText":false},"authors":{"content":[{"#name":"author-group","$":{"id":"augrp0010"},"$$":[{"#name":"author","$":{"author-id":"S0277953619305908-c287722a5225f9b141af7f2fd68c9754","id":"au1","orcid":"0000-0002-0261-4634"},"$$":[{"#name":"given-name","_":"A."},{"#name":"surname","_":"Angelis"},{"#name":"cross-ref","$":{"id":"crosref0010","refid":"aff1"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"a"}]},{"#name":"cross-ref","$":{"id":"crosref0015","refid":"cor1"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"∗"}]},{"#name":"encoded-e-address","__encoded":"JTdCJTIyJTIzbmFtZSUyMiUzQSUyMmUtYWRkcmVzcyUyMiUyQyUyMiUyNCUyMiUzQSU3QiUyMnhtbG5zJTNBeGxpbmslMjIlM0F0cnVlJTJDJTIyaWQlMjIlM0ElMjJlYWRkMDAxMCUyMiUyQyUyMnR5cGUlMjIlM0ElMjJlbWFpbCUyMiUyQyUyMmhyZWYlMjIlM0ElMjJtYWlsdG8lM0FhLm4uYW5nZWxpcyU0MGxzZS5hYy51ayUyMiU3RCUyQyUyMl8lMjIlM0ElMjJhLm4uYW5nZWxpcyU0MGxzZS5hYy51ayUyMiU3RA=="}]},{"#name":"author","$":{"author-id":"S0277953619305908-51d646e976b0af13f636b3e862661c3d","id":"au2"},"$$":[{"#name":"given-name","_":"M."},{"#name":"surname","_":"Linch"},{"#name":"cross-ref","$":{"id":"crosref0020","refid":"aff2"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"b"}]}]},{"#name":"author","$":{"author-id":"S0277953619305908-28d193f99d2c9ca6389f653f3c769073","id":"au3","orcid":"0000-0003-1063-080X"},"$$":[{"#name":"given-name","_":"G."},{"#name":"surname","_":"Montibeller"},{"#name":"cross-ref","$":{"id":"crosref0025","refid":"aff3"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"c"}]}]},{"#name":"author","$":{"author-id":"S0277953619305908-38a47c2070bc3aa2a90d9fc3df3375c3","id":"au4"},"$$":[{"#name":"given-name","_":"T."},{"#name":"surname","_":"Molina-Lopez"},{"#name":"cross-ref","$":{"id":"crosref0030","refid":"aff4"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"d"}]}]},{"#name":"author","$":{"author-id":"S0277953619305908-581ce3854a355b3fe0941ec77502cb55","id":"au5"},"$$":[{"#name":"given-name","_":"A."},{"#name":"surname","_":"Zawada"},{"#name":"cross-ref","$":{"id":"crosref0035","refid":"aff5"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"e"}]}]},{"#name":"author","$":{"author-id":"S0277953619305908-720a4b19b5de97cc85553baefb6533b4","id":"au6"},"$$":[{"#name":"given-name","_":"K."},{"#name":"surname","_":"Orzel"},{"#name":"cross-ref","$":{"id":"crosref0040","refid":"aff5"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"e"}]}]},{"#name":"author","$":{"author-id":"S0277953619305908-755c3870d74bc68d72ad88453464728a","id":"au7"},"$$":[{"#name":"given-name","_":"F."},{"#name":"surname","_":"Arickx"},{"#name":"cross-ref","$":{"id":"crosref0045","refid":"aff6"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"f"}]}]},{"#name":"author","$":{"author-id":"S0277953619305908-c0405b904e245d709dccec5bfd692cdc","id":"au8"},"$$":[{"#name":"given-name","_":"J."},{"#name":"surname","_":"Espin"},{"#name":"cross-ref","$":{"id":"crosref0050","refid":"aff7"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"g"}]},{"#name":"cross-ref","$":{"id":"crosref0055","refid":"aff8"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"h"}]}]},{"#name":"author","$":{"author-id":"S0277953619305908-ae2d09c1d7b6c9b9660a3a41e1db6a0c","id":"au9"},"$$":[{"#name":"given-name","_":"P."},{"#name":"surname","_":"Kanavos"},{"#name":"cross-ref","$":{"id":"crosref0060","refid":"aff1"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"a"}]},{"#name":"cross-ref","$":{"id":"crosref0065","refid":"cor1"},"$$":[{"#name":"sup","$":{"loc":"post"},"_":"∗"}]},{"#name":"encoded-e-address","__encoded":"JTdCJTIyJTIzbmFtZSUyMiUzQSUyMmUtYWRkcmVzcyUyMiUyQyUyMiUyNCUyMiUzQSU3QiUyMnhtbG5zJTNBeGxpbmslMjIlM0F0cnVlJTJDJTIyaWQlMjIlM0ElMjJlYWRkMDAxNSUyMiUyQyUyMnR5cGUlMjIlM0ElMjJlbWFpbCUyMiUyQyUyMmhyZWYlMjIlM0ElMjJtYWlsdG8lM0FwLmcua2FuYXZvcyU0MGxzZS5hYy51ayUyMiU3RCUyQyUyMl8lMjIlM0ElMjJwLmcua2FuYXZvcyU0MGxzZS5hYy51ayUyMiU3RA=="}]},{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-3fec92ade7230cc15f276671c70889f2","id":"aff1"},"$$":[{"#name":"label","_":"a"},{"#name":"textfn","_":"LSE Health and Department of Health Policy, London School of Economics, London, UK"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"LSE Health and Department of Health Policy"},{"#name":"organization","_":"London School of Economics"},{"#name":"city","_":"London"},{"#name":"country","_":"UK"}]},{"#name":"source-text","$":{"id":"srct0010"},"_":"LSE Health and Department of Health Policy, London School of Economics, London, UK"}]},{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-4cd9f000c8f091a4086f407593dc9044","id":"aff2"},"$$":[{"#name":"label","_":"b"},{"#name":"textfn","_":"University College London Cancer Institute and University College London Hospital, London, UK"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"University College London Cancer Institute and University College London Hospital"},{"#name":"city","_":"London"},{"#name":"country","_":"UK"}]},{"#name":"source-text","$":{"id":"srct0015"},"_":"University College London Cancer Institute and University College London Hospital, London, UK"}]},{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-d18db3b9ab9c1fe3dc94793db0f5d2a5","id":"aff3"},"$$":[{"#name":"label","_":"c"},{"#name":"textfn","_":"School of Business and Economics, Loughborough University, Loughborough, UK"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"School of Business and Economics"},{"#name":"organization","_":"Loughborough University"},{"#name":"city","_":"Loughborough"},{"#name":"country","_":"UK"}]},{"#name":"source-text","$":{"id":"srct0020"},"_":"School of Business and Economics, Loughborough University, Loughborough, UK"}]},{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-93f389e99e6a3db6d66c9f593cae64e1","id":"aff4"},"$$":[{"#name":"label","_":"d"},{"#name":"textfn","_":"Andalusian Agency for Health Technology Assessment, Sevilla, Spain"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"Andalusian Agency for Health Technology Assessment"},{"#name":"city","_":"Sevilla"},{"#name":"country","_":"Spain"}]},{"#name":"source-text","$":{"id":"srct0025"},"_":"Andalusian Agency for Health Technology Assessment, Sevilla, Spain"}]},{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-46d1406218f2c1fe6e188ca48dd30cfa","id":"aff5"},"$$":[{"#name":"label","_":"e"},{"#name":"textfn","_":"Agency for Health Technology Assessment and Tariff System, Warsaw, Poland"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"Agency for Health Technology Assessment and Tariff System"},{"#name":"city","_":"Warsaw"},{"#name":"country","_":"Poland"}]},{"#name":"source-text","$":{"id":"srct0030"},"_":"Agency for Health Technology Assessment and Tariff System, Warsaw, Poland"}]},{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-dd7f29fc19536db3d74c7274ec5635bf","id":"aff6"},"$$":[{"#name":"label","_":"f"},{"#name":"textfn","_":"National Institute for Health and Disability Insurance, Brussels, Belgium"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"National Institute for Health and Disability Insurance"},{"#name":"city","_":"Brussels"},{"#name":"country","_":"Belgium"}]},{"#name":"source-text","$":{"id":"srct0035"},"_":"National Institute for Health and Disability Insurance, Brussels, Belgium"}]},{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-0bc661983b03088075224befe400a5ba","id":"aff7"},"$$":[{"#name":"label","_":"g"},{"#name":"textfn","_":"Andalusian School of Public Health, Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"Andalusian School of Public Health"},{"#name":"organization","_":"Instituto de Investigación Biosanitaria (ibs.GRANADA)"},{"#name":"city","_":"Granada"},{"#name":"country","_":"Spain"}]},{"#name":"source-text","$":{"id":"srct0040"},"_":"Andalusian School of Public Health, Instituto de Investigacion Biosanitaria (ibs.GRANADA), Granada, Spain"}]},{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-d3d2cdc333066a990603c354995af007","id":"aff8"},"$$":[{"#name":"label","_":"h"},{"#name":"textfn","_":"CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"CIBER de Epidemiología y Salud Pública (CIBERESP)"},{"#name":"city","_":"Madrid"},{"#name":"country","_":"Spain"}]},{"#name":"source-text","$":{"id":"srct0045"},"_":"CIBER de Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain"}]},{"#name":"correspondence","$":{"id":"cor1"},"$$":[{"#name":"label","_":"∗"},{"#name":"text","_":"Corresponding authors. LSE Health and Department of Health Policy, London School of Economics, Houghton Street, London, WC2A 2AE, UK."},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"LSE Health and Department of Health Policy"},{"#name":"organization","_":"London School of Economics"},{"#name":"address-line","_":"Houghton Street"},{"#name":"city","_":"London"},{"#name":"postal-code","_":"WC2A 2AE"},{"#name":"country","_":"UK"}]}]}]}],"floats":[],"footnotes":[],"affiliations":{"aff1":{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-3fec92ade7230cc15f276671c70889f2","id":"aff1"},"$$":[{"#name":"label","_":"a"},{"#name":"textfn","_":"LSE Health and Department of Health Policy, London School of Economics, London, UK"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"LSE Health and Department of Health Policy"},{"#name":"organization","_":"London School of Economics"},{"#name":"city","_":"London"},{"#name":"country","_":"UK"}]},{"#name":"source-text","$":{"id":"srct0010"},"_":"LSE Health and Department of Health Policy, London School of Economics, London, UK"}]},"aff2":{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-4cd9f000c8f091a4086f407593dc9044","id":"aff2"},"$$":[{"#name":"label","_":"b"},{"#name":"textfn","_":"University College London Cancer Institute and University College London Hospital, London, UK"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"University College London Cancer Institute and University College London Hospital"},{"#name":"city","_":"London"},{"#name":"country","_":"UK"}]},{"#name":"source-text","$":{"id":"srct0015"},"_":"University College London Cancer Institute and University College London Hospital, London, UK"}]},"aff3":{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-d18db3b9ab9c1fe3dc94793db0f5d2a5","id":"aff3"},"$$":[{"#name":"label","_":"c"},{"#name":"textfn","_":"School of Business and Economics, Loughborough University, Loughborough, UK"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"School of Business and Economics"},{"#name":"organization","_":"Loughborough University"},{"#name":"city","_":"Loughborough"},{"#name":"country","_":"UK"}]},{"#name":"source-text","$":{"id":"srct0020"},"_":"School of Business and Economics, Loughborough University, Loughborough, UK"}]},"aff4":{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-93f389e99e6a3db6d66c9f593cae64e1","id":"aff4"},"$$":[{"#name":"label","_":"d"},{"#name":"textfn","_":"Andalusian Agency for Health Technology Assessment, Sevilla, Spain"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"Andalusian Agency for Health Technology Assessment"},{"#name":"city","_":"Sevilla"},{"#name":"country","_":"Spain"}]},{"#name":"source-text","$":{"id":"srct0025"},"_":"Andalusian Agency for Health Technology Assessment, Sevilla, Spain"}]},"aff5":{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-46d1406218f2c1fe6e188ca48dd30cfa","id":"aff5"},"$$":[{"#name":"label","_":"e"},{"#name":"textfn","_":"Agency for Health Technology Assessment and Tariff System, Warsaw, Poland"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"Agency for Health Technology Assessment and Tariff System"},{"#name":"city","_":"Warsaw"},{"#name":"country","_":"Poland"}]},{"#name":"source-text","$":{"id":"srct0030"},"_":"Agency for Health Technology Assessment and Tariff System, Warsaw, Poland"}]},"aff6":{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-dd7f29fc19536db3d74c7274ec5635bf","id":"aff6"},"$$":[{"#name":"label","_":"f"},{"#name":"textfn","_":"National Institute for Health and Disability Insurance, Brussels, Belgium"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"National Institute for Health and Disability Insurance"},{"#name":"city","_":"Brussels"},{"#name":"country","_":"Belgium"}]},{"#name":"source-text","$":{"id":"srct0035"},"_":"National Institute for Health and Disability Insurance, Brussels, Belgium"}]},"aff7":{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-0bc661983b03088075224befe400a5ba","id":"aff7"},"$$":[{"#name":"label","_":"g"},{"#name":"textfn","_":"Andalusian School of Public Health, Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"Andalusian School of Public Health"},{"#name":"organization","_":"Instituto de Investigación Biosanitaria (ibs.GRANADA)"},{"#name":"city","_":"Granada"},{"#name":"country","_":"Spain"}]},{"#name":"source-text","$":{"id":"srct0040"},"_":"Andalusian School of Public Health, Instituto de Investigacion Biosanitaria (ibs.GRANADA), Granada, Spain"}]},"aff8":{"#name":"affiliation","$":{"affiliation-id":"S0277953619305908-d3d2cdc333066a990603c354995af007","id":"aff8"},"$$":[{"#name":"label","_":"h"},{"#name":"textfn","_":"CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain"},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"CIBER de Epidemiología y Salud Pública (CIBERESP)"},{"#name":"city","_":"Madrid"},{"#name":"country","_":"Spain"}]},{"#name":"source-text","$":{"id":"srct0045"},"_":"CIBER de Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain"}]}},"correspondences":{"cor1":{"#name":"correspondence","$":{"id":"cor1"},"$$":[{"#name":"label","_":"∗"},{"#name":"text","_":"Corresponding authors. LSE Health and Department of Health Policy, London School of Economics, Houghton Street, London, WC2A 2AE, UK."},{"#name":"affiliation","$":{"xmlns:sa":true},"$$":[{"#name":"organization","_":"LSE Health and Department of Health Policy"},{"#name":"organization","_":"London School of Economics"},{"#name":"address-line","_":"Houghton Street"},{"#name":"city","_":"London"},{"#name":"postal-code","_":"WC2A 2AE"},{"#name":"country","_":"UK"}]}]}},"attachments":[],"scopusAuthorIds":{},"articles":{}},"authorMetadata":[],"banner":{"expanded":false},"biographies":{},"body":{},"chapters":{"toc":[],"isLoading":false},"changeViewLinks":{"showFullTextLink":false,"showAbstractLink":false},"citingArticles":{},"clientConfig":{"adobeSuite":"elsevier-sd-prod","arsUrl":"https://ars.els-cdn.com","assetRoute":"https://sdfestaticassets-us-east-1.sciencedirectassets.com/prod/0408e3544c5d8a31f29fd84f48c3b04cd8f090f1","recommendationsFeedback":{"enabled":true,"url":"https://feedback.recs.d.elsevier.com/raw/events","timeout":60000},"googleMapsApiKey":"AIzaSyCBYU6I6lrbEU6wQXUEIte3NwGtm3jwHQc","mediaBaseUrl":"https://ars.els-cdn.com/content/image/","xocsMediaPlayerBaseUrl":"https://sdfestaticassets-us-east-1.sciencedirectassets.com/shared-assets/147/js/ableplayer","strictMode":false,"seamlessAccess":{"enableSeamlessAccess":true,"scriptUrl":"https://unpkg.com/@theidentityselector/thiss-ds@1.0.13/dist/thiss-ds.js","persistenceUrl":"https://service.seamlessaccess.org/ps/","persistenceContext":"seamlessaccess.org","scienceDirectUrl":"https://www.sciencedirect.com","shibAuthUrl":"https://auth.elsevier.com/ShibAuth/institutionLogin"},"reaxys":{"apiUrl":"https://reaxys-sdlc.reaxys.com","origin":"sciencedirect","queryBuilderHostPath":"https://www.reaxys.com/reaxys/secured/hopinto.do","url":"https://www.reaxys.com"},"oneTrustCookie":{"enabled":true},"ssrn":{"url":"https://papers.ssrn.com","path":"/sol3/papers.cfm"},"aiNavigation":{"enabled":true,"version":"V1"}},"combinedContentItems":{"content":[{"#name":"keywords","$$":[{"#name":"keywords","$":{"xmlns:ce":true,"xmlns:aep":true,"xmlns:xoe":true,"xmlns:mml":true,"xmlns:xs":true,"xmlns:xlink":true,"xmlns:xocs":true,"xmlns:tb":true,"xmlns:xsi":true,"xmlns:cals":true,"xmlns:sb":true,"xmlns:sa":true,"xmlns:ja":true,"xmlns":true,"class":"keyword","id":"kwrds0010","lang":"en","view":"all"},"$$":[{"#name":"section-title","$":{"id":"sectitle0020"},"_":"Keywords"},{"#name":"keyword","$":{"id":"kwrd0010"},"$$":[{"#name":"text","_":"Multiple Criteria Decision Analysis (MCDA)"}]},{"#name":"keyword","$":{"id":"kwrd0015"},"$$":[{"#name":"text","_":"Health Technology Assessment (HTA)"}]},{"#name":"keyword","$":{"id":"kwrd0020"},"$$":[{"#name":"text","_":"Advance Value Framework (AVF)"}]},{"#name":"keyword","$":{"id":"kwrd0025"},"$$":[{"#name":"text","_":"Decision conference"}]},{"#name":"keyword","$":{"id":"kwrd0030"},"$$":[{"#name":"text","_":"Value assessment"}]},{"#name":"keyword","$":{"id":"kwrd0035"},"$$":[{"#name":"text","_":"Decision making"}]},{"#name":"keyword","$":{"id":"kwrd0040"},"$$":[{"#name":"text","_":"Pharmaceuticals"}]},{"#name":"keyword","$":{"id":"kwrd0045"},"$$":[{"#name":"text","_":"Oncology"}]}]}]}],"floats":[],"footnotes":[],"attachments":[]},"crossMark":{"isOpen":false},"domainConfig":{"assetRoute":"https://sdfestaticassets-us-east-1.sciencedirectassets.com/prod/0408e3544c5d8a31f29fd84f48c3b04cd8f090f1","cdnAssetsHost":"https://sdfestaticassets-us-east-1.sciencedirectassets.com"},"downloadIssue":{"openOnPageLoad":false,"isOpen":false,"downloadCapOpen":false,"articles":[],"selected":[]},"enrichedContent":{"tableOfContents":false,"researchData":{"hasResearchData":false,"dataProfile":{},"openData":{},"mendeleyData":{},"databaseLinking":{}},"geospatialData":{"attachments":[]},"interactiveCaseInsights":{},"virtualMicroscope":{}},"entitledRecommendations":{"openOnPageLoad":false,"isOpen":false,"articles":[],"selected":[],"currentPage":1,"totalPages":1},"exam":{},"helpText":{"keyDates":{"html":"<div class=\"key-dates-help\"><h3 class=\"u-margin-s-bottom u-h4\">Publication milestones</h3><p class=\"u-margin-m-bottom\">The dates displayed for an article provide information on when various publication milestones were reached at the journal that has published the article. Where applicable, activities on preceding journals at which the article was previously under consideration are not shown (for instance submission, revisions, rejection).</p><p class=\"u-margin-xs-bottom\">The publication milestones include:</p><ul class=\"key-dates-help-list u-margin-m-bottom u-padding-s-left\"><li><span class=\"u-text-italic\">Received</span>: The date the article was originally submitted to the journal.</li><li><span class=\"u-text-italic\">Revised</span>: The date the most recent revision of the article was submitted to the journal. Dates corresponding to intermediate revisions are not shown.</li><li><span class=\"u-text-italic\">Accepted</span>: The date the article was accepted for publication in the journal.</li><li><span class=\"u-text-italic\">Available online</span>: The date a version of the article was made available online in the journal.</li><li><span class=\"u-text-italic\">Version of Record</span>: The date the finalized version of the article was made available in the journal.</li></ul><p>More information on publishing policies can be found on the <a class=\"anchor anchor-secondary u-display-inline anchor-underline\" href=\"https://www.elsevier.com/about/policies-and-standards/publishing-ethics\" target=\"_blank\"><span class=\"anchor-text-container\"><span class=\"anchor-text\">Publishing Ethics Policies</span></span></a> page. View our <a class=\"anchor anchor-secondary u-display-inline anchor-underline\" href=\"https://www.elsevier.com/researcher/author/submit-your-paper\" target=\"_blank\"><span class=\"anchor-text-container\"><span class=\"anchor-text\">Publishing with Elsevier: step-by-step</span></span></a> page to learn more about the publishing process. For any questions on your own submission or other questions related to publishing an article, <a class=\"anchor anchor-secondary u-display-inline anchor-underline\" href=\"https://service.elsevier.com/app/phone/supporthub/publishing\" target=\"_blank\"><span class=\"anchor-text-container\"><span class=\"anchor-text\">contact our Researcher support team.</span></span></a></p></div>","title":"What do these dates mean?"}},"glossary":{},"issueNavigation":{"previous":{},"next":{}},"linkingHubLinks":{},"metrics":{"metricGroup":{"citations":[],"captures":[],"mentions":[],"socialMedia":[]},"isLoading":false,"error":false,"hasMetrics":false},"preview":{},"rawtext":"","recommendations":{},"references":{},"referenceLinks":{"internal":[],"internalLoaded":false,"external":[]},"refersTo":{},"referredToBy":{},"relatedContent":{"isModal":false,"isOpenSpecialIssueArticles":false,"isOpenVirtualSpecialIssueLink":false,"isOpenRecommendations":true,"isOpenSubstances":true,"citingArticles":[false,false,false,false,false,false],"recommendations":[false,false,false,false,false,false]},"seamlessAccess":{},"specialIssueArticles":{},"substances":{},"supplementaryFilesData":[],"tableOfContents":{"showEntitledTocLinks":true},"tail":{},"transientError":{"isOpen":false},"sidePanel":{"openState":1},"viewConfig":{"articleFeature":{"aiNavigation":false},"pathPrefix":""},"virtualSpecialIssue":{"showVirtualSpecialIssueLink":false},"usageProps":{"itemStage":"S300","isAip":false,"tombAip":"0","sample":false},"userCookiePreferences":{"STRICTLY_NECESSARY":true,"PERFORMANCE":false,"FUNCTIONAL":false,"TARGETING":false}};
      </script>
      <noscript>
      JavaScript is disabled on your browser.
      Please enable JavaScript to use all the features on this page.
      <img src=https://smetrics.elsevier.com/b/ss/elsevier-sd-prod/1/G.4--NS/1749597544067?pageName=sd%3Aproduct%3Ajournal%3Aarticle&c16=els%3Arp%3Ast&c2=sd&v185=img&v33=ae%3AANON_GUEST&c1=ae%3A228598&c12=ae%3A12975512 />
    </noscript>
      <a class="anchor sr-only sr-only-focusable u-display-inline anchor-primary" href="#screen-reader-main-content"><span class="anchor-text-container"><span class="anchor-text">Skip to main content</span></span></a><a class="anchor sr-only sr-only-focusable u-display-inline anchor-primary" href="#screen-reader-main-title"><span class="anchor-text-container"><span class="anchor-text">Skip to article</span></span></a>
      <div id="root"><div class="App" id="app" data-aa-name="root"><div class="page"><div class="sd-flex-container"><div class="sd-flex-content"><header id="gh-cnt"><div id="gh-main-cnt" class="u-flex-center-ver u-position-relative u-padding-s-hor u-padding-l-hor-from-xl"><a id="gh-branding" class="u-flex-center-ver" href="/" aria-label="ScienceDirect home page" data-aa-region="header" data-aa-name="ScienceDirect"><img class="gh-logo" src="https://sdfestaticassets-us-east-1.sciencedirectassets.com/shared-assets/24/images/elsevier-non-solus-new-grey.svg" alt="Elsevier logo" height="48" width="54"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" height="15" viewBox="0 0 190 23" role="img" class="gh-wordmark u-margin-s-left" aria-labelledby="gh-wm-science-direct" focusable="false" aria-hidden="true" alt="ScienceDirect Wordmark"><title id="gh-wm-science-direct">ScienceDirect</title><g><path fill="#EB6500" d="M3.81 6.9c0-1.48 0.86-3.04 3.7-3.04 1.42 0 3.1 0.43 4.65 1.32l0.13-2.64c-1.42-0.63-2.97-0.96-4.78-0.96 -4.62 0-6.6 2.44-6.6 5.45 0 5.61 8.78 6.14 8.78 9.93 0 1.48-1.15 3.04-3.86 3.04 -1.72 0-3.4-0.56-4.72-1.39l-0.36 2.64c1.55 0.76 3.57 1.06 5.15 1.06 4.26 0 6.7-2.48 6.7-5.51C12.59 11.49 3.81 10.76 3.81 6.9M20.27 9.01c0.23-0.13 0.69-0.26 1.72-0.26 1.72 0 2.41 0.3 2.41 1.58h2.38c0-0.36 0-0.79-0.03-1.09 -0.23-1.98-2.15-2.67-4.88-2.67 -3 0-6.7 2.31-6.7 7.76 0 5.22 2.77 7.99 6.63 7.99 1.68 0 3.47-0.36 4.95-1.39l-0.2-2.31c-0.99 0.82-2.84 1.52-4.06 1.52 -2.14 0-4.55-1.71-4.55-5.91C17.93 10.2 20.01 9.18 20.27 9.01"></path><rect x="29.42" y="6.97" fill="#EB6500" width="2.54" height="14.95"></rect><path fill="#EB6500" d="M30.67 0.7c-0.92 0-1.65 0.92-1.65 1.81 0 0.93 0.76 1.85 1.65 1.85 0.89 0 1.68-0.96 1.68-1.88C32.35 1.55 31.56 0.7 30.67 0.7M48.06 14.13c0-5.18-1.42-7.56-6.01-7.56 -3.86 0-6.67 2.77-6.67 7.92 0 4.92 2.97 7.82 6.73 7.82 2.81 0 4.36-0.63 5.68-1.42l-0.2-2.31c-0.89 0.79-2.94 1.55-4.69 1.55 -3.14 0-4.88-1.95-4.88-5.51v-0.49H48.06M39.91 9.18c0.17-0.17 1.29-0.46 1.98-0.46 2.48 0 3.76 0.53 3.86 3.43h-7.46C38.56 10.27 39.71 9.37 39.91 9.18zM58.82 6.57c-2.24 0-3.63 1.12-4.85 2.61l-0.4-2.21h-2.34l0.13 1.19c0.1 0.76 0.13 1.78 0.13 2.97v10.79h2.54V11.88c0.69-0.96 2.15-2.48 2.48-2.64 0.23-0.13 1.29-0.4 2.08-0.4 2.28 0 2.48 1.15 2.54 3.43 0.03 1.19 0.03 3.17 0.03 3.17 0.03 3-0.1 6.47-0.1 6.47h2.54c0 0 0.07-4.49 0.07-6.96 0-1.48 0.03-2.97-0.1-4.46C63.31 7.43 61.49 6.57 58.82 6.57M72.12 9.01c0.23-0.13 0.69-0.26 1.72-0.26 1.72 0 2.41 0.3 2.41 1.58h2.38c0-0.36 0-0.79-0.03-1.09 -0.23-1.98-2.15-2.67-4.88-2.67 -3 0-6.7 2.31-6.7 7.76 0 5.22 2.77 7.99 6.63 7.99 1.68 0 3.47-0.36 4.95-1.39l-0.2-2.31c-0.99 0.82-2.84 1.52-4.06 1.52 -2.15 0-4.55-1.71-4.55-5.91C69.77 10.2 71.85 9.18 72.12 9.01M92.74 14.13c0-5.18-1.42-7.56-6.01-7.56 -3.86 0-6.67 2.77-6.67 7.92 0 4.92 2.97 7.82 6.73 7.82 2.81 0 4.36-0.63 5.68-1.42l-0.2-2.31c-0.89 0.79-2.94 1.55-4.69 1.55 -3.14 0-4.88-1.95-4.88-5.51v-0.49H92.74M84.59 9.18c0.17-0.17 1.29-0.46 1.98-0.46 2.48 0 3.76 0.53 3.86 3.43h-7.46C83.24 10.27 84.39 9.37 84.59 9.18zM103.9 1.98h-7.13v19.93h6.83c7.26 0 9.77-5.68 9.77-10.03C113.37 7.33 110.93 1.98 103.9 1.98M103.14 19.8h-3.76V4.1h4.09c5.38 0 6.96 4.39 6.96 7.79C110.43 16.87 108.19 19.8 103.14 19.8zM118.38 0.7c-0.92 0-1.65 0.92-1.65 1.81 0 0.93 0.76 1.85 1.65 1.85 0.89 0 1.69-0.96 1.69-1.88C120.07 1.55 119.28 0.7 118.38 0.7"></path><rect x="117.13" y="6.97" fill="#EB6500" width="2.54" height="14.95"></rect><path fill="#EB6500" d="M130.2 6.6c-1.62 0-2.87 1.45-3.4 2.74l-0.43-2.37h-2.34l0.13 1.19c0.1 0.76 0.13 1.75 0.13 2.9v10.86h2.54v-9.51c0.53-1.29 1.72-3.7 3.17-3.7 0.96 0 1.06 0.99 1.06 1.22l2.08-0.6V9.18c0-0.03-0.03-0.17-0.06-0.4C132.8 7.36 131.91 6.6 130.2 6.6M145.87 14.13c0-5.18-1.42-7.56-6.01-7.56 -3.86 0-6.67 2.77-6.67 7.92 0 4.92 2.97 7.82 6.73 7.82 2.81 0 4.36-0.63 5.68-1.42l-0.2-2.31c-0.89 0.79-2.94 1.55-4.69 1.55 -3.14 0-4.89-1.95-4.89-5.51v-0.49H145.87M137.72 9.18c0.17-0.17 1.29-0.46 1.98-0.46 2.48 0 3.76 0.53 3.86 3.43h-7.46C136.37 10.27 137.52 9.37 137.72 9.18zM153.23 9.01c0.23-0.13 0.69-0.26 1.72-0.26 1.72 0 2.41 0.3 2.41 1.58h2.38c0-0.36 0-0.79-0.03-1.09 -0.23-1.98-2.14-2.67-4.88-2.67 -3 0-6.7 2.31-6.7 7.76 0 5.22 2.77 7.99 6.63 7.99 1.69 0 3.47-0.36 4.95-1.39l-0.2-2.31c-0.99 0.82-2.84 1.52-4.06 1.52 -2.15 0-4.55-1.71-4.55-5.91C150.89 10.2 152.97 9.18 153.23 9.01M170 19.44c-0.92 0.36-1.72 0.69-2.51 0.69 -1.16 0-1.58-0.66-1.58-2.34V8.95h3.93V6.97h-3.93V2.97h-2.48v3.99h-2.71v1.98h2.71v9.67c0 2.64 1.39 3.73 3.33 3.73 1.15 0 2.54-0.39 3.43-0.79L170 19.44M173.68 5.96c-1.09 0-2-0.87-2-1.97 0-1.1 0.91-1.97 2-1.97s1.98 0.88 1.98 1.98C175.66 5.09 174.77 5.96 173.68 5.96zM173.67 2.46c-0.85 0-1.54 0.67-1.54 1.52 0 0.85 0.69 1.54 1.54 1.54 0.85 0 1.54-0.69 1.54-1.54C175.21 3.13 174.52 2.46 173.67 2.46zM174.17 5.05c-0.09-0.09-0.17-0.19-0.25-0.3l-0.41-0.56h-0.16v0.87h-0.39V2.92c0.22-0.01 0.47-0.03 0.66-0.03 0.41 0 0.82 0.16 0.82 0.64 0 0.29-0.21 0.55-0.49 0.63 0.23 0.32 0.45 0.62 0.73 0.91H174.17zM173.56 3.22l-0.22 0.01v0.63h0.22c0.26 0 0.43-0.05 0.43-0.34C174 3.28 173.83 3.21 173.56 3.22z"></path></g></svg></a><div class="gh-nav-cnt u-hide-from-print"><div class="gh-nav-links-container gh-nav-links-container-h u-hide-from-print gh-nav-content-container"><nav aria-label="links" class="gh-nav gh-nav-links gh-nav-h"><ul class="gh-nav-list u-list-reset"><li class="gh-nav-item gh-move-to-spine"><a class="anchor gh-nav-action text-s anchor-secondary anchor-medium" href="/browse/journals-and-books" id="gh-journals-books-link" data-aa-region="header" data-aa-name="Journals &amp; Books"><span class="anchor-text-container"><span class="anchor-text">Journals &amp; Books</span></span></a></li></ul></nav><nav aria-label="utilities" class="gh-nav gh-nav-utilities gh-nav-h"><ul class="gh-nav-list u-list-reset"><li class="gh-nav-help text-s u-flex-center-ver u-gap-6 gh-nav-action"><div class="gh-move-to-spine gh-help-button gh-help-icon gh-nav-item"><div class="popover" id="gh-help-icon-popover"><div id="popover-trigger-gh-help-icon-popover"><input type="hidden"><button class="button-link button-link-secondary gh-icon-btn button-link-medium button-link-icon-left" type="button" aria-expanded="false"><svg focusable="false" viewBox="0 0 114 128" height="20" width="20" class="icon icon-help gh-icon"><path d="M57 8C35.69 7.69 15.11 21.17 6.68 40.71c-8.81 19.38-4.91 43.67 9.63 59.25 13.81 15.59 36.85 21.93 56.71 15.68 21.49-6.26 37.84-26.81 38.88-49.21 1.59-21.15-10.47-42.41-29.29-52.1C74.76 10.17 65.88 7.99 57 8zm0 10c20.38-.37 39.57 14.94 43.85 34.85 4.59 18.53-4.25 39.23-20.76 48.79-17.05 10.59-40.96 7.62-54.9-6.83-14.45-13.94-17.42-37.85-6.83-54.9C26.28 26.5 41.39 17.83 57 18zm-.14 14C45.31 32.26 40 40.43 40 50v2h10v-2c0-4.22 2.22-9.66 8-9.24 5.5.4 6.32 5.14 5.78 8.14C62.68 55.06 52 58.4 52 69.4V76h10v-5.56c0-8.16 11.22-11.52 12-21.7.74-9.86-5.56-16.52-16-16.74-.39-.01-.76-.01-1.14 0zM52 82v10h10V82H52z"></path></svg><span class="button-link-text-container"><span class="button-link-text">Help</span></span></button></div></div></div></li><li class="gh-nav-search text-s u-flex-center-ver u-gap-6 gh-nav-action"><div class="gh-search-toggle gh-nav-item search-button-link"><a class="anchor button-link-secondary anchor-secondary u-margin-l-left gh-nav-action gh-icon-btn anchor-medium anchor-icon-left anchor-with-icon" href="/search" id="gh-search-link" data-aa-button="search-in-header-opened-from-article" role="button"><svg focusable="false" viewBox="0 0 100 128" height="20" class="icon icon-search gh-icon"><path d="M19.22 76.91c-5.84-5.84-9.05-13.6-9.05-21.85s3.21-16.01 9.05-21.85c5.84-5.83 13.59-9.05 21.85-9.05 8.25 0 16.01 3.22 21.84 9.05 5.84 5.84 9.05 13.6 9.05 21.85s-3.21 16.01-9.05 21.85c-5.83 5.83-13.59 9.05-21.84 9.05-8.26 0-16.01-3.22-21.85-9.05zm80.33 29.6L73.23 80.19c5.61-7.15 8.68-15.9 8.68-25.13 0-10.91-4.25-21.17-11.96-28.88-7.72-7.71-17.97-11.96-28.88-11.96S19.9 18.47 12.19 26.18C4.47 33.89.22 44.15.22 55.06s4.25 21.17 11.97 28.88C19.9 91.65 30.16 95.9 41.07 95.9c9.23 0 17.98-3.07 25.13-8.68l26.32 26.32 7.03-7.03"></path></svg><span class="anchor-text-container"><span class="anchor-text">Search</span></span></a></div></li></ul></nav></div></div><div class="gh-profile-container gh-move-to-spine u-hide-from-print"><a class="anchor text-s u-clr-grey8 u-margin-l-left gh-icon-btn anchor-primary anchor-medium anchor-icon-left anchor-with-icon" href="/user/login?targetURL=%2Fscience%2Farticle%2Fpii%2FS0277953619305908&amp;from=globalheader" id="gh-myaccount-btn" data-aa-region="header" data-aa-name="personalsignin"><svg focusable="false" viewBox="0 0 106 128" height="20" aria-hidden="true" class="icon icon-person gh-cta-btn-icon"><path d="M11.07 120l.84-9.29C13.88 91.92 35.25 87.78 53 87.78c17.74 0 39.11 4.13 41.08 22.84l.84 9.38h10.04l-.93-10.34C101.88 89.23 83.89 78 53 78S4.11 89.22 1.95 109.73L1.04 120h10.03M53 17.71c-9.72 0-18.24 8.69-18.24 18.59 0 13.67 7.84 23.98 18.24 23.98S71.24 49.97 71.24 36.3c0-9.9-8.52-18.59-18.24-18.59zM53 70c-15.96 0-28-14.48-28-33.67C25 20.97 37.82 8 53 8s28 12.97 28 28.33C81 55.52 68.96 70 53 70"></path></svg><span class="anchor-text-container"><span class="anchor-text">My account</span></span></a></div><a class="anchor text-s u-clr-grey8 gh-move-to-spine u-hide-from-print u-margin-l-left anchor-secondary gh-icon-btn anchor-medium anchor-icon-left anchor-with-icon" href="/user/institution/login?targetURL=%2Fscience%2Farticle%2Fpii%2FS0277953619305908" id="gh-institutionalsignin-btn" data-aa-region="header" data-aa-name="institutionalsignin"><svg focusable="false" viewBox="0 0 106 128" height="20" aria-hidden="true" class="icon icon-institution gh-cta-btn-icon"><path d="M84 98h10v10H12V98h10V52h14v46h10V52h14v46h10V52h14v46zM12 36.86l41-20.84 41 20.84V42H12v-5.14zM104 52V30.74L53 4.8 2 30.74V52h10v36H2v30h102V88H94V52h10z"></path></svg><span class="anchor-text-container"><span class="anchor-text">Sign in</span></span></a><div id="gh-mobile-menu" class="mobile-menu u-hide-from-print"><div class="gh-hamburger u-fill-grey7"><button class="button-link u-flex-center-ver button-link-primary button-link-icon-left" type="button" aria-label="Toggle mobile menu" aria-expanded="false"><svg class="gh-hamburger-svg-el gh-hamburger-closed" role="img" aria-hidden="true" height="20" width="20"><path d="M0 14h40v2H0zm0-7h40v2H0zm0-7h40v2H0z"></path></svg></button></div><div id="gh-overlay" class="mobile-menu-overlay u-overlay u-display-none" role="button" tabindex="-1"></div><div id="gh-drawer" aria-label="Mobile menu" class="" role="navigation"></div></div></div></header><div id="sd-ai-navigation-container"></div><div id="reading-assistant-main-body-section"></div><div class="Article" id="mathjax-container" role="main"><div class="accessbar-sticky"><div id="screen-reader-main-content"></div><div role="region" aria-label="Download options and search"><div class="accessbar"><div class="accessbar-label"></div><ul aria-label="PDF Options"><li class="ViewPDF"><a class="link-button accessbar-utility-component accessbar-utility-link link-button-primary link-button-icon-left" target="_blank" aria-label="View PDF. Opens in a new window." href="/science/article/pii/S0277953619305908/pdfft?md5=e88082fe9ad8ac078c8fe972c5265562&amp;pid=1-s2.0-S0277953619305908-main.pdf" rel="nofollow"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="link-button-text-container"><span class="link-button-text"><span>View&nbsp;<strong>PDF</strong></span></span></span></a></li><li class="DownloadFullIssue"><button class="button-link accessbar-utility-component button-link-primary" type="button" aria-label="Download full issue"><span class="button-link-text-container"><span class="button-link-text"><span>Download full issue</span></span></span></button></li></ul><form class="QuickSearch" action="/search#submit" method="get" aria-label="form"><div class="search-input"><div class="search-input-container search-input-container-no-label"><label class="search-input-label u-hide-visually" for="article-quick-search">Search ScienceDirect</label><input type="search" id="article-quick-search" name="qs" class="search-input-field" aria-describedby="article-quick-search-description-message" aria-invalid="false" aria-label="Search ScienceDirect" placeholder="Search ScienceDirect" value=""></div><div class="search-input-message-container"><div class="search-input-validation-error" aria-live="polite"></div><div id="article-quick-search-description-message"></div></div></div><button type="submit" class="button u-margin-xs-left button-primary small button-icon-only" aria-disabled="false" aria-label="Submit search"><svg focusable="false" viewBox="0 0 100 128" height="20" class="icon icon-search"><path d="M19.22 76.91c-5.84-5.84-9.05-13.6-9.05-21.85s3.21-16.01 9.05-21.85c5.84-5.83 13.59-9.05 21.85-9.05 8.25 0 16.01 3.22 21.84 9.05 5.84 5.84 9.05 13.6 9.05 21.85s-3.21 16.01-9.05 21.85c-5.83 5.83-13.59 9.05-21.84 9.05-8.26 0-16.01-3.22-21.85-9.05zm80.33 29.6L73.23 80.19c5.61-7.15 8.68-15.9 8.68-25.13 0-10.91-4.25-21.17-11.96-28.88-7.72-7.71-17.97-11.96-28.88-11.96S19.9 18.47 12.19 26.18C4.47 33.89.22 44.15.22 55.06s4.25 21.17 11.97 28.88C19.9 91.65 30.16 95.9 41.07 95.9c9.23 0 17.98-3.07 25.13-8.68l26.32 26.32 7.03-7.03"></path></svg></button><input type="hidden" name="origin" value="article"><input type="hidden" name="zone" value="qSearch"></form></div></div></div><div class="article-wrapper grid row"><div role="navigation" class="u-display-block-from-lg col-lg-6 u-padding-s-top sticky-table-of-contents" aria-label="Table of contents"><div class="TableOfContents" lang="en"><div class="Outline" id="toc-outline"><h2 class="u-h4">Outline</h2><ol class="u-padding-xs-bottom"><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary" href="#abs0015" data-aa-button="sd:product:journal:article:type=anchor:name=outlinelink" title="Highlights"><span class="anchor-text-container"><span class="anchor-text">Highlights</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary" href="#abs0010" data-aa-button="sd:product:journal:article:type=anchor:name=outlinelink" title="Abstract"><span class="anchor-text-container"><span class="anchor-text">Abstract</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary" href="#kwrds0010" data-aa-button="sd:product:journal:article:type=anchor:name=outlinelink" title="Keywords"><span class="anchor-text-container"><span class="anchor-text">Keywords</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary" href="#sec1" data-aa-button="sd:product:journal:article:type=anchor:name=outlinelink" title="1. Introduction"><span class="anchor-text-container"><span class="anchor-text">1. Introduction</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary" href="#sec2" data-aa-button="sd:product:journal:article:type=anchor:name=outlinelink" title="2. Methods"><span class="anchor-text-container"><span class="anchor-text">2. Methods</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary" href="#sec3" data-aa-button="sd:product:journal:article:type=anchor:name=outlinelink" title="3. Results"><span class="anchor-text-container"><span class="anchor-text">3. Results</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary" href="#sec4" data-aa-button="sd:product:journal:article:type=anchor:name=outlinelink" title="4. Discussion"><span class="anchor-text-container"><span class="anchor-text">4. Discussion</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary" href="#sec5" data-aa-button="sd:product:journal:article:type=anchor:name=outlinelink" title="5. Conclusion"><span class="anchor-text-container"><span class="anchor-text">5. Conclusion</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary" href="#ack0010" data-aa-button="sd:product:journal:article:type=anchor:name=outlinelink" title="Acknowledgements"><span class="anchor-text-container"><span class="anchor-text">Acknowledgements</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary" href="#appsec1" data-aa-button="sd:product:journal:article:type=anchor:name=outlinelink" title="Appendix"><span class="anchor-text-container"><span class="anchor-text">Appendix. </span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary" href="#cebib0010" data-aa-button="sd:product:journal:article:type=anchor:name=outlinelink" title="References"><span class="anchor-text-container"><span class="anchor-text">References</span></span></a></li></ol><button class="button-link u-margin-xs-top u-margin-s-bottom button-link-primary button-link-icon-right" type="button" aria-expanded="false" data-aa-button="sd:product:journal:article:type=menu:name=show-full-outline"><span class="button-link-text-container"><span class="button-link-text">Show full outline</span></span><svg focusable="false" viewBox="0 0 92 128" height="20" class="icon icon-navigate-down"><path d="M1 51l7-7 38 38 38-38 7 7-45 45z"></path></svg></button><div class="PageDivider"></div></div><div class="CitedBy" id="toc-cited-by"><h2 class="u-h4"><a class="anchor anchor-primary" href="#section-cited-by"><span class="anchor-text-container"><span class="anchor-text">Cited by (43)</span></span></a></h2><div class="PageDivider"></div></div><div class="Figures" id="toc-figures"><h2 class="u-h4">Figures (7)</h2><ol class="u-margin-s-bottom"><li><a class="anchor u-display-block anchor-primary anchor-icon-only anchor-with-icon" href="#fig1" data-aa-button="sd:product:journal:article:type=anchor:name=figure"><img alt="Fig. 1. Preliminary value tree for metastatic prostate cancer (pre-workshop)" class="u-display-block" height="137px" src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr1.sml" width="219px"></a></li><li><a class="anchor u-display-block anchor-primary anchor-icon-only anchor-with-icon" href="#fig2" data-aa-button="sd:product:journal:article:type=anchor:name=figure"><img alt="Fig. 2. Criteria valuation drug profiles across the six common criteria" class="u-display-block" height="163px" src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr2.sml" width="77px"></a></li><li><a class="anchor u-display-block anchor-primary anchor-icon-only anchor-with-icon" href="#fig3" data-aa-button="sd:product:journal:article:type=anchor:name=figure"><img alt="Fig. 3. Relative criteria weights stacked bars across the four HTA settings" class="u-display-block" height="105px" src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr3.sml" width="219px"></a></li><li><a class="anchor u-display-block anchor-primary anchor-icon-only anchor-with-icon" href="#fig4" data-aa-button="sd:product:journal:article:type=anchor:name=figure"><img alt="Fig. 4. Stacked bar plot of treatments' overall weighted preference value scores across…" class="u-display-block" height="148px" src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr4.sml" width="219px"></a></li><li><a class="anchor u-display-block anchor-primary anchor-icon-only anchor-with-icon" href="#fig5" data-aa-button="sd:product:journal:article:type=anchor:name=figure"><img alt="Fig. 5. Cost benefit plots of treatments overall weighted preference value scores…" class="u-display-block" height="150px" src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr5.sml" width="219px"></a></li><li><a class="anchor u-display-block anchor-primary anchor-icon-only anchor-with-icon" href="#dfig1" data-aa-button="sd:product:journal:article:type=anchor:name=figure"><img alt="Fig. A1. Final value trees for metastatic prostate cancer across the four HTA settings" class="u-display-block" height="164px" src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-fx1.sml" width="142px"></a></li></ol><button class="button-link u-margin-xs-top u-margin-s-bottom button-link-primary button-link-icon-right" type="button" data-aa-button="sd:product:journal:article:type=menu:name=show-figures"><span class="button-link-text-container"><span class="button-link-text">Show 1 more figure</span></span><svg focusable="false" viewBox="0 0 92 128" height="20" class="icon icon-navigate-down"><path d="M1 51l7-7 38 38 38-38 7 7-45 45z"></path></svg></button><div class="PageDivider"></div></div><div class="Tables" id="toc-tables"><h2 class="u-h4">Tables (6)</h2><ol class="u-padding-s-bottom"><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary anchor-icon-left anchor-with-icon" href="#tbl1" data-aa-button="sd:product:journal:article:type=anchor:name=table" title="Criteria definitions, their consideration in each jurisdiction and their ranking."><svg focusable="false" viewBox="0 0 98 128" height="20" class="icon icon-table"><path d="M54 68h32v32H54V68zm-42 0h32v32H12V68zm0-42h32v32H12V26zm42 0h32v32H54V26zM2 110h94V16H2v94z"></path></svg><span class="anchor-text-container"><span class="anchor-text">Table 1</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary anchor-icon-left anchor-with-icon" href="#tbl2" data-aa-button="sd:product:journal:article:type=anchor:name=table" title="Performance matrix and reference levels considered across the final criteria attributes."><svg focusable="false" viewBox="0 0 98 128" height="20" class="icon icon-table"><path d="M54 68h32v32H54V68zm-42 0h32v32H12V68zm0-42h32v32H12V26zm42 0h32v32H54V26zM2 110h94V16H2v94z"></path></svg><span class="anchor-text-container"><span class="anchor-text">Table 2</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary anchor-icon-left anchor-with-icon" href="#tbl3" data-aa-button="sd:product:journal:article:type=anchor:name=table" title="Number of criteria per cluster, relative weights per criteria cluster and their ranking across the four HTA settings."><svg focusable="false" viewBox="0 0 98 128" height="20" class="icon icon-table"><path d="M54 68h32v32H54V68zm-42 0h32v32H12V68zm0-42h32v32H12V26zm42 0h32v32H54V26zM2 110h94V16H2v94z"></path></svg><span class="anchor-text-container"><span class="anchor-text">Table 3</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary anchor-icon-left anchor-with-icon" href="#tbl4" data-aa-button="sd:product:journal:article:type=anchor:name=table" title="Overall weighted preference value (WPV) scores, costs and costs per unit of value across the four HTA settings."><svg focusable="false" viewBox="0 0 98 128" height="20" class="icon icon-table"><path d="M54 68h32v32H54V68zm-42 0h32v32H12V68zm0-42h32v32H12V26zm42 0h32v32H54V26zM2 110h94V16H2v94z"></path></svg><span class="anchor-text-container"><span class="anchor-text">Table 4</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary anchor-icon-left anchor-with-icon" href="#tblA1" data-aa-button="sd:product:journal:article:type=anchor:name=table" title="Criteria definition and sources of evidence."><svg focusable="false" viewBox="0 0 98 128" height="20" class="icon icon-table"><path d="M54 68h32v32H54V68zm-42 0h32v32H12V68zm0-42h32v32H12V26zm42 0h32v32H54V26zM2 110h94V16H2v94z"></path></svg><span class="anchor-text-container"><span class="anchor-text">Table A1</span></span></a></li><li class="toc-list-entry-outline-padding"><a class="anchor u-truncate-anchor-text anchor-primary anchor-icon-left anchor-with-icon" href="#tblA2" data-aa-button="sd:product:journal:article:type=anchor:name=table" title="Pre-decision conference performance reference levels and basis of selection."><svg focusable="false" viewBox="0 0 98 128" height="20" class="icon icon-table"><path d="M54 68h32v32H54V68zm-42 0h32v32H12V68zm0-42h32v32H12V26zm42 0h32v32H54V26zM2 110h94V16H2v94z"></path></svg><span class="anchor-text-container"><span class="anchor-text">Table A2</span></span></a></li></ol><div class="PageDivider"></div></div></div></div><article class="col-lg-12 col-md-16 pad-left pad-right u-padding-s-top" lang="en"><div class="Publication" id="publication"><div class="publication-brand u-display-block-from-sm"><a class="anchor u-display-flex anchor-primary" href="/journal/social-science-and-medicine" title="Go to Social Science &amp; Medicine on ScienceDirect"><span class="anchor-text-container"><span class="anchor-text"><img class="publication-brand-image" src="https://sdfestaticassets-us-east-1.sciencedirectassets.com/prod/0408e3544c5d8a31f29fd84f48c3b04cd8f090f1/image/elsevier-non-solus.svg" alt="Elsevier"></span></span></a></div><div class="publication-volume u-text-center"><h2 class="publication-title u-h3" id="publication-title"><a class="anchor anchor-secondary publication-title-link" href="/journal/social-science-and-medicine" title="Go to Social Science &amp; Medicine on ScienceDirect"><span class="anchor-text-container"><span class="anchor-text">Social Science &amp; Medicine</span></span></a></h2><div class="text-xs"><a class="anchor anchor-primary" href="/journal/social-science-and-medicine/vol/246/suppl/C" title="Go to table of contents for this volume/issue"><span class="anchor-text-container"><span class="anchor-text">Volume 246</span></span></a>, <!-- -->February 2020<!-- -->, 112595</div></div><div class="publication-cover u-display-block-from-sm"><a class="anchor u-display-flex anchor-primary" href="/journal/social-science-and-medicine/vol/246/suppl/C"><span class="anchor-text-container"><span class="anchor-text"><img class="publication-cover-image" src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619X00258-cov150h.gif" alt="Social Science &amp; Medicine"></span></span></a></div></div><h1 id="screen-reader-main-title" class="Head u-font-serif u-h2 u-margin-s-ver"><span class="title-text">Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework</span></h1><div class="Banner" id="banner"><div class="wrapper truncated"><div aria-live="polite"></div><div class="AuthorGroups"><div class="author-group" id="author-group"><span class="sr-only">Author links open overlay panel</span><button class="button-link button-link-secondary button-link-underline" type="button" data-sd-ui-side-panel-opener="true" data-xocs-content-type="author" data-xocs-content-id="au1"><span class="button-link-text-container"><span class="button-link-text"><span class="react-xocs-alternative-link"><span class="given-name">A.</span> <span class="text surname">Angelis</span> </span><span class="author-ref" id="baff1"><sup>a</sup></span><svg focusable="false" viewBox="0 0 106 128" height="20" title="Correspondence author icon" class="icon icon-person react-xocs-author-icon u-fill-grey8"><path d="M11.07 120l.84-9.29C13.88 91.92 35.25 87.78 53 87.78c17.74 0 39.11 4.13 41.08 22.84l.84 9.38h10.04l-.93-10.34C101.88 89.23 83.89 78 53 78S4.11 89.22 1.95 109.73L1.04 120h10.03M53 17.71c-9.72 0-18.24 8.69-18.24 18.59 0 13.67 7.84 23.98 18.24 23.98S71.24 49.97 71.24 36.3c0-9.9-8.52-18.59-18.24-18.59zM53 70c-15.96 0-28-14.48-28-33.67C25 20.97 37.82 8 53 8s28 12.97 28 28.33C81 55.52 68.96 70 53 70"></path></svg><svg focusable="false" viewBox="0 0 102 128" height="20" title="Author email or social media contact details icon" class="icon icon-envelope react-xocs-author-icon u-fill-grey8"><path d="M55.8 57.2c-1.78 1.31-5.14 1.31-6.9 0L17.58 34h69.54L55.8 57.19zM0 32.42l42.94 32.62c2.64 1.95 6.02 2.93 9.4 2.93s6.78-.98 9.42-2.93L102 34.34V24H0zM92 88.9L73.94 66.16l-8.04 5.95L83.28 94H18.74l18.38-23.12-8.04-5.96L10 88.94V51.36L0 42.9V104h102V44.82l-10 8.46V88.9"></path></svg></span></span></button>, <button class="button-link button-link-secondary button-link-underline" type="button" data-sd-ui-side-panel-opener="true" data-xocs-content-type="author" data-xocs-content-id="au2"><span class="button-link-text-container"><span class="button-link-text"><span class="react-xocs-alternative-link"><span class="given-name">M.</span> <span class="text surname">Linch</span> </span><span class="author-ref" id="baff2"><sup>b</sup></span></span></span></button>, <button class="button-link button-link-secondary button-link-underline" type="button" data-sd-ui-side-panel-opener="true" data-xocs-content-type="author" data-xocs-content-id="au3"><span class="button-link-text-container"><span class="button-link-text"><span class="react-xocs-alternative-link"><span class="given-name">G.</span> <span class="text surname">Montibeller</span> </span><span class="author-ref" id="baff3"><sup>c</sup></span></span></span></button>, <button class="button-link button-link-secondary button-link-underline" type="button" data-sd-ui-side-panel-opener="true" data-xocs-content-type="author" data-xocs-content-id="au4"><span class="button-link-text-container"><span class="button-link-text"><span class="react-xocs-alternative-link"><span class="given-name">T.</span> <span class="text surname">Molina-Lopez</span> </span><span class="author-ref" id="baff4"><sup>d</sup></span></span></span></button>, <button class="button-link button-link-secondary button-link-underline" type="button" data-sd-ui-side-panel-opener="true" data-xocs-content-type="author" data-xocs-content-id="au5"><span class="button-link-text-container"><span class="button-link-text"><span class="react-xocs-alternative-link"><span class="given-name">A.</span> <span class="text surname">Zawada</span> </span><span class="author-ref" id="baff5"><sup>e</sup></span></span></span></button>, <button class="button-link button-link-secondary button-link-underline" type="button" data-sd-ui-side-panel-opener="true" data-xocs-content-type="author" data-xocs-content-id="au6"><span class="button-link-text-container"><span class="button-link-text"><span class="react-xocs-alternative-link"><span class="given-name">K.</span> <span class="text surname">Orzel</span> </span><span class="author-ref" id="baff5"><sup>e</sup></span></span></span></button>, <button class="button-link button-link-secondary button-link-underline" type="button" data-sd-ui-side-panel-opener="true" data-xocs-content-type="author" data-xocs-content-id="au7"><span class="button-link-text-container"><span class="button-link-text"><span class="react-xocs-alternative-link"><span class="given-name">F.</span> <span class="text surname">Arickx</span> </span><span class="author-ref" id="baff6"><sup>f</sup></span></span></span></button>, <button class="button-link button-link-secondary button-link-underline" type="button" data-sd-ui-side-panel-opener="true" data-xocs-content-type="author" data-xocs-content-id="au8"><span class="button-link-text-container"><span class="button-link-text"><span class="react-xocs-alternative-link"><span class="given-name">J.</span> <span class="text surname">Espin</span> </span><span class="author-ref" id="baff7"><sup>g</sup></span> <span class="author-ref" id="baff8"><sup>h</sup></span></span></span></button>, <button class="button-link button-link-secondary button-link-underline" type="button" data-sd-ui-side-panel-opener="true" data-xocs-content-type="author" data-xocs-content-id="au9"><span class="button-link-text-container"><span class="button-link-text"><span class="react-xocs-alternative-link"><span class="given-name">P.</span> <span class="text surname">Kanavos</span> </span><span class="author-ref" id="baff1"><sup>a</sup></span><svg focusable="false" viewBox="0 0 106 128" height="20" title="Correspondence author icon" class="icon icon-person react-xocs-author-icon u-fill-grey8"><path d="M11.07 120l.84-9.29C13.88 91.92 35.25 87.78 53 87.78c17.74 0 39.11 4.13 41.08 22.84l.84 9.38h10.04l-.93-10.34C101.88 89.23 83.89 78 53 78S4.11 89.22 1.95 109.73L1.04 120h10.03M53 17.71c-9.72 0-18.24 8.69-18.24 18.59 0 13.67 7.84 23.98 18.24 23.98S71.24 49.97 71.24 36.3c0-9.9-8.52-18.59-18.24-18.59zM53 70c-15.96 0-28-14.48-28-33.67C25 20.97 37.82 8 53 8s28 12.97 28 28.33C81 55.52 68.96 70 53 70"></path></svg><svg focusable="false" viewBox="0 0 102 128" height="20" title="Author email or social media contact details icon" class="icon icon-envelope react-xocs-author-icon u-fill-grey8"><path d="M55.8 57.2c-1.78 1.31-5.14 1.31-6.9 0L17.58 34h69.54L55.8 57.19zM0 32.42l42.94 32.62c2.64 1.95 6.02 2.93 9.4 2.93s6.78-.98 9.42-2.93L102 34.34V24H0zM92 88.9L73.94 66.16l-8.04 5.95L83.28 94H18.74l18.38-23.12-8.04-5.96L10 88.94V51.36L0 42.9V104h102V44.82l-10 8.46V88.9"></path></svg></span></span></button></div></div></div><button class="button-link u-margin-s-ver button-link-primary button-link-icon-right" type="button" id="show-more-btn" data-aa-button="icon-expand"><span class="button-link-text-container"><span class="button-link-text">Show more</span></span><svg focusable="false" viewBox="0 0 92 128" height="20" class="icon icon-navigate-down"><path d="M1 51l7-7 38 38 38-38 7 7-45 45z"></path></svg></button><div class="banner-options u-padding-xs-bottom"><div class="toc-button-wrap u-display-inline-block u-display-none-from-lg u-margin-s-right"><button class="button-link button-link-secondary button-link-icon-left button-link-has-colored-icon" type="button"><svg focusable="false" viewBox="0 0 128 128" height="20" class="icon icon-list"><path d="M23 26a9 9 0 0 0-9 9 9 9 0 0 0 9 9 9 9 0 0 0 9-9 9 9 0 0 0-9-9zm23 4v10h68V30zM23 56a9 9 0 0 0-9 9 9 9 0 0 0 9 9 9 9 0 0 0 9-9 9 9 0 0 0-9-9zm23 4v10h68V60zM23 86a9 9 0 0 0-9 9 9 9 0 0 0 9 9 9 9 0 0 0 9-9 9 9 0 0 0-9-9zm23 4v10h68V90z"></path></svg><span class="button-link-text-container"><span class="button-link-text">Outline</span></span></button></div><button class="button-link AddToMendeley button-link-secondary u-margin-s-right u-display-inline-flex-from-md button-link-icon-left button-link-has-colored-icon" type="button"><svg focusable="false" viewBox="0 0 86 128" height="20" class="icon icon-plus"><path d="M48 58V20H38v38H0v10h38v38h10V68h38V58z"></path></svg><span class="button-link-text-container"><span class="button-link-text">Add to Mendeley</span></span></button><div class="Social u-display-inline-block" id="social"><div class="popover social-popover" id="social-popover"><div id="popover-trigger-social-popover"><button class="button-link button-link-secondary u-margin-s-right button-link-icon-left button-link-has-colored-icon" type="button" aria-expanded="false" aria-haspopup="true"><svg focusable="false" viewBox="0 0 114 128" height="20" class="icon icon-share"><path d="M90 112c-6.62 0-12-5.38-12-12s5.38-12 12-12 12 5.38 12 12-5.38 12-12 12zM24 76c-6.62 0-12-5.38-12-12s5.38-12 12-12 12 5.38 12 12-5.38 12-12 12zm66-60c6.62 0 12 5.38 12 12s-5.38 12-12 12-12-5.38-12-12 5.38-12 12-12zm0 62c-6.56 0-12.44 2.9-16.48 7.48L45.1 70.2c.58-1.98.9-4.04.9-6.2s-.32-4.22-.9-6.2l28.42-15.28C77.56 47.1 83.44 50 90 50c12.14 0 22-9.86 22-22S102.14 6 90 6s-22 9.86-22 22c0 1.98.28 3.9.78 5.72L40.14 49.1C36.12 44.76 30.38 42 24 42 11.86 42 2 51.86 2 64s9.86 22 22 22c6.38 0 12.12-2.76 16.14-7.12l28.64 15.38c-.5 1.84-.78 3.76-.78 5.74 0 12.14 9.86 22 22 22s22-9.86 22-22-9.86-22-22-22z"></path></svg><span class="button-link-text-container"><span class="button-link-text">Share</span></span></button></div></div></div><div class="ExportCitation u-display-inline-block" id="export-citation"><div class="popover export-citation-popover" id="export-citation-popover"><div id="popover-trigger-export-citation-popover"><button class="button-link button-link-secondary button-link-icon-left button-link-has-colored-icon" type="button" aria-expanded="false" aria-haspopup="true"><svg focusable="false" viewBox="0 0 104 128" height="20" class="icon icon-cited-by-66"><path d="M2 58.78V106h44V64H12v-5.22C12 40.28 29.08 32 46 32V22C20.1 22 2 37.12 2 58.78zM102 32V22c-25.9 0-44 15.12-44 36.78V106h44V64H68v-5.22C68 40.28 85.08 32 102 32z"></path></svg><span class="button-link-text-container"><span class="button-link-text">Cite</span></span></button></div></div></div></div></div><div class="ArticleIdentifierLinks u-margin-xs-bottom text-xs" id="article-identifier-links"><a class="anchor doi anchor-primary" href="https://doi.org/10.1016/j.socscimed.2019.112595" target="_blank" rel="noreferrer noopener" aria-label="Persistent link using digital object identifier" title="Persistent link using digital object identifier"><span class="anchor-text-container"><span class="anchor-text">https://doi.org/10.1016/j.socscimed.2019.112595</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor rights-and-content anchor-primary" href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S0277953619305908&amp;orderBeanReset=true" target="_blank" rel="noreferrer noopener"><span class="anchor-text-container"><span class="anchor-text">Get rights and content</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div><div class="LicenseInfo text-xs u-margin-xs-bottom"><div class="License"><span>Under a Creative Commons </span><a class="anchor anchor-primary" href="http://creativecommons.org/licenses/by-nc-nd/4.0/" target="_blank" rel="noreferrer noopener"><span class="anchor-text-container"><span class="anchor-text">license</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div><div class="AccessLabel"><span class="access-indicator"></span>Open access</div></div><section class="ReferencedArticles"></section><section class="ReferencedArticles"></section><div class="PageDivider"></div><div class="Abstracts u-font-serif" id="abstracts"><div class="abstract author-highlights" id="abs0015" lang="en"><h2 class="section-title u-h4 u-margin-l-top u-margin-xs-bottom">Highlights</h2><div id="abssec0015"><div class="u-margin-s-bottom" id="abspara0025"><ul class="list"><li class="react-xocs-list-item"><span class="list-label">•</span><span class="list-content"><div class="u-margin-s-bottom" id="p0010">An MCDA value framework was piloted with HTA decision-makers in four EU countries.</div></span></li><li class="react-xocs-list-item"><span class="list-label">•</span><span class="list-content"><div class="u-margin-s-bottom" id="p0015">The value drivers of three prostate cancer drugs and their importance were analysed.</div></span></li><li class="react-xocs-list-item"><span class="list-label">•</span><span class="list-content"><div class="u-margin-s-bottom" id="p0020">Decision-maker value preferences were elicited during four decision conferences.</div></span></li><li class="react-xocs-list-item"><span class="list-label">•</span><span class="list-content"><div class="u-margin-s-bottom" id="p0025">Value rankings of treatment options were similar and consistent across countries.</div></span></li><li class="react-xocs-list-item"><span class="list-label">•</span><span class="list-content"><div class="u-margin-s-bottom" id="p0030">The proposed MCDA methodology has prospects to act as a decision support tool.</div></span></li></ul></div></div></div><div class="abstract author" id="abs0010" lang="en"><h2 class="section-title u-h4 u-margin-l-top u-margin-xs-bottom">Abstract</h2><div id="abssec0010"><div class="u-margin-s-bottom" id="abspara0010">Multiple Criteria Decision Analysis (MCDA) has emerged as a methodology for Health Technology Assessment (HTA). However, limited empirical evidence is available on its use by decision-makers; where available, it only comes from single-setting exercises, while cross-country comparative studies are unavailable. This study applies the Advance Value Framework (AVF), an MCDA methodology for HTA based on multi-attribute value theory, through a series of <a href="/topics/agricultural-and-biological-sciences/case-study" title="Learn more about case studies from ScienceDirect's AI-generated Topic Pages" class="topic-link">case studies</a> with decision-makers in four countries, to explore its feasibility and compare decision-makers' value preferences and results.</div><div class="u-margin-s-bottom" id="fspara0045"><span>The AVF was applied in the evaluation of three drugs for metastatic, castrate resistant, <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/prostate-cancer" title="Learn more about prostate cancer from ScienceDirect's AI-generated Topic Pages" class="topic-link">prostate cancer</a> (abiraterone, </span><a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/cabazitaxel" title="Learn more about cabazitaxel from ScienceDirect's AI-generated Topic Pages" class="topic-link">cabazitaxel</a> and enzalutamide) in the post-chemotherapy indication. Decision conferences were organised in four European countries in collaboration with their HTA or health insurance organisations by involving relevant assessors and experts: Sweden (TLV), Andalusia/Spain (AETSA), Poland (AOTMiT) and Belgium (INAMI-RIZIV). Participants' value preferences, including performance scoring and criteria weighting, were elicited through a facilitated decision-analysis modelling approach using the MACBETH technique.</div><div class="u-margin-s-bottom" id="abspara0015">Between 6 and 11 criteria were included in each jurisdiction's value model, allocated across four criteria domains; Therapeutic Benefit criteria consistently ranked first in relative importance across all countries. Consistent drug rankings were observed in all settings, with <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/enzalutamide" title="Learn more about enzalutamide from ScienceDirect's AI-generated Topic Pages" class="topic-link">enzalutamide</a><span> generating the highest overall weighted preference value (WPV) score, followed by <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/abiraterone" title="Learn more about abiraterone from ScienceDirect's AI-generated Topic Pages" class="topic-link">abiraterone</a><span> and cabazitaxel. Dividing drugs' overall WPV scores by their costs produced the lowest “cost per unit of value” for <a href="/topics/agricultural-and-biological-sciences/enzalutamide" title="Learn more about enzalutamide from ScienceDirect's AI-generated Topic Pages" class="topic-link">enzalutamide</a><span>, followed by <a href="/topics/agricultural-and-biological-sciences/abiraterone" title="Learn more about abiraterone from ScienceDirect's AI-generated Topic Pages" class="topic-link">abiraterone</a> and cabazitaxel. These results come in contrast with the actual country HTA recommendations and pricing decisions.</span></span></span></div><div class="u-margin-s-bottom" id="abspara0020">Overall, although some differences in value preferences were observed between countries, drug rankings remained the same. The MCDA methodology employed could act as a decision support tool in HTA, due to the transparency in the construction of value preferences in a collaborative manner.</div></div></div></div><ul id="issue-navigation" class="issue-navigation u-margin-s-bottom u-bg-grey1"><li class="previous move-left u-padding-s-ver u-padding-s-left"><a class="button-alternative button-alternative-tertiary u-display-flex button-alternative-icon-left" href="/science/article/pii/S0277953619307440"><svg focusable="false" viewBox="0 0 54 128" height="20" class="icon icon-navigate-left"><path d="M1 61l45-45 7 7-38 38 38 38-7 7z"></path></svg><span class="button-alternative-text-container"><span class="button-alternative-text">Previous <span class="extra-detail-1">article</span><span class="extra-detail-2"> in issue</span></span></span></a></li><li class="next move-right u-padding-s-ver u-padding-s-right"><a class="button-alternative button-alternative-tertiary u-display-flex button-alternative-icon-right" href="/science/article/pii/S0277953619305829"><span class="button-alternative-text-container"><span class="button-alternative-text">Next <span class="extra-detail-1">article</span><span class="extra-detail-2"> in issue</span></span></span><svg focusable="false" viewBox="0 0 54 128" height="20" class="icon icon-navigate-right"><path d="M1 99l38-38L1 23l7-7 45 45-45 45z"></path></svg></a></li></ul><div class="Keywords u-font-serif"><div class="keywords-section" id="kwrds0010"><h2 class="section-title u-h4 u-margin-l-top u-margin-xs-bottom">Keywords</h2><div class="keyword" id="kwrd0010"><span>Multiple Criteria Decision Analysis (MCDA)</span></div><div class="keyword" id="kwrd0015"><span>Health Technology Assessment (HTA)</span></div><div class="keyword" id="kwrd0020"><span>Advance Value Framework (AVF)</span></div><div class="keyword" id="kwrd0025"><span>Decision conference</span></div><div class="keyword" id="kwrd0030"><span>Value assessment</span></div><div class="keyword" id="kwrd0035"><span>Decision making</span></div><div class="keyword" id="kwrd0040"><span>Pharmaceuticals</span></div><div class="keyword" id="kwrd0045"><span>Oncology</span></div></div></div><div class="Body u-font-serif" id="body"><div><section id="sec1"><h2 id="sectitle0025" class="u-h4 u-margin-l-top u-margin-xs-bottom">1. Introduction</h2><div class="u-margin-s-bottom" id="p0035">In recent years, the introduction of new and costly health technologies, particularly in oncology, combined with moderate health gains, has sparked extensive debate on their value for patients and health care systems, how this value should be assessed and what should be the evaluation criteria informing coverage decisions (<a class="anchor anchor-primary" href="#bib35" name="bbib35" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib35"><span class="anchor-text-container"><span class="anchor-text">Cohen, 2017</span></span></a>; <a class="anchor anchor-primary" href="#bib69" name="bbib69" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib69"><span class="anchor-text-container"><span class="anchor-text">Linley and Hughes, 2013</span></span></a>). The debate has been fuelled by diverging coverage recommendations across settings for several medicines, often related to diseases associated with high morbidity and mortality (<a class="anchor anchor-primary" href="#bib34" name="bbib34" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib34"><span class="anchor-text-container"><span class="anchor-text">Clement et al., 2009</span></span></a>; <a class="anchor anchor-primary" href="#bib49" name="bbib49" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib49"><span class="anchor-text-container"><span class="anchor-text">Faden et al., 2009</span></span></a>; <a class="anchor anchor-primary" href="#bib82" name="bbib82" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib82"><span class="anchor-text-container"><span class="anchor-text">Nicod and Kanavos, 2012</span></span></a><span>). Difference in opinion often arises in <a href="/topics/agricultural-and-biological-sciences/resource-allocation" title="Learn more about resource allocation from ScienceDirect's AI-generated Topic Pages" class="topic-link">resource allocation</a> decisions amongst different stakeholders, attributable, at least in part, to current evaluation methodologies not adequately capturing different notions of value (</span><a class="anchor anchor-primary" href="#bib44" name="bbib44" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib44"><span class="anchor-text-container"><span class="anchor-text">Drummond et al., 2013</span></span></a>); this includes, for example, the Quality Adjusted Life Year (QALY), the use of which in economic evaluations can at times be regarded as blunt and insufficient, among other reasons because it may not adequately reflect important value aspects in a variety of disease areas (<a class="anchor anchor-primary" href="#bib42" name="bbib42" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib42"><span class="anchor-text-container"><span class="anchor-text">Devlin and Lorgelly, 2017</span></span></a>; <a class="anchor anchor-primary" href="#bib45" name="bbib45" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib45"><span class="anchor-text-container"><span class="anchor-text">Efthymiadou et al., 2019</span></span></a>; <a class="anchor anchor-primary" href="#bib117" name="bbib117" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib117"><span class="anchor-text-container"><span class="anchor-text">Wouters et al., 2015</span></span></a>). Given the limited consideration of overall value in traditional economic evaluations, additional parameters have been included in value assessments; however, this is often done in a non-systematic or ad-hoc manner, which may impact the transparency of decision-making processes (<a class="anchor anchor-primary" href="#bib8" name="bbib8" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib8"><span class="anchor-text-container"><span class="anchor-text">Angelis et al., 2018</span></span></a>) and lead to inconsistencies in drug coverage decisions.</div><div class="u-margin-s-bottom" id="p0040">A growing body of literature is increasingly debating the use of highly expensive new drugs, which are perceived to bring marginal added clinical benefit on the grounds of poor value-for-money and high budget impact (<a class="anchor anchor-primary" href="#bib78" name="bbib78" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib78"><span class="anchor-text-container"><span class="anchor-text">Nadler et al., 2006</span></span></a>; <a class="anchor anchor-primary" href="#bib100" name="bbib100" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib100"><span class="anchor-text-container"><span class="anchor-text">Shih et al., 2013</span></span></a>; <a class="anchor anchor-primary" href="#bib102" name="bbib102" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib102"><span class="anchor-text-container"><span class="anchor-text">Sulmasy and Moy, 2014</span></span></a>). High and rising drug prices and the need to understand the importance of different evaluation criteria have catalysed the generation of numerous “value frameworks” aiming to inform payers, clinicians and patients on the assessment of new medicines, required for making coverage and treatment selection decisions (<a class="anchor anchor-primary" href="#bib2" name="bbib2" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib2"><span class="anchor-text-container"><span class="anchor-text">Anderson et al., 2014</span></span></a>; <a class="anchor anchor-primary" href="#bib11" name="bbib11" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib11"><span class="anchor-text-container"><span class="anchor-text">Bach, 2015</span></span></a>; <a class="anchor anchor-primary" href="#bib30" name="bbib30" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib30"><span class="anchor-text-container"><span class="anchor-text">Cherny et al., 2015</span></span></a>; <a class="anchor anchor-primary" href="#bib98" name="bbib98" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib98"><span class="anchor-text-container"><span class="anchor-text">Schnipper et al., 2015</span></span></a>). Although this is an important step towards a more inclusive value-based assessment approach (<a class="anchor anchor-primary" href="#bib72" name="bbib72" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib72"><span class="anchor-text-container"><span class="anchor-text">Malone et al., 2016</span></span></a>), aspects of these frameworks may be based on weak methodologies or ad hoc considerations, which could potentially result in misleading recommendations or decisions (<a class="anchor anchor-primary" href="#bib4" name="bbib4" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib4"><span class="anchor-text-container"><span class="anchor-text">Angelis and Kanavos, 2016</span></span></a>).</div><div class="u-margin-s-bottom" id="p0045">In response to some of the concerns raised above, multiple criteria decision analysis (MCDA) has emerged as a likely alternative or supplementary approach to traditional economic evaluation techniques with the prospects of addressing some of their limitations in Health Technology Assessment (HTA) (<a class="anchor anchor-primary" href="#bib7" name="bbib7" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib7"><span class="anchor-text-container"><span class="anchor-text">Angelis et al., 2017</span></span></a>; <a class="anchor anchor-primary" href="#bib43" name="bbib43" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib43"><span class="anchor-text-container"><span class="anchor-text">Devlin and Sussex, 2011</span></span></a>; <a class="anchor anchor-primary" href="#bib55" name="bbib55" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib55"><span class="anchor-text-container"><span class="anchor-text">Goetghebeur et al., 2008</span></span></a>; <a class="anchor anchor-primary" href="#bib62" name="bbib62" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib62"><span class="anchor-text-container"><span class="anchor-text">Kanavos and Angelis, 2013</span></span></a>; <a class="anchor anchor-primary" href="#bib74" name="bbib74" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib74"><span class="anchor-text-container"><span class="anchor-text">Marsh et al., 2014</span></span></a>; <a class="anchor anchor-primary" href="#bib93" name="bbib93" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib93"><span class="anchor-text-container"><span class="anchor-text">Radaelli et al., 2014</span></span></a>; <a class="anchor anchor-primary" href="#bib107" name="bbib107" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib107"><span class="anchor-text-container"><span class="anchor-text">Thokala, 2011</span></span></a>), but also for eliciting stakeholder preferences and facilitating treatment selection (<a class="anchor anchor-primary" href="#bib39" name="bbib39" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib39"><span class="anchor-text-container"><span class="anchor-text">Danner et al., 2011</span></span></a>; <a class="anchor anchor-primary" href="#bib58" name="bbib58" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib58"><span class="anchor-text-container"><span class="anchor-text">Ijzerman et al., 2008</span></span></a>; <a class="anchor anchor-primary" href="#bib106" name="bbib106" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib106"><span class="anchor-text-container"><span class="anchor-text">Tervonen et al., 2015</span></span></a>). A number of MCDA empirical studies have explored the question of value in a number of therapeutic areas, often simulating hypothetical HTA settings (<a class="anchor anchor-primary" href="#bib9" name="bbib9" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib9"><span class="anchor-text-container"><span class="anchor-text">Angelis et al., 2017</span></span></a>; <a class="anchor anchor-primary" href="#bib56" name="bbib56" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib56"><span class="anchor-text-container"><span class="anchor-text">Goetghebeur et al., 2010</span></span></a>; <a class="anchor anchor-primary" href="#bib103" name="bbib103" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib103"><span class="anchor-text-container"><span class="anchor-text">Sussex et al., 2013</span></span></a>; <a class="anchor anchor-primary" href="#bib115" name="bbib115" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib115"><span class="anchor-text-container"><span class="anchor-text">Wagner et al., 2017</span></span></a>). However, very few studies have explored the same issue by eliciting the preferences of HTA agencies and sitting decision makers and only in single-case exercises (<a class="anchor anchor-primary" href="#bib3" name="bbib3" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib3"><span class="anchor-text-container"><span class="anchor-text">Angelis, 2018</span></span></a>; <a class="anchor anchor-primary" href="#bib61" name="bbib61" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib61"><span class="anchor-text-container"><span class="anchor-text">Jaramillo et al., 2016</span></span></a>; <a class="anchor anchor-primary" href="#bib111" name="bbib111" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib111"><span class="anchor-text-container"><span class="anchor-text">Tony et al., 2011</span></span></a>). To the best of our knowledge, no study has ever elicited and compared the value preferences of sitting decision-makers across multiple settings using a full MCDA methodology, while considering identical sets of evidence.</div><div class="u-margin-s-bottom" id="p0050">By involving HTA agencies and health insurance organisations in four EU Member States, we applied the Advance Value Framework (AVF), a recently developed multi-criteria value framework applicable to HTA (<a class="anchor anchor-primary" href="#bib5" name="bbib5" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib5"><span class="anchor-text-container"><span class="anchor-text">Angelis and Kanavos, 2016b</span></span></a>, <a class="anchor anchor-primary" href="#bib6" name="bbib6" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib6"><span class="anchor-text-container"><span class="anchor-text">Angelis and Kanavos, 2017</span></span></a><span>), to assess the value of treatment options indicated for metastatic castrate resistant <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/prostate-cancer" title="Learn more about prostate cancer from ScienceDirect's AI-generated Topic Pages" class="topic-link">prostate cancer</a><span> (mCRPC) following <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/first-line-chemotherapy" title="Learn more about first line chemotherapy from ScienceDirect's AI-generated Topic Pages" class="topic-link">first line chemotherapy</a>. This indication was selected because of its high disease burden and the availability of several new and expensive biologic drugs, making it a highly relevant appraisal topic for several HTA agencies.</span></span></div><div class="u-margin-s-bottom" id="p0055">The main research questions of the study relate, first, to testing the feasibility of this MCDA methodology for HTA decision-makers and, second, to observing any differences in their value perceptions as reflected through the consistency of drugs' value rankings, including value trade-offs.</div></section><section id="sec2"><h2 id="sectitle0030" class="u-h4 u-margin-l-top u-margin-xs-bottom">2. Methods</h2><section id="sec2.1"><h3 id="sectitle0035" class="u-h4 u-margin-m-top u-margin-xs-bottom">2.1. Methodological Framework</h3><div class="u-margin-s-bottom" id="p0060">An MCDA approach based on Multi-Attribute Value Theory (MAVT) was adopted (<a class="anchor anchor-primary" href="#bib65" name="bbib65" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib65"><span class="anchor-text-container"><span class="anchor-text">Keeney and Raiffa, 1993</span></span></a>; <a class="anchor anchor-primary" href="#bib114" name="bbib114" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib114"><span class="anchor-text-container"><span class="anchor-text">von Winterfeldt and Edwards, 1986</span></span></a>), involving the phases of problem structuring, model building, model assessment, model appraisal, and development of action plans (<a class="anchor anchor-primary" href="#bib5" name="bbib5" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib5"><span class="anchor-text-container"><span class="anchor-text">Angelis and Kanavos, 2016b</span></span></a>). A series of facilitated workshops were organised taking the form of decision conferences (<a class="anchor anchor-primary" href="#bib89" name="bbib89" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib89"><span class="anchor-text-container"><span class="anchor-text">Phillips, 2007</span></span></a>), adopting a facilitated decision analysis modelling approach (<a class="anchor anchor-primary" href="#bib53" name="bbib53" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib53"><span class="anchor-text-container"><span class="anchor-text">Franco and Montibeller, 2010b</span></span></a>; <a class="anchor anchor-primary" href="#bib90" name="bbib90" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib90"><span class="anchor-text-container"><span class="anchor-text">Phillips and Phillips, 1993</span></span></a>), in collaboration with decision-makers from four HTA agencies and health insurance bodies: the Dental and Pharmaceutical Benefits Agency (TLV, Sweden), the Andalusian Health Technology Assessment Agency (AETSA, Spain), the Agency for Health Technology Assessment and Tariff System (AOTMiT, Poland), and the National Health Insurance Agency (INAMI-RIZIV, Belgium). The agencies in these countries were selected in order to represent a set of organisations with different governance structure (arms' length HTA agency, e.g. AOTMiT, TLV and AETSA, vs integrated HTA function, e.g. INAMI-RIZIV) and responsibilities (regulatory, e.g. TLV, vs advisory, e.g. AOTMiT and AETSA). The research was undertaken in the context of Advance-HTA, an EU-funded project focusing on HTA methodological advancements (<a class="anchor anchor-primary" href="#bib70" name="bbib70" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib70"><span class="anchor-text-container"><span class="anchor-text">London School of Economics, 2019</span></span></a>), and all four HTA organisations were contacted to participate under the auspices of the project.</div><div class="u-margin-s-bottom" id="p0065">The methodological process used in terms of the design, implementation and analysis, is aligned with the ISPOR good practice guidelines on the use of MCDA for health care decisions (<a class="anchor anchor-primary" href="#bib73" name="bbib73" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib73"><span class="anchor-text-container"><span class="anchor-text">Marsh et al., 2016</span></span></a>).</div></section><section id="sec2.2"><h3 id="sectitle0040" class="u-h4 u-margin-m-top u-margin-xs-bottom">2.2. Problem Structuring: clinical practice and scope of the exercise</h3><div class="u-margin-s-bottom" id="p0070"><span><a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/prostate-cancer" title="Learn more about Prostate cancer from ScienceDirect's AI-generated Topic Pages" class="topic-link">Prostate cancer</a> is the second most commonly diagnosed cancer in men globally, the most frequently diagnosed cancer among men in developed countries and the fifth leading cause of cancer death globally (</span><a class="anchor anchor-primary" href="#bib112" name="bbib112" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib112"><span class="anchor-text-container"><span class="anchor-text">Torre, 2015</span></span></a><span>). <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/mortality-rate" title="Learn more about Death rates from ScienceDirect's AI-generated Topic Pages" class="topic-link">Death rates</a> have been decreasing in most developed countries and this has been attributed mainly to improved treatment and/or early detection (</span><a class="anchor anchor-primary" href="#bib29" name="bbib29" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib29"><span class="anchor-text-container"><span class="anchor-text">Center et al., 2012</span></span></a>).</div><div class="u-margin-s-bottom" id="p0075">The decision context relates to the assessment of value of second line treatments for mCRPC based on the approved European Medicines Agency (EMA) indication (<a class="anchor anchor-primary" href="#bib46" name="bbib46" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib46"><span class="anchor-text-container"><span class="anchor-text">EMA, 2016a</span></span></a>, <a class="anchor anchor-primary" href="#bib47" name="bbib47" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib47"><span class="anchor-text-container"><span class="anchor-text">b</span></span></a>, <a class="anchor anchor-primary" href="#bib48" name="bbib48" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib48"><span class="anchor-text-container"><span class="anchor-text">c</span></span></a>), the subsequently defined scope of Technology Appraisals (TAs) by a number of HTA agencies and the ESMO guidelines (<a class="anchor anchor-primary" href="#bib57" name="bbib57" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib57"><span class="anchor-text-container"><span class="anchor-text">Horwich et al., 2013</span></span></a>; <a class="anchor anchor-primary" href="#bib79" name="bbib79" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib79"><span class="anchor-text-container"><span class="anchor-text">NICE, 2012a</span></span></a>, <a class="anchor anchor-primary" href="#bib80" name="bbib80" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib80"><span class="anchor-text-container"><span class="anchor-text">b</span></span></a>, <a class="anchor anchor-primary" href="#bib81" name="bbib81" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib81"><span class="anchor-text-container"><span class="anchor-text">2014</span></span></a>; <a class="anchor anchor-primary" href="#bib108" name="bbib108" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib108"><span class="anchor-text-container"><span class="anchor-text">TLV, 2014</span></span></a>, <a class="anchor anchor-primary" href="#bib109" name="bbib109" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib109"><span class="anchor-text-container"><span class="anchor-text">2015a</span></span></a>).</div><div class="u-margin-s-bottom" id="p0080"><span><span>The first treatment to demonstrate a survival benefit for mCRPC patients was <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/docetaxel" title="Learn more about docetaxel from ScienceDirect's AI-generated Topic Pages" class="topic-link">docetaxel</a> chemotherapy in combination with </span><a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/prednisolone" title="Learn more about prednisolone from ScienceDirect's AI-generated Topic Pages" class="topic-link">prednisolone</a><span><span> when compared to <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/mitoxantrone" title="Learn more about mitoxantrone from ScienceDirect's AI-generated Topic Pages" class="topic-link">mitoxantrone</a> in combination with </span><a href="/topics/agricultural-and-biological-sciences/prednisolone" title="Learn more about prednisolone from ScienceDirect's AI-generated Topic Pages" class="topic-link">prednisolone</a> (</span></span><a class="anchor anchor-primary" href="#bib25" name="bbib25" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib25"><span class="anchor-text-container"><span class="anchor-text">Berthold et al., 2008</span></span></a>; <a class="anchor anchor-primary" href="#bib105" name="bbib105" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib105"><span class="anchor-text-container"><span class="anchor-text">Tannock et al., 2004</span></span></a><span>). Subsequently, new therapeutic agents have been tested in the post-chemotherapy setting with considerable success. <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/abiraterone" title="Learn more about Abiraterone from ScienceDirect's AI-generated Topic Pages" class="topic-link">Abiraterone</a><span>, a <a href="/topics/agricultural-and-biological-sciences/steroidogenesis" title="Learn more about steroid synthesis from ScienceDirect's AI-generated Topic Pages" class="topic-link">steroid synthesis</a><span> inhibitor, in combination with prednisolone showed a 3.9-month improvement in survival compared to prednisolone alone in patients pre-treated with <a href="/topics/agricultural-and-biological-sciences/docetaxel" title="Learn more about docetaxel from ScienceDirect's AI-generated Topic Pages" class="topic-link">docetaxel</a> (14.8 vs 10.9 months, HR 0.65, p &lt; 0.001) (</span></span></span><a class="anchor anchor-primary" href="#bib40" name="bbib40" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib40"><span class="anchor-text-container"><span class="anchor-text">de Bono et al., 2011</span></span></a><span>). Similarly, <a href="/topics/agricultural-and-biological-sciences/enzalutamide" title="Learn more about enzalutamide from ScienceDirect's AI-generated Topic Pages" class="topic-link">enzalutamide</a><span>, an <a href="/topics/agricultural-and-biological-sciences/androgen-receptor" title="Learn more about androgen receptor from ScienceDirect's AI-generated Topic Pages" class="topic-link">androgen receptor</a> antagonist, showed a 4.8-month improvement in survival (18.4 vs 13.6 months, HR 0.63, p &lt; 0.001) compared to placebo alone in the same patient group (</span></span><a class="anchor anchor-primary" href="#bib97" name="bbib97" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib97"><span class="anchor-text-container"><span class="anchor-text">Scher et al., 2012</span></span></a><span>). Cross-resistance appears to exist between abiraterone and <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/enzalutamide" title="Learn more about enzalutamide from ScienceDirect's AI-generated Topic Pages" class="topic-link">enzalutamide</a> meaning that patients are unlikely to derive clinical benefit by switching from one agent to the other (</span><a class="anchor anchor-primary" href="#bib26" name="bbib26" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib26"><span class="anchor-text-container"><span class="anchor-text">Bianchini et al., 2014</span></span></a>; <a class="anchor anchor-primary" href="#bib71" name="bbib71" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib71"><span class="anchor-text-container"><span class="anchor-text">Loriot et al., 2013</span></span></a><span><span>). The third agent that is widely used following progression on docetaxel is <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/cabazitaxel" title="Learn more about cabazitaxel from ScienceDirect's AI-generated Topic Pages" class="topic-link">cabazitaxel</a>, a </span><a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/taxane" title="Learn more about taxane from ScienceDirect's AI-generated Topic Pages" class="topic-link">taxane</a><span> chemotherapy. Cabazitaxel led to an <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/overall-survival" title="Learn more about overall survival from ScienceDirect's AI-generated Topic Pages" class="topic-link">overall survival</a> (OS) benefit of 2.4 months (15.1 vs 12.7 months, HR 0.70, p &lt; 0.0001) compared to mitoxantrone (</span></span><a class="anchor anchor-primary" href="#bib41" name="bbib41" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib41"><span class="anchor-text-container"><span class="anchor-text">de Bono et al., 2010</span></span></a>). Given this therapeutic landscape for patients with mCRPC who have progressed on first line docetaxel chemotherapy, characterised by an availability of different treatments and the apparent cross-resistance between some of them, we adopt post-chemotherapy mCRPC as the decision context for the application of the AVF methodology.</div></section><section id="sec2.3"><h3 id="sectitle0045" class="u-h4 u-margin-m-top u-margin-xs-bottom">2.3. Model Building: Advance Value Tree adaptation, treatments compared and reference levels</h3><div class="u-margin-s-bottom" id="p0085"><span>The model building phase comprised a number of tasks, notably the Advance Value Tree adaptation for mCRPC, the consideration of alternative <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/pharmacotherapy" title="Learn more about drug treatments from ScienceDirect's AI-generated Topic Pages" class="topic-link">drug treatments</a> together with the respective evidence, and the definition of criteria, attributes and their associated ranges, all of which are discussed below. Detailed discussion on the rationale of each non disease-specific criterion and their value scales can be found elsewhere (</span><a class="anchor anchor-primary" href="#bib6" name="bbib6" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib6"><span class="anchor-text-container"><span class="anchor-text">Angelis and Kanavos, 2017</span></span></a>; <a class="anchor anchor-primary" href="#bib9" name="bbib9" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib9"><span class="anchor-text-container"><span class="anchor-text">Angelis et al., 2017</span></span></a>).</div><section id="sec2.3.1"><h4 id="sectitle0050" class="u-margin-m-top u-margin-xs-bottom">2.3.1. Adaptation of the Advance Value Tree for metastatic prostate cancer</h4><div class="u-margin-s-bottom" id="p0090">At the core of AVF lies the Advance Value Tree, a hierarchical structure of evaluation criteria taking the form of a generic value tree reflecting value concerns of HTA experts and decision-makers for new medicines (<a class="anchor anchor-primary" href="#bib6" name="bbib6" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib6"><span class="anchor-text-container"><span class="anchor-text">Angelis and Kanavos, 2017</span></span></a>). The Advance Value Tree consists of five criteria domains, aiming to capture the essential value attributes of new medicines in the HTA context under a prescriptive decision-aid approach. These are divided into (a) Burden of Disease (BoD); (b) Therapeutic Benefit (THE); (c) Safety Profile (SAF); (d) Innovation Level (INN); and (e) Socioeconomic Impact (SOC), summarised by the following value function:<span class="display"><span class="formula" id="fd1"><span class="label">(1)</span><span class="math"><span class="MathJax_Preview" style=""></span><span class="MathJax_SVG" id="MathJax-Element-3-Frame" tabindex="0" style="font-size: 90%; display: inline-block; position: relative;" data-mathml="<math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;><mrow is=&quot;true&quot;><mi is=&quot;true&quot;>V</mi><mi is=&quot;true&quot;>a</mi><mi is=&quot;true&quot;>l</mi><mi is=&quot;true&quot;>u</mi><mi is=&quot;true&quot;>e</mi><mo linebreak=&quot;badbreak&quot; is=&quot;true&quot;>=</mo><mi mathvariant=&quot;bold-italic&quot; is=&quot;true&quot;>f</mi><mrow is=&quot;true&quot;><mo stretchy=&quot;true&quot; is=&quot;true&quot;>(</mo><mrow is=&quot;true&quot;><mi mathvariant=&quot;bold-italic&quot; is=&quot;true&quot;>BoD</mi><mo is=&quot;true&quot;>,</mo><mi mathvariant=&quot;bold-italic&quot; is=&quot;true&quot;>THE</mi><mo is=&quot;true&quot;>,</mo><mi mathvariant=&quot;bold-italic&quot; is=&quot;true&quot;>SAF</mi><mo is=&quot;true&quot;>,</mo><mi mathvariant=&quot;bold-italic&quot; is=&quot;true&quot;>INN</mi><mo is=&quot;true&quot;>,</mo><mi mathvariant=&quot;bold-italic&quot; is=&quot;true&quot;>SOC</mi></mrow><mo stretchy=&quot;true&quot; is=&quot;true&quot;>)</mo></mrow></mrow></math>" role="presentation"><svg xmlns:xlink="http://www.w3.org/1999/xlink" width="44.491ex" height="2.779ex" viewBox="0 -846.5 19155.9 1196.3" role="img" focusable="false" style="vertical-align: -0.812ex;" aria-hidden="true"><g stroke="currentColor" fill="currentColor" stroke-width="0" transform="matrix(1 0 0 -1 0 0)"><g is="true"><g is="true"><use xlink:href="#MJMATHI-56"></use></g><g is="true" transform="translate(769,0)"><use xlink:href="#MJMATHI-61"></use></g><g is="true" transform="translate(1299,0)"><use xlink:href="#MJMATHI-6C"></use></g><g is="true" transform="translate(1597,0)"><use xlink:href="#MJMATHI-75"></use></g><g is="true" transform="translate(2170,0)"><use xlink:href="#MJMATHI-65"></use></g><g is="true" transform="translate(2914,0)"><use xlink:href="#MJMAIN-3D"></use></g><g is="true" transform="translate(3970,0)"><use xlink:href="#MJMATHBI-66"></use></g><g is="true" transform="translate(4761,0)"><g is="true"><use xlink:href="#MJMAIN-28"></use></g><g is="true" transform="translate(389,0)"><g is="true"><use xlink:href="#MJMATHBI-42"></use><use xlink:href="#MJMATHBI-6F" x="866" y="0"></use><use xlink:href="#MJMATHBI-44" x="1452" y="0"></use></g><g is="true" transform="translate(2390,0)"><use xlink:href="#MJMAIN-2C"></use></g><g is="true" transform="translate(2835,0)"><use xlink:href="#MJMATHBI-54"></use><use xlink:href="#MJMATHBI-48" x="637" y="0"></use><use xlink:href="#MJMATHBI-45" x="1620" y="0"></use></g><g is="true" transform="translate(5266,0)"><use xlink:href="#MJMAIN-2C"></use></g><g is="true" transform="translate(5711,0)"><use xlink:href="#MJMATHBI-53"></use><use xlink:href="#MJMATHBI-41" x="693" y="0"></use><use xlink:href="#MJMATHBI-46" x="1563" y="0"></use></g><g is="true" transform="translate(7963,0)"><use xlink:href="#MJMAIN-2C"></use></g><g is="true" transform="translate(8408,0)"><use xlink:href="#MJMATHBI-49"></use><use xlink:href="#MJMATHBI-4E" x="511" y="0"></use><use xlink:href="#MJMATHBI-4E" x="1462" y="0"></use></g><g is="true" transform="translate(10821,0)"><use xlink:href="#MJMAIN-2C"></use></g><g is="true" transform="translate(11266,0)"><use xlink:href="#MJMATHBI-53"></use><use xlink:href="#MJMATHBI-4F" x="693" y="0"></use><use xlink:href="#MJMATHBI-43" x="1531" y="0"></use></g></g><g is="true" transform="translate(14004,0)"><use xlink:href="#MJMAIN-29"></use></g></g></g></g></svg><span class="MJX_Assistive_MathML" role="presentation"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow is="true"><mi is="true">V</mi><mi is="true">a</mi><mi is="true">l</mi><mi is="true">u</mi><mi is="true">e</mi><mo linebreak="badbreak" is="true">=</mo><mi mathvariant="bold-italic" is="true">f</mi><mrow is="true"><mo stretchy="true" is="true">(</mo><mrow is="true"><mi mathvariant="bold-italic" is="true">BoD</mi><mo is="true">,</mo><mi mathvariant="bold-italic" is="true">THE</mi><mo is="true">,</mo><mi mathvariant="bold-italic" is="true">SAF</mi><mo is="true">,</mo><mi mathvariant="bold-italic" is="true">INN</mi><mo is="true">,</mo><mi mathvariant="bold-italic" is="true">SOC</mi></mrow><mo stretchy="true" is="true">)</mo></mrow></mrow></math></span></span><script type="math/mml" id="MathJax-Element-3"><math><mrow is="true"><mi is="true">V</mi><mi is="true">a</mi><mi is="true">l</mi><mi is="true">u</mi><mi is="true">e</mi><mo linebreak="badbreak" is="true">=</mo><mi mathvariant="bold-italic" is="true">f</mi><mrow is="true"><mo stretchy="true" is="true">(</mo><mrow is="true"><mi mathvariant="bold-italic" is="true">BoD</mi><mo is="true">,</mo><mi mathvariant="bold-italic" is="true">THE</mi><mo is="true">,</mo><mi mathvariant="bold-italic" is="true">SAF</mi><mo is="true">,</mo><mi mathvariant="bold-italic" is="true">INN</mi><mo is="true">,</mo><mi mathvariant="bold-italic" is="true">SOC</mi></mrow><mo stretchy="true" is="true">)</mo></mrow></mrow></math></script></span></span></span></div><div class="u-margin-s-bottom"><div id="p0095">The Advance Value Tree was adapted into a disease-specific mCRPC value model using a bottom-up approach by comparing the characteristics of the drugs under consideration (<a class="anchor anchor-primary" href="#bib52" name="bbib52" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib52"><span class="anchor-text-container"><span class="anchor-text">Franco and Montibeller, 2010a</span></span></a>). In consultation with a specialist medical oncologist (co-author of the paper), the generic evaluation criteria were converted into disease-specific criteria, while adhering to required criteria properties such as non-redundancy and preferential-independence (<a class="anchor anchor-primary" href="#bib64" name="bbib64" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib64"><span class="anchor-text-container"><span class="anchor-text">Keeney, 1992</span></span></a>), to ensure methodological robustness and an adequate value model rooted in decision theory. Based on the above, a preliminary mCRPC-specific value tree was produced with four criteria domains and a total of 18 criteria as shown in <a class="anchor anchor-primary" href="#fig1" name="bfig1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="fig1"><span class="anchor-text-container"><span class="anchor-text">Fig. 1</span></span></a>, each operationalised by an attribute, i.e. performance indicator. The BoD domain was not considered in the adaptation process on the grounds of conciseness, as all drugs were indicated for the same indication which would have identical BoD.</div><figure class="figure text-xs" id="fig1"><span><img src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr1.jpg" height="501" alt="Fig. 1" aria-describedby="cap0030"><ol class="u-margin-s-bottom"><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr1_lrg.jpg" target="_blank" download="" title="Download high-res image (339KB)"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download high-res image (339KB)</span></span></span></a></li><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr1.jpg" target="_blank" download="" title="Download full-size image"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download full-size image</span></span></span></a></li></ol></span><span class="captions text-s"><span id="cap0030"><p id="fspara0020"><span class="label">Fig. 1</span>. Preliminary value tree for metastatic prostate cancer (pre-workshop).</p><div class="u-margin-s-bottom" id="fspara0020a">Notes: Contra. = Contraindications; MoA = Mechanism of action; HRQoL = Health related quality of life; <a href="/topics/agricultural-and-biological-sciences/prostate-specific-antigen" title="Learn more about PSA from ScienceDirect's AI-generated Topic Pages" class="topic-link">PSA</a> = Prostate-specific antigen; ATC = Anatomical therapeutic chemical (classification). Image produced using Hiview3 3.2.0.4.</div></span></span></figure></div><div class="u-margin-s-bottom"><div id="p0100">Criteria definitions (together with their consideration in each jurisdiction and their rankings) are provided in <a class="anchor anchor-primary" href="#tbl1" name="btbl1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="tbl1"><span class="anchor-text-container"><span class="anchor-text">Table 1</span></span></a>. The preliminary version of the mCRPC value tree was subsequently validated by decision conference participants, in line with a “socio-technical” approach, a constructive decision-aid process allowing groups of participants to interact with and learn from each other (<a class="anchor anchor-primary" href="#bib13" name="bbib13" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib13"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa and Beinat, 2005</span></span></a>).</div><div class="tables colsep-0 frame-topbot rowsep-0" id="tbl1"><span class="captions text-s"><span id="cap0055"><p id="tspara0040"><span class="label">Table 1</span>. Criteria definitions, their consideration in each jurisdiction and their ranking.</p></span></span><div class="groups"><table><thead><tr class="rowsep-1 valign-top"><th scope="col" rowspan="2">Criteria Sub-Domain</th><th scope="col" rowspan="2">Evaluation criteria</th><th scope="col" rowspan="2">Definition</th><th scope="col" colspan="4">Country (competent HTA organisation)</th></tr><tr class="rowsep-1 valign-top"><th scope="col">Belgium (INAMI/RIZIV)</th><th scope="col">Poland (AOTMiT)</th><th scope="col">Andalusia (AETSA)</th><th scope="col">Sweden (TLV)</th></tr></thead><tbody><tr class="valign-top"><td class="align-left" colspan="7"><strong>Criteria Domain 1: Therapeutic Benefit</strong></td></tr><tr class="valign-top"><td class="align-left">Direct endpoints</td><td class="align-left">Overall survival x Health related quality of life*</td><td class="align-left">The median time from treatment randomisation to death adjusted for the mean health related quality of life using the EQ-5D utility score</td><td class="align-left">✔(1st)</td><td class="align-left">✔(1st)</td><td class="align-left">✔(1st)</td><td class="align-left">✔(1st)</td></tr><tr class="valign-top"><td class="align-left" rowspan="2">Indirect endpoints</td><td class="align-left">Radiographic tumour progression</td><td class="align-left">The median survival time on which patients have not experienced disease progression (using RECIST criteria)</td><td class="align-left">✔(5th)</td><td class="align-left">✔(5th)</td><td class="align-left">✔(4th)</td><td class="align-left">✔(5th)</td></tr><tr class="valign-top"><td class="align-left">PSA response</td><td class="align-left">The proportion of patients having a ≥50% reduction in PSA</td><td></td><td></td><td class="align-left">✔(8th)</td><td></td></tr><tr class="valign-top"><td class="align-left" colspan="7"><strong>Criteria Domain 2: Safety Profile</strong></td></tr><tr class="valign-top"><td class="align-left">Tolerability</td><td class="align-left">Treatment discontinuation</td><td class="align-left">The proportion of patients discontinuing treatment due to adverse events</td><td class="align-left">✔(3rd)</td><td class="align-left">✔(3rd)</td><td class="align-left">✔(2nd)</td><td class="align-left">✔(2nd)</td></tr><tr class="valign-top"><td class="align-left">Contra-indications &amp; warnings</td><td class="align-left">Contra-indications</td><td class="align-left">The existence of any type of contra-indication accompanying the treatment</td><td class="align-left">✔(4th)</td><td></td><td class="align-left">✔(3rd)</td><td class="align-left">✔(4th)</td></tr><tr class="valign-top"><td class="align-left" colspan="7"><strong>Criteria Domain 3: Innovation Level</strong></td></tr><tr class="valign-top"><td class="align-left" rowspan="5">Type and timing of MoA</td><td class="align-left">ATC Level 1</td><td class="align-left">The technology's relative market entrance in regards to its ATC Level 1 (Anatomical)</td><td></td><td></td><td></td><td></td></tr><tr class="valign-top"><td class="align-left">ATC Level 2</td><td class="align-left">The technology's relative market entrance in regards to its ATC Level 2 (Therapeutic)</td><td></td><td></td><td></td><td></td></tr><tr class="valign-top"><td class="align-left">ATC Level 3</td><td class="align-left">The technology's relative market entrance in regards to its ATC Level 3 (Pharmacological)</td><td></td><td></td><td></td><td></td></tr><tr class="valign-top"><td class="align-left">ATC Level 4</td><td class="align-left">The technology's relative market entrance in regards to its ATC Level 4 (Chemical)</td><td class="align-left">✔(6th)</td><td></td><td class="align-left">✔(10th)</td><td></td></tr><tr class="valign-top"><td class="align-left">ATC Level 5</td><td class="align-left">The technology's relative market entrance in regards to its ATC Level 5 (Molecular)</td><td></td><td></td><td></td><td></td></tr><tr class="valign-top"><td class="align-left" rowspan="4">Spill-over effect</td><td class="align-left">Phase 1</td><td class="align-left">The number of new indications for which the technology is investigated in Phase 1 clinical trials</td><td></td><td></td><td></td><td></td></tr><tr class="valign-top"><td class="align-left">Phase 2</td><td class="align-left">The number of new indications for which the technology is investigated in Phase 2 clinical trials</td><td class="align-left">✔(8th)</td><td></td><td></td><td></td></tr><tr class="valign-top"><td class="align-left">Phase 3</td><td class="align-left">The number of new indications for which the technology is investigated in Phase 3 clinical trials</td><td class="align-left">✔(9th)</td><td></td><td class="align-left">✔(9th)</td><td></td></tr><tr class="valign-top"><td class="align-left">Marketing authorisation</td><td class="align-left">The number of new indications that the technology has gained an approval for at the stage of marketing authorisation</td><td class="align-left">✔(10th)</td><td></td><td class="align-left">✔(7th)</td><td></td></tr><tr class="valign-top"><td class="align-left" rowspan="2">Patient convenience</td><td class="align-left">Delivery posology</td><td class="align-left">The combination of the delivery system (RoA and dosage form) with the posology (frequency of dosing and duration of administration) of the treatment</td><td class="align-left">✔(7th)</td><td class="align-left">✔(4th)</td><td class="align-left">✔(6th)</td><td class="align-left">✔(7th)</td></tr><tr class="valign-top"><td class="align-left">Special instructions</td><td class="align-left">The existence of any special instructions accompanying the administration of the treatment</td><td class="align-left">✔(11th)</td><td class="align-left">✔(6th)</td><td class="align-left">✔(11th)</td><td class="align-left">✔(6th)</td></tr><tr class="valign-top"><td class="align-left" colspan="7"><strong>Criteria Domain 4: Socioeconomic Impact</strong></td></tr><tr class="valign-top"><td class="align-left">Direct costs</td><td class="align-left">Medical costs impact</td><td class="align-left">The impact of the technology on direct medical costs excluding the purchasing costs of the technology</td><td class="align-left">✔(2nd)</td><td class="align-left">✔(2nd)</td><td class="align-left">✔(5th)</td><td class="align-left">✔(3rd)</td></tr></tbody></table></div><div class="legend"><div class="u-margin-s-bottom" id="tspara0045">Notes: *: Aggregation between OS and HRQoL criteria took place due to preference-dependence leading to a combined criterion; PSA&nbsp;=&nbsp;prostate-specific antigen; MoA = Mechanism of Action; ATC&nbsp;=&nbsp;Anatomical Therapeutic Chemical classification system; RoA&nbsp;=&nbsp;<a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/route-of-administration" title="Learn more about Route of Administration from ScienceDirect's AI-generated Topic Pages" class="topic-link">Route of Administration</a>.</div><div class="u-margin-s-bottom" id="fspara0050">Source: The authors, based on input from decision conferences.</div></div></div></div></section><section id="sec2.3.2"><h4 id="sectitle0055" class="u-margin-m-top u-margin-xs-bottom">2.3.2. Alternative treatments compared and evidence considered</h4><div class="u-margin-s-bottom" id="p0105"><span>The alternative drug options assessed in the exercise were cabazitaxel in combination with prednisolone, abiraterone in combination with prednisolone and enzalutamide <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/monotherapy" title="Learn more about monotherapy from ScienceDirect's AI-generated Topic Pages" class="topic-link">monotherapy</a><span>. The key evidence sources used to assess their performance included (a) the peer review publications concerning their pivotal <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/clinical-trial" title="Learn more about clinical trials from ScienceDirect's AI-generated Topic Pages" class="topic-link">clinical trials</a> that were considered for their licensing by the EMA (</span></span><a class="anchor anchor-primary" href="#bib41" name="bbib41" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib41"><span class="anchor-text-container"><span class="anchor-text">de Bono et al., 2010</span></span></a>, <a class="anchor anchor-primary" href="#bib40" name="bbib40" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib40"><span class="anchor-text-container"><span class="anchor-text">2011</span></span></a>; <a class="anchor anchor-primary" href="#bib51" name="bbib51" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib51"><span class="anchor-text-container"><span class="anchor-text">Fizazi et al., 2012</span></span></a>; <a class="anchor anchor-primary" href="#bib97" name="bbib97" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib97"><span class="anchor-text-container"><span class="anchor-text">Scher et al., 2012</span></span></a>); (b) the Product Information sections of EMA's European Public Assessment Reports (EPAR) (Annex I and III) (<a class="anchor anchor-primary" href="#bib46" name="bbib46" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib46"><span class="anchor-text-container"><span class="anchor-text">EMA, 2016a</span></span></a>, <a class="anchor anchor-primary" href="#bib47" name="bbib47" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib47"><span class="anchor-text-container"><span class="anchor-text">b</span></span></a>, <a class="anchor anchor-primary" href="#bib48" name="bbib48" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib48"><span class="anchor-text-container"><span class="anchor-text">c</span></span></a>); (c) the Anatomical Therapeutic Chemical (ATC) classification system indexes available through the portal of the WHO Collaborating Centre for Drug Statistics Methodology (<a class="anchor anchor-primary" href="#bib116" name="bbib116" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib116"><span class="anchor-text-container"><span class="anchor-text">World Health Organisation Collaborating Centre, 2016</span></span></a><span>); and (d) the US <a href="/topics/agricultural-and-biological-sciences/national-library-of-medicine" title="Learn more about National Library of Medicine from ScienceDirect's AI-generated Topic Pages" class="topic-link">National Library of Medicine</a> clinical trials database (</span><a class="anchor anchor-primary" href="#bib83" name="bbib83" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib83"><span class="anchor-text-container"><span class="anchor-text">NIH, 2016</span></span></a>). Additional sources of evidence included national sources (<a class="anchor anchor-primary" href="#bib27" name="bbib27" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib27"><span class="anchor-text-container"><span class="anchor-text">BNF, 2015</span></span></a>; <a class="anchor anchor-primary" href="#bib37" name="bbib37" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib37"><span class="anchor-text-container"><span class="anchor-text">Connock et al., 2011</span></span></a>; <a class="anchor anchor-primary" href="#bib79" name="bbib79" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib79"><span class="anchor-text-container"><span class="anchor-text">NICE, 2012a</span></span></a>, <a class="anchor anchor-primary" href="#bib80" name="bbib80" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib80"><span class="anchor-text-container"><span class="anchor-text">b</span></span></a>, <a class="anchor anchor-primary" href="#bib81" name="bbib81" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib81"><span class="anchor-text-container"><span class="anchor-text">2014</span></span></a>; <a class="anchor anchor-primary" href="#bib94" name="bbib94" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib94"><span class="anchor-text-container"><span class="anchor-text">Riemsa et al., 2013</span></span></a>) and other peer review literature (<a class="anchor anchor-primary" href="#bib28" name="bbib28" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib28"><span class="anchor-text-container"><span class="anchor-text">Burström et al., 2001</span></span></a>; <a class="anchor anchor-primary" href="#bib36" name="bbib36" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib36"><span class="anchor-text-container"><span class="anchor-text">Collins et al., 2007</span></span></a>; <a class="anchor anchor-primary" href="#bib63" name="bbib63" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib63"><span class="anchor-text-container"><span class="anchor-text">Kearns et al., 2013</span></span></a>; <a class="anchor anchor-primary" href="#bib101" name="bbib101" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib101"><span class="anchor-text-container"><span class="anchor-text">Sullivan et al., 2007</span></span></a>), which was relevant to the study indication. Sources of evidence used relating to the performance of drugs across evaluation criteria are shown in Appendix <a class="anchor anchor-primary" href="#appsec1" name="bappsec1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="appsec1"><span class="anchor-text-container"><span class="anchor-text">Table A1</span></span></a>, alongside additional information on the evidence considered.</div></section><section id="sec2.3.3"><h4 id="sectitle0060" class="u-margin-m-top u-margin-xs-bottom">2.3.3. Options performance and references levels</h4><div class="u-margin-s-bottom" id="p0110">By considering the performance of the alternative drug options across the value scales, “lower” (x_l) and “higher” (x_h) reference levels were defined to serve as benchmarks for the value scores of 0 and 100 respectively, acting as value anchors for constructing value functions and eliciting their relative weights (<a class="anchor anchor-primary" href="#bib17" name="bbib17" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib17"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa and Vansnick, 1999</span></span></a>; <a class="anchor anchor-primary" href="#bib64" name="bbib64" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib64"><span class="anchor-text-container"><span class="anchor-text">Keeney, 1992</span></span></a>). The “lower” reference levels denoted a less preferred state reflecting a “satisfactory” performance level, whereas the “higher” reference levels denoted a more preferred state reflecting an “ideal” performance level.</div><div class="u-margin-s-bottom" id="p0115">The reference levels for the clinical attributes informing the Therapeutic and Safety criteria domains, were defined in consultation with the clinical oncologist (co-author of the paper). In principle, the rationale involved adopting the Best Supportive Care (BSC) performance as a “satisfactory” reference level, with a hypothetical 20% improvement of the best available performance acting as the “ideal” reference level (e.g. ‘overall survival’), or alternatively the best possible limit of the performance scale acting as an “ideal” level in cases where this was naturally restricted (e.g. ‘treatment discontinuation’). The 20% hypothetical performance improvement was selected because it was perceived to be a realistically plausible scenario for future treatment options. By considering the performance of best available option(s) among the treatments evaluated and accounting for plausible performance improvement in the near future, the value scale essentially reflected characteristics of a “global” scale to account for the performance of future options not captured in the exercise, i.e. <em>what is best plausible</em> (<a class="anchor anchor-primary" href="#bib24" name="bbib24" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib24"><span class="anchor-text-container"><span class="anchor-text">Belton and Stewart, 2002</span></span></a>). Where a BSC performance was not meaningful to act as a “lower” reference level, then the lowest (i.e. worst) possible limit of the performance scale was adopted (e.g. ‘Phase 3’), or, alternatively, 20% lower than the lowest performing option was used (e.g. ‘medical costs impact’). An exception to the above was the ‘health related quality of life’ (HRQoL) attribute for which the stable disease state's utility score was adopted as the “lower” level and the general population utility score was used as the “higher” level.</div><div class="u-margin-s-bottom"><div id="p0120">The emerging partial value function scores of the drugs for each criterion can take negative values or values higher than 100 where v(x<sub>lower</sub>) = 0 and v(x<sub>higher</sub>) = 100. “Lower” and “higher” reference levels for all attributes at the pre-decision conference stage and the basis of their selection are outlined in Appendix <a class="anchor anchor-primary" href="#appsec1" name="bappsec1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="appsec1"><span class="anchor-text-container"><span class="anchor-text">Table A2</span></span></a>. A matrix listing the performance of drug options across the final criteria that were considered in the decision conferences, together with their reference levels, is shown in <a class="anchor anchor-primary" href="#tbl2" name="btbl2" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="tbl2"><span class="anchor-text-container"><span class="anchor-text">Table 2</span></span></a>.</div><div class="tables colsep-0 frame-topbot rowsep-0" id="tbl2"><span class="captions text-s"><span id="cap0060"><p id="tspara0050"><span class="label">Table 2</span>. Performance matrix and reference levels considered across the final criteria attributes.</p></span></span><div class="groups"><table><thead><tr class="rowsep-1 valign-top"><th scope="col"><strong>Criterion</strong></th><th scope="col"><strong>Attribute</strong></th><th scope="col"><strong>Lower level</strong></th><th scope="col"><strong>Abiraterone</strong></th><th scope="col"><strong>Cabazitaxel</strong></th><th scope="col"><strong>Enzalutamide</strong></th><th scope="col"><strong>Higher level</strong></th></tr></thead><tbody><tr class="valign-top"><td class="align-left">Overall survival (OS)*</td><td class="align-left">Months</td><td class="align-left">13.6</td><td class="align-left">15.8</td><td class="align-left">15.1</td><td class="align-left">18.4</td><td class="align-left">22.1</td></tr><tr class="valign-top"><td class="align-left">Health Related Quality of Life (HRQoL), stable disease*</td><td class="align-left">Utility (EQ-5D)</td><td class="align-left">0.72</td><td class="align-left">0.76</td><td class="align-left">0.76***</td><td class="align-left">0.76</td><td class="align-left">0.82</td></tr><tr class="valign-top"><td class="align-left">Health Related Quality of Life (HRQoL), progressive disease*</td><td class="align-left">Utility (EQ-5D)</td><td class="align-left">0.64</td><td class="align-left">0.64</td><td class="align-left">0.64</td><td class="align-left">0.64</td><td class="align-left">0.82</td></tr><tr class="valign-top"><td class="align-left">OS X HRQoL**</td><td class="align-left">Quality adjusted life months (QALMs)</td><td class="align-left">9.2</td><td class="align-left">11</td><td class="align-left">10.5</td><td class="align-left">12.8</td><td class="align-left">18.1</td></tr><tr class="valign-top"><td class="align-left">Radiographic tumour progression, i.e. progression free survival (PFS)</td><td class="align-left">Months</td><td class="align-left">2.9</td><td class="align-left">5.6</td><td class="align-left">8.8</td><td class="align-left">8.3</td><td class="align-left">10.6</td></tr><tr class="valign-top"><td class="align-left">PSA response</td><td class="align-left">% of patients</td><td class="align-left">1.5</td><td class="align-left">29.5</td><td class="align-left">39.2</td><td class="align-left">54</td><td class="align-left">64.8</td></tr><tr class="valign-top"><td class="align-left">Treatment discontinuation</td><td class="align-left">% of patients</td><td class="align-left">10</td><td class="align-left">19</td><td class="align-left">18</td><td class="align-left">8</td><td class="align-left">0</td></tr><tr class="valign-top"><td class="align-left">Contra-indication(s)</td><td class="align-left">Type of contra-indication</td><td class="align-left">hyp&nbsp;+&nbsp;hep imp&nbsp;+&nbsp;low neut</td><td class="align-left">hyp&nbsp;+&nbsp;hep imp</td><td class="align-left">hyp&nbsp;+&nbsp;hep imp&nbsp;+&nbsp;low neut</td><td class="align-left">hyp</td><td class="align-left">None</td></tr><tr class="valign-top"><td class="align-left">ATC Level 4, i.e. chemical mechanism of action</td><td class="align-left">Relative market entrance</td><td class="align-left">5th</td><td class="align-left">2nd</td><td class="align-left">2nd</td><td class="align-left">1st</td><td class="align-left">1st</td></tr><tr class="valign-top"><td class="align-left">Phase 2</td><td class="align-left">Number of new indications</td><td class="align-left">0</td><td class="align-left">1</td><td class="align-left">13</td><td class="align-left">4</td><td class="align-left">16</td></tr><tr class="valign-top"><td class="align-left">Phase 3</td><td class="align-left">Number of new indications</td><td class="align-left">0</td><td class="align-left">1</td><td class="align-left">2</td><td class="align-left">0</td><td class="align-left">2</td></tr><tr class="valign-top"><td class="align-left">Marketing authorisation</td><td class="align-left">Number of new indications</td><td class="align-left">0</td><td class="align-left">0</td><td class="align-left">0</td><td class="align-left">0</td><td class="align-left">1</td></tr><tr class="valign-top"><td class="align-left">Delivery posology</td><td class="align-left">Type of delivery system &amp; posology combinations</td><td class="align-left">Oral, daily - one off&nbsp;+&nbsp;IV, every 3 weeks - 1&nbsp;h</td><td class="align-left">Oral, daily - one off</td><td class="align-left">Oral, daily - one off&nbsp;+&nbsp;IV, every 3 weeks - 1&nbsp;h</td><td class="align-left">Oral, daily - one off</td><td class="align-left">Oral, daily - one off</td></tr><tr class="valign-top"><td class="align-left">Special instructions</td><td class="align-left">Type(s) of special instructions</td><td class="align-left">Concomitant and/or pre- med&nbsp;+&nbsp;no food</td><td class="align-left">Concomitant and/or pre- med&nbsp;+&nbsp;no food</td><td class="align-left">Concomitant and/or pre- med</td><td class="align-left">None</td><td class="align-left">None</td></tr><tr class="valign-top"><td class="align-left">Medical costs impact</td><td class="align-left">GBP</td><td class="align-left">10,000</td><td class="align-left">5,750</td><td class="align-left">7,992</td><td class="align-left">567</td><td class="align-left">0</td></tr></tbody></table></div><div class="legend"><div class="u-margin-s-bottom" id="tspara0055">Notes: * Used for the calculation of the quality adjusted life months (QALMs) attribute of the aggregated OS x HRQoL criterion; ** Calculated assuming an equal 50% split in time duration between the stable disease and progressive disease states in HRQoL; *** Used the same score of the other two options as data not available; hyp&nbsp;=&nbsp;hypersensitivity; hep imp&nbsp;=&nbsp;hepatic impairment; low <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/dicarbonate" title="Learn more about neut from ScienceDirect's AI-generated Topic Pages" class="topic-link">neut</a><span>&nbsp;=&nbsp;low <a href="/topics/agricultural-and-biological-sciences/neutrophil" title="Learn more about neutrophil from ScienceDirect's AI-generated Topic Pages" class="topic-link">neutrophil</a> count.</span></div><div class="u-margin-s-bottom" id="fspara0050d">Source: The authors based on the literature.</div></div></div></div></section></section><section id="sec2.4"><h3 id="sectitle0065" class="u-h4 u-margin-m-top u-margin-xs-bottom">2.4. Model Assessment and Appraisal: decision conferences, MCDA technique and cost calculation</h3><div class="u-margin-s-bottom" id="p0125">The model assessment and appraisal phases comprised the tasks of conducting the decision conferences, the application of the MCDA technique for the elicitation of value preferences and treatments' cost calculation. These are discussed below.</div><section id="sec2.4.1"><h4 id="sectitle0070" class="u-margin-m-top u-margin-xs-bottom">2.4.1. Decision conferences</h4><div class="u-margin-s-bottom" id="p0130">Model assessment and model appraisal took place through a series of decision conferences (<a class="anchor anchor-primary" href="#bib89" name="bbib89" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib89"><span class="anchor-text-container"><span class="anchor-text">Phillips, 2007</span></span></a>), taking the form of facilitated workshops with the participation of decision-makers. These included assessors and national experts, all of whom were affiliated with the four study HTA organisations, either as members of staff or visiting external experts (their difference being in full-time employment versus part-time or visiting capacity employment). For the purposes of this study, they were both regarded as “decision-makers”, given their influence on methodological development within the agencies and on the appraisals' decision outcomes. Across the four countries, between four (for the case of TLV) and 13 (for the case of AOTMiT) participants were involved, typically comprising health care professionals (clinicians, pharmacists), HTA methodology experts (health economists, statisticians, HTA agency directors) and institutional executives (members of HTA appraisal committees, representatives from insurance funds and national medicines agencies). Background material introducing the scope of the exercise in greater detail was sent to participants one week before each decision conference. Decision conferences were hosted at the head offices of the different HTA organisations between June 2015 and April 2016: Stockholm (TLV), Seville (AETSA), Warsaw (AOTMiT), and Brussels (INAMI-RIZIV).</div><div class="u-margin-s-bottom" id="p0135">The lead author acted as an impartial facilitator, assisted the groups' deliberative interactions and guided participants through the decision problem using the preliminary version of the mCRPC-specific value tree (<a class="anchor anchor-primary" href="#fig1" name="bfig1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="fig1"><span class="anchor-text-container"><span class="anchor-text">Fig. 1</span></span></a>) and the relevant data. This acted as the model's starting point that was subsequently validated, based on which value judgements and preferences were elicited in each decision conference while seeking group interaction and agreement (<a class="anchor anchor-primary" href="#bib53" name="bbib53" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib53"><span class="anchor-text-container"><span class="anchor-text">Franco and Montibeller, 2010b</span></span></a>; <a class="anchor anchor-primary" href="#bib88" name="bbib88" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib88"><span class="anchor-text-container"><span class="anchor-text">Phillips, 1984</span></span></a>; <a class="anchor anchor-primary" href="#bib92" name="bbib92" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib92"><span class="anchor-text-container"><span class="anchor-text">Phillips and Bana e Costa, 2007</span></span></a>; <a class="anchor anchor-primary" href="#bib96" name="bbib96" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib96"><span class="anchor-text-container"><span class="anchor-text">Schein, 1999</span></span></a>). The <em>Appendix</em> provides more information on the decision conferences.</div></section><section id="sec2.4.2"><h4 id="sectitle0075" class="u-margin-m-top u-margin-xs-bottom">2.4.2. MCDA technique</h4><div class="u-margin-s-bottom" id="p0140">AVF adopts a value measurement MCDA methodology making use of a simple additive (i.e. linear, weighted average) value model for the aggregation of scores and weights (<a class="anchor anchor-primary" href="#bib6" name="bbib6" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib6"><span class="anchor-text-container"><span class="anchor-text">Angelis and Kanavos, 2017</span></span></a>). This assumes preference independence between the different criteria, with overall value V(.) of an option <em>a</em> defined by the equation below (<a class="anchor anchor-primary" href="#bib64" name="bbib64" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib64"><span class="anchor-text-container"><span class="anchor-text">Keeney, 1992</span></span></a>; <a class="anchor anchor-primary" href="#bib114" name="bbib114" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib114"><span class="anchor-text-container"><span class="anchor-text">von Winterfeldt and Edwards, 1986</span></span></a>):<span class="display"><span class="formula" id="fd2"><span class="label">(2)</span><span class="math"><span class="MathJax_Preview" style=""></span><span class="MathJax_SVG" id="MathJax-Element-4-Frame" tabindex="0" style="font-size: 90%; display: inline-block; position: relative;" data-mathml="<math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;><mi is=&quot;true&quot;>V</mi><mfenced is=&quot;true&quot;><mi is=&quot;true&quot;>a</mi></mfenced><mo is=&quot;true&quot;>=</mo><munderover is=&quot;true&quot;><mo is=&quot;true&quot;>&amp;#x2211;</mo><mrow is=&quot;true&quot;><mi is=&quot;true&quot;>i</mi><mo is=&quot;true&quot;>=</mo><mn is=&quot;true&quot;>1</mn></mrow><mi is=&quot;true&quot;>m</mi></munderover><mspace width=&quot;0.25em&quot; is=&quot;true&quot; /><msub is=&quot;true&quot;><mi is=&quot;true&quot;>w</mi><mi is=&quot;true&quot;>i</mi></msub><mspace width=&quot;0.25em&quot; is=&quot;true&quot; /><msub is=&quot;true&quot;><mi is=&quot;true&quot;>v</mi><mi is=&quot;true&quot;>i</mi></msub><mfenced is=&quot;true&quot;><mi is=&quot;true&quot;>a</mi></mfenced></math>" role="presentation"><svg xmlns:xlink="http://www.w3.org/1999/xlink" width="21.612ex" height="2.779ex" viewBox="0 -846.5 9305.3 1196.3" role="img" focusable="false" style="vertical-align: -0.812ex;" aria-hidden="true"><g stroke="currentColor" fill="currentColor" stroke-width="0" transform="matrix(1 0 0 -1 0 0)"><g is="true"><use xlink:href="#MJMATHI-56"></use></g><g is="true" transform="translate(769,0)"><use xlink:href="#MJMAIN-28" x="0" y="0"></use><g is="true" transform="translate(389,0)"><use xlink:href="#MJMATHI-61"></use></g><use xlink:href="#MJMAIN-29" x="919" y="0"></use></g><g is="true" transform="translate(2078,0)"><use xlink:href="#MJMAIN-3D"></use></g><g is="true" transform="translate(3134,0)"><g is="true"><use xlink:href="#MJSZ1-2211"></use></g><g is="true" transform="translate(1056,477)"><use transform="scale(0.707)" xlink:href="#MJMATHI-6D"></use></g><g is="true" transform="translate(1056,-287)"><g is="true"><use transform="scale(0.707)" xlink:href="#MJMATHI-69"></use></g><g is="true" transform="translate(244,0)"><use transform="scale(0.707)" xlink:href="#MJMAIN-3D"></use></g><g is="true" transform="translate(794,0)"><use transform="scale(0.707)" xlink:href="#MJMAIN-31"></use></g></g></g><g is="true"></g><g is="true" transform="translate(5856,0)"><g is="true"><use xlink:href="#MJMATHI-77"></use></g><g is="true" transform="translate(716,-150)"><use transform="scale(0.707)" xlink:href="#MJMATHI-69"></use></g></g><g is="true"></g><g is="true" transform="translate(7166,0)"><g is="true"><use xlink:href="#MJMATHI-76"></use></g><g is="true" transform="translate(485,-150)"><use transform="scale(0.707)" xlink:href="#MJMATHI-69"></use></g></g><g is="true" transform="translate(7996,0)"><use xlink:href="#MJMAIN-28" x="0" y="0"></use><g is="true" transform="translate(389,0)"><use xlink:href="#MJMATHI-61"></use></g><use xlink:href="#MJMAIN-29" x="919" y="0"></use></g></g></svg><span class="MJX_Assistive_MathML" role="presentation"><math xmlns="http://www.w3.org/1998/Math/MathML"><mi is="true">V</mi><mfenced is="true"><mi is="true">a</mi></mfenced><mo is="true">=</mo><munderover is="true"><mo is="true">∑</mo><mrow is="true"><mi is="true">i</mi><mo is="true">=</mo><mn is="true">1</mn></mrow><mi is="true">m</mi></munderover><mspace width="0.25em" is="true"></mspace><msub is="true"><mi is="true">w</mi><mi is="true">i</mi></msub><mspace width="0.25em" is="true"></mspace><msub is="true"><mi is="true">v</mi><mi is="true">i</mi></msub><mfenced is="true"><mi is="true">a</mi></mfenced></math></span></span><script type="math/mml" id="MathJax-Element-4"><math><mi is="true">V</mi><mfenced is="true"><mi is="true">a</mi></mfenced><mo is="true">=</mo><munderover is="true"><mo is="true">∑</mo><mrow is="true"><mi is="true">i</mi><mo is="true">=</mo><mn is="true">1</mn></mrow><mi is="true">m</mi></munderover><mspace width="0.25em" is="true"></mspace><msub is="true"><mi is="true">w</mi><mi is="true">i</mi></msub><mspace width="0.25em" is="true"></mspace><msub is="true"><mi is="true">v</mi><mi is="true">i</mi></msub><mfenced is="true"><mi is="true">a</mi></mfenced></math></script></span></span></span>where <em>m</em> is the number of evaluation criteria, <em>w</em><sub><em>i</em></sub> <em>v</em><sub><em>i</em></sub><em>(a)</em> is the weighted partial value function of evaluation criterion <em>i</em> for treatment <em>a</em>, and <em>V</em>(a) is the overall value of the treatment a. V(.) is therefore an overall value function based on multi-attribute value theory (<a class="anchor anchor-primary" href="#bib65" name="bbib65" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib65"><span class="anchor-text-container"><span class="anchor-text">Keeney and Raiffa, 1993</span></span></a>).</div><div class="u-margin-s-bottom" id="p0145">A value function associated with each attribute, converting the treatment performance on the attribute range to a value scale, was elicited from the participants during each decision conference using the Measuring Attractiveness by a Categorical Based Evaluation Technique (MACBETH) questioning protocol and the M-MACBETH software (<a class="anchor anchor-primary" href="#bib17" name="bbib17" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib17"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa and Vansnick, 1999</span></span></a>). This protocol requires pairwise comparisons where qualitative judgements about the difference in value between different pairs of attribute levels (i.e. difference in value between x and y units of a criterion's performance indicator) are expressed using seven qualitative categories (i.e. no difference, very weak difference, weak difference, moderate difference, strong difference, very strong difference, or extreme difference) (<a class="anchor anchor-primary" href="#bib19" name="bbib19" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib19"><span class="anchor-text-container"><span class="anchor-text">Bana E Costa et al., 2012</span></span></a>; <a class="anchor anchor-primary" href="#bib22" name="bbib22" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib22"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa and Vansnick, 1994</span></span></a>). MACBETH provides a constructive and user-friendly approach to generate a cardinal (interval) value scale based on the input of these qualitative pair-wise judgements, which are then converted into value scores via an optimization algorithm (<a class="anchor anchor-primary" href="#bib15" name="bbib15" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib15"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa et al., 2016b</span></span></a>); this approach has been widely used as a decision support tool (<a class="anchor anchor-primary" href="#bib16" name="bbib16" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib16"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa et al., 2014</span></span></a>; <a class="anchor anchor-primary" href="#bib18" name="bbib18" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib18"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa et al., 2002</span></span></a>; <a class="anchor anchor-primary" href="#bib21" name="bbib21" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib21"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa and Oliveira, 2012</span></span></a>; <a class="anchor anchor-primary" href="#bib23" name="bbib23" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib23"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa and Vansnick, 1997</span></span></a>).</div><div class="u-margin-s-bottom" id="p0150">Weights for a multi-attribute value function should be elicited using indirect questioning protocols that consider a performance range for each attribute (<a class="anchor anchor-primary" href="#bib67" name="bbib67" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib67"><span class="anchor-text-container"><span class="anchor-text">Keeney, 2002</span></span></a>), as for example the value of a “swing” between two reference levels. The weights are scaling constants that convert partial value scores into overall value scores that must reflect value trade-offs and, therefore, should not be interpreted as measurements of ‘direct importance’. An indirect (qualitative) swing weighting technique was applied to elicit relative criteria weights by first ordering the swings of each attribute and then valuing their differences using the MACBETH qualitative categories (<a class="anchor anchor-primary" href="#bib19" name="bbib19" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib19"><span class="anchor-text-container"><span class="anchor-text">Bana E Costa et al., 2012</span></span></a>).</div><div class="u-margin-s-bottom" id="p0155">The above MACBETH-based scoring and weighting techniques were operationalised using the software M-MACBETH (<a class="anchor anchor-primary" href="#bib17" name="bbib17" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib17"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa and Vansnick, 1999</span></span></a>). The software automatically checks the consistency between qualitative judgement inputs and derives value scores and weights using linear programming rules. It also automates the additive aggregation of value scores and weights in order to derive overall weighted preference value (WPV) scores and allows for sensitivity analysis on the criteria weights. Additionally, the software enables the use of visual graphics to build a model of values, acting as a facilitation tool to inform both the design and the evaluation phases of the methodological framework (<a class="anchor anchor-primary" href="#bib14" name="bbib14" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib14"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa et al., 2016a</span></span></a>; <a class="anchor anchor-primary" href="#bib17" name="bbib17" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib17"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa and Vansnick, 1999</span></span></a>; <a class="anchor anchor-primary" href="#bib20" name="bbib20" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib20"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa et al., 1999</span></span></a>). As part of a broader deliberative process, manual consistency checks were also performed by the facilitator, both to confirm the cardinality of the value scales and the understanding of the swing weights, followed by discussion and interpretation of the overall results. More information regarding the technical details of MACBETH is available in the <em>Appendix</em>.</div></section><section id="sec2.4.3"><h4 id="sectitle0080" class="u-margin-m-top u-margin-xs-bottom">2.4.3. Cost calculation</h4><div class="u-margin-s-bottom" id="p0160">UK list prices at ex-factory level were used as found in the BNF (<a class="anchor anchor-primary" href="#bib27" name="bbib27" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib27"><span class="anchor-text-container"><span class="anchor-text">BNF, 2015</span></span></a>). This acted as a neutral benchmark in order to allow the measurement of cost(s) in a common unit across all study settings, so that overall WPV scores could then be viewed against the same cost denominator to produce comparable cost-value ratios. Access to confidential prices through risk sharing agreements was not possible. Information on the recommended dosages and treatment durations were sourced from the pivotal trial peer review publications and the respective EMA EPARs (<a class="anchor anchor-primary" href="#bib40" name="bbib40" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib40"><span class="anchor-text-container"><span class="anchor-text">de Bono et al., 2011</span></span></a>; <a class="anchor anchor-primary" href="#bib41" name="bbib41" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib41"><span class="anchor-text-container"><span class="anchor-text">de Bono et al., 2010</span></span></a>; <a class="anchor anchor-primary" href="#bib46" name="bbib46" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib46"><span class="anchor-text-container"><span class="anchor-text">EMA, 2016a</span></span></a>, <a class="anchor anchor-primary" href="#bib47" name="bbib47" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib47"><span class="anchor-text-container"><span class="anchor-text">b</span></span></a>, <a class="anchor anchor-primary" href="#bib48" name="bbib48" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib48"><span class="anchor-text-container"><span class="anchor-text">c</span></span></a>; <a class="anchor anchor-primary" href="#bib97" name="bbib97" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib97"><span class="anchor-text-container"><span class="anchor-text">Scher et al., 2012</span></span></a>). Drug administration costs for cabazitaxel were kept consistent with the respective NICE TA (<a class="anchor anchor-primary" href="#bib80" name="bbib80" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib80"><span class="anchor-text-container"><span class="anchor-text">NICE, 2012b</span></span></a>), whereas for abiraterone and enzaluatmide these costs were not applicable as they are orally administered.</div></section></section></section><section id="sec3"><h2 id="sectitle0085" class="u-h4 u-margin-l-top u-margin-xs-bottom">3. Results</h2><section id="sec3.1"><h3 id="sectitle0090" class="u-h4 u-margin-m-top u-margin-xs-bottom">3.1. Final value trees, options performance, criteria weights and value functions</h3><div class="u-margin-s-bottom" id="p0165">Across the four countries, decision conferences were characterised by increased interaction and extensive debate between participants, especially in cases where there was disagreement about certain values. Because the majority of participants had a shared understanding of the decision problem but also a sense of common purpose and commitment to a way forward, all of which are conditions for good practice in decision conferencing, the deliberative process of each decision conference instigated a fruitful discussion and exchange of views around different criteria values and their relative importance.</div><div class="u-margin-s-bottom" id="p0170">General consensus was reached among participants in terms of criteria consideration and model validation with no major value aspects deemed to be missing. All criteria included in each country's final mCRPC value tree, as emerged following open interaction with decision conference participants and their rankings, are shown in <a class="anchor anchor-primary" href="#tbl1" name="btbl1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="tbl1"><span class="anchor-text-container"><span class="anchor-text">Table 1</span></span></a> (schematic illustrations of the individual value trees are shown in Appendix <a class="anchor anchor-primary" href="#appsec1" name="bappsec1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="appsec1"><span class="anchor-text-container"><span class="anchor-text">Fig. A1</span></span></a>). The main reason for not including a criterion in the value tree was because participants would consider it to be non-fundamental to the evaluation, in all cases of which a zero weight was assigned. Most of the criteria that were assigned a zero weight belonged to the Innovation Level (INN) domain, which comprised the highest number of criteria.</div><div class="u-margin-s-bottom" id="p0175">The performance of the drug options across the different criteria attributes that were considered to be fundamental in the model (i.e. weight greater than zero) together with the “lower” and “higher” reference levels are shown in <a class="anchor anchor-primary" href="#tbl2" name="btbl2" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="tbl2"><span class="anchor-text-container"><span class="anchor-text">Table 2</span></span></a>.</div><div class="u-margin-s-bottom"><div id="p0180">Between 6 (AOTMiT) and 11 (AETSA/INAMI) criteria were included in each country's final value tree, as shown in <a class="anchor anchor-primary" href="#tbl3" name="btbl3" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="tbl3"><span class="anchor-text-container"><span class="anchor-text">Table 3</span></span></a>. In terms of the different criteria domains composition, the Therapeutic Benefit contained between two (TLV/AOTMiT/INAMI) and three (AETSA) criteria, the Safety Profile between one (AOTMiT) and two (TLV/AETSA/INAMI) criteria, the Innovation Level between two (TLV/AOTMiT) and six (INAMI) criteria, and the Socioeconomic Impact always one criterion.</div><div class="tables colsep-0 frame-topbot rowsep-0" id="tbl3"><span class="captions text-s"><span id="cap0065"><p id="tspara0060"><span class="label">Table 3</span>. Number of criteria per cluster, relative weights per criteria cluster and their ranking across the four HTA settings.</p></span></span><div class="groups"><table><thead><tr class="rowsep-1 valign-top"><th scope="col" rowspan="2"><strong>HTA Agency</strong>/Criteria Clusters</th><th scope="col" colspan="3"><strong>Sweden (TLV)</strong></th><th scope="col" colspan="3"><strong>Andalusia (AETSA)</strong></th><th scope="col" colspan="3"><strong>Poland (AOTMiT)</strong></th><th scope="col" colspan="3"><strong>Belgium (INAMI-RIZIV)</strong></th></tr><tr class="rowsep-1 valign-top"><th scope="col">Criteria numbers</th><th scope="col">Criteria weights</th><th scope="col">Criteria ranking</th><th scope="col">Criteria numbers</th><th scope="col">Criteria weights</th><th scope="col">Criteria ranking</th><th scope="col">Criteria numbers</th><th scope="col">Criteria weights</th><th scope="col">Criteria ranking</th><th scope="col">Criteria numbers</th><th scope="col">Criteria weights</th><th scope="col">Criteria ranking</th></tr></thead><tbody><tr class="valign-top"><td class="align-left">Therapeutic Benefit</td><td class="align-left">2</td><td class="align-left">44.5</td><td class="align-left">1st</td><td class="align-left">3</td><td class="align-left">54.3</td><td class="align-left">1st</td><td class="align-left">2</td><td class="align-left">40.0</td><td class="align-left">1st</td><td class="align-left">2</td><td class="align-left">40.0</td><td class="align-left">1st</td></tr><tr class="valign-top"><td class="align-left">Safety Profile</td><td class="align-left">2</td><td class="align-left">33.3</td><td class="align-left">2nd</td><td class="align-left">2</td><td class="align-left">26.0</td><td class="align-left">2nd</td><td class="align-left">1</td><td class="align-left">20.0</td><td class="align-left">3rd</td><td class="align-left">2</td><td class="align-left">26.7</td><td class="align-left">2nd</td></tr><tr class="valign-top"><td class="align-left">Innovation Level</td><td class="align-left">2</td><td class="align-left">7.4</td><td class="align-left">4th</td><td class="align-left">5</td><td class="align-left">11.8</td><td class="align-left">3rd</td><td class="align-left">2</td><td class="align-left">10.0</td><td class="align-left">4th</td><td class="align-left">6</td><td class="align-left">13.3</td><td class="align-left">4th</td></tr><tr class="valign-top"><td class="align-left">Socioeconomic Impact</td><td class="align-left">1</td><td class="align-left">14.8</td><td class="align-left">3rd</td><td class="align-left">1</td><td class="align-left">7.9</td><td class="align-left">4th</td><td class="align-left">1</td><td class="align-left">30.0</td><td class="align-left">2nd</td><td class="align-left">1</td><td class="align-left">20.0</td><td class="align-left">3rd</td></tr><tr class="valign-top"><td class="align-left"><em>Total</em></td><td class="align-left">7</td><td class="align-left">100</td><td></td><td class="align-left">11</td><td class="align-left">100</td><td></td><td class="align-left">6</td><td class="align-left">100</td><td></td><td class="align-left">11</td><td class="align-left">100</td><td></td></tr></tbody></table></div><div class="legend"><div class="u-margin-s-bottom" id="tspara0065">Source: The authors based on input from decision conferences.</div></div></div></div><div class="u-margin-s-bottom" id="p0185"><span>During the elicitation of the ‘overall survival’ (OS) and/or ‘HRQoL’ criteria value functions, it became evident that these criteria might be preference dependent. When participants were asked to judge the difference in value between different increments in their performance (either in ‘OS’ or ‘HRQoL’), a request for clarification was raised by some participants relating to what level of performance this change was associated with on the other criterion. In order to address the plausible preference-dependence observed, we combined together the two criteria in an aggregated form. The two criteria were combined by multiplying the number of months in ‘OS’ and their EQ-5D utility scores in ‘HRQoL’ attributes respectively, assuming an equal (i.e. 50%) distribution of stable and progressive disease states, essentially deriving quality adjusted life months (QALMs). An example of a MACBETH value judgements matrix and its conversion into a value function for the case of the ‘radiographic tumour progression' (i.e. <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/progression-free-survival" title="Learn more about progression free survival from ScienceDirect's AI-generated Topic Pages" class="topic-link">progression free survival</a> (PFS)) criterion in months is shown in Appendix </span><a class="anchor anchor-primary" href="#appsec1" name="bappsec1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="appsec1"><span class="anchor-text-container"><span class="anchor-text">Fig. A2</span></span></a>.</div><div class="u-margin-s-bottom" id="p0190">There was a common set of six criteria that were considered as fundamental in all countries: (a) ‘OS x HRQoL’; (b) ‘radiographic tumour progression’ (PFS); (c) ‘treatment discontinuation’; (d) ‘delivery posology’; (e) ‘special instructions’; and (f) ‘medical costs impact’. This common set of criteria comprised the complete set of TLV's value tree (n = 6), whereas AOTMIT's value tree also considered ‘contraindications’ (n = 7). Further to these, AETSA's value tree considered ‘Prostate-specific antigen (PSA) response’, ‘ATCL4’, ‘Phase 3’ and ‘marketing authorisation’ (n = 11), whereas INAMI's value tree considered the same additional criteria but with ‘Phase 2’ instead of ‘PSA response’ (n = 11).</div><div class="u-margin-s-bottom"><div id="p0195">Overall, the different groups of decision conference participants agreed in the valuation of performance for the six common criteria that were considered across all four countries, as revealed through the elicitation of their value functions. <a class="anchor anchor-primary" href="#fig2" name="bfig2" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="fig2"><span class="anchor-text-container"><span class="anchor-text">Fig. 2</span></span></a> plots the value scores of each drug across the six common criteria showing very similar valuations between countries.</div><figure class="figure text-xs" id="fig2"><span><img src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr2.jpg" height="821" alt="Fig. 2" aria-describedby="cap0035"><ol class="u-margin-s-bottom"><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr2_lrg.jpg" target="_blank" download="" title="Download high-res image (359KB)"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download high-res image (359KB)</span></span></span></a></li><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr2.jpg" target="_blank" download="" title="Download full-size image"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download full-size image</span></span></span></a></li></ol></span><span class="captions text-s"><span id="cap0035"><p id="fspara0025"><span class="label">Fig. 2</span>. Criteria valuation drug profiles across the six common criteria.</p></span></span></figure></div><div class="u-margin-s-bottom"><div id="p0200">The weights of relative importance assigned to the different criteria across the four jurisdictions are shown in <a class="anchor anchor-primary" href="#fig3" name="bfig3" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="fig3"><span class="anchor-text-container"><span class="anchor-text">Fig. 3</span></span></a>. By taking into account the relative swings of the criteria attributes, i.e. the gap between the “lower” and “higher” reference levels, quantitative weights were derived for each criterion using M-MACBETH. The ‘OS x HRQoL’ aggregated criterion was always assigned the highest relative weight out of 100 ([31,44] for INAMI and AETSA, respectively), followed either by ‘treatment discontinuation’ ([17,21] for AETSA and TLV, respectively) or ‘medical costs impact’ ([20,30] for INAMI and AOTMiT, respectively). Depending on the country, the 3rd ranked criterion was then either ‘treatment discontinuation’ (AOTMiT, INAMI), ‘medical costs impact’ (TLV), or ‘contraindications’ (AETSA) and ‘PFS’ was ranked 4th or 5th. ‘Special instructions’, although a fundamental criterion across settings, was ranked last in three out of four settings with the ‘delivery posology’ usually at a higher position, with the exception of TLV where that order was reversed.</div><figure class="figure text-xs" id="fig3"><span><img src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr3.jpg" height="258" alt="Fig. 3" aria-describedby="cap0040"><ol class="u-margin-s-bottom"><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr3_lrg.jpg" target="_blank" download="" title="Download high-res image (181KB)"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download high-res image (181KB)</span></span></span></a></li><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr3.jpg" target="_blank" download="" title="Download full-size image"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download full-size image</span></span></span></a></li></ol></span><span class="captions text-s"><span id="cap0040"><p id="fspara0030"><span class="label">Fig. 3</span>. Relative criteria weights stacked bars across the four HTA settings.</p></span></span></figure></div><div class="u-margin-s-bottom" id="p0205">In terms of the total weights assigned across the different criteria domains, the Therapeutic Benefit weight ranged from 40% to 54% (for AOTMiT/INAMI and AETSA, respectively), the Safety Profile weight ranged from 20% to 33% (for AOTMiT and TLV, respectively), the Innovation Level weight ranged from 7% to 13% (for TLV and INAMI, respectively) and the Socioeconomic Impact weight ranged from 8% to 30% (for AETSA and AOTMiT, respectively) (<a class="anchor anchor-primary" href="#tbl3" name="btbl3" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="tbl3"><span class="anchor-text-container"><span class="anchor-text">Table 3</span></span></a>). The above differences in relative weights reflect the different priorities of decision-makers, including the number of fundamental objectives being considered.</div></section><section id="sec3.2"><h3 id="sectitle0095" class="u-h4 u-margin-m-top u-margin-xs-bottom">3.2. Overall drug rankings and value-for-money analysis</h3><div class="u-margin-s-bottom"><div id="p0210">With regards to the overall WPV scores shown in <a class="anchor anchor-primary" href="#tbl4" name="btbl4" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="tbl4"><span class="anchor-text-container"><span class="anchor-text">Table 4</span></span></a><span>, <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/enzalutamide" title="Learn more about enzalutamide from ScienceDirect's AI-generated Topic Pages" class="topic-link">enzalutamide</a><span> consistently yielded the highest score across all four countries, always followed by <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/abiraterone" title="Learn more about abiraterone from ScienceDirect's AI-generated Topic Pages" class="topic-link">abiraterone</a><span> and <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/cabazitaxel" title="Learn more about cabazitaxel from ScienceDirect's AI-generated Topic Pages" class="topic-link">cabazitaxel</a><span>. The overall scores of <a href="/topics/agricultural-and-biological-sciences/abiraterone" title="Learn more about abiraterone from ScienceDirect's AI-generated Topic Pages" class="topic-link">abiraterone</a> and cabazitaxel were in part influenced by a “negative” performance in the ‘treatment discontinuation’ attribute (19% and 18% respectively) which lay below the lower reference level of the scale (i.e. 10%), affecting negatively their overall value scores.</span></span></span></span></div><div class="tables colsep-0 frame-topbot rowsep-0" id="tbl4"><span class="captions text-s"><span id="cap0070"><p id="tspara0070"><span class="label">Table 4</span>. Overall weighted preference value (WPV) scores, costs and costs per unit of value across the four HTA settings.</p></span></span><div class="groups"><table><thead><tr class="rowsep-1 valign-top"><th scope="col"><strong>Treatments</strong></th><th scope="col" colspan="2"><strong>Enzalutamide</strong></th><th scope="col" colspan="2"><strong>Abiraterone</strong></th><th scope="col" colspan="2"><strong>Cabazitaxel</strong></th></tr><tr class="rowsep-1 valign-top"><th scope="col">HTA agency</th><th scope="col"><strong>Overall WPV score</strong></th><th scope="col"><strong>Ranking per country</strong></th><th scope="col"><strong>Overall WPV score</strong></th><th scope="col"><strong>Ranking per country</strong></th><th scope="col"><strong>Overall WPV score</strong></th><th scope="col"><strong>Ranking per country</strong></th></tr></thead><tbody><tr class="valign-top"><td class="align-left">Sweden (TLV)</td><td class="align-left">55.1</td><td class="align-left">1st</td><td class="align-left">2.4</td><td class="align-left">2nd</td><td class="align-left">−3.4</td><td class="align-left">3rd</td></tr><tr class="valign-top"><td class="align-left">Andalusia (AETSA)</td><td class="align-left">49.1</td><td class="align-left">1st</td><td class="align-left">8.8</td><td class="align-left">2nd</td><td class="align-left">4.4</td><td class="align-left">3rd</td></tr><tr class="valign-top"><td class="align-left">Poland (AOTMiT)</td><td class="align-left">59.9</td><td class="align-left">1st</td><td class="align-left">12.1</td><td class="align-left">2nd</td><td class="align-left">3.5</td><td class="align-left">3rd</td></tr><tr class="valign-top"><td class="align-left">Belgium (INAMI-RIZIV)</td><td class="align-left">58.6</td><td class="align-left">1st</td><td class="align-left">16.0</td><td class="align-left">2nd</td><td class="align-left">10.9</td><td class="align-left">3rd</td></tr><tr class="valign-top"><td class="align-left rowsep-1"><em>Costs (£)</em></td><td class="align-left rowsep-1" colspan="2">24,600</td><td class="align-left rowsep-1" colspan="2">21,900</td><td class="align-left rowsep-1" colspan="2">23,900</td></tr><tr class="valign-top"><td class="rowsep-1"></td><td class="align-left rowsep-1"><strong>Cost per unit of value</strong></td><td class="align-left rowsep-1"><strong>Ranking per country</strong></td><td class="align-left rowsep-1"><strong>Cost per unit of value</strong></td><td class="align-left rowsep-1"><strong>Ranking per country</strong></td><td class="align-left rowsep-1"><strong>Cost per unit of value</strong></td><td class="align-left rowsep-1"><strong>Ranking per country</strong></td></tr><tr class="valign-top"><td class="align-left">Sweden (TLV)</td><td class="align-left">447</td><td class="align-left">1st</td><td class="align-left">9,221</td><td class="align-left">2nd</td><td class="align-left">N/A</td><td class="align-left">3rd</td></tr><tr class="valign-top"><td class="align-left">Andalusia (AETSA)</td><td class="align-left">501</td><td class="align-left">1st</td><td class="align-left">2,496</td><td class="align-left">2nd</td><td class="align-left">5,481</td><td class="align-left">3rd</td></tr><tr class="valign-top"><td class="align-left">Poland (AOTMiT)</td><td class="align-left">410</td><td class="align-left">1st</td><td class="align-left">1,805</td><td class="align-left">2nd</td><td class="align-left">6,816</td><td class="align-left">3rd</td></tr><tr class="valign-top"><td class="align-left">Belgium (INAMI-RIZIV)</td><td class="align-left">420</td><td class="align-left">1st</td><td class="align-left">1,366</td><td class="align-left">2nd</td><td class="align-left">2,196</td><td class="align-left">3rd</td></tr></tbody></table></div><div class="legend"><div class="u-margin-s-bottom" id="tspara0075">Note: No cost per unit of value was calculated because of the negative overall WPV score (i.e. having a worst overall performance compared to the performance of the lower reference level), which would produce a negative cost per unit of value (£23,900/(-3.4) = −7,072) and would therefore faulty “improve” the median figure of the treatment.</div><div class="u-margin-s-bottom" id="tspara0080">Source: The authors based on input from decision conferences.</div></div></div></div><div class="u-margin-s-bottom"><div id="p0215">A stacked bar plot of the drugs' overall WPV scores across all settings is shown in <a class="anchor anchor-primary" href="#fig4" name="bfig4" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="fig4"><span class="anchor-text-container"><span class="anchor-text">Fig. 4</span></span></a><span>. By using rounded up cost figures for <a href="/topics/agricultural-and-biological-sciences/enzalutamide" title="Learn more about enzalutamide from ScienceDirect's AI-generated Topic Pages" class="topic-link">enzalutamide</a> (£24,600), abiraterone (£21,900) and cabazitaxel (£23,900, of which £22,190 related to drug cost and the remainder £1,710 to administration cost) and dividing them with overall WPV scores, their costs per MCDA value unit ranged as follows: (a) enzalutamide: £410 - £501 (for AOTMiT and AETSA, respectively); (b) abiraterone: £1,366 - £9,221 (for INAMI and TLV, respectively); and (c) cabazitaxel: £2,196 - £6,816 (for INAMI and AOTMiT, respectively) (</span><a class="anchor anchor-primary" href="#tbl4" name="btbl4" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="tbl4"><span class="anchor-text-container"><span class="anchor-text">Table 4</span></span></a>). The overall value score of each option was driven by the fundamental objectives considered (i.e. criteria influencing the model), the criteria weights which were anchored on reference levels, and the shape of value functions which would influence the value scores.</div><figure class="figure text-xs" id="fig4"><span><img src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr4.jpg" height="481" alt="Fig. 4" aria-describedby="cap0045"><ol class="u-margin-s-bottom"><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr4_lrg.jpg" target="_blank" download="" title="Download high-res image (535KB)"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download high-res image (535KB)</span></span></span></a></li><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr4.jpg" target="_blank" download="" title="Download full-size image"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download full-size image</span></span></span></a></li></ol></span><span class="captions text-s"><span id="cap0045"><p id="fspara0035"><span class="label">Fig. 4</span>. Stacked bar plot of treatments' overall weighted preference value scores across the four HTA settings.</p></span></span></figure></div><div class="u-margin-s-bottom"><div id="p0220">In terms of value-for-money, cabazitaxel was shown to be dominated by abiraterone, and was very close to being dominated by enzalutamide (i.e. a difference of £500 based on the prices used). Enzalutamide on the other hand was associated with a higher cost (a difference of £2,500 based on the prices used) and a higher overall WPV score compared to abiraterone, with a difference in score ranging between 40.4 and 52.7 value units (for AETSA and TLV, respectively). Cost benefit plots of the different options, using their overall WPV scores versus their purchasing (plus any administration) costs across the four HTA organisations is shown in <a class="anchor anchor-primary" href="#fig5" name="bfig5" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="fig5"><span class="anchor-text-container"><span class="anchor-text">Fig. 5</span></span></a>.</div><figure class="figure text-xs" id="fig5"><span><img src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr5.jpg" height="520" alt="Fig. 5" aria-describedby="cap0050"><ol class="u-margin-s-bottom"><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr5_lrg.jpg" target="_blank" download="" title="Download high-res image (442KB)"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download high-res image (442KB)</span></span></span></a></li><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-gr5.jpg" target="_blank" download="" title="Download full-size image"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download full-size image</span></span></span></a></li></ol></span><span class="captions text-s"><span id="cap0050"><p id="fspara0040"><span class="label">Fig. 5</span>. Cost benefit plots of treatments overall weighted preference value scores versus their purchasing costs across the four HTA settings (TLV top left, AETSA top right, AOTMiT, bottom left, INAMI bottom right). Images produced using the M-MACBETH (beta) software version 3.0.0.</p></span></span></figure></div></section><section id="sec3.3"><h3 id="sectitle0100" class="u-h4 u-margin-m-top u-margin-xs-bottom">3.3. Similarities and differences in value perceptions across settings</h3><div class="u-margin-s-bottom" id="p0225">By looking at <a class="anchor anchor-primary" href="#tbl3" name="btbl3" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="tbl3"><span class="anchor-text-container"><span class="anchor-text">Table 3</span></span></a> (and <a class="anchor anchor-primary" href="#fig3" name="bfig3" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="fig3"><span class="anchor-text-container"><span class="anchor-text">Fig. 3</span></span></a>) of the results, a number of similarities and differences in value preferences are observed across the four settings. The largest number of evaluation criteria were considered in Andalusia and Belgium (11 each), compared to Sweden and Poland (7 and 6, respectively), partly due to a higher number of Innovation Level criteria (5 and 6, compared to 2 each, respectively). In terms of the relative importance of criteria domains, the Therapeutic Benefit cluster consistently ranked 1st across all settings. The Safety Profile cluster was ranked 2nd in three settings (except for Poland, where the Socioeconomic Impact cluster ranked higher (30% vs 20%)). The Socioeconomic Impact cluster ranked 3rd in Sweden and Belgium but 4th in Andalusia (8%). Finally, the Innovation Level cluster ranked 4th in three countries with the exception of Andalusia where it ranked 3rd (12%). The low relative importance of the Innovation Level cluster partly justifies why a hypothetical change in the final consideration of Innovation Level criteria across the different countries does not influence the ranking of the treatments, as described in the next section.</div><div class="u-margin-s-bottom" id="p0230">Despite the observed differences in evaluation criteria considered, the relative criteria weights assigned and the elicited value functions, the overall ranking of the treatments remained identical across countries (<a class="anchor anchor-primary" href="#tbl4" name="btbl4" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="tbl4"><span class="anchor-text-container"><span class="anchor-text">Table 4</span></span></a> and <a class="anchor anchor-primary" href="#fig4" name="bfig4" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="fig4"><span class="anchor-text-container"><span class="anchor-text">Fig. 4</span></span></a>) with enzalutamide consistently having the highest score, followed by abiraterone and cabazitaxel in all four settings.</div></section><section id="sec3.4"><h3 id="sectitle0105" class="u-h4 u-margin-m-top u-margin-xs-bottom">3.4. Sensitivity and robustness analysis</h3><div class="u-margin-s-bottom" id="p0235">Following each decision conference, deterministic sensitivity analysis was conducted to address parameter uncertainty on criteria weights. Specifically, changes to baseline weights were explored to check their possible impact on treatments' overall value rankings. The results of the sensitivity analysis demonstrated that the ranking of treatments was robust to the relative criteria weights across the different settings.</div><div class="u-margin-s-bottom" id="p0240">The most sensitive criterion weight, which could change enzalutamide's ranking order from 1st to 2nd, was ‘PFS’ in the cases of INAMI and AETSA where a 10 and 11 times change (from 8.9% to 90.6% and from 8.0% to 88.5%) respectively, would be required for cabazitaxel to rank 1st and enzalutamide 2nd. In other words, a higher than 10-times difference on the ‘PFS’ weight would be required for cabazitaxel to outperform enzalutamide, with changes of higher order required in other criteria weights for either cabazitaxel or abiraterone to rank 1st, in any of the study settings. Criteria weights were more sensitive to the outperformance of abiraterone by cabazitaxel as the 2nd best treatment. Again, the most sensitive weight was for ‘PFS’ in the INAMI and AETSA cases, where a 2-times change (from 8.9% to 17.4% and from 8.0% to 16.7% respectively) would be needed for cabazitaxel to rank 2nd and abiraterone 3rd. This meant that the lowest change across criteria weights needed for an impact on treatment rankings to be observed was for the case of PFS with INAMI, where at least a 2-times difference was required for abiraterone to be outperformed. For the case of TLV and AOTMiT, the most sensitive criterion was treatment discontinuation in which a 3-times change would be needed (from 21.2% to 54.6% and from 20% to 60% respectively) for cabazitaxel to rank 2nd best.</div><div class="u-margin-s-bottom" id="p0245">The final consideration of the Innovation Level criteria cluster was explored in greater detail given that their relevance might be disputed. Removing the ‘ATCL4’ criterion and any spill-over effect criteria (i.e. ‘Phase-2’, ‘Phase-3’, ‘MA’) from the value tree of AETSA and INAMI, and any patient convenience criteria (i.e. ‘delivery posology’, ‘special instructions’) from all country value trees would not affect the treatment rankings.</div></section></section><section id="sec4"><h2 id="sectitle0110" class="u-h4 u-margin-l-top u-margin-xs-bottom">4. Discussion</h2><section id="sec4.1"><h3 id="sectitle0110a" class="u-h4 u-margin-m-top u-margin-xs-bottom">4.1. Policy implications</h3><div class="u-margin-s-bottom" id="p0250">This study is the first comparative MCDA exercise utilising the Advance Value Framework and engaging sitting HTA decision-makers across four EU Member States to elicit and compare their preferences in the evaluation of three mCRPC treatments. In doing so, the objective was to test the feasibility of MCDA methods for HTA decision-makers and identify differences in value perceptions.</div><div class="u-margin-s-bottom" id="p0255">Based on the evidence used, our results showed that the most valuable therapy for second line mCRPC was enzalutamide, followed by abiraterone and cabazitaxel. Each treatment was assessed and ranked based on their overall WPV scores, reflecting the value of their performance against a set of evaluation criteria, weighted against their relative importance. These overall scores were based on the value preferences of decision-makers that were collected via a decision conference in each setting, yielding a comprehensive and transparent multi-dimensional benefit component. Subsequent consideration of drug costs (purchasing and administration) enabled the demonstration of value-for-money in the form of estimated “cost per unit of value” ratios which showed the second-ranked treatment (abiraterone) to dominate the third (cabazitaxel).</div><div class="u-margin-s-bottom" id="p0260">It should be noted that the constructed benefit metric used excludes the cost of the treatments, i.e. the WPV score considers the impact of the technology on medical costs other than the purchasing cost of the technology. Therefore, evaluation of the treatments based solely on their overall WPV scores might not be appropriately designed to inform an HTA decision context that considers the interventions' incremental cost per incremental benefit, but, rather, a value-based approach to reimbursement or pricing negotiation.</div><div class="u-margin-s-bottom" id="p0265">Attempting a comparison of the ranking achieved in this exercise with what has occurred in reality might prove challenging, partly because of how the clinical evidence was treated in the exercise, but also because it is not publicly known whether and how any of the additional value dimensions evaluated in the exercise were considered in the relevant HTA decision-making processes. In Sweden, although abiraterone's ICER vs BSC (manufacturer estimate of SEK820,000/QALY) (<a class="anchor anchor-primary" href="#bib109" name="bbib109" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib109"><span class="anchor-text-container"><span class="anchor-text">TLV, 2015a</span></span></a>), was lower compared to enzalutamide's ICER vs BSC (TLV best estimate of SEK1,100,000/QALY) (<a class="anchor anchor-primary" href="#bib108" name="bbib108" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib108"><span class="anchor-text-container"><span class="anchor-text">TLV, 2014</span></span></a>), or lower vs enzalutamide (SEK800,000/QALY) (<a class="anchor anchor-primary" href="#bib110" name="bbib110" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib110"><span class="anchor-text-container"><span class="anchor-text">TLV, 2015b</span></span></a>), TLV assumed that both treatments had the same clinical effect; consequently, TLV focused on a cost-minimisation approach rather than a cost-utility analysis, leading to the implementation of a confidential risk sharing agreement (RSA) as part of which discounts could be provided based on treatment duration. A similar conclusion was reached in Spain, where the Ministry of Health in its Clinical Assessment Report (Informe de Posicionamento Terapeutico - IPT) recommended that there was no clinically relevant difference between the benefit-risk balance of enzalutamide and abiraterone, and therefore decisions should be guided based on drug costs (<a class="anchor anchor-primary" href="#bib1" name="bbib1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib1"><span class="anchor-text-container"><span class="anchor-text">AEMPS, 2015</span></span></a>). Pricing and reimbursement decisions were then taken by the Interministerial Committee for Pricing and Reimbursement, but the final assessment is not publicly available. At regional/hospital level, a group of hospital pharmacists conducted a full health (clinical and economic) technology assessment, where enzalutamide and abiraterone were considered to be therapeutically equivalent (<a class="anchor anchor-primary" href="#bib54" name="bbib54" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib54"><span class="anchor-text-container"><span class="anchor-text">GHEMA, 2016</span></span></a>). In Poland, although AOTMiT accepted that some additional clinical benefit existed for enzalutamide compared to abiraterone (mainly in secondary endpoints), enzalutamide was not found to be cost-effective compared to abiraterone; however, a confidential RSA enabled a final positive recommendation by AOTMiT (<a class="anchor anchor-primary" href="#bib10" name="bbib10" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib10"><span class="anchor-text-container"><span class="anchor-text">AOTMiT, 2017</span></span></a>). The final decision implemented by the Ministry of Health was to reimburse enzalutamide, in a way similar to that of abiraterone (<a class="anchor anchor-primary" href="#bib85" name="bbib85" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib85"><span class="anchor-text-container"><span class="anchor-text">Obwieszczenie, 2017</span></span></a>). In Belgium, following an indirect comparison, no clinically relevant differences were found in the treatment outcomes of abiraterone versus enzalutamide (<a class="anchor anchor-primary" href="#bib59" name="bbib59" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib59"><span class="anchor-text-container"><span class="anchor-text">INAMI, 2019</span></span></a>); eventually, a managed entry agreement (MEA) enabled reimbursement.</div><div class="u-margin-s-bottom" id="p0270">Consequently, based on the evidence used to populate the MCDA model, the hypothetical coverage decisions emerging from the ranking of the treatments based on their overall WPV scores might have been different. Given the higher overall value of enzalutamide compared to abiraterone, a cost minimisation approach or price parity attained between the two, as inferred following the risk sharing agreements in place, might not have been justified.</div><div class="u-margin-s-bottom" id="p0275">One reason why our value models differentiate these treatments is because they have captured benefits that go beyond the current formal remits of HTA agencies, therefore, the results should be viewed as ‘proof-of-concept’ for the purposes of testing this methodology. Furthermore, the decision context addressed in the exercise was a one-off evaluation problem within the indication of mCRPC which might contradict the operational scope of some HTA agencies and health insurance bodies relating to repeated decisions around the reimbursement of drugs across different disease areas.</div><div class="u-margin-s-bottom" id="p0280">The extent to which HTA decision-makers can be relied upon, or not, to reflect societal preferences when constructing their value preferences is a very important topic for discussion but not aimed to be addressed in this study. Here, we simply elicited decision-makers' own preferences without considering whether these might be representative for society or not. In reality, evidence in Belgium suggests that health care coverage related preferences of decision-makers differ to those of the public (<a class="anchor anchor-primary" href="#bib33" name="bbib33" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib33"><span class="anchor-text-container"><span class="anchor-text">Cleemput et al., 2018</span></span></a>), and, therefore, more research would be needed to reveal such discrepancies.</div><div class="u-margin-s-bottom" id="p0285">Overall, the HTA decision-makers that participated in the four decision conferences provided positive feedback on the potential usefulness of the AVF and the MCDA approach in general, raising the prospects of this value framework acting as a decision support tool in the evaluation of new medicines. According to participants, key advantages of the AVF included the feasibility to transparently assess the performance of the options across a number of explicit evaluation criteria, while allowing the elicitation of value trade-offs (i.e. their relative importance), and the framework's overall facilitative nature in the construction and analysis of group value preferences. Our results are in line with past empirical evidence on a different oncology indication (<a class="anchor anchor-primary" href="#bib9" name="bbib9" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib9"><span class="anchor-text-container"><span class="anchor-text">Angelis et al., 2017</span></span></a>).</div></section><section id="sec4.2"><h3 id="sectitle0115" class="u-h4 u-margin-m-top u-margin-xs-bottom">4.2. Challenges of MCDA applications in HTA</h3><div class="u-margin-s-bottom" id="p0290">The assessment across four settings has offered a number of important insights relating to the application of MCDA in HTA and the challenges this represents. In order for any MCDA methodology to become a useful tool for HTA decision-makers and serve their needs, certain requirements must be met: first, sound methods should be used to ensure technical requirements are fulfilled (<a class="anchor anchor-primary" href="#bib65" name="bbib65" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib65"><span class="anchor-text-container"><span class="anchor-text">Keeney and Raiffa, 1993</span></span></a>); second, social aspects of the process should be treated carefully to ensure various socio-technical requirements are fulfilled (<a class="anchor anchor-primary" href="#bib12" name="bbib12" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib12"><span class="anchor-text-container"><span class="anchor-text">Baltussen et al., 2017</span></span></a>); and, third, tools and guidelines should be available and tailored for the appropriate audience ensuring that best practice requirements are fulfilled (<a class="anchor anchor-primary" href="#bib91" name="bbib91" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib91"><span class="anchor-text-container"><span class="anchor-text">Phillips, 2017</span></span></a>).</div><div class="u-margin-s-bottom" id="p0295">Among the first group of technical requirements, one key challenge of MCDA studies in HTA relates to the theoretical properties that are required for the evaluation criteria. Due to the popularity of using a simple additive (i.e. weighted average) value model, the violation of preference-independence is of particular relevance as it might undermine the validity of such models and the insights offered by the results (<a class="anchor anchor-primary" href="#bib75" name="bbib75" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib75"><span class="anchor-text-container"><span class="anchor-text">Marsh et al., 2018</span></span></a>; <a class="anchor anchor-primary" href="#bib77" name="bbib77" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib77"><span class="anchor-text-container"><span class="anchor-text">Morton, 2017</span></span></a>). Evidence suggests that preference dependencies might exist between health gain and disease severity (<a class="anchor anchor-primary" href="#bib84" name="bbib84" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib84"><span class="anchor-text-container"><span class="anchor-text">Nord et al., 2009</span></span></a>), or between OS and HRQoL (<a class="anchor anchor-primary" href="#bib6" name="bbib6" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib6"><span class="anchor-text-container"><span class="anchor-text">Angelis and Kanavos, 2017</span></span></a>). The latter also featured strongly in this study, where such a preference dependence between OS and HRQoL was detected during the decision conferences and, as a result, the two criteria were combined together. Beyond combining the two criteria into a common aggregated one, other more technically complex solutions exist for addressing preference dependencies, such as using other functional forms of aggregation for combining scores and weights together, as for example multiplicative models (<a class="anchor anchor-primary" href="#bib31" name="bbib31" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib31"><span class="anchor-text-container"><span class="anchor-text">Chongtrakul et al., 2005</span></span></a>). Furthermore, tests for identifying preference dependencies have existed for many years (<a class="anchor anchor-primary" href="#bib38" name="bbib38" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib38"><span class="anchor-text-container"><span class="anchor-text">Currim and Sarin, 1984</span></span></a>; <a class="anchor anchor-primary" href="#bib64" name="bbib64" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib64"><span class="anchor-text-container"><span class="anchor-text">Keeney, 1992</span></span></a>; <a class="anchor anchor-primary" href="#bib95" name="bbib95" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib95"><span class="anchor-text-container"><span class="anchor-text">Rodrigues et al., 2017</span></span></a>).</div><div class="u-margin-s-bottom" id="p0300">Other technical challenges relate to the need for evaluation criteria to be non-overlapping so that there is no double counting, and that criteria weights are connected to the attribute ranges (<a class="anchor anchor-primary" href="#bib75" name="bbib75" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib75"><span class="anchor-text-container"><span class="anchor-text">Marsh et al., 2018</span></span></a>). If one of these conditions is not satisfied, criteria weights could misrepresent decision makers' true value preferences. Furthermore, a number of cognitive biases may affect value judgments and thus appropriate elicitation protocols and de-biasing tools must be employed (<a class="anchor anchor-primary" href="#bib76" name="bbib76" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib76"><span class="anchor-text-container"><span class="anchor-text">Montibeller and Winterfeldt, 2015</span></span></a>).</div><div class="u-margin-s-bottom" id="p0305">In order to avoid double-counting, a clear justification of their inclusion is needed, which should be on the grounds of addressing the fundamental objectives of the analysis, rather than be informed based on the existence of available evidence and data (<a class="anchor anchor-primary" href="#bib64" name="bbib64" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib64"><span class="anchor-text-container"><span class="anchor-text">Keeney, 1992</span></span></a>; <a class="anchor anchor-primary" href="#bib68" name="bbib68" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib68"><span class="anchor-text-container"><span class="anchor-text">Keeney and Gregory, 2005</span></span></a>). This process could be supported by the use of problem structuring tools aiming to distinguish between ‘fundamental objectives’ and ‘means objectives’ (<a class="anchor anchor-primary" href="#bib52" name="bbib52" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib52"><span class="anchor-text-container"><span class="anchor-text">Franco and Montibeller, 2010a</span></span></a>), as we adopted in this exercise.</div><div class="u-margin-s-bottom" id="p0310">In terms of weighting, asking direct questions for the general importance of criteria is known to be one of the most common mistakes when eliciting value trade-offs (<a class="anchor anchor-primary" href="#bib64" name="bbib64" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib64"><span class="anchor-text-container"><span class="anchor-text">Keeney, 1992</span></span></a>, <a class="anchor anchor-primary" href="#bib67" name="bbib67" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib67"><span class="anchor-text-container"><span class="anchor-text">2002</span></span></a>). Instead, sound weighting procedures for the assignment of relative weights should be deployed using explicit lower and higher reference levels of performance (<a class="anchor anchor-primary" href="#bib24" name="bbib24" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib24"><span class="anchor-text-container"><span class="anchor-text">Belton and Stewart, 2002</span></span></a>; <a class="anchor anchor-primary" href="#bib67" name="bbib67" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib67"><span class="anchor-text-container"><span class="anchor-text">Keeney, 2002</span></span></a>). Ideally, user-friendly indirect technique protocols should be adopted that can reduce bias, similar to what we aimed for in this exercise through the explicit definition of reference levels and the implementation of the qualitative (MACBETH) swing weighting technique.</div><div class="u-margin-s-bottom" id="p0315"><span>A further challenge relates to the linking of MCDA results with coverage and <a href="/topics/agricultural-and-biological-sciences/resource-allocation" title="Learn more about resource allocation from ScienceDirect's AI-generated Topic Pages" class="topic-link">resource allocation</a> decisions, possibly through the use of specific value thresholds, that can reflect the efficiency and opportunity cost of funding decisions (</span><a class="anchor anchor-primary" href="#bib99" name="bbib99" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib99"><span class="anchor-text-container"><span class="anchor-text">Sculpher et al., 2017</span></span></a>). In economic evaluation, incremental cost effectiveness ratio (ICER) thresholds are supposed to reflect the opportunity cost of the benefit foregone elsewhere in the health care system that would have resulted from the coverage of alternative technologies (<a class="anchor anchor-primary" href="#bib32" name="bbib32" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib32"><span class="anchor-text-container"><span class="anchor-text">Claxton et al., 2015</span></span></a>). Assuming that a QALY-based ICER threshold is accurate, it could be used as a benchmark to create an MCDA value threshold by extrapolating the ICER threshold in proportion to how much of the MCDA model's weight is accounted for by non-QALY value components (<a class="anchor anchor-primary" href="#bib87" name="bbib87" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib87"><span class="anchor-text-container"><span class="anchor-text">Phelps and Madhavan, 2018</span></span></a>). Alternatively, following the generation of a multi-dimensional benefit component, purchasing costs could be used to derive treatment cost-value ratios to inform resource allocation decisions within a fixed budget (<a class="anchor anchor-primary" href="#bib86" name="bbib86" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib86"><span class="anchor-text-container"><span class="anchor-text">Peacock et al., 2007</span></span></a>), similar to our approach in this exercise with the calculation of the “cost per unit of value”.</div></section><section id="sec4.3"><h3 id="sectitle0120" class="u-h4 u-margin-m-top u-margin-xs-bottom">4.3. Study limitations</h3><div class="u-margin-s-bottom" id="p0320"><span>The study has a number of limitations, related both to the clinical evidence used and the MCDA process followed, therefore results should be interpreted with caution. First, in terms of the clinical data used, there was a lack of relative treatment effects; in order to counteract that, absolute treatment effects from different <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/clinical-trial" title="Learn more about clinical trials from ScienceDirect's AI-generated Topic Pages" class="topic-link">clinical trials</a> were used based on the assumption that they are directly comparable which might not be accurate even for similar patient populations in the relevant studies. As a result, differences in the performance of the options that have been valued might in reality not be statistical significant, e.g. in OS. Ideally, one would need indirect comparisons or a network meta-analysis (NMA) through a mixed treatment comparison (</span><a class="anchor anchor-primary" href="#bib60" name="bbib60" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib60"><span class="anchor-text-container"><span class="anchor-text">Jansen et al., 2011</span></span></a><span>), therefore, an evidence synthesis step would be required as part of the model-building phase, as for example in the case of assessing the comparative benefit-risk of <a href="/topics/pharmacology-toxicology-and-pharmaceutical-science/hydroxymethylglutaryl-coenzyme-a-reductase-inhibitor" title="Learn more about statins from ScienceDirect's AI-generated Topic Pages" class="topic-link">statins</a> in primary prevention (</span><a class="anchor anchor-primary" href="#bib106" name="bbib106" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib106"><span class="anchor-text-container"><span class="anchor-text">Tervonen et al., 2015</span></span></a>) or second-generation antidepressants (<a class="anchor anchor-primary" href="#bib113" name="bbib113" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib113"><span class="anchor-text-container"><span class="anchor-text">van Valkenhoef et al., 2012</span></span></a>).</div><div class="u-margin-s-bottom" id="p0325">Second, another limitation relating to clinical evidence could be that only the treatments' impact on HRQoL for the stable disease state was assessed, because no treatment was assumed to have any effect during progression (<a class="anchor anchor-primary" href="#bib81" name="bbib81" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib81"><span class="anchor-text-container"><span class="anchor-text">NICE, 2014</span></span></a>). This might not be true for other disease indications in which case the relevant HRQoL attribute would have to capture both the stable and progressive disease states.</div><div class="u-margin-s-bottom" id="p0330">Third, there are a number of limitations in terms of the MCDA process adopted. One of them relates to the relatively small number of participants in two of the decision conferences (TLV and AETSA), which could reflect a limited representation of perspectives for the purpose of informing policy-making. Group sizes of between 7 and 15 participants are known to be ideal as they are large enough to represent all major perspectives but small enough to work towards agreement, effectively allowing for efficient group processes to emerge while preserving individuality (<a class="anchor anchor-primary" href="#bib90" name="bbib90" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib90"><span class="anchor-text-container"><span class="anchor-text">Phillips and Phillips, 1993</span></span></a>). However, in this instance capturing an all-round set of perspectives was not among the primary aims of the study.</div><div class="u-margin-s-bottom" id="p0435">Another issue relates to the value scale of the treatment discontinuation attribute in which the “lower” reference level of “10%” could be perceived as a limitation because it contributed towards the negative partial value scores of two treatments whose performance was worse. This took place in consultation with an oncologist, based on evidence from one of the clinical trials' placebo-controlled arms, because it was perceived to better resemble BSC used in practice; although others might have chosen a different performance level to define the “lower” reference level, the overall ranking of the treatments did not change after altering the lowest reference level to a much less preferred hypothetical performance (20% lower than the worst performing option), while keeping the weights constant.</div><div class="u-margin-s-bottom" id="p0335">One major advantage of MCDA is that it can be tailor-made to reflect decision-makers' needs, by taking into account different fundamental objectives through the consideration of various criteria, reflecting their priorities (by eliciting relative weights) and representing their preferences (by eliciting value functions). However, it should be recognised that the emerging differences described above prevent a generalised direct comparison of overall value scores for the alternative options; such a comparison would require identical value trees (i.e. the same set of criteria, weights and value functions across settings), in addition to the same evidence on options performance. The ranking comparisons that we have made in this study using ordinal scales reflect these limitations.</div></section></section><section id="sec5"><h2 id="sectitle0125" class="u-h4 u-margin-l-top u-margin-xs-bottom">5. Conclusion</h2><div class="u-margin-s-bottom" id="p0340">In this study we tested the application of AVF, a multi-criteria value framework, in collaboration with HTA decision-makers in order to deduce its feasibility and compare results across settings, in an effort to investigate its potential usefulness and limitations for the purposes of HTA. We found that the AVF methodology can act as a valuable decision support tool because of the transparent construction of value preferences in a collaborative manner, which facilitates the evaluation processes of groups, including the elicitation of value preferences on performance and trade-offs. Although we observed setting-specific differences in value perceptions, the rankings of drugs remained consistent across all countries. In alignment with the evidence used and generated in the study, a coverage decision based on this methodology might have pointed towards a different recommendation denoting differences in value between the first two treatments, in contrast with the cost minimisation approach adopted or the price parity attained between the two in real life.</div><div class="u-margin-s-bottom" id="p0345">Despite certain limitations relating to data and process issues and the existence of broader methodological challenges with the use of MCDA in HTA, the present study has demonstrated that an MCDA value framework can, in fact, provide meaningful valuations of novel health technologies, which in turn could inform coverage decisions.</div><div class="u-margin-s-bottom" id="p0350">The MCDA methodology adopted enabled participants in the study countries to reflect on certain value dimensions and incorporate these more explicitly in the deliberation process, supporting its use as a transparent value communication tool. Future research could involve similar cross-county <a href="/topics/agricultural-and-biological-sciences/case-study" title="Learn more about case studies from ScienceDirect's AI-generated Topic Pages" class="topic-link">case studies</a>, the advancement of MCDA methods in alignment with HTA policy needs, or repeating the study with different participants to understand whether similarities and differences identified in this study can be replicated.</div></section></div><section id="ack0010"><h2 id="sectitle0130" class="u-h4 u-margin-l-top u-margin-xs-bottom">Acknowledgements</h2><div class="u-margin-s-bottom" id="p0355">This paper has been conducted in the context of the Advance-HTA project, which has received funding from the <span id="gs1">European Commission's FP-7 Research</span> Programme (grant agreement number: <a class="anchor anchor-primary" href="#gs1"><span class="anchor-text-container"><span class="anchor-text">305983</span></span></a>). The views reflected in the paper do not represent the views of the European Commission. M.L. receives&nbsp;funding from the National Institute for Health Research&nbsp;(NIHR), UCL Hospitals Biomedical Research Centre, and&nbsp;CRUK UCL Experimental Cancer Medicine Centre.&nbsp;M.L. has received research funding from Bristol- Myers&nbsp;Squibb (BMS), AstraZeneca/MedImmune, Sanofi and Astellas and has&nbsp;received consulting fees from Janssen Pharmaceuticals, BioNTech and BMS.</div><div class="u-margin-s-bottom" id="p0360">We are grateful to Carlos Bana e Costa, Larry Phillips and Douglas Lundin for constructive feedback and suggestions on earlier versions of the paper. This research was made possible through the participation of a number of experts and stakeholders in four decision conferences that took place in collaboration with the Swedish Dental and Pharmaceutical Benefits Agency (TLV) in Stockholm, the Andalusian Health Technology Assessment Agency (AETSA) in Seville, the Polish Agency for Health Technology Assessment and Tariff System (AOTMiT) in Warsaw, and the Belgian Health Insurance Fund (INAMI-RIZIV) in Brussels. We are indebted to all participants for their valuable time and involvement. Thanks are also due to Olina Efthymiadou and Erica Visintin for valuable research assistance with drug costs and innovation spill-over effects calculations. Finally, we would like to thank all partners of the Advance-HTA consortium for their feedback throughout the project. All outstanding errors are our own.</div></section><div class="Appendices"><section id="appsec1"><h2 class="u-h4 u-margin-l-top u-margin-xs-bottom">Appendix. </h2><section id="appsec1.1"><h3 id="sectitle0135" class="u-h4 u-margin-m-top u-margin-xs-bottom">Model Building: Alternative treatments compared and evidence considered</h3><div class="u-margin-s-bottom" id="p0365">The source of evidence used for identifying the performance of options across the evaluation criteria is shown in <a class="anchor anchor-primary" href="#appsec1" name="bappsec1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="appsec1"><span class="anchor-text-container"><span class="anchor-text">Table A1</span></span></a>.</div></section><section id="appsec1.2"><h3 id="sectitle0140" class="u-h4 u-margin-m-top u-margin-xs-bottom">Model Building: Options performance and references levels</h3><div class="u-margin-s-bottom" id="p0370">For the case of clinical therapeutic attributes, “lower” reference levels were based on best standard of care (BSC) performance, coming from the respective placebo arm of the <em>AFFIRM</em> trial, with the exception of the HRQoL attribute (EQ-5D utility score) that was based on the utility of stable disease with no treatment coming from past NICE TAs (<a class="anchor anchor-primary" href="#bib79" name="bbib79" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib79"><span class="anchor-text-container"><span class="anchor-text">NICE, 2012a</span></span></a>, <a class="anchor anchor-primary" href="#bib80" name="bbib80" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib80"><span class="anchor-text-container"><span class="anchor-text">b</span></span></a>). The “higher” reference levels were derived by adding a 20% absolute improvement to the performance level of the best performing option, besides for the case of the HRQoL attribute (EQ-5D utility score) that was based on the general Swedish population (<a class="anchor anchor-primary" href="#bib28" name="bbib28" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib28"><span class="anchor-text-container"><span class="anchor-text">Burström et al., 2001</span></span></a>). The rationale was to design a value scale incorporating a “global” reference level (<a class="anchor anchor-primary" href="#bib24" name="bbib24" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib24"><span class="anchor-text-container"><span class="anchor-text">Belton and Stewart, 2002</span></span></a>), reflecting an “ideal” performance (as proxied by the 20% improvement in best available performance), corresponding to the 100 anchor level of the value scale. This could also offer a flexibility margin to be able to incorporate the performance of future improved options within the same elicited value scale. Consequently, two reference levels within the attribute range were defined in most cases: i) the “lower” reference level (x_l) (i.e. BSC-based satisfactory performance), acting at the same time as the minimum limit of the attribute range (x_*); and ii) the “higher” reference level (x_h) (i.e. 20% better than the best performing option), acting at the same time as the maximum limit of the attribute range (x^*) to give x_*&nbsp;=&nbsp;x_l&nbsp;≤&nbsp;x_h&nbsp;=&nbsp;x^*.</div><div class="u-margin-s-bottom" id="p0375">A similar, but reverse, logic was used for setting the reference levels of the “treatment discontinuation” attribute in the safety cluster; the “lower” reference level was defined to be equal to the BSC (i.e. placebo) arm of the <em>AFFIRM</em> trial. However, contrary to the logic adopted so far for the therapeutic benefit criteria, the “higher” reference level was not set equal to 20% worse than the best performing option (because the lower the performance, the higher the value), but rather equal to the minimum, i.e. worst possible, natural limit of the attribute scale (i.e. 0%) which was regarded as an “ideal” level. In turn, the minimum limit of the scale was derived by worsening the performance of the worst performing treatment option by 20%. A similar approach was used for setting the reference levels of the qualitative “contraindications” attribute, defining the “higher” reference level equal to the maximum (i.e. most attractive) limit of the attribute scale (i.e. none known contraindications) and the “lower” reference level equal to the minimum (i.e. least attractive) limit of the attribute scale.</div><div class="u-margin-s-bottom" id="p0380">For the innovation attributes, the “higher” reference level was set either equal to 20% better than the best performing option for the case of natural quantitative attributes (e.g. number of new indications for which the technology is investigated in a given clinical development stage), or equal to the maximum, i.e. best possible, limit of the scale for the case of constructed qualitative attributes (e.g. the existence of any special instructions, the technology's relative market entrance in regards to its ATC Level). Given that the BSC performance was irrelevant to be used as satisfactory level in the innovation attributes and any efforts to derive a “satisfactory” level would be subjective in nature, the minimum limit of the scale for each attribute was used as a “lower” reference level. Therefore the “lower” reference level was based on the worst performance plausible as inferred from the lowest possible limits of the scales, both for the case of natural quantitative attributes (e.g. 0 number of new indications for which the technology is investigated in a given clinical development stage), and the case of constructed qualitative attributes (e.g. worst possible combination of special instructions, 5th entrance at an ATC level).</div><div class="u-margin-s-bottom" id="p0385">For the socioeconomics attribute (impact on direct costs), the “higher” reference level was based on BSC's impact on cost (i.e. £0 impact on costs), given that by definition impact on costs for all treatment options are incremental to BSC, and the “lower” reference level was derived by adding a 20% absolute increment to the worst performing option (i.e. to the one with the biggest impact on costs).</div><div class="u-margin-s-bottom" id="p0390">“Lower” and “higher” performance reference levels for all criteria at the pre-workshop stage and the basis of their selection are outlined in <a class="anchor anchor-primary" href="#appsec1" name="bappsec1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="appsec1"><span class="anchor-text-container"><span class="anchor-text">Table A2</span></span></a> (assuming no impact of luteinizing hormone-releasing hormone analogue).</div></section><section id="appsec1.3"><h3 id="sectitle0145" class="u-h4 u-margin-m-top u-margin-xs-bottom">Model Assessment and Appraisal: Decision conferences</h3><div class="u-margin-s-bottom" id="p0395">On the day of each decision conference the preliminary model was validated with the participants by revising it cluster by cluster through an open discussion, seeking group consensus and adopting an iterative and interactive model-building process where debate was encouraged and differences of opinion were actively sought.</div><div class="u-margin-s-bottom" id="p0400">In terms of the decision-aiding methodology used, the lead author acted as an impartial facilitator with the aim of enhancing content and process interaction, while refraining from contributing to the content of the group's discussions, essentially guiding the group in how to think about the issues but not what to think (<a class="anchor anchor-primary" href="#bib92" name="bbib92" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib92"><span class="anchor-text-container"><span class="anchor-text">Phillips and Bana e Costa, 2007</span></span></a>; <a class="anchor anchor-primary" href="#bib96" name="bbib96" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib96"><span class="anchor-text-container"><span class="anchor-text">Schein, 1999</span></span></a>).</div><div class="u-margin-s-bottom" id="p0405">In terms of facilities, the rooms of the decision conferences had Π-shaped table(s) layout for all the participants to have direct eye to eye contact, with an overhead projector screen and a second portable projector or large TV screen. The M-MACBETH software (more information provided in the MCDA technique section of the main text and below) was operated using a laptop, the screen of which was connected to the projector, and the second screen was used to show the list of the evaluation criteria together with their “lower” and “higher” reference levels.</div><div class="u-margin-s-bottom" id="p0410">The decision conferences took place over a full working day or over two half working days; in the former case, there was one lunch break and two coffee breaks throughout the day, whereas in the latter case a coffee break took place around the middle of each session. In each decision conference, the day started with an overview of the MCDA methodology adopted and the description of the preliminary version of the value tree which was then analysed cluster by cluster. At the beginning of each cluster the value tree was validated; the various criteria were explained, followed by a group discussion relating to their relevance and completeness. As a result of this iterative process, some of the criteria were not included because they were perceived as irrelevant or non-fundamental. Schematic illustrations of the final versions of the value trees are shown in <a class="anchor anchor-primary" href="#appsec1" name="bappsec1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="appsec1"><span class="anchor-text-container"><span class="anchor-text">Fig. A1</span></span></a>. Then, value functions were elicited for the different criteria and relative weights were assigned within the clusters. Finally, relative weights were assigned across clusters, enabling the calculation of the options' overall WPV scores.</div></section><section id="appsec1.4"><h3 id="sectitle0150" class="u-h4 u-margin-m-top u-margin-xs-bottom">Model Assessment and Appraisal: MCDA technique</h3><div class="u-margin-s-bottom" id="p0415">MACBETH uses seven semantic categories ranging between “no difference” to “extreme difference”, in order to distinguish between the value of different performance levels. Based on these qualitative judgements of difference and by analysing judgmental inconsistencies it facilitates the move from ordinal preference modelling, a cognitively less demanding elicitation of preferences, to a quantitative value function. The approach has evolved through the course of theoretical research and real world practical applications, making it an interactive decision support system that facilitates decision-makers’ communication. An example of the type of questioning being asked would be “What do you judge to be the difference of value between x’ and x”?” where x’ and x” are two different performance reference levels of criterion x, across the plausible range (i.e. x<sub>*</sub>&nbsp;≤&nbsp;x’, x”&nbsp;≤&nbsp;x*). The value judgements matrix for the radiographic tumour progression, i.e. progression free survival (PFS) criterion and its conversion into a value function is provided as an example in <a class="anchor anchor-primary" href="#appsec1" name="bappsec1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="appsec1"><span class="anchor-text-container"><span class="anchor-text">Fig. A2</span></span></a>.</div><div class="u-margin-s-bottom" id="p0420">Following the elicitation of value functions, criteria baseline weights can be elicited. Questions of direct importance for a criterion such as “<em>How important is a given criterion</em>?” are known to be as one of the most common mistakes when making value trade-offs because they are assessing them independent of the respective consequences of the options (<a class="anchor anchor-primary" href="#bib67" name="bbib67" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib67"><span class="anchor-text-container"><span class="anchor-text">Keeney, 2002</span></span></a>). In contrast, an indirect weighting technique that assesses value trade-offs in tandem with the respective ranges of attributes, i.e. performance reference levels, should be employed. For example, the quantitative swing weighting technique asks for judgments of relative value between ‘swings’ (i.e. changes from standard lower level x<sub>*</sub> to higher reference level x* on each xth attribute) taking the form “<em>How would you rank the relative importance of the criteria</em> <em>considering their attributes ranges</em>, <em>relative to 100 for the highest-ranked criterion considering its range</em>?”. Each swing, i.e. a relative change from a lower performance level to a higher performance level, is valued between 0 and 100, with the most valuable swing anchored as 100 (<a class="anchor anchor-primary" href="#bib114" name="bbib114" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib114"><span class="anchor-text-container"><span class="anchor-text">von Winterfeldt and Edwards, 1986</span></span></a>). Normalised weights are then calculated, as a proportion of each swing weight, so the normalised weights sum to 100%. Relative criteria weights were calculated using an alternative qualitative swing weighting protocol, by using the MACBETH procedure to elicit the differences in attractiveness between the lower and higher reference levels of the different attributes, initially at individual level and then at criteria cluster level (<a class="anchor anchor-primary" href="#bib15" name="bbib15" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib15"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa et al., 2016b</span></span></a>; <a class="anchor anchor-primary" href="#bib19" name="bbib19" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib19"><span class="anchor-text-container"><span class="anchor-text">Bana E Costa et al., 2012</span></span></a>).</div><div class="u-margin-s-bottom" id="p0425">Finally, criteria preference value scores and the respective weights can be combined together through an additive aggregation approach as described in equation <a class="anchor anchor-primary" href="#fd2" name="bfd2" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="fd2"><span class="anchor-text-container"><span class="anchor-text">(2)</span></span></a> (if the adequate conditions of complete and transitive preferences are met as well as multi-attribute preferential independence conditions (<a class="anchor anchor-primary" href="#bib114" name="bbib114" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib114"><span class="anchor-text-container"><span class="anchor-text">von Winterfeldt and Edwards, 1986</span></span></a>)).</div><div class="u-margin-s-bottom" id="p0430">The M-MACBETH software automatically performs consistency checking between the qualitative judgements expressed, and in addition a second consistency check was manually performed by the lead author which acted as the facilitator to validate the cardinality, i.e. interval nature, of the emerging value scale. This was done by comparing the sizes of the intervals between the proposed scores and inviting participants to adjust them if necessary (<a class="anchor anchor-primary" href="#bib50" name="bbib50" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib50"><span class="anchor-text-container"><span class="anchor-text">Fasolo and Bana e Costa, 2014</span></span></a>), a requirement which is essential for the application of simple additive value models.<span class="display"><div class="tables colsep-0 frame-topbot rowsep-0" id="tblA1"><span class="captions text-s"><span id="cap0010"><p id="tspara0010"><span class="label">Table A1</span>. Criteria definition and sources of evidence.</p></span></span><div class="groups"><table><thead><tr class="rowsep-1 valign-top"><th scope="col" rowspan="2">Cluster</th><th scope="col" rowspan="2">Criterion</th><th scope="col" rowspan="2">Definition</th><th scope="col" colspan="3">Evidence source</th></tr><tr class="rowsep-1 valign-top"><th scope="col">Abiraterone</th><th scope="col">Cabazitaxel</th><th scope="col">Enzalutamide</th></tr></thead><tbody><tr class="valign-top"><td class="align-left" rowspan="4"><strong>THERAPEUTIC BENEFIT</strong></td><td class="align-left">Overall survival</td><td class="align-left">The median time from treatment randomisation to death</td><td class="align-left"><a class="anchor anchor-primary" href="#bib40" name="bbib40" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib40"><span class="anchor-text-container"><span class="anchor-text">de Bono et al. (2011)</span></span></a></td><td class="align-left"><a class="anchor anchor-primary" href="#bib41" name="bbib41" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib41"><span class="anchor-text-container"><span class="anchor-text">de Bono et al. (2010)</span></span></a></td><td class="align-left"><a class="anchor anchor-primary" href="#bib97" name="bbib97" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib97"><span class="anchor-text-container"><span class="anchor-text">Scher et al. (2012)</span></span></a></td></tr><tr class="valign-top"><td class="align-left">Health related quality of life</td><td class="align-left">Health related quality of life using the EQ-5D score</td><td class="align-left"><a class="anchor anchor-primary" href="#bib101" name="bbib101" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib101"><span class="anchor-text-container"><span class="anchor-text">Sullivan et al., (2007)</span></span></a>; TA 255; TA259; TA316</td><td class="align-left">N/A – assumed, based on <a class="anchor anchor-primary" href="#bib101" name="bbib101" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib101"><span class="anchor-text-container"><span class="anchor-text">Sullivan et al., (2007)</span></span></a>; TA 255; TA259; TA316</td><td class="align-left"><a class="anchor anchor-primary" href="#bib101" name="bbib101" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib101"><span class="anchor-text-container"><span class="anchor-text">Sullivan et al., (2007)</span></span></a>; TA 255; TA259; TA316</td></tr><tr class="valign-top"><td class="align-left">Radiographic tumour progression</td><td class="align-left">The median survival time on which patients have not experienced disease progression (using RECIST criteria)</td><td class="align-left"><a class="anchor anchor-primary" href="#bib40" name="bbib40" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib40"><span class="anchor-text-container"><span class="anchor-text">de Bono et al. (2011)</span></span></a></td><td class="align-left"><a class="anchor anchor-primary" href="#bib41" name="bbib41" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib41"><span class="anchor-text-container"><span class="anchor-text">de Bono et al. (2010)</span></span></a></td><td class="align-left"><a class="anchor anchor-primary" href="#bib97" name="bbib97" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib97"><span class="anchor-text-container"><span class="anchor-text">Scher et al. (2012)</span></span></a></td></tr><tr class="valign-top"><td class="align-left">PSA response</td><td class="align-left">The proportion of patients having a ≥50% reduction in PSA</td><td class="align-left"><a class="anchor anchor-primary" href="#bib51" name="bbib51" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib51"><span class="anchor-text-container"><span class="anchor-text">Fizazi et al. (2012)</span></span></a></td><td class="align-left"><a class="anchor anchor-primary" href="#bib41" name="bbib41" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib41"><span class="anchor-text-container"><span class="anchor-text">de Bono et al. (2010)</span></span></a></td><td class="align-left"><a class="anchor anchor-primary" href="#bib97" name="bbib97" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib97"><span class="anchor-text-container"><span class="anchor-text">Scher et al., 2012</span></span></a></td></tr><tr class="valign-top"><td class="align-left" rowspan="2"><strong>SAFETY PROFILE</strong></td><td class="align-left">Treatment discontinuation</td><td class="align-left">The proportion of patients discontinuing treatment due to AEs</td><td class="align-left"><a class="anchor anchor-primary" href="#bib40" name="bbib40" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib40"><span class="anchor-text-container"><span class="anchor-text">de Bono et al. (2011)</span></span></a></td><td class="align-left"><a class="anchor anchor-primary" href="#bib41" name="bbib41" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib41"><span class="anchor-text-container"><span class="anchor-text">de Bono et al. (2010)</span></span></a></td><td class="align-left"><a class="anchor anchor-primary" href="#bib97" name="bbib97" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib97"><span class="anchor-text-container"><span class="anchor-text">Scher et al. (2012)</span></span></a></td></tr><tr class="valign-top"><td class="align-left">Contra-indications</td><td class="align-left">The existence of any type of contra-indication accompanying the treatment</td><td class="align-left">EPAR,<br>Prescribing info</td><td class="align-left">EPAR,<br>Prescribing info</td><td class="align-left">EPAR,<br>Prescribing info</td></tr><tr class="valign-top"><td class="align-left" rowspan="11"><strong>INNOVATION LEVEL</strong></td><td class="align-left">ATC Level 1</td><td class="align-left">The technology's relative market entrance in regards to its ATC Level 1 (Anatomical)</td><td class="align-left">WHO ATC index</td><td class="align-left">WHO ATC index</td><td class="align-left">WHO ATC index</td></tr><tr class="valign-top"><td class="align-left">ATC Level 2</td><td class="align-left">The technology's relative market entrance in regards to its ATC Level 2 (Therapeutic)</td><td class="align-left">WHO ATC index</td><td class="align-left">WHO ATC index</td><td class="align-left">WHO ATC index</td></tr><tr class="valign-top"><td class="align-left">ATC Level 3</td><td class="align-left">The technology's relative market entrance in regards to its ATC Level 3 (Pharmacological)</td><td class="align-left">WHO ATC index</td><td class="align-left">WHO ATC index</td><td class="align-left">WHO ATC index</td></tr><tr class="valign-top"><td class="align-left">ATC Level 4</td><td class="align-left">The technology's relative market entrance in regards to its ATC Level 4 (Chemical)</td><td class="align-left">WHO ATC index</td><td class="align-left">WHO ATC index</td><td class="align-left">WHO ATC index</td></tr><tr class="valign-top"><td class="align-left">ATC Level 5</td><td class="align-left">The technology's relative market entrance in regards to its ATC Level 5 (Molecular)</td><td class="align-left">WHO ATC index</td><td class="align-left">WHO ATC index</td><td class="align-left">WHO ATC index</td></tr><tr class="valign-top"><td class="align-left">Phase 1</td><td class="align-left">The number of new indications for which the technology is investigated in Phase 1 clinical trials</td><td class="align-left">ClinicalTrials.gov</td><td class="align-left">ClinicalTrials.gov</td><td class="align-left">ClinicalTrials.gov</td></tr><tr class="valign-top"><td class="align-left">Phase 2</td><td class="align-left">The number of new indications for which the technology is investigated in Phase 2 clinical trials</td><td class="align-left">ClinicalTrials.gov</td><td class="align-left">ClinicalTrials.gov</td><td class="align-left">ClinicalTrials.gov</td></tr><tr class="valign-top"><td class="align-left">Phase 3</td><td class="align-left">The number of new indications for which the technology is investigated in Phase 3 clinical trials</td><td class="align-left">ClinicalTrials.gov</td><td class="align-left">ClinicalTrials.gov</td><td class="align-left">ClinicalTrials.gov</td></tr><tr class="valign-top"><td class="align-left">Marketing authorisation</td><td class="align-left">The number of new indications that the technology has gained an approval for at the stage of marketing authorisation</td><td class="align-left">ClinicalTrials.gov</td><td class="align-left">ClinicalTrials.gov</td><td class="align-left">ClinicalTrials.gov</td></tr><tr class="valign-top"><td class="align-left">Delivery posology</td><td class="align-left">The combination of the delivery system (RoA and dosage form) with the posology (frequency of dosing and duration of administration) of the treatment</td><td class="align-left">EPAR,<br>Prescribing info</td><td class="align-left">EPAR,<br>Prescribing info</td><td class="align-left">EPAR,<br>Prescribing info</td></tr><tr class="valign-top"><td class="align-left">Special instructions</td><td class="align-left">The existence of any special instructions accompanying the administration of the treatment</td><td class="align-left">EPAR,<br>Prescribing info</td><td class="align-left">EPAR,<br>Prescribing info</td><td class="align-left">EPAR,<br>Prescribing info</td></tr><tr class="valign-top"><td class="align-left"><strong>SOCIOECONOMIC IMPACT</strong></td><td class="align-left">Medical costs impact</td><td class="align-left">The impact of the technology on direct medical costs excluding the purchasing costs of the technology*</td><td class="align-left">BNF 69,<br>Prescribing info, <a class="anchor anchor-primary" href="#bib37" name="bbib37" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib37"><span class="anchor-text-container"><span class="anchor-text">Connock et al., (2011)</span></span></a>, <a class="anchor anchor-primary" href="#bib94" name="bbib94" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib94"><span class="anchor-text-container"><span class="anchor-text">Riemsa et al., (2013)</span></span></a>, TA259</td><td class="align-left">BNF 69, Prescribing info, <a class="anchor anchor-primary" href="#bib41" name="bbib41" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="bib41"><span class="anchor-text-container"><span class="anchor-text">de Bono et al., (2010)</span></span></a>, TA255</td><td class="align-left">BNF 69, TA316</td></tr></tbody></table></div><div class="legend"><div class="u-margin-s-bottom" id="tspara0015">Notes: * These costs include i) concomitant medications, ii) outpatient visits, diagnostic/laboratory tests, hospitalisations and other monitoring costs (including management AEs), and iii) terminal care.</div><div class="u-margin-s-bottom" id="tspara0020">Source: The authors.</div></div></div></span><span class="display"><div class="tables colsep-0 frame-topbot rowsep-0" id="tblA2"><span class="captions text-s"><span id="cap0015"><p id="tspara0025"><span class="label">Table A2</span>. Pre-decision conference performance reference levels and basis of selection.</p></span></span><div class="groups"><table><thead><tr class="rowsep-1 valign-top"><th scope="col"><strong>Cluster</strong></th><th scope="col"><strong>Criterion</strong></th><th scope="col"><strong>Attribute</strong></th><th scope="col"><strong>Lower level</strong></th><th scope="col"><strong>Basis</strong></th><th scope="col"><strong>Higher level</strong></th><th scope="col"><strong>Basis</strong></th></tr></thead><tbody><tr class="valign-top"><td class="align-left" rowspan="4">THERAPEUTIC BENEFIT</td><td class="align-left">Overall survival</td><td class="align-left">months</td><td class="align-left">13.6</td><td class="align-left">Best supportive care (BSC)</td><td class="align-left">22.1</td><td class="align-left">20% higher than the best performing option</td></tr><tr class="valign-top"><td class="align-left">Health related quality of life</td><td class="align-left">utility (EQ-5D)</td><td class="align-left">0.72</td><td class="align-left">Utility used for stable disease</td><td class="align-left">0.82</td><td class="align-left">Utility scores of general population</td></tr><tr class="valign-top"><td class="align-left">Radiographic tumour progression</td><td class="align-left">months</td><td class="align-left">2.9</td><td class="align-left">BSC</td><td class="align-left">10.6</td><td class="align-left">20% higher than the best performing option</td></tr><tr class="valign-top"><td class="align-left">PSA response</td><td class="align-left">% patients</td><td class="align-left">1.5</td><td class="align-left">BSC</td><td class="align-left">64.8</td><td class="align-left">20% higher than the best performing option</td></tr><tr class="valign-top"><td class="align-left" rowspan="2">SAFETY<br>PROFILE</td><td class="align-left">Treatment discontinuation (% of patients)</td><td class="align-left">% patients</td><td class="align-left">10</td><td class="align-left">BSC</td><td class="align-left">0</td><td class="align-left">Highest possible limit of the scale</td></tr><tr class="valign-top"><td class="align-left">Contra-indications</td><td class="align-left">types of contra-indications</td><td class="align-left">Hypersensitivity&nbsp;+&nbsp;hepatic impairment&nbsp;+&nbsp;low neutrophil counts</td><td class="align-left">Lowest possible limit of the scale</td><td class="align-left">None known contraindications</td><td class="align-left">Highest possible limit of the scale</td></tr><tr class="valign-top"><td class="align-left" rowspan="11">INNOVATION<br>LEVEL</td><td class="align-left">ATC Level 1</td><td class="align-left">relative market entrance</td><td class="align-left">5th</td><td class="align-left">Lowest possible limit of the scale</td><td class="align-left">1st</td><td class="align-left">Highest possible limit of the scale</td></tr><tr class="valign-top"><td class="align-left">ATC Level 2</td><td class="align-left">relative market entrance</td><td class="align-left">5th</td><td class="align-left">Lowest possible limit of the scale</td><td class="align-left">1st</td><td class="align-left">Highest possible limit of the scale</td></tr><tr class="valign-top"><td class="align-left">ATC Level 3</td><td class="align-left">relative market entrance</td><td class="align-left">5th</td><td class="align-left">Lowest possible limit of the scale</td><td class="align-left">1st</td><td class="align-left">Highest possible limit of the scale</td></tr><tr class="valign-top"><td class="align-left">ATC Level 4</td><td class="align-left">relative market entrance</td><td class="align-left">5th</td><td class="align-left">Lowest possible limit of the scale</td><td class="align-left">1st</td><td class="align-left">Highest possible limit of the scale</td></tr><tr class="valign-top"><td class="align-left">ATC Level 5</td><td class="align-left">relative market entrance</td><td class="align-left">5th</td><td class="align-left">Lowest possible limit of the scale</td><td class="align-left">1st</td><td class="align-left">Highest possible limit of the scale</td></tr><tr class="valign-top"><td class="align-left">Phase 1</td><td class="align-left">number of new indications</td><td class="align-left">0</td><td class="align-left">Lowest possible limit of the scale</td><td class="align-left">10</td><td class="align-left">20% higher than the best performing option</td></tr><tr class="valign-top"><td class="align-left">Phase 2</td><td class="align-left">number of new indications</td><td class="align-left">0</td><td class="align-left">Lowest possible limit of the scale</td><td class="align-left">16</td><td class="align-left">20% higher than the best performing option</td></tr><tr class="valign-top"><td class="align-left">Phase 3</td><td class="align-left">number of new indications</td><td class="align-left">0</td><td class="align-left">Lowest possible limit of the scale</td><td class="align-left">2</td><td class="align-left">20% higher than the best performing option</td></tr><tr class="valign-top"><td class="align-left">Marketing authorisation</td><td class="align-left">number of new indications</td><td class="align-left">0</td><td class="align-left">Lowest possible limit of the scale</td><td class="align-left">1</td><td class="align-left">20% higher than the best performing option</td></tr><tr class="valign-top"><td class="align-left">Delivery Posology</td><td class="align-left">types of delivery system &amp; posology combinations</td><td class="align-left">Oral, every day - one off&nbsp;+&nbsp;IV, every 3 weeks - 1&nbsp;h*</td><td class="align-left">Lowest possible limit of the scale</td><td class="align-left">Oral, every day - one off*</td><td class="align-left">Highest possible limit of the scale</td></tr><tr class="valign-top"><td class="align-left">Special instructions</td><td class="align-left">types of special instructions</td><td class="align-left">No food&nbsp;+&nbsp;concomitant and/or pre-medication*</td><td class="align-left">Lowest possible limit of the scale</td><td class="align-left">None*</td><td class="align-left">Highest possible limit of the scale</td></tr><tr class="valign-top"><td class="align-left">SOCIOECONOMIC IMPACT</td><td class="align-left">Medical costs impact</td><td class="align-left">GBP</td><td class="align-left">10,000</td><td class="align-left">20% higher than the worst performing option (rounded up)</td><td class="align-left">0</td><td class="align-left">BSC</td></tr></tbody></table></div><div class="legend"><div class="u-margin-s-bottom" id="tspara0030">Note: * Assuming no impact on Luteinizing hormone-releasing hormone (LHRH) analogue.</div><div class="u-margin-s-bottom" id="tspara0035">Source: The authors based on the literature.</div></div></div></span><span class="display"><figure class="figure text-xs" id="dfig1"><span><img src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-fx1.jpg" height="927" alt="Fig. A1" aria-describedby="cap0020"><ol class="u-margin-s-bottom"><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-fx1_lrg.jpg" target="_blank" download="" title="Download high-res image (1MB)"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download high-res image (1MB)</span></span></span></a></li><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-fx1.jpg" target="_blank" download="" title="Download full-size image"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download full-size image</span></span></span></a></li></ol></span><span class="captions text-s"><span id="cap0020"><p id="fspara0010"><span class="label">Fig. A1</span>. Final value trees for metastatic prostate cancer across the four HTA settings.</p><div class="u-margin-s-bottom" id="fspara0010a">Images produced using the M-MACBETH (beta) software version 3.0.0.</div></span></span></figure></span><span class="display"><figure class="figure text-xs" id="dfig2"><span><img src="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-fx2.jpg" height="683" alt="Fig. A2" aria-describedby="cap0025"><ol class="u-margin-s-bottom"><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-fx2_lrg.jpg" target="_blank" download="" title="Download high-res image (522KB)"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download high-res image (522KB)</span></span></span></a></li><li><a class="anchor download-link u-font-sans anchor-primary" href="https://ars.els-cdn.com/content/image/1-s2.0-S0277953619305908-fx2.jpg" target="_blank" download="" title="Download full-size image"><span class="anchor-text-container"><span class="anchor-text">Download: <span class="download-link-title">Download full-size image</span></span></span></a></li></ol></span><span class="captions text-s"><span id="cap0025"><p id="fspara0015"><span class="label">Fig. A2</span>. Example of value judgements matrix for the 'Radiographic tumour progression' i.e. progression free survival (PFS) criterion measured in months and its conversion into a value function.</p><div class="u-margin-s-bottom" id="fspara0015a">Note: In the Radiographic tumour progression' i.e. progression free survival (PFS) example, measured in median months, the question asked was the following: “<em>What do you judge to be the difference of value between 2.9 and 10.6 months PFS? No difference, very weak, weak, moderate, strong, very strong, or extreme?</em>” Once a decision was reached (by consensus or majority voting), the next question came along: “<em>What do you judge to be the difference of value between 5.5 and 10.6 months PFS? No difference, very weak, weak, moderate, strong, very strong, or extreme?”</em> The same process was followed until value judgments for all the different combinations of attribute levels were elicited, filling in the different rows from the right-hand side (i.e. lower range) to the left-hand side (i.e. higher range). Image produced using the M-MACBETH (beta) software version 3.0.0.</div></span></span></figure></span></div></section></section></div></div><div class="related-content-links u-display-none-from-md"><button class="button-link button-link-primary button-link-small" type="button"><span class="button-link-text-container"><span class="button-link-text">Recommended articles</span></span></button></div><div class="Tail"></div><div><section class="bibliography u-font-serif text-s" id="cebib0010"><h2 class="section-title u-h4 u-margin-l-top u-margin-xs-bottom">References</h2><section class="bibliography-sec" id="cebibsec0010"><ol class="references" id="reference-links-cebibsec0010"><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib1" id="ref-id-bib1" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">AEMPS, 2015</span></span></a></span><span class="reference" id="sref1"><div class="contribution"><div class="authors u-font-sans">AEMPS</div><div id="ref-id-sref1" class="title text-m">Informe de Posicionamiento Terapéutico Pt-Enzalutamida/V1/30072015</div></div><div class="host u-font-sans">Agencia Española de Medicamentos y Productos Sanitarios (2015)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Informe%20de%20Posicionamiento%20Terap%C3%A9utico%20Pt-EnzalutamidaV130072015&amp;publication_year=2015&amp;author=AEMPS" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref1"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib2" id="ref-id-bib2" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Anderson et al., 2014</span></span></a></span><span class="reference" id="sref2"><div class="contribution"><div class="authors u-font-sans">J.L. Anderson, P.A. Heidenreich, P.G. Barnett, M.A. Creager, G.C. Fonarow, R.J. Gibbons, <em> et al.</em></div><div id="ref-id-sref2" class="title text-m">ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American college of cardiology/American heart association task force on performance measures and task force on practice guidelines</div></div><div class="host u-font-sans">J. Am. Coll. Cardiol., 63 (2014), pp. 2304-2322</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0735109714016842/pdfft?md5=96c3e693702b441b52c81e3504a87820&amp;pid=1-s2.0-S0735109714016842-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref2"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0735109714016842" aria-describedby="ref-id-sref2"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84901630147&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref2"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=ACCAHA%20statement%20on%20costvalue%20methodology%20in%20clinical%20practice%20guidelines%20and%20performance%20measures%3A%20a%20report%20of%20the%20American%20college%20of%20cardiologyAmerican%20heart%20association%20task%20force%20on%20performance%20measures%20and%20task%20force%20on%20practice%20guidelines&amp;publication_year=2014&amp;author=J.L.%20Anderson&amp;author=P.A.%20Heidenreich&amp;author=P.G.%20Barnett&amp;author=M.A.%20Creager&amp;author=G.C.%20Fonarow&amp;author=R.J.%20Gibbons" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref2"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib3" id="ref-id-bib3" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Angelis, 2018</span></span></a></span><span class="reference" id="sref3"><div class="contribution"><div class="authors u-font-sans">A. Angelis</div><div id="ref-id-sref3" class="title text-m">Evaluating the benefits of new drugs in health technology assessment using multiple criteria decision analysis: a case study on metastatic prostate cancer with the dental and pharmaceuticals benefits agency (TLV) in Sweden</div></div><div class="host u-font-sans">MDM Pol. Pract., 3 (2018)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Evaluating%20the%20benefits%20of%20new%20drugs%20in%20health%20technology%20assessment%20using%20multiple%20criteria%20decision%20analysis%3A%20a%20case%20study%20on%20metastatic%20prostate%20cancer%20with%20the%20dental%20and%20pharmaceuticals%20benefits%20agency%20%20in%20Sweden&amp;publication_year=2018&amp;author=A.%20Angelis" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref3"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib4" id="ref-id-bib4" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Angelis and Kanavos, 2016</span></span></a></span><span class="reference" id="sref4"><div class="contribution"><div class="authors u-font-sans">A. Angelis, P. Kanavos</div><div id="ref-id-sref4" class="title text-m">Critique of the American society of clinical oncology value assessment framework for cancer treatments: putting methodologic robustness first</div></div><div class="host u-font-sans">J. Clin. Oncol., 34 (24) (2016), pp. 2935-2936, <a class="anchor anchor-primary" href="https://doi.org/10.1200/JCO.2015.64.9673" target="_blank"><span class="anchor-text-container"><span class="anchor-text">10.1200/JCO.2015.64.9673</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84982112064&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref4"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Critique%20of%20the%20American%20society%20of%20clinical%20oncology%20value%20assessment%20framework%20for%20cancer%20treatments%3A%20putting%20methodologic%20robustness%20first&amp;publication_year=2016&amp;author=A.%20Angelis&amp;author=P.%20Kanavos" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref4"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib5" id="ref-id-bib5" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Angelis and Kanavos, 2016b</span></span></a></span><span class="reference" id="sref5"><div class="contribution"><div class="authors u-font-sans">A. Angelis, P. Kanavos</div><div id="ref-id-sref5" class="title text-m">Value-based assessment of new medical technologies: towards a robust methodological framework for the application of multiple criteria decision analysis in the context of health technology assessment</div></div><div class="host u-font-sans">PharmacoEconomics, 34 (2016), pp. 435-446</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1007/s40273-015-0370-z" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref5"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84953338530&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref5"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Value-based%20assessment%20of%20new%20medical%20technologies%3A%20towards%20a%20robust%20methodological%20framework%20for%20the%20application%20of%20multiple%20criteria%20decision%20analysis%20in%20the%20context%20of%20health%20technology%20assessment&amp;publication_year=2016&amp;author=A.%20Angelis&amp;author=P.%20Kanavos" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref5"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib6" id="ref-id-bib6" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Angelis and Kanavos, 2017</span></span></a></span><span class="reference" id="sref6"><div class="contribution"><div class="authors u-font-sans">A. Angelis, P. Kanavos</div><div id="ref-id-sref6" class="title text-m">Multiple criteria decision analysis (MCDA) for evaluating new medicines in health technology assessment and beyond: the advance value framework</div></div><div class="host u-font-sans">Soc. Sci. Med., 188 (2017), pp. 137-156</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0277953617303933/pdfft?md5=e5db453a7ed21b6dbd33006b3b322690&amp;pid=1-s2.0-S0277953617303933-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref6"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0277953617303933" aria-describedby="ref-id-sref6"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-85026473174&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref6"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Multiple%20criteria%20decision%20analysis%20%20for%20evaluating%20new%20medicines%20in%20health%20technology%20assessment%20and%20beyond%3A%20the%20advance%20value%20framework&amp;publication_year=2017&amp;author=A.%20Angelis&amp;author=P.%20Kanavos" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref6"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib7" id="ref-id-bib7" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Angelis et al., 2017</span></span></a></span><span class="reference" id="sref7"><div class="contribution"><div class="authors u-font-sans">A. Angelis, P. Kanavos, G. Montibeller</div><div id="ref-id-sref7" class="title text-m">Resource allocation and priority setting in health care: a multi-criteria decision analysis problem of value?</div></div><div class="host u-font-sans">Glob. Pol., 8 (52) (2017), pp. 76-83, <a class="anchor anchor-primary" href="https://doi.org/10.1111/1758-5899.12387" target="_blank"><span class="anchor-text-container"><span class="anchor-text">10.1111/1758-5899.12387</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-85017554626&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref7"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Resource%20allocation%20and%20priority%20setting%20in%20health%20care%3A%20a%20multi-criteria%20decision%20analysis%20problem%20of%20value&amp;publication_year=2017&amp;author=A.%20Angelis&amp;author=P.%20Kanavos&amp;author=G.%20Montibeller" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref7"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib8" id="ref-id-bib8" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Angelis et al., 2018</span></span></a></span><span class="reference" id="sref8"><div class="contribution"><div class="authors u-font-sans">A. Angelis, A. Lange, P. Kanavos</div><div id="ref-id-sref8" class="title text-m">Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries</div></div><div class="host u-font-sans">Eur. J. Health Econ., 19 (1) (2018), pp. 123-152, <a class="anchor anchor-primary" href="https://doi.org/10.1007/s10198-017-0871-0" target="_blank"><span class="anchor-text-container"><span class="anchor-text">10.1007/s10198-017-0871-0</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-85015638735&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref8"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Using%20health%20technology%20assessment%20to%20assess%20the%20value%20of%20new%20medicines%3A%20results%20of%20a%20systematic%20review%20and%20expert%20consultation%20across%20eight%20European%20countries&amp;publication_year=2018&amp;author=A.%20Angelis&amp;author=A.%20Lange&amp;author=P.%20Kanavos" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref8"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib9" id="ref-id-bib9" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Angelis et al., 2017</span></span></a></span><span class="reference" id="sref9"><div class="contribution"><div class="authors u-font-sans">A. Angelis, G. Montibeller, D. Hochhauser, P. Kanavos</div><div id="ref-id-sref9" class="title text-m">Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting</div></div><div class="host u-font-sans">BMC Med. Inf. Decis. Mak., 17 (2017)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Multiple%20criteria%20decision%20analysis%20in%20the%20context%20of%20health%20technology%20assessment%3A%20a%20simulation%20exercise%20on%20metastatic%20colorectal%20cancer%20with%20multiple%20stakeholders%20in%20the%20English%20setting&amp;publication_year=2017&amp;author=A.%20Angelis&amp;author=G.%20Montibeller&amp;author=D.%20Hochhauser&amp;author=P.%20Kanavos" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref9"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib10" id="ref-id-bib10" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">AOTMiT, 2017</span></span></a></span><span class="reference" id="sref10"><div class="contribution"><div class="authors u-font-sans">AOTMiT</div><div id="ref-id-sref10" class="title text-m">Rekomendacja Nr 19/2017 Z Dnia 27 Marca 2017 R. Prezesa Agencji Oceny Technologii Medycznych I Taryfikacji W Sprawie Objęcia Refundacją Produktu Leczniczego Xtandi, Enzalutamidum, Kapsułki Miękkie, 40 Mg, 112 Kaps</div></div><div class="host u-font-sans"> (2017)</div><div class="comment">w ramach programu lekowego „Leczenie opornego na kastrację raka gruczołu krokowego z przerzutami (ICD-10 C-61)</div><div class="host u-font-sans"><a class="anchor anchor-primary" href="http://bipold.aotm.gov.pl/assets/files/zlecenia_mz/2017/008/REK/RP_19_2017_Xtandi.pdf" target="_blank"><span class="anchor-text-container"><span class="anchor-text">http://bipold.aotm.gov.pl/assets/files/zlecenia_mz/2017/008/REK/RP_19_2017_Xtandi.pdf</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Rekomendacja%20Nr%20192017%20Z%20Dnia%2027%20Marca%202017%20R.%20Prezesa%20Agencji%20Oceny%20Technologii%20Medycznych%20I%20Taryfikacji%20W%20Sprawie%20Obj%C4%99cia%20Refundacj%C4%85%20Produktu%20Leczniczego%20Xtandi%2C%20Enzalutamidum%2C%20Kapsu%C5%82ki%20Mi%C4%99kkie%2C%2040%20Mg%2C%20112%20Kaps&amp;publication_year=2017&amp;author=AOTMiT" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref10"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib11" id="ref-id-bib11" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Bach, 2015</span></span></a></span><span class="reference" id="sref11"><div class="contribution"><div class="authors u-font-sans">P. Bach</div><div id="ref-id-sref11" class="title text-m">DrugAbacus App</div></div><div class="host u-font-sans">Memorial Sloan Kettering Cancer Center (2015)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=DrugAbacus%20App&amp;publication_year=2015&amp;author=P.%20Bach" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref11"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib12" id="ref-id-bib12" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Baltussen et al., 2017</span></span></a></span><span class="reference" id="sref12"><div class="contribution"><div class="authors u-font-sans">R. Baltussen, M.P.M. Jansen, L. Bijlmakers, J. Grutters, A. Kluytmans, R.P. Reuzel, <em> et al.</em></div><div id="ref-id-sref12" class="title text-m">Value assessment frameworks for HTA agencies: the organization of evidence-informed deliberative processes</div></div><div class="host u-font-sans">Value Health, 20 (2017), pp. 256-260</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S1098301516341286/pdfft?md5=7dfedfed7be28c5bc8fcc6928e834a6c&amp;pid=1-s2.0-S1098301516341286-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref12"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S1098301516341286" aria-describedby="ref-id-sref12"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-85013662322&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref12"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Value%20assessment%20frameworks%20for%20HTA%20agencies%3A%20the%20organization%20of%20evidence-informed%20deliberative%20processes&amp;publication_year=2017&amp;author=R.%20Baltussen&amp;author=M.P.M.%20Jansen&amp;author=L.%20Bijlmakers&amp;author=J.%20Grutters&amp;author=A.%20Kluytmans&amp;author=R.P.%20Reuzel" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref12"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib13" id="ref-id-bib13" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa and Beinat, 2005</span></span></a></span><span class="reference" id="sref13"><div class="contribution"><div class="authors u-font-sans">C. Bana e Costa, E. Beinat</div><div id="ref-id-sref13" class="title text-m">Model-structuring in Public Decision-Aiding. Operational Research Working Papers</div></div><div class="host u-font-sans">London School of Economics and Political Science, London (2005)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Model-structuring%20in%20Public%20Decision-Aiding.%20Operational%20Research%20Working%20Papers&amp;publication_year=2005&amp;author=C.%20Bana%20e%20Costa&amp;author=E.%20Beinat" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref13"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib14" id="ref-id-bib14" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa et al., 2016a</span></span></a></span><span class="reference" id="sref14"><div class="contribution"><div class="authors u-font-sans">C. Bana e Costa, J. De Corte, J. Vansnick</div><div id="ref-id-sref14" class="title text-m">M-MACBETH website</div></div><div class="host u-font-sans"> (2016)</div><div class="host u-font-sans"><a class="anchor anchor-primary" href="http://m-macbeth.com/" target="_blank"><span class="anchor-text-container"><span class="anchor-text">http://m-macbeth.com/</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=M-MACBETH%20website&amp;publication_year=2016&amp;author=C.%20Bana%20e%20Costa&amp;author=J.%20De%20Corte&amp;author=J.%20Vansnick" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref14"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib15" id="ref-id-bib15" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa et al., 2016b</span></span></a></span><span class="reference" id="sref15"><div class="contribution"><div class="authors u-font-sans">C. Bana e Costa, J. De Corte, J. Vansnick</div><div id="ref-id-sref15" class="title text-m">On the mathematical foundations of MACBETH</div></div><div class="host u-font-sans">S. Greco, M. Ehrgott, J. Figueira (Eds.), Multiple Criteria Decision Analysis: State of the Art Surveys, Springer, New York (2016)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=On%20the%20mathematical%20foundations%20of%20MACBETH&amp;publication_year=2016&amp;author=C.%20Bana%20e%20Costa&amp;author=J.%20De%20Corte&amp;author=J.%20Vansnick" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref15"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib16" id="ref-id-bib16" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa et al., 2014</span></span></a></span><span class="reference" id="sref16"><div class="contribution"><div class="authors u-font-sans">C. Bana e Costa, J. Lourenço, M. Oliveira, J. Bana e Costa</div><div id="ref-id-sref16" class="title text-m">A socio-technical approach for group decision support in public strategic planning: the pernambuco PPA case</div></div><div class="host u-font-sans">Group Decis. Negot., 23 (2014), pp. 5-29</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1007/s10726-012-9326-2" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref16"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84891660250&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref16"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=A%20socio-technical%20approach%20for%20group%20decision%20support%20in%20public%20strategic%20planning%3A%20the%20pernambuco%20PPA%20case&amp;publication_year=2014&amp;author=C.%20Bana%20e%20Costa&amp;author=J.%20Louren%C3%A7o&amp;author=M.%20Oliveira&amp;author=J.%20Bana%20e%20Costa" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref16"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib17" id="ref-id-bib17" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa and Vansnick, 1999</span></span></a></span><span class="reference" id="sref17"><div class="contribution"><div class="authors u-font-sans">C. Bana e Costa, J. Vansnick</div><div id="ref-id-sref17" class="title text-m">The MACBETH approach: basic ideas, software, and an application</div></div><div class="host u-font-sans">N. Meskens, M. Roubens (Eds.), Advances in Decision Analysis, Springer Netherlands (1999), pp. 131-157</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1007/978-94-017-0647-6_9" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref17"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=The%20MACBETH%20approach%3A%20basic%20ideas%2C%20software%2C%20and%20an%20application&amp;publication_year=1999&amp;author=C.%20Bana%20e%20Costa&amp;author=J.%20Vansnick" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref17"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib18" id="ref-id-bib18" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa et al., 2002</span></span></a></span><span class="reference" id="sref18"><div class="contribution"><div class="authors u-font-sans">C.A. Bana e Costa, É.C. Corrêa, J.-M. De Corte, J.-C. Vansnick</div><div id="ref-id-sref18" class="title text-m">Facilitating bid evaluation in Public call for tenders: a socio-technical approach</div></div><div class="host u-font-sans">Omega, 30 (2002), p. 227</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0305048302000294/pdfft?md5=e7112fbf4ec20bae1632e920661b7bbf&amp;pid=1-s2.0-S0305048302000294-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref18"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0305048302000294" aria-describedby="ref-id-sref18"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-0036275927&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref18"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Facilitating%20bid%20evaluation%20in%20Public%20call%20for%20tenders%3A%20a%20socio-technical%20approach&amp;publication_year=2002&amp;author=C.A.%20Bana%20e%20Costa&amp;author=%C3%89.C.%20Corr%C3%AAa&amp;author=J.-M.%20De%20Corte&amp;author=J.-C.%20Vansnick" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref18"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib19" id="ref-id-bib19" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Bana E Costa et al., 2012</span></span></a></span><span class="reference" id="sref19"><div class="contribution"><div class="authors u-font-sans">C.A. Bana E Costa, J.-M. De Corte, J.-C. Vansnick</div><div id="ref-id-sref19" class="title text-m">Macbeth</div></div><div class="host u-font-sans">Int. J. Inf. Technol. Decis. Mak., 11 (2012), pp. 359-387</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84862066894&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref19"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Macbeth&amp;publication_year=2012&amp;author=C.A.%20Bana%20E%20Costa&amp;author=J.-M.%20De%20Corte&amp;author=J.-C.%20Vansnick" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref19"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib20" id="ref-id-bib20" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa et al., 1999</span></span></a></span><span class="reference" id="sref20"><div class="contribution"><div class="authors u-font-sans">C.A. Bana e Costa, L. Ensslin, É.C. Corrêa, J.-C. Vansnick</div><div id="ref-id-sref20" class="title text-m">Decision Support Systems in action: integrated application in a multicriteria decision aid process</div></div><div class="host u-font-sans">Eur. J. Oper. Res., 113 (1999), pp. 315-335</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0377221798002197/pdfft?md5=cd5680c0b39c3c8f0d22fc2785f72b48&amp;pid=1-s2.0-S0377221798002197-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref20"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0377221798002197" aria-describedby="ref-id-sref20"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-0033102260&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref20"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Decision%20Support%20Systems%20in%20action%3A%20integrated%20application%20in%20a%20multicriteria%20decision%20aid%20process&amp;publication_year=1999&amp;author=C.A.%20Bana%20e%20Costa&amp;author=L.%20Ensslin&amp;author=%C3%89.C.%20Corr%C3%AAa&amp;author=J.-C.%20Vansnick" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref20"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib21" id="ref-id-bib21" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa and Oliveira, 2012</span></span></a></span><span class="reference" id="sref21"><div class="contribution"><div class="authors u-font-sans">C.A. Bana e Costa, M.D. Oliveira</div><div id="ref-id-sref21" class="title text-m">A multicriteria decision analysis model for faculty evaluation</div></div><div class="host u-font-sans">Omega, 40 (2012), pp. 424-436</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0305048311001265/pdfft?md5=0d1f0132a6dfdb6edd7918cb5cf4d5d5&amp;pid=1-s2.0-S0305048311001265-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref21"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0305048311001265" aria-describedby="ref-id-sref21"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-80053351509&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref21"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=A%20multicriteria%20decision%20analysis%20model%20for%20faculty%20evaluation&amp;publication_year=2012&amp;author=C.A.%20Bana%20e%20Costa&amp;author=M.D.%20Oliveira" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref21"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib22" id="ref-id-bib22" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa and Vansnick, 1994</span></span></a></span><span class="reference" id="sref22"><div class="contribution"><div class="authors u-font-sans">C.A. Bana e Costa, J.-C. Vansnick</div><div id="ref-id-sref22" class="title text-m">Macbeth — an interactive path towards the construction of cardinal value functions</div></div><div class="host u-font-sans">Int. Trans. Oper. Res., 1 (1994), p. 489</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/0969601694900108/pdf?md5=b534eb6c63820acea5079ba004efe247&amp;pid=1-s2.0-0969601694900108-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref22"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/0969601694900108" aria-describedby="ref-id-sref22"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-0002872910&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref22"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Macbeth%20%20an%20interactive%20path%20towards%20the%20construction%20of%20cardinal%20value%20functions&amp;publication_year=1994&amp;author=C.A.%20Bana%20e%20Costa&amp;author=J.-C.%20Vansnick" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref22"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib23" id="ref-id-bib23" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Bana e Costa and Vansnick, 1997</span></span></a></span><span class="reference" id="sref23"><div class="contribution"><div class="authors u-font-sans">C.A. Bana e Costa, J.-C. Vansnick</div><div id="ref-id-sref23" class="title text-m">Applications of the MACBETH approach in the framework of an additive aggregation model</div></div><div class="host u-font-sans">J. Multi-Criteria Decis. Anal., 6 (1997), pp. 107-114</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-0000588240&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref23"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Applications%20of%20the%20MACBETH%20approach%20in%20the%20framework%20of%20an%20additive%20aggregation%20model&amp;publication_year=1997&amp;author=C.A.%20Bana%20e%20Costa&amp;author=J.-C.%20Vansnick" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref23"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib24" id="ref-id-bib24" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Belton and Stewart, 2002</span></span></a></span><span class="reference" id="sref24"><div class="contribution"><div class="authors u-font-sans">V. Belton, T. Stewart</div><div id="ref-id-sref24" class="title text-m">Multiple Criteria Decision Analysis: an Integrated Approach</div></div><div class="host u-font-sans">Kluwer Academic Publishers, Dordrecht (2002)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Multiple%20Criteria%20Decision%20Analysis%3A%20an%20Integrated%20Approach&amp;publication_year=2002&amp;author=V.%20Belton&amp;author=T.%20Stewart" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref24"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib25" id="ref-id-bib25" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Berthold et al., 2008</span></span></a></span><span class="reference" id="sref25"><div class="contribution"><div class="authors u-font-sans">D.R. Berthold, G.R. Pond, F. Soban, R. de Wit, M. Eisenberger, I.F. Tannock</div><div id="ref-id-sref25" class="title text-m">Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study</div></div><div class="host u-font-sans">J. Clin. Oncol.: Offic. J. Am. Soc. Clin. Oncol., 26 (2008), pp. 242-245</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-38349167518&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref25"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Docetaxel%20plus%20prednisone%20or%20mitoxantrone%20plus%20prednisone%20for%20advanced%20prostate%20cancer%3A%20updated%20survival%20in%20the%20TAX%20327%20study&amp;publication_year=2008&amp;author=D.R.%20Berthold&amp;author=G.R.%20Pond&amp;author=F.%20Soban&amp;author=R.%20de%20Wit&amp;author=M.%20Eisenberger&amp;author=I.F.%20Tannock" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref25"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib26" id="ref-id-bib26" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Bianchini et al., 2014</span></span></a></span><span class="reference" id="sref26"><div class="contribution"><div class="authors u-font-sans">D. Bianchini, D. Lorente, A. Rodriguez-Vida, A. Omlin, C. Pezaro, R. Ferraldeschi, <em> et al.</em></div><div id="ref-id-sref26" class="title text-m">Antitumour Activity of Enzalutamide (MDV3100) in Patients with Metastatic Castration-Resistant Prostate Cancer (CRPC) Pre-treated with Docetaxel and Abiraterone</div></div><div class="host u-font-sans">vol. 50, European Journal Of Cancer, Oxford, England (2014), pp. 78-84</div><div class="comment">1990</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0959804913007880/pdfft?md5=5e9db490e5899ea3a45c7176380048c4&amp;pid=1-s2.0-S0959804913007880-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref26"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0959804913007880" aria-describedby="ref-id-sref26"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84891633214&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref26"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Antitumour%20Activity%20of%20Enzalutamide%20%20in%20Patients%20with%20Metastatic%20Castration-Resistant%20Prostate%20Cancer%20%20Pre-treated%20with%20Docetaxel%20and%20Abiraterone&amp;publication_year=2014&amp;author=D.%20Bianchini&amp;author=D.%20Lorente&amp;author=A.%20Rodriguez-Vida&amp;author=A.%20Omlin&amp;author=C.%20Pezaro&amp;author=R.%20Ferraldeschi" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref26"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib27" id="ref-id-bib27" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">BNF, 2015</span></span></a></span><span class="reference" id="sref27"><div class="contribution"><div class="authors u-font-sans">BNF</div></div><div class="host u-font-sans" id="ref-id-sref27">British National Formulary, vol. 69 (2015)</div><div class="host u-font-sans"><a class="anchor anchor-primary" href="https://www.bnf.org/" target="_blank"><span class="anchor-text-container"><span class="anchor-text">https://www.bnf.org/</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar?q=BNF.%20(2015).%20British%20National%20Formulary%2069.%20https%3A%2F%2Fwww.bnf.org%2F." target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref27"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib28" id="ref-id-bib28" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Burström et al., 2001</span></span></a></span><span class="reference" id="sref28"><div class="contribution"><div class="authors u-font-sans">K. Burström, M. Johannesson, F. Diderichsen</div><div id="ref-id-sref28" class="title text-m">Swedish population health-related quality of life results using the EQ-5D</div></div><div class="host u-font-sans">Qual. Life Res.: Int. J. Qual. Life Asp. Treat. Care Rehabilitat., 10 (2001), pp. 621-635</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-0035681528&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref28"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Swedish%20population%20health-related%20quality%20of%20life%20results%20using%20the%20EQ-5D&amp;publication_year=2001&amp;author=K.%20Burstr%C3%B6m&amp;author=M.%20Johannesson&amp;author=F.%20Diderichsen" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref28"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib29" id="ref-id-bib29" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Center et al., 2012</span></span></a></span><span class="reference" id="sref29"><div class="contribution"><div class="authors u-font-sans">M.M. Center, A. Jemal, J. Lortet-Tieulent, E. Ward, J. Ferlay, O. Brawley, <em> et al.</em></div><div id="ref-id-sref29" class="title text-m">International variation in prostate cancer incidence and mortality rates</div></div><div class="host u-font-sans">Eur. Urol., 61 (2012), pp. 1079-1092</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0302283812003053/pdfft?md5=5dfd36c62baba3e863a1571c506d4427&amp;pid=1-s2.0-S0302283812003053-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref29"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0302283812003053" aria-describedby="ref-id-sref29"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84860266865&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref29"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=International%20variation%20in%20prostate%20cancer%20incidence%20and%20mortality%20rates&amp;publication_year=2012&amp;author=M.M.%20Center&amp;author=A.%20Jemal&amp;author=J.%20Lortet-Tieulent&amp;author=E.%20Ward&amp;author=J.%20Ferlay&amp;author=O.%20Brawley" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref29"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib30" id="ref-id-bib30" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Cherny et al., 2015</span></span></a></span><span class="reference" id="sref30"><div class="contribution"><div class="authors u-font-sans">N.I. Cherny, R. Sullivan, U. Dafni, J.M. Kerst, A. Sobrero, C. Zielinski, <em> et al.</em></div><div id="ref-id-sref30" class="title text-m">A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)</div></div><div class="host u-font-sans">Ann. Oncol.: Offic. J. Eur. Soc. Med. Oncol. ESMO, 26 (2015), pp. 1547-1573</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S092375341931868X/pdfft?md5=7de560d50409a480e21652c05fd53910&amp;pid=1-s2.0-S092375341931868X-mainext.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref30"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S092375341931868X" aria-describedby="ref-id-sref30"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://doi.org/10.1093/annonc/mdv249" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref30"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84940648261&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref30"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=A%20standardised%2C%20generic%2C%20validated%20approach%20to%20stratify%20the%20magnitude%20of%20clinical%20benefit%20that%20can%20be%20anticipated%20from%20anti-cancer%20therapies%3A%20the%20European%20Society%20for%20Medical%20Oncology%20Magnitude%20of%20Clinical%20Benefit%20Scale%20&amp;publication_year=2015&amp;author=N.I.%20Cherny&amp;author=R.%20Sullivan&amp;author=U.%20Dafni&amp;author=J.M.%20Kerst&amp;author=A.%20Sobrero&amp;author=C.%20Zielinski" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref30"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib31" id="ref-id-bib31" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Chongtrakul et al., 2005</span></span></a></span><span class="reference" id="sref31"><div class="contribution"><div class="authors u-font-sans">P. Chongtrakul, N. Sumpradit, W. Yoongthong</div><div id="ref-id-sref31" class="title text-m">ISafE and the Evidence-Based Approach for Essential Medicines Selection in Thailand</div></div><div class="host u-font-sans">Essential Drugs Monitor (2005), pp. 18-19</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=ISafE%20and%20the%20Evidence-Based%20Approach%20for%20Essential%20Medicines%20Selection%20in%20Thailand&amp;publication_year=2005&amp;author=P.%20Chongtrakul&amp;author=N.%20Sumpradit&amp;author=W.%20Yoongthong" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref31"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib32" id="ref-id-bib32" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Claxton et al., 2015</span></span></a></span><span class="reference" id="sref32"><div class="contribution"><div class="authors u-font-sans">K. Claxton, S. Martin, M. Soares, N. Rice, E. Spackman, S. Hinde, <em> et al.</em></div><div id="ref-id-sref32" class="title text-m">Methods for the estimation of the National Institute for Health and care excellence cost- effectiveness threshold</div></div><div class="host u-font-sans">Health Technol. Assess., 19 (2015), pp. 1-503</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84923209923&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref32"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Methods%20for%20the%20estimation%20of%20the%20National%20Institute%20for%20Health%20and%20care%20excellence%20cost-%20effectiveness%20threshold&amp;publication_year=2015&amp;author=K.%20Claxton&amp;author=S.%20Martin&amp;author=M.%20Soares&amp;author=N.%20Rice&amp;author=E.%20Spackman&amp;author=S.%20Hinde" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref32"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib33" id="ref-id-bib33" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Cleemput et al., 2018</span></span></a></span><span class="reference" id="sref33"><div class="contribution"><div class="authors u-font-sans">I. Cleemput, S. Devriese, L. Kohn, C. Devos, J. van Til, C.G.M. Groothuis-Oudshoorn, <em> et al.</em></div><div id="ref-id-sref33" class="title text-m">What does the public want? Structural consideration of citizen preferences in health care coverage decisions</div></div><div class="host u-font-sans">MDM Pol. Pract., 3 (2018)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=What%20does%20the%20public%20want%20Structural%20consideration%20of%20citizen%20preferences%20in%20health%20care%20coverage%20decisions&amp;publication_year=2018&amp;author=I.%20Cleemput&amp;author=S.%20Devriese&amp;author=L.%20Kohn&amp;author=C.%20Devos&amp;author=J.%20van%20Til&amp;author=C.G.M.%20Groothuis-Oudshoorn" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref33"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib34" id="ref-id-bib34" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Clement et al., 2009</span></span></a></span><span class="reference" id="sref34"><div class="contribution"><div class="authors u-font-sans">F.M. Clement, A. Harris, J.J. Li, K. Yong, K.M. Lee, B.J. Manns</div><div id="ref-id-sref34" class="title text-m">Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada</div></div><div class="host u-font-sans">J. Am. Med. Assoc., 302 (2009), pp. 1437-1443</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1001/jama.2009.1409" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref34"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-70349914121&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref34"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Using%20effectiveness%20and%20cost-effectiveness%20to%20make%20drug%20coverage%20decisions%3A%20a%20comparison%20of%20Britain%2C%20Australia%2C%20and%20Canada&amp;publication_year=2009&amp;author=F.M.%20Clement&amp;author=A.%20Harris&amp;author=J.J.%20Li&amp;author=K.%20Yong&amp;author=K.M.%20Lee&amp;author=B.J.%20Manns" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref34"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib35" id="ref-id-bib35" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Cohen, 2017</span></span></a></span><span class="reference" id="sref35"><div class="contribution"><div class="authors u-font-sans">D. Cohen</div><div id="ref-id-sref35" class="title text-m">Cancer drugs: high price, uncertain value</div></div><div class="host u-font-sans">BMJ, 359 (2017)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Cancer%20drugs%3A%20high%20price%2C%20uncertain%20value&amp;publication_year=2017&amp;author=D.%20Cohen" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref35"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib36" id="ref-id-bib36" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Collins et al., 2007</span></span></a></span><span class="reference" id="sref36"><div class="contribution"><div class="authors u-font-sans">R. Collins, E. Fenwick, R. Trowman, R. Perard, G. Norman, K. Light, <em> et al.</em></div><div id="ref-id-sref36" class="title text-m">A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer</div></div><div class="host u-font-sans">Health Technol. Assess., 11 (2007), p. iii</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=A%20systematic%20review%20and%20economic%20model%20of%20the%20clinical%20effectiveness%20and%20cost-effectiveness%20of%20docetaxel%20in%20combination%20with%20prednisone%20or%20prednisolone%20for%20the%20treatment%20of%20hormone-refractory%20metastatic%20prostate%20cancer&amp;publication_year=2007&amp;author=R.%20Collins&amp;author=E.%20Fenwick&amp;author=R.%20Trowman&amp;author=R.%20Perard&amp;author=G.%20Norman&amp;author=K.%20Light" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref36"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib37" id="ref-id-bib37" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Connock et al., 2011</span></span></a></span><span class="reference" id="sref37"><div class="contribution"><div class="authors u-font-sans">M. Connock, E. Cummins, D. Shyangdan, B. Hall, A. Grove, A. Clarke</div><div id="ref-id-sref37" class="title text-m">Abiraterone Acetate for the Treatment of Metastatic, Castrate-Resistant Prostate Cancer Following Previous Cytotoxic Chemotherapy: A Single Technology Appraisal</div></div><div class="host u-font-sans">Warwick Evidence (2011)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Abiraterone%20Acetate%20for%20the%20Treatment%20of%20Metastatic%2C%20Castrate-Resistant%20Prostate%20Cancer%20Following%20Previous%20Cytotoxic%20Chemotherapy%3A%20A%20Single%20Technology%20Appraisal&amp;publication_year=2011&amp;author=M.%20Connock&amp;author=E.%20Cummins&amp;author=D.%20Shyangdan&amp;author=B.%20Hall&amp;author=A.%20Grove&amp;author=A.%20Clarke" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref37"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib38" id="ref-id-bib38" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Currim and Sarin, 1984</span></span></a></span><span class="reference" id="sref38"><div class="contribution"><div class="authors u-font-sans">I.S. Currim, R.K. Sarin</div><div id="ref-id-sref38" class="title text-m">A comparative evaluation of multiattribute consumer preference models</div></div><div class="host u-font-sans">Manag. Sci., 30 (1984), pp. 543-561</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1287/mnsc.30.5.543" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref38"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-0021424075&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref38"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=A%20comparative%20evaluation%20of%20multiattribute%20consumer%20preference%20models&amp;publication_year=1984&amp;author=I.S.%20Currim&amp;author=R.K.%20Sarin" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref38"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib39" id="ref-id-bib39" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Danner et al., 2011</span></span></a></span><span class="reference" id="sref39"><div class="contribution"><div class="authors u-font-sans">M. Danner, J.M. Hummel, F. Volz, J.G. van Manen, B. Wiegard, C.-M. Dintsios, <em> et al.</em></div><div id="ref-id-sref39" class="title text-m">Integrating patients' views into health technology assessment: analytic hierarchy process (AHP) as a method to elicit patient preferences</div></div><div class="host u-font-sans">Int. J. Technol. Assess. Health Care, 27 (2011), pp. 369-375</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84858992519&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref39"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Integrating%20patients%20views%20into%20health%20technology%20assessment%3A%20analytic%20hierarchy%20process%20%20as%20a%20method%20to%20elicit%20patient%20preferences&amp;publication_year=2011&amp;author=M.%20Danner&amp;author=J.M.%20Hummel&amp;author=F.%20Volz&amp;author=J.G.%20van%20Manen&amp;author=B.%20Wiegard&amp;author=C.-M.%20Dintsios" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref39"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib40" id="ref-id-bib40" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">de Bono et al., 2011</span></span></a></span><span class="reference" id="sref40"><div class="contribution"><div class="authors u-font-sans">J.S. de Bono, C.J. Logothetis, A. Molina, K. Fizazi, S. North, L. Chu, <em> et al.</em></div><div id="ref-id-sref40" class="title text-m">Abiraterone and increased survival in metastatic prostate cancer</div></div><div class="host u-font-sans">N. Engl. J. Med., 364 (2011), pp. 1995-2005</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-79957443342&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref40"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Abiraterone%20and%20increased%20survival%20in%20metastatic%20prostate%20cancer&amp;publication_year=2011&amp;author=J.S.%20de%20Bono&amp;author=C.J.%20Logothetis&amp;author=A.%20Molina&amp;author=K.%20Fizazi&amp;author=S.%20North&amp;author=L.%20Chu" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref40"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib41" id="ref-id-bib41" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">de Bono et al., 2010</span></span></a></span><span class="reference" id="sref41"><div class="contribution"><div class="authors u-font-sans">J.S. de Bono, S. Oudard, M. Ozguroglu, S. Hansen, J.-P. Machiels, I. Kocak, <em> et al.</em></div><div id="ref-id-sref41" class="title text-m">Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial</div></div><div class="host u-font-sans">Lancet, 376 (2010), pp. 1147-1154</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S014067361061389X/pdfft?md5=8f7f27e8f48040fd5c989eef318af1f0&amp;pid=1-s2.0-S014067361061389X-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref41"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S014067361061389X" aria-describedby="ref-id-sref41"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-77957682309&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref41"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Prednisone%20plus%20cabazitaxel%20or%20mitoxantrone%20for%20metastatic%20castration-resistant%20prostate%20cancer%20progressing%20after%20docetaxel%20treatment%3A%20a%20randomised%20open-label%20trial&amp;publication_year=2010&amp;author=J.S.%20de%20Bono&amp;author=S.%20Oudard&amp;author=M.%20Ozguroglu&amp;author=S.%20Hansen&amp;author=J.-P.%20Machiels&amp;author=I.%20Kocak" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref41"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib42" id="ref-id-bib42" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Devlin and Lorgelly, 2017</span></span></a></span><span class="reference" id="sref42"><div class="contribution"><div class="authors u-font-sans">N. Devlin, P. Lorgelly</div><div id="ref-id-sref42" class="title text-m">QALYs as a measure of value in cancer</div></div><div class="host u-font-sans">J. Canc. Pol., 11 (2017), pp. 19-25</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S2213538316300236/pdfft?md5=a4ff7f4a58c58071abba493c4c058afb&amp;pid=1-s2.0-S2213538316300236-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref42"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S2213538316300236" aria-describedby="ref-id-sref42"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84998910247&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref42"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=QALYs%20as%20a%20measure%20of%20value%20in%20cancer&amp;publication_year=2017&amp;author=N.%20Devlin&amp;author=P.%20Lorgelly" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref42"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib43" id="ref-id-bib43" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Devlin and Sussex, 2011</span></span></a></span><span class="reference" id="sref43"><div class="contribution"><div class="authors u-font-sans">N. Devlin, J. Sussex</div><div id="ref-id-sref43" class="title text-m">Incorporating Multiple Criteria in HTA: Methods and Processes</div></div><div class="host u-font-sans">Office of Health Economics, London (2011)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Incorporating%20Multiple%20Criteria%20in%20HTA%3A%20Methods%20and%20Processes&amp;publication_year=2011&amp;author=N.%20Devlin&amp;author=J.%20Sussex" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref43"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib44" id="ref-id-bib44" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Drummond et al., 2013</span></span></a></span><span class="reference" id="sref44"><div class="contribution"><div class="authors u-font-sans">M. Drummond, R. Tarricone, A. Torbica</div><div id="ref-id-sref44" class="title text-m">Assessing the added value of health technologies: reconciling different perspectives</div></div><div class="host u-font-sans">Value Health: J. Int. Soc. Pharmacoecon. Outcomes Res., 16 (2013), pp. S7-S13</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S1098301512041587/pdfft?md5=a2c9c65a06f58a7c792e658dadd9055b&amp;pid=1-s2.0-S1098301512041587-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref44"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S1098301512041587" aria-describedby="ref-id-sref44"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84872344931&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref44"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Assessing%20the%20added%20value%20of%20health%20technologies%3A%20reconciling%20different%20perspectives&amp;publication_year=2013&amp;author=M.%20Drummond&amp;author=R.%20Tarricone&amp;author=A.%20Torbica" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref44"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib45" id="ref-id-bib45" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Efthymiadou et al., 2019</span></span></a></span><span class="reference" id="sref45"><div class="contribution"><div class="authors u-font-sans">O. Efthymiadou, J. Mossman, P. Kanavos</div><div id="ref-id-sref45" class="title text-m">Health related quality of life aspects not captured by EQ-5D-5L: results from an international survey of patients</div></div><div class="host u-font-sans">Health Policy, 123 (2019), pp. 159-165</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0168851018306778/pdfft?md5=77af9bcf3702265879cd6da7ac249ead&amp;pid=1-s2.0-S0168851018306778-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref45"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0168851018306778" aria-describedby="ref-id-sref45"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-85059163756&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref45"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Health%20related%20quality%20of%20life%20aspects%20not%20captured%20by%20EQ-5D-5L%3A%20results%20from%20an%20international%20survey%20of%20patients&amp;publication_year=2019&amp;author=O.%20Efthymiadou&amp;author=J.%20Mossman&amp;author=P.%20Kanavos" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref45"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib46" id="ref-id-bib46" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">EMA, 2016a</span></span></a></span><span class="reference" id="sref46"><div class="contribution"><div class="authors u-font-sans">EMA</div><div id="ref-id-sref46" class="title text-m">Jevtana (Cabazitaxel) EPAR - Product Information</div></div><div class="host u-font-sans">European Medicines Agency (2016)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Jevtana%20%20EPAR%20-%20Product%20Information&amp;publication_year=2016&amp;author=EMA" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref46"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib47" id="ref-id-bib47" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">EMA, 2016b</span></span></a></span><span class="reference" id="sref47"><div class="contribution"><div class="authors u-font-sans">EMA</div><div id="ref-id-sref47" class="title text-m">Xtandi (Enzalutamide) EPAR - Product Information</div></div><div class="host u-font-sans">European Medicines Agency (2016)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Xtandi%20%20EPAR%20-%20Product%20Information&amp;publication_year=2016&amp;author=EMA" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref47"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib48" id="ref-id-bib48" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">EMA, 2016c</span></span></a></span><span class="reference" id="sref48"><div class="contribution"><div class="authors u-font-sans">EMA</div><div id="ref-id-sref48" class="title text-m">Zytiga (Abiraterone) EPAR - Product Information</div></div><div class="host u-font-sans">European Medicines Agency (2016)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Zytiga%20%20EPAR%20-%20Product%20Information&amp;publication_year=2016&amp;author=EMA" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref48"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib49" id="ref-id-bib49" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Faden et al., 2009</span></span></a></span><span class="reference" id="sref49"><div class="contribution"><div class="authors u-font-sans">R.R. Faden, K. Chalkidou, J. Appleby, H.R. Waters, J.P. Leider</div><div id="ref-id-sref49" class="title text-m">Expensive cancer drugs: a comparison between the United States and the United Kingdom</div></div><div class="host u-font-sans">Milbank Q., 87 (2009), pp. 789-819</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1111/j.1468-0009.2009.00579.x" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref49"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-72449203777&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref49"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Expensive%20cancer%20drugs%3A%20a%20comparison%20between%20the%20United%20States%20and%20the%20United%20Kingdom&amp;publication_year=2009&amp;author=R.R.%20Faden&amp;author=K.%20Chalkidou&amp;author=J.%20Appleby&amp;author=H.R.%20Waters&amp;author=J.P.%20Leider" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref49"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib50" id="ref-id-bib50" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Fasolo and Bana e Costa, 2014</span></span></a></span><span class="reference" id="sref50"><div class="contribution"><div class="authors u-font-sans">B. Fasolo, C.A. Bana e Costa</div><div id="ref-id-sref50" class="title text-m">Tailoring value elicitation to decision makers' numeracy and fluency: expressing value judgments in numbers or words</div></div><div class="host u-font-sans">Omega, 44 (2014), pp. 83-90</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0305048313000960/pdfft?md5=78a898ee8c07ed1857e3adcc3dca8210&amp;pid=1-s2.0-S0305048313000960-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref50"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0305048313000960" aria-describedby="ref-id-sref50"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84887659737&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref50"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Tailoring%20value%20elicitation%20to%20decision%20makers%20numeracy%20and%20fluency%3A%20expressing%20value%20judgments%20in%20numbers%20or%20words&amp;publication_year=2014&amp;author=B.%20Fasolo&amp;author=C.A.%20Bana%20e%20Costa" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref50"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib51" id="ref-id-bib51" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Fizazi et al., 2012</span></span></a></span><span class="reference" id="sref51"><div class="contribution"><div class="authors u-font-sans">K. Fizazi, H.I. Scher, A. Molina, C.J. Logothetis, K.N. Chi, R.J. Jones, <em> et al.</em></div><div id="ref-id-sref51" class="title text-m">Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study</div></div><div class="host u-font-sans">Lancet Oncol., 13 (2012), pp. 983-992</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S1470204512703790/pdfft?md5=63e4cc052f86d427c65ff9d32711533a&amp;pid=1-s2.0-S1470204512703790-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref51"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S1470204512703790" aria-describedby="ref-id-sref51"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84866948935&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref51"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Abiraterone%20acetate%20for%20treatment%20of%20metastatic%20castration-resistant%20prostate%20cancer%3A%20final%20overall%20survival%20analysis%20of%20the%20COU-AA-301%20randomised%2C%20double-blind%2C%20placebo-controlled%20phase%203%20study&amp;publication_year=2012&amp;author=K.%20Fizazi&amp;author=H.I.%20Scher&amp;author=A.%20Molina&amp;author=C.J.%20Logothetis&amp;author=K.N.%20Chi&amp;author=R.J.%20Jones" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref51"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib52" id="ref-id-bib52" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Franco and Montibeller, 2010a</span></span></a></span><span class="reference" id="sref52"><div class="contribution"><div class="authors u-font-sans">L. Franco, G. Montibeller</div><div id="ref-id-sref52" class="title text-m">Problem Structuring for Multicriteria Decision Analysis Interventions Analysis Interventions</div></div><div class="host u-font-sans">Wiley Encyclopedia of Operations Research and Management Science (2010)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Problem%20Structuring%20for%20Multicriteria%20Decision%20Analysis%20Interventions%20Analysis%20Interventions&amp;publication_year=2010&amp;author=L.%20Franco&amp;author=G.%20Montibeller" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref52"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib53" id="ref-id-bib53" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Franco and Montibeller, 2010b</span></span></a></span><span class="reference" id="sref53"><div class="contribution"><div class="authors u-font-sans">L.A. Franco, G. Montibeller</div><div id="ref-id-sref53" class="title text-m">Facilitated modelling in operational research</div></div><div class="host u-font-sans">Eur. J. Oper. Res., 205 (2010), pp. 489-500</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0377221709006699/pdfft?md5=64ac01e53767bdc168eeef69a5f42c5b&amp;pid=1-s2.0-S0377221709006699-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref53"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0377221709006699" aria-describedby="ref-id-sref53"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-77649338730&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref53"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Facilitated%20modelling%20in%20operational%20research&amp;publication_year=2010&amp;author=L.A.%20Franco&amp;author=G.%20Montibeller" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref53"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib54" id="ref-id-bib54" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">GHEMA, 2016</span></span></a></span><span class="reference" id="sref54"><div class="contribution"><div class="authors u-font-sans">GHEMA</div><div id="ref-id-sref54" class="title text-m">ENZALUTAMIDA en cáncer próstata metastásico resistente a la castración (previo a quimioterapia). Grupo de Evaluación de Novedades, EStandarización e Investigación en Selección de Medicamentos</div></div><div class="host u-font-sans"> (2016)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=ENZALUTAMIDA%20en%20c%C3%A1ncer%20pr%C3%B3stata%20metast%C3%A1sico%20resistente%20a%20la%20castraci%C3%B3n%20.%20Grupo%20de%20Evaluaci%C3%B3n%20de%20Novedades%2C%20EStandarizaci%C3%B3n%20e%20Investigaci%C3%B3n%20en%20Selecci%C3%B3n%20de%20Medicamentos&amp;publication_year=2016&amp;author=GHEMA" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref54"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib55" id="ref-id-bib55" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Goetghebeur et al., 2008</span></span></a></span><span class="reference" id="sref55"><div class="contribution"><div class="authors u-font-sans">M.M. Goetghebeur, M. Wagner, H. Khoury, R.J. Levitt, L.J. Erickson, D. Rindress</div><div id="ref-id-sref55" class="title text-m">Evidence and Value: impact on DEcisionMaking--the EVIDEM framework and potential applications</div></div><div class="host u-font-sans">BMC Health Serv. Res., 8 (2008), p. 270</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-65449173946&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref55"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Evidence%20and%20Value%3A%20impact%20on%20DEcisionMaking--the%20EVIDEM%20framework%20and%20potential%20applications&amp;publication_year=2008&amp;author=M.M.%20Goetghebeur&amp;author=M.%20Wagner&amp;author=H.%20Khoury&amp;author=R.J.%20Levitt&amp;author=L.J.%20Erickson&amp;author=D.%20Rindress" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref55"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib56" id="ref-id-bib56" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Goetghebeur et al., 2010</span></span></a></span><span class="reference" id="sref56"><div class="contribution"><div class="authors u-font-sans">M.M. Goetghebeur, M. Wagner, H. Khoury, D. Rindress, J. Grégoire, C. Deal</div><div id="ref-id-sref56" class="title text-m">Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patients</div></div><div class="host u-font-sans">Cost Eff. Resour. Allocation, 8 (2010), p. 1</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Combining%20multicriteria%20decision%20analysis%2C%20ethics%20and%20health%20technology%20assessment%3A%20applying%20the%20EVIDEM%20decisionmaking%20framework%20to%20growth%20hormone%20for%20Turner%20syndrome%20patients&amp;publication_year=2010&amp;author=M.M.%20Goetghebeur&amp;author=M.%20Wagner&amp;author=H.%20Khoury&amp;author=D.%20Rindress&amp;author=J.%20Gr%C3%A9goire&amp;author=C.%20Deal" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref56"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib57" id="ref-id-bib57" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Horwich et al., 2013</span></span></a></span><span class="reference" id="sref57"><div class="contribution"><div class="authors u-font-sans">A. Horwich, C. Parker, T. de Reijke, V. Kataja</div><div id="ref-id-sref57" class="title text-m">Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up</div></div><div class="host u-font-sans">Ann. Oncol.: Offic. J. Eur. Soc. Med. Oncol. ESMO, 24 (Suppl. 6) (2013), pp. vi106-vi114</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0923753419315509/pdfft?md5=a1aff8b74c495ef45b96742c77506a32&amp;pid=1-s2.0-S0923753419315509-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref57"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0923753419315509" aria-describedby="ref-id-sref57"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://doi.org/10.1093/annonc/mdt208" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref57"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84885350053&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref57"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Prostate%20cancer%3A%20ESMO%20Clinical%20Practice%20Guidelines%20for%20diagnosis%2C%20treatment%20and%20follow-up&amp;publication_year=2013&amp;author=A.%20Horwich&amp;author=C.%20Parker&amp;author=T.%20de%20Reijke&amp;author=V.%20Kataja" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref57"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib58" id="ref-id-bib58" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Ijzerman et al., 2008</span></span></a></span><span class="reference" id="sref58"><div class="contribution"><div class="authors u-font-sans">M.J. Ijzerman, J.A. van Til, G.J. Snoek</div><div id="ref-id-sref58" class="title text-m">Comparison of two multi-criteria decision techniques for eliciting treatment preferences in people with neurological disorders</div></div><div class="host u-font-sans">Patient, 1 (2008), pp. 265-272</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.2165/1312067-200801040-00008" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref58"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Comparison%20of%20two%20multi-criteria%20decision%20techniques%20for%20eliciting%20treatment%20preferences%20in%20people%20with%20neurological%20disorders&amp;publication_year=2008&amp;author=M.J.%20Ijzerman&amp;author=J.A.%20van%20Til&amp;author=G.J.%20Snoek" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref58"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib59" id="ref-id-bib59" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">INAMI, 2019</span></span></a></span><span class="reference" id="sref59"><div class="contribution"><div class="authors u-font-sans">INAMI</div><div id="ref-id-sref59" class="title text-m">Remboursement de médicaments : Décisions ministérielles et rapports d’évaluation de la CRM</div></div><div class="host u-font-sans"> (2019)</div><div class="host u-font-sans"><a class="anchor anchor-primary" href="https://www.inami.fgov.be/fr/programmes-web/Pages/applications-rapports-crm.aspx" target="_blank"><span class="anchor-text-container"><span class="anchor-text">https://www.inami.fgov.be/fr/programmes-web/Pages/applications-rapports-crm.aspx</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Remboursement%20de%20m%C3%A9dicaments%20%3A%20D%C3%A9cisions%20minist%C3%A9rielles%20et%20rapports%20d%C3%A9valuation%20de%20la%20CRM&amp;publication_year=2019&amp;author=INAMI" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref59"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib60" id="ref-id-bib60" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Jansen et al., 2011</span></span></a></span><span class="reference" id="sref60"><div class="contribution"><div class="authors u-font-sans">J.P. Jansen, R. Fleurence, B. Devine, R. Itzler, A. Barrett, N. Hawkins, <em> et al.</em></div><div id="ref-id-sref60" class="title text-m">Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1</div></div><div class="host u-font-sans">Value Health: J. Int. Soc. Pharmacoecon. Outcomes Res., 14 (2011), pp. 417-428</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S1098301511014045/pdfft?md5=c21b9aee187f6fd79905984ef58e03c9&amp;pid=1-s2.0-S1098301511014045-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref60"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S1098301511014045" aria-describedby="ref-id-sref60"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-79959925787&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref60"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Interpreting%20indirect%20treatment%20comparisons%20and%20network%20meta-analysis%20for%20health-care%20decision%20making%3A%20report%20of%20the%20ISPOR%20Task%20Force%20on%20Indirect%20Treatment%20Comparisons%20Good%20Research%20Practices%3A%20part%201&amp;publication_year=2011&amp;author=J.P.%20Jansen&amp;author=R.%20Fleurence&amp;author=B.%20Devine&amp;author=R.%20Itzler&amp;author=A.%20Barrett&amp;author=N.%20Hawkins" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref60"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib61" id="ref-id-bib61" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Jaramillo et al., 2016</span></span></a></span><span class="reference" id="sref61"><div class="contribution"><div class="authors u-font-sans">H.E.C. Jaramillo, M. Goetghebeur, O. Moreno-Mattar</div><div id="ref-id-sref61" class="title text-m">Testing multi-criteria decision analysis for more transparent resource-allocation decision making in Colombia</div></div><div class="host u-font-sans">32 (2016), pp. 307-314</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1017/S0266462316000350" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref61"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84989929871&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref61"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Testing%20multi-criteria%20decision%20analysis%20for%20more%20transparent%20resource-allocation%20decision%20making%20in%20Colombia&amp;publication_year=2016&amp;author=H.E.C.%20Jaramillo&amp;author=M.%20Goetghebeur&amp;author=O.%20Moreno-Mattar" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref61"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib62" id="ref-id-bib62" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Kanavos and Angelis, 2013</span></span></a></span><span class="reference" id="sref62"><div class="contribution"><div class="authors u-font-sans">P. Kanavos, A. Angelis</div><div id="ref-id-sref62" class="title text-m">Multiple Criteria Decision Analysis for Value Based Assessment of New Medical Technologies: a Conceptual Framework. The LSE Health Working Paper Series in Health Policy and Economics</div></div><div class="host u-font-sans">London School of Economics and Political Science (2013)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Multiple%20Criteria%20Decision%20Analysis%20for%20Value%20Based%20Assessment%20of%20New%20Medical%20Technologies%3A%20a%20Conceptual%20Framework.%20The%20LSE%20Health%20Working%20Paper%20Series%20in%20Health%20Policy%20and%20Economics&amp;publication_year=2013&amp;author=P.%20Kanavos&amp;author=A.%20Angelis" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref62"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib63" id="ref-id-bib63" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Kearns et al., 2013</span></span></a></span><span class="reference" id="sref63"><div class="contribution"><div class="authors u-font-sans">B. Kearns, M. Lloyd Jones, M. Stevenson, C. Littlewood</div><div id="ref-id-sref63" class="title text-m">Cabazitaxel for the second-line treatment of metastatic hormone-refractory prostate cancer: a NICE single technology appraisal</div></div><div class="host u-font-sans">PharmacoEconomics, 31 (2013), pp. 479-488</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1007/s40273-013-0050-9" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref63"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84877944939&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref63"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Cabazitaxel%20for%20the%20second-line%20treatment%20of%20metastatic%20hormone-refractory%20prostate%20cancer%3A%20a%20NICE%20single%20technology%20appraisal&amp;publication_year=2013&amp;author=B.%20Kearns&amp;author=M.%20Lloyd%20Jones&amp;author=M.%20Stevenson&amp;author=C.%20Littlewood" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref63"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib64" id="ref-id-bib64" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Keeney, 1992</span></span></a></span><span class="reference" id="sref64"><div class="contribution"><div class="authors u-font-sans">R. Keeney</div><div id="ref-id-sref64" class="title text-m">Value Focused Thinking: a Path to Creative Decision Making</div></div><div class="host u-font-sans">Harvard University Press, Cambridge (1992)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Value%20Focused%20Thinking%3A%20a%20Path%20to%20Creative%20Decision%20Making&amp;publication_year=1992&amp;author=R.%20Keeney" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref64"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib65" id="ref-id-bib65" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Keeney and Raiffa, 1993</span></span></a></span><span class="reference" id="sref65"><div class="contribution"><div class="authors u-font-sans">R. Keeney, H. Raiffa</div><div id="ref-id-sref65" class="title text-m">Decisions with Multiple Objectives: Preferences and Value Trade-Offs</div></div><div class="host u-font-sans">Cambridge University Press, Cambridge (1993)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Decisions%20with%20Multiple%20Objectives%3A%20Preferences%20and%20Value%20Trade-Offs&amp;publication_year=1993&amp;author=R.%20Keeney&amp;author=H.%20Raiffa" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref65"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib67" id="ref-id-bib67" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Keeney, 2002</span></span></a></span><span class="reference" id="sref67"><div class="contribution"><div class="authors u-font-sans">R.L. Keeney</div><div id="ref-id-sref67" class="title text-m">Common mistakes in making value trade-offs</div></div><div class="host u-font-sans">Oper. Res., 50 (2002), p. 935</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-0036877242&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref67"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Common%20mistakes%20in%20making%20value%20trade-offs&amp;publication_year=2002&amp;author=R.L.%20Keeney" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref67"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib68" id="ref-id-bib68" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Keeney and Gregory, 2005</span></span></a></span><span class="reference" id="sref68"><div class="contribution"><div class="authors u-font-sans">R.L. Keeney, R.S. Gregory</div><div id="ref-id-sref68" class="title text-m">Selecting attributes to measure the achievement of objectives</div></div><div class="host u-font-sans">Oper. Res., 53 (2005), pp. 1-11</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1287/opre.1040.0158" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref68"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-14644422604&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref68"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Selecting%20attributes%20to%20measure%20the%20achievement%20of%20objectives&amp;publication_year=2005&amp;author=R.L.%20Keeney&amp;author=R.S.%20Gregory" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref68"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib69" id="ref-id-bib69" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Linley and Hughes, 2013</span></span></a></span><span class="reference" id="sref69"><div class="contribution"><div class="authors u-font-sans">W.G. Linley, D.A. Hughes</div><div id="ref-id-sref69" class="title text-m">Societal views on NICE, cancer drugs fund and value-based pricing criteria for prioritising medicines: a cross-sectional survey of 4118 adults in Great Britain</div></div><div class="host u-font-sans">Health Econ., 22 (2013), pp. 948-964</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1002/hec.2872" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref69"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84880132926&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref69"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Societal%20views%20on%20NICE%2C%20cancer%20drugs%20fund%20and%20value-based%20pricing%20criteria%20for%20prioritising%20medicines%3A%20a%20cross-sectional%20survey%20of%204118%20adults%20in%20Great%20Britain&amp;publication_year=2013&amp;author=W.G.%20Linley&amp;author=D.A.%20Hughes" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref69"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib70" id="ref-id-bib70" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">London School of Economics, 2019</span></span></a></span><span class="reference" id="sref70"><div class="contribution"><div class="authors u-font-sans">London School of Economics</div><div id="ref-id-sref70" class="title text-m">ADVANCE_HTA Project</div></div><div class="host u-font-sans"> (2019)</div><div class="host u-font-sans"><a class="anchor anchor-primary" href="http://www.lse.ac.uk/lse-health/research/projects/advance-hta" target="_blank"><span class="anchor-text-container"><span class="anchor-text">http://www.lse.ac.uk/lse-health/research/projects/advance-hta</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=ADVANCE_HTA%20Project&amp;publication_year=2019&amp;author=London%20School%20of%20Economics" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref70"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib71" id="ref-id-bib71" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Loriot et al., 2013</span></span></a></span><span class="reference" id="sref71"><div class="contribution"><div class="authors u-font-sans">Y. Loriot, D. Bianchini, E. Ileana, S. Sandhu, A. Patrikidou, C. Pezaro, <em> et al.</em></div><div id="ref-id-sref71" class="title text-m">Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)</div></div><div class="host u-font-sans">Ann. Oncol.: Offic. J. Eur. Soc. Med. Oncol. ESMO, 24 (2013), pp. 1807-1812</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0923753419366670/pdfft?md5=f378adfd06a419fa976220868162cac3&amp;pid=1-s2.0-S0923753419366670-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref71"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0923753419366670" aria-describedby="ref-id-sref71"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://doi.org/10.1093/annonc/mdt136" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref71"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84882789820&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref71"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Antitumour%20activity%20of%20abiraterone%20acetate%20against%20metastatic%20castration-resistant%20prostate%20cancer%20progressing%20after%20docetaxel%20and%20enzalutamide%20&amp;publication_year=2013&amp;author=Y.%20Loriot&amp;author=D.%20Bianchini&amp;author=E.%20Ileana&amp;author=S.%20Sandhu&amp;author=A.%20Patrikidou&amp;author=C.%20Pezaro" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref71"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib72" id="ref-id-bib72" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Malone et al., 2016</span></span></a></span><span class="reference" id="sref72"><div class="contribution"><div class="authors u-font-sans">D.C. Malone, N.S. Berg, K. Claxton, L.P. Garrison Jr., M. Ijzerman, K. Marsh, <em> et al.</em></div><div id="ref-id-sref72" class="title text-m">International society for pharmacoeconomics and outcomes research comments on the American society of clinical oncology value framework</div></div><div class="host u-font-sans">J. Clin. Oncol.: Offic. J. Am. Soc. Clin. Oncol., 34 (2016), pp. 2936-2937</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84982151756&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref72"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=International%20society%20for%20pharmacoeconomics%20and%20outcomes%20research%20comments%20on%20the%20American%20society%20of%20clinical%20oncology%20value%20framework&amp;publication_year=2016&amp;author=D.C.%20Malone&amp;author=N.S.%20Berg&amp;author=K.%20Claxton&amp;author=L.P.%20Garrison%20Jr.&amp;author=M.%20Ijzerman&amp;author=K.%20Marsh" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref72"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib73" id="ref-id-bib73" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Marsh et al., 2016</span></span></a></span><span class="reference" id="sref73"><div class="contribution"><div class="authors u-font-sans">K. Marsh, M. Ijzerman, P. Thokala, R. Baltussen, M. Boysen, Z. Kaló, <em> et al.</em></div><div id="ref-id-sref73" class="title text-m">Multiple criteria decision analysis for health care decision making-emerging good practices: report 2 of the ISPOR MCDA emerging good practices task force</div></div><div class="host u-font-sans">Value Health: J. Int. Soc. Pharmacoecon. Outcomes Res., 19 (2016), pp. 125-137</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S1098301515300152/pdfft?md5=bf6019293ec9aa48e530bd0a8cab8782&amp;pid=1-s2.0-S1098301515300152-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref73"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S1098301515300152" aria-describedby="ref-id-sref73"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84959574946&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref73"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Multiple%20criteria%20decision%20analysis%20for%20health%20care%20decision%20making-emerging%20good%20practices%3A%20report%202%20of%20the%20ISPOR%20MCDA%20emerging%20good%20practices%20task%20force&amp;publication_year=2016&amp;author=K.%20Marsh&amp;author=M.%20Ijzerman&amp;author=P.%20Thokala&amp;author=R.%20Baltussen&amp;author=M.%20Boysen&amp;author=Z.%20Kal%C3%B3" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref73"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib74" id="ref-id-bib74" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Marsh et al., 2014</span></span></a></span><span class="reference" id="sref74"><div class="contribution"><div class="authors u-font-sans">K. Marsh, T. Lanitis, D. Neasham, P. Orfanos, J. Caro</div><div id="ref-id-sref74" class="title text-m">Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature</div></div><div class="host u-font-sans">PharmacoEconomics, 32 (2014), pp. 345-365</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1007/s40273-014-0135-0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref74"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84897496021&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref74"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Assessing%20the%20value%20of%20healthcare%20interventions%20using%20multi-criteria%20decision%20analysis%3A%20a%20review%20of%20the%20literature&amp;publication_year=2014&amp;author=K.%20Marsh&amp;author=T.%20Lanitis&amp;author=D.%20Neasham&amp;author=P.%20Orfanos&amp;author=J.%20Caro" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref74"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib75" id="ref-id-bib75" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Marsh et al., 2018</span></span></a></span><span class="reference" id="sref75"><div class="contribution"><div class="authors u-font-sans">K. Marsh, M. Sculpher, J.J. Caro, T. Tervonen</div><div id="ref-id-sref75" class="title text-m">The Use of MCDA in HTA: Great Potential, but More Effort Needed. Value in Health</div></div><div class="host u-font-sans"> (2018)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=The%20Use%20of%20MCDA%20in%20HTA%3A%20Great%20Potential%2C%20but%20More%20Effort%20Needed.%20Value%20in%20Health&amp;publication_year=2018&amp;author=K.%20Marsh&amp;author=M.%20Sculpher&amp;author=J.J.%20Caro&amp;author=T.%20Tervonen" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref75"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib76" id="ref-id-bib76" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Montibeller and Winterfeldt, 2015</span></span></a></span><span class="reference" id="sref76"><div class="contribution"><div class="authors u-font-sans">G. Montibeller, D. Winterfeldt</div><div id="ref-id-sref76" class="title text-m">Cognitive and motivational biases in decision and risk analysis</div></div><div class="host u-font-sans">Risk Anal.: Int. J., 35 (2015), pp. 1230-1251</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1111/risa.12360" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref76"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84938200812&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref76"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Cognitive%20and%20motivational%20biases%20in%20decision%20and%20risk%20analysis&amp;publication_year=2015&amp;author=G.%20Montibeller&amp;author=D.%20Winterfeldt" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref76"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib77" id="ref-id-bib77" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Morton, 2017</span></span></a></span><span class="reference" id="sref77"><div class="contribution"><div class="authors u-font-sans">A. Morton</div><div id="ref-id-sref77" class="title text-m">Treacle and smallpox: two tests for multicriteria decision analysis models in health technology assessment</div></div><div class="host u-font-sans">Value Health, 20 (2017), pp. 512-515</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S1098301516340529/pdfft?md5=bbae12d8ac21054ce9e11dffc2e56871&amp;pid=1-s2.0-S1098301516340529-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref77"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S1098301516340529" aria-describedby="ref-id-sref77"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-85008233369&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref77"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Treacle%20and%20smallpox%3A%20two%20tests%20for%20multicriteria%20decision%20analysis%20models%20in%20health%20technology%20assessment&amp;publication_year=2017&amp;author=A.%20Morton" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref77"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib78" id="ref-id-bib78" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Nadler et al., 2006</span></span></a></span><span class="reference" id="sref78"><div class="contribution"><div class="authors u-font-sans">E. Nadler, B. Eckert, P.J. Neumann</div><div id="ref-id-sref78" class="title text-m">Do oncologists believe new cancer drugs offer good value?</div></div><div class="host u-font-sans">The Oncologist, 11 (2006), pp. 90-95</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1634/theoncologist.11-2-90" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref78"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-32944472716&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref78"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Do%20oncologists%20believe%20new%20cancer%20drugs%20offer%20good%20value&amp;publication_year=2006&amp;author=E.%20Nadler&amp;author=B.%20Eckert&amp;author=P.J.%20Neumann" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref78"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib79" id="ref-id-bib79" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">NICE, 2012a</span></span></a></span><span class="reference" id="sref79"><div class="contribution"><div class="authors u-font-sans">NICE</div><div id="ref-id-sref79" class="title text-m">Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen</div></div><div class="host u-font-sans">Technology Appraisal Guidance, vol. 259, National Institute for Health and Care Excellence (2012)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Abiraterone%20for%20castration-resistant%20metastatic%20prostate%20cancer%20previously%20treated%20with%20a%20docetaxel-containing%20regimen&amp;publication_year=2012&amp;author=NICE" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref79"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib80" id="ref-id-bib80" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">NICE, 2012b</span></span></a></span><span class="reference" id="sref80"><div class="contribution"><div class="authors u-font-sans">NICE</div><div id="ref-id-sref80" class="title text-m">Cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen</div></div><div class="host u-font-sans">Technology Appraisal Guidance, vol. 255, National Institute for Health and Care Excellence (2012)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Cabazitaxel%20for%20hormone-refractory%20metastatic%20prostate%20cancer%20previously%20treated%20with%20a%20docetaxel-containing%20regimen&amp;publication_year=2012&amp;author=NICE" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref80"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib81" id="ref-id-bib81" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">NICE, 2014</span></span></a></span><span class="reference" id="sref81"><div class="contribution"><div class="authors u-font-sans">NICE</div><div id="ref-id-sref81" class="title text-m">Enzalutamide for metastatic hormone-relapsed prostate cancer previously treated with a docetaxel - containing regimen</div></div><div class="host u-font-sans">Technology Appraisal Guidance, vol. 316, National Institute for Health and Care Excellence (2014)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Enzalutamide%20for%20metastatic%20hormone-relapsed%20prostate%20cancer%20previously%20treated%20with%20a%20docetaxel%20-%20containing%20regimen&amp;publication_year=2014&amp;author=NICE" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref81"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib82" id="ref-id-bib82" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Nicod and Kanavos, 2012</span></span></a></span><span class="reference" id="sref82"><div class="contribution"><div class="authors u-font-sans">E. Nicod, P. Kanavos</div><div id="ref-id-sref82" class="title text-m">Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions</div></div><div class="host u-font-sans">Health Policy, 108 (2012), pp. 167-177</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S016885101200276X/pdfft?md5=a5d870ed55807d624b16b7bbf9cb28e4&amp;pid=1-s2.0-S016885101200276X-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref82"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S016885101200276X" aria-describedby="ref-id-sref82"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84870059526&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref82"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Commonalities%20and%20differences%20in%20HTA%20outcomes%3A%20a%20comparative%20analysis%20of%20five%20countries%20and%20implications%20for%20coverage%20decisions&amp;publication_year=2012&amp;author=E.%20Nicod&amp;author=P.%20Kanavos" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref82"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib83" id="ref-id-bib83" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">NIH, 2016</span></span></a></span><span class="reference" id="sref83"><div class="contribution"><div class="authors u-font-sans">NIH</div><div id="ref-id-sref83" class="title text-m">ClinicalTrials.gov</div></div><div class="host u-font-sans">US National Institutes of Health (2016)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=ClinicalTrials.gov&amp;publication_year=2016&amp;author=NIH" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref83"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib84" id="ref-id-bib84" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Nord et al., 2009</span></span></a></span><span class="reference" id="sref84"><div class="contribution"><div class="authors u-font-sans">E. Nord, N. Daniels, M. Kamlet</div><div id="ref-id-sref84" class="title text-m">QALYs: some challenges</div></div><div class="host u-font-sans">Value Health, 12 (2009), pp. S10-S15</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S1098301510600472/pdfft?md5=d50130ad0c6e10e897f6febae49a1a72&amp;pid=1-s2.0-S1098301510600472-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref84"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S1098301510600472" aria-describedby="ref-id-sref84"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://doi.org/10.1111/j.1524-4733.2009.00516.x" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref84"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-61349157877&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref84"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=QALYs%3A%20some%20challenges&amp;publication_year=2009&amp;author=E.%20Nord&amp;author=N.%20Daniels&amp;author=M.%20Kamlet" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref84"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib85" id="ref-id-bib85" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Obwieszczenie, 2017</span></span></a></span><span class="reference" id="sref85"><div class="contribution"><div class="authors u-font-sans">M. Obwieszczenie</div><div id="ref-id-sref85" class="title text-m">Obwieszczenie Ministra Zdrowia Z Dnia 25 Października 2017 R. W Sprawie Wykazu Refundowanych Leków, Środków Spożywczych Specjalnego Przeznaczenia Żywieniowego Oraz Wyrobów Medycznych (DZ. URZ. Min. Zdr. 2017.105)</div></div><div class="host u-font-sans"> (2017)</div><div class="host u-font-sans"><a class="anchor anchor-primary" href="http://www.bip.mz.gov.pl/legislacja/akty-prawne-1/obwieszczenie-ministra-zdrowia-z-dnia-25-pazdziernika-2017-r-w-sprawie-wykazu-refundowanych-lekow-srodkow-spozywczych-specjalnego-przeznaczenia-zywieniowego-oraz-wyrobow-medycznych-na-1-listopada-20/" target="_blank"><span class="anchor-text-container"><span class="anchor-text">http://www.bip.mz.gov.pl/legislacja/akty-prawne-1/obwieszczenie-ministra-zdrowia-z-dnia-25-pazdziernika-2017-r-w-sprawie-wykazu-refundowanych-lekow-srodkow-spozywczych-specjalnego-przeznaczenia-zywieniowego-oraz-wyrobow-medycznych-na-1-listopada-20/</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Obwieszczenie%20Ministra%20Zdrowia%20Z%20Dnia%2025%20Pa%C5%BAdziernika%202017%20R.%20W%20Sprawie%20Wykazu%20Refundowanych%20Lek%C3%B3w%2C%20%C5%9Arodk%C3%B3w%20Spo%C5%BCywczych%20Specjalnego%20Przeznaczenia%20%C5%BBywieniowego%20Oraz%20Wyrob%C3%B3w%20Medycznych%20&amp;publication_year=2017&amp;author=M.%20Obwieszczenie" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref85"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib86" id="ref-id-bib86" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Peacock et al., 2007</span></span></a></span><span class="reference" id="sref86"><div class="contribution"><div class="authors u-font-sans">S.J. Peacock, J.R.J. Richardson, R. Carter, D. Edwards</div><div id="ref-id-sref86" class="title text-m">Priority setting in health care using multi- attribute utility theory and programme budgeting and marginal analysis ( PBMA)</div></div><div class="host u-font-sans">Soc. Sci. Med., 64 (2007), pp. 897-910</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0277953606005041/pdfft?md5=f2b6611e49f353e6f36fb89229b7742a&amp;pid=1-s2.0-S0277953606005041-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref86"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0277953606005041" aria-describedby="ref-id-sref86"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-33846178298&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref86"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Priority%20setting%20in%20health%20care%20using%20multi-%20attribute%20utility%20theory%20and%20programme%20budgeting%20and%20marginal%20analysis%20&amp;publication_year=2007&amp;author=S.J.%20Peacock&amp;author=J.R.J.%20Richardson&amp;author=R.%20Carter&amp;author=D.%20Edwards" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref86"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib87" id="ref-id-bib87" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Phelps and Madhavan, 2018</span></span></a></span><span class="reference" id="sref87"><div class="contribution"><div class="authors u-font-sans">C. Phelps, G. Madhavan</div><div id="ref-id-sref87" class="title text-m">Resource allocation in decision support frameworks</div></div><div class="host u-font-sans">Cost Eff. Resour. Allocation, 16 (2018)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Resource%20allocation%20in%20decision%20support%20frameworks&amp;publication_year=2018&amp;author=C.%20Phelps&amp;author=G.%20Madhavan" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref87"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib88" id="ref-id-bib88" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Phillips, 1984</span></span></a></span><span class="reference" id="sref88"><div class="contribution"><div class="authors u-font-sans">L. Phillips</div><div id="ref-id-sref88" class="title text-m">A theory of requisite decision models</div></div><div class="host u-font-sans">Acta Psychol., 56 (1984), pp. 29-48</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/0001691884900052/pdf?md5=44f6c27632e8e84fbc8addfb10a8fdbf&amp;pid=1-s2.0-0001691884900052-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref88"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/0001691884900052" aria-describedby="ref-id-sref88"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-0003050647&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref88"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=A%20theory%20of%20requisite%20decision%20models&amp;publication_year=1984&amp;author=L.%20Phillips" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref88"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib89" id="ref-id-bib89" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Phillips, 2007</span></span></a></span><span class="reference" id="sref89"><div class="contribution"><div class="authors u-font-sans">L. Phillips</div><div id="ref-id-sref89" class="title text-m">Decision conferencing</div></div><div class="host u-font-sans">W. Edwards, R. Miles, D. von Winterfeldt (Eds.), Advances in Decision Analysis: from Foundations to Applications, Cambridge University Press, Cambridge (2007)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Decision%20conferencing&amp;publication_year=2007&amp;author=L.%20Phillips" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref89"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib90" id="ref-id-bib90" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Phillips and Phillips, 1993</span></span></a></span><span class="reference" id="sref90"><div class="contribution"><div class="authors u-font-sans">L. Phillips, M. Phillips</div><div id="ref-id-sref90" class="title text-m">Facilitated work groups: theory and practice</div></div><div class="host u-font-sans">J. Oper. Res. Soc., 44 (1993)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Facilitated%20work%20groups%3A%20theory%20and%20practice&amp;publication_year=1993&amp;author=L.%20Phillips&amp;author=M.%20Phillips" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref90"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib91" id="ref-id-bib91" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Phillips, 2017</span></span></a></span><span class="reference" id="sref91"><div class="contribution"><div class="authors u-font-sans">L.D. Phillips</div><div id="ref-id-sref91" class="title text-m">Best practice for MCDA in healthcare</div></div><div class="host u-font-sans">K. Marsh, M. Goetghebeur, P. Thokala, R. Baltussen (Eds.), Multi-Criteria Decision Analysis to Support Healthcare Decisions, Springer (2017)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Best%20practice%20for%20MCDA%20in%20healthcare&amp;publication_year=2017&amp;author=L.D.%20Phillips" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref91"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib92" id="ref-id-bib92" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Phillips and Bana e Costa, 2007</span></span></a></span><span class="reference" id="sref92"><div class="contribution"><div class="authors u-font-sans">L.D. Phillips, C.A. Bana e Costa</div><div id="ref-id-sref92" class="title text-m">Transparent prioritisation, budgeting and resource allocation with multi-criteria decision analysis and decision conferencing</div></div><div class="host u-font-sans">Ann. Oper. Res., 154 (2007), pp. 51-68</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1007/s10479-007-0183-3" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref92"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-34547279499&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref92"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Transparent%20prioritisation%2C%20budgeting%20and%20resource%20allocation%20with%20multi-criteria%20decision%20analysis%20and%20decision%20conferencing&amp;publication_year=2007&amp;author=L.D.%20Phillips&amp;author=C.A.%20Bana%20e%20Costa" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref92"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib93" id="ref-id-bib93" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Radaelli et al., 2014</span></span></a></span><span class="reference" id="sref93"><div class="contribution"><div class="authors u-font-sans">G. Radaelli, E. Lettieri, C. Masella, L. Merlino, A. Strada, M. Tringali</div><div id="ref-id-sref93" class="title text-m">Implementation of EUnetHTA core Model® in Lombardia: the VTS framework</div></div><div class="host u-font-sans">Int. J. Technol. Assess. Health Care, 30 (2014), pp. 105-112</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84902121091&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref93"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Implementation%20of%20EUnetHTA%20core%20Model%20in%20Lombardia%3A%20the%20VTS%20framework&amp;publication_year=2014&amp;author=G.%20Radaelli&amp;author=E.%20Lettieri&amp;author=C.%20Masella&amp;author=L.%20Merlino&amp;author=A.%20Strada&amp;author=M.%20Tringali" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref93"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib94" id="ref-id-bib94" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Riemsa et al., 2013</span></span></a></span><span class="reference" id="sref94"><div class="contribution"><div class="authors u-font-sans">R. Riemsa, B. Ramaekers, F. Tomini, R. Wolff, A. van Asselt, M. Joore, <em> et al.</em></div><div id="ref-id-sref94" class="title text-m">Abiraterone for the Treatment of Chemotherapy Naïve Metastatic Castration-Resistant Prostate Cancer: a Single Technology Appraisal</div></div><div class="host u-font-sans">Kleijnen Systematic Reviews Ltd (2013)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Abiraterone%20for%20the%20Treatment%20of%20Chemotherapy%20Na%C3%AFve%20Metastatic%20Castration-Resistant%20Prostate%20Cancer%3A%20a%20Single%20Technology%20Appraisal&amp;publication_year=2013&amp;author=R.%20Riemsa&amp;author=B.%20Ramaekers&amp;author=F.%20Tomini&amp;author=R.%20Wolff&amp;author=A.%20van%20Asselt&amp;author=M.%20Joore" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref94"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib95" id="ref-id-bib95" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Rodrigues et al., 2017</span></span></a></span><span class="reference" id="sref95"><div class="contribution"><div class="authors u-font-sans">T.C. Rodrigues, G. Montibeller, M.D. Oliveira, C.A. Bana E Costa</div><div id="ref-id-sref95" class="title text-m">Modelling multicriteria value interactions with Reasoning Maps</div></div><div class="host u-font-sans">Eur. J. Oper. Res., 258 (2017), pp. 1054-1071</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0377221716307998/pdfft?md5=6b90a2691caa796cb6237a5c2c9863ea&amp;pid=1-s2.0-S0377221716307998-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref95"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0377221716307998" aria-describedby="ref-id-sref95"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-85006277050&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref95"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Modelling%20multicriteria%20value%20interactions%20with%20Reasoning%20Maps&amp;publication_year=2017&amp;author=T.C.%20Rodrigues&amp;author=G.%20Montibeller&amp;author=M.D.%20Oliveira&amp;author=C.A.%20Bana%20E%20Costa" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref95"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib96" id="ref-id-bib96" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Schein, 1999</span></span></a></span><span class="reference" id="sref96"><div class="contribution"><div class="authors u-font-sans">E. Schein</div><div id="ref-id-sref96" class="title text-m">Process Consultation Revisited: Building the Helping Relationship</div></div><div class="host u-font-sans">Addison–Wesley, Reading (1999)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Process%20Consultation%20Revisited%3A%20Building%20the%20Helping%20Relationship&amp;publication_year=1999&amp;author=E.%20Schein" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref96"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib97" id="ref-id-bib97" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Scher et al., 2012</span></span></a></span><span class="reference" id="sref97"><div class="contribution"><div class="authors u-font-sans">H.I. Scher, K. Fizazi, F. Saad, M.-E. Taplin, C.N. Sternberg, K. Miller, <em> et al.</em></div><div id="ref-id-sref97" class="title text-m">Increased survival with enzalutamide in prostate cancer after chemotherapy</div></div><div class="host u-font-sans">N. Engl. J. Med., 367 (2012), pp. 1187-1197</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1056/NEJMoa1207506" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref97"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84866770294&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref97"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Increased%20survival%20with%20enzalutamide%20in%20prostate%20cancer%20after%20chemotherapy&amp;publication_year=2012&amp;author=H.I.%20Scher&amp;author=K.%20Fizazi&amp;author=F.%20Saad&amp;author=M.-E.%20Taplin&amp;author=C.N.%20Sternberg&amp;author=K.%20Miller" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref97"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib98" id="ref-id-bib98" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Schnipper et al., 2015</span></span></a></span><span class="reference" id="sref98"><div class="contribution"><div class="authors u-font-sans">L.E. Schnipper, N.E. Davidson, D.S. Wollins, C. Tyne, D.W. Blayney, D. Blum, <em> et al.</em></div><div id="ref-id-sref98" class="title text-m">American society of clinical oncology statement: a conceptual framework to assess the value of cancer treatment options</div></div><div class="host u-font-sans">J. Clin. Oncol.: Offic. J. Am. Soc. Clin. Oncol., 33 (2015), pp. 2563-2577</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84939251874&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref98"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=American%20society%20of%20clinical%20oncology%20statement%3A%20a%20conceptual%20framework%20to%20assess%20the%20value%20of%20cancer%20treatment%20options&amp;publication_year=2015&amp;author=L.E.%20Schnipper&amp;author=N.E.%20Davidson&amp;author=D.S.%20Wollins&amp;author=C.%20Tyne&amp;author=D.W.%20Blayney&amp;author=D.%20Blum" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref98"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib99" id="ref-id-bib99" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Sculpher et al., 2017</span></span></a></span><span class="reference" id="sref99"><div class="contribution"><div class="authors u-font-sans">M. Sculpher, K. Claxton, S.D. Pearson</div><div id="ref-id-sref99" class="title text-m">Developing a value framework: the need to reflect the opportunity costs of funding decisions</div></div><div class="host u-font-sans">Value Health, 20 (2017), pp. 234-239</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S1098301516341304/pdfft?md5=7df6783ebdf831949dd6e14434449e89&amp;pid=1-s2.0-S1098301516341304-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref99"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S1098301516341304" aria-describedby="ref-id-sref99"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-85013639249&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref99"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Developing%20a%20value%20framework%3A%20the%20need%20to%20reflect%20the%20opportunity%20costs%20of%20funding%20decisions&amp;publication_year=2017&amp;author=M.%20Sculpher&amp;author=K.%20Claxton&amp;author=S.D.%20Pearson" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref99"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib100" id="ref-id-bib100" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Shih et al., 2013</span></span></a></span><span class="reference" id="sref100"><div class="contribution"><div class="authors u-font-sans">Y.C.T. Shih, P.A. Ganz, D. Aberle, A. Abernethy, J. Bekelman, O. Brawley, <em> et al.</em></div><div id="ref-id-sref100" class="title text-m">Delivering high-quality and affordable care throughout the cancer care continuum</div></div><div class="host u-font-sans">J. Clin. Oncol., 31 (2013), pp. 4151-4157</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84891686782&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref100"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Delivering%20high-quality%20and%20affordable%20care%20throughout%20the%20cancer%20care%20continuum&amp;publication_year=2013&amp;author=Y.C.T.%20Shih&amp;author=P.A.%20Ganz&amp;author=D.%20Aberle&amp;author=A.%20Abernethy&amp;author=J.%20Bekelman&amp;author=O.%20Brawley" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref100"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib101" id="ref-id-bib101" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Sullivan et al., 2007</span></span></a></span><span class="reference" id="sref101"><div class="contribution"><div class="authors u-font-sans">P. Sullivan, P. Mulani, M. Fishman, D. Sleep</div><div id="ref-id-sref101" class="title text-m">Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer</div></div><div class="host u-font-sans">Int. J. Qual. Life Asp. Treat. Care Rehabilit. Offic. J. Int. Soc. Qual. Life Res., 16 (2007), pp. 571-575</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1007/s11136-006-9156-2" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref101"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-33947519066&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref101"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Quality%20of%20life%20findings%20from%20a%20multicenter%2C%20multinational%2C%20observational%20study%20of%20patients%20with%20metastatic%20hormone-refractory%20prostate%20cancer&amp;publication_year=2007&amp;author=P.%20Sullivan&amp;author=P.%20Mulani&amp;author=M.%20Fishman&amp;author=D.%20Sleep" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref101"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib102" id="ref-id-bib102" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Sulmasy and Moy, 2014</span></span></a></span><span class="reference" id="sref102"><div class="contribution"><div class="authors u-font-sans">D. Sulmasy, B. Moy</div><div id="ref-id-sref102" class="title text-m">Debating the oncologist's role in defining the value of cancer care: our duty is to our patients</div></div><div class="host u-font-sans">J. Clin. Oncol., 32 (2014), pp. 4039-4041</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84919769081&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref102"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Debating%20the%20oncologists%20role%20in%20defining%20the%20value%20of%20cancer%20care%3A%20our%20duty%20is%20to%20our%20patients&amp;publication_year=2014&amp;author=D.%20Sulmasy&amp;author=B.%20Moy" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref102"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib103" id="ref-id-bib103" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Sussex et al., 2013</span></span></a></span><span class="reference" id="sref103"><div class="contribution"><div class="authors u-font-sans">J. Sussex, P. Rollet, M. Garau, C. Schmitt, A. Kent, A. Hutchings</div><div id="ref-id-sref103" class="title text-m">A pilot study of multicriteria decision analysis for valuing orphan medicines</div></div><div class="host u-font-sans">Value Health, 16 (2013), pp. 1163-1169</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S1098301513043568/pdfft?md5=ddd171ebfd4e04c29e6c11140c7bfe09&amp;pid=1-s2.0-S1098301513043568-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref103"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S1098301513043568" aria-describedby="ref-id-sref103"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84890312186&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref103"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=A%20pilot%20study%20of%20multicriteria%20decision%20analysis%20for%20valuing%20orphan%20medicines&amp;publication_year=2013&amp;author=J.%20Sussex&amp;author=P.%20Rollet&amp;author=M.%20Garau&amp;author=C.%20Schmitt&amp;author=A.%20Kent&amp;author=A.%20Hutchings" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref103"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib105" id="ref-id-bib105" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Tannock et al., 2004</span></span></a></span><span class="reference" id="sref105"><div class="contribution"><div class="authors u-font-sans">I.F. Tannock, R. de Wit, W.R. Berry, J. Horti, A. Pluzanska, K.N. Chi, <em> et al.</em></div><div id="ref-id-sref105" class="title text-m">Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer</div></div><div class="host u-font-sans">N. Engl. J. Med., 351 (2004), pp. 1502-1512</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-4744366279&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref105"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Docetaxel%20plus%20prednisone%20or%20mitoxantrone%20plus%20prednisone%20for%20advanced%20prostate%20cancer&amp;publication_year=2004&amp;author=I.F.%20Tannock&amp;author=R.%20de%20Wit&amp;author=W.R.%20Berry&amp;author=J.%20Horti&amp;author=A.%20Pluzanska&amp;author=K.N.%20Chi" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref105"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib106" id="ref-id-bib106" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Tervonen et al., 2015</span></span></a></span><span class="reference" id="sref106"><div class="contribution"><div class="authors u-font-sans">T. Tervonen, H. Naci, G. van Valkenhoef, A.E. Ades, A. Angelis, H.L. Hillege, <em> et al.</em></div><div id="ref-id-sref106" class="title text-m">Applying multiple criteria decision analysis to comparative benefit-risk assessment: choosing among statins in primary prevention</div></div><div class="host u-font-sans">Med. Decis. Mak., 35 (2015), pp. 859-871</div><div class="comment">An International Journal of the Society for Medical Decision Making</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84941756692&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref106"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Applying%20multiple%20criteria%20decision%20analysis%20to%20comparative%20benefit-risk%20assessment%3A%20choosing%20among%20statins%20in%20primary%20prevention&amp;publication_year=2015&amp;author=T.%20Tervonen&amp;author=H.%20Naci&amp;author=G.%20van%20Valkenhoef&amp;author=A.E.%20Ades&amp;author=A.%20Angelis&amp;author=H.L.%20Hillege" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref106"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib107" id="ref-id-bib107" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Thokala, 2011</span></span></a></span><span class="reference" id="sref107"><div class="contribution"><div class="authors u-font-sans">P. Thokala</div><div id="ref-id-sref107" class="title text-m">Multi Criteria Decision Analysis for Health Technology Assessment: Report by the Decision Support Unit</div></div><div class="host u-font-sans">University of Shefﬁeld, Sheffield (2011)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Multi%20Criteria%20Decision%20Analysis%20for%20Health%20Technology%20Assessment%3A%20Report%20by%20the%20Decision%20Support%20Unit&amp;publication_year=2011&amp;author=P.%20Thokala" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref107"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib108" id="ref-id-bib108" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">TLV, 2014</span></span></a></span><span class="reference" id="sref108"><div class="contribution"><div class="authors u-font-sans">TLV</div><div id="ref-id-sref108" class="title text-m">Designation 2775/2013. Tandvårds- Och Läkemedelsförmånsverket</div></div><div class="host u-font-sans"> (2014)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Designation%2027752013.%20Tandv%C3%A5rds-%20Och%20L%C3%A4kemedelsf%C3%B6rm%C3%A5nsverket&amp;publication_year=2014&amp;author=TLV" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref108"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib109" id="ref-id-bib109" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">TLV, 2015a</span></span></a></span><span class="reference" id="sref109"><div class="contribution"><div class="authors u-font-sans">TLV</div><div id="ref-id-sref109" class="title text-m">Designation 4774/2014. Tandvårds- Och Läkemedelsförmånsverket</div></div><div class="host u-font-sans"> (2015)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Designation%2047742014.%20Tandv%C3%A5rds-%20Och%20L%C3%A4kemedelsf%C3%B6rm%C3%A5nsverket&amp;publication_year=2015&amp;author=TLV" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref109"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib110" id="ref-id-bib110" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">TLV, 2015b</span></span></a></span><span class="reference" id="sref110"><div class="contribution"><div class="authors u-font-sans">TLV</div><div id="ref-id-sref110" class="title text-m">Designation 4852/2014. Tandvårds- Och Läkemedelsförmånsverket</div></div><div class="host u-font-sans"> (2015)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Designation%2048522014.%20Tandv%C3%A5rds-%20Och%20L%C3%A4kemedelsf%C3%B6rm%C3%A5nsverket&amp;publication_year=2015&amp;author=TLV" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref110"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib111" id="ref-id-bib111" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Tony et al., 2011</span></span></a></span><span class="reference" id="sref111"><div class="contribution"><div class="authors u-font-sans">M. Tony, M. Wagner, H. Khoury, D. Rindress, T. Papastavros, P. Oh, <em> et al.</em></div><div id="ref-id-sref111" class="title text-m">Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada</div></div><div class="host u-font-sans">BMC Health Serv. Res., 11 (2011), p. 329</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-82255167655&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref111"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Bridging%20health%20technology%20assessment%20%20with%20multicriteria%20decision%20analyses%20%3A%20field%20testing%20of%20the%20EVIDEM%20framework%20for%20coverage%20decisions%20by%20a%20public%20payer%20in%20Canada&amp;publication_year=2011&amp;author=M.%20Tony&amp;author=M.%20Wagner&amp;author=H.%20Khoury&amp;author=D.%20Rindress&amp;author=T.%20Papastavros&amp;author=P.%20Oh" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref111"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib112" id="ref-id-bib112" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Torre, 2015</span></span></a></span><span class="reference" id="sref112"><div class="contribution"><div class="authors u-font-sans">L.A. Torre</div><div id="ref-id-sref112" class="title text-m">Global cancer statistics, 2012</div></div><div class="host u-font-sans">CA A Cancer J. Clin., 65 (2015), p. 87</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.3322/caac.21262" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref112"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Global%20cancer%20statistics%2C%202012&amp;publication_year=2015&amp;author=L.A.%20Torre" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref112"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib113" id="ref-id-bib113" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">van Valkenhoef et al., 2012</span></span></a></span><span class="reference" id="sref113"><div class="contribution"><div class="authors u-font-sans">G. van Valkenhoef, T. Tervonen, J. Zhao, B. de Brock, H.L. Hillege, D. Postmus</div><div id="ref-id-sref113" class="title text-m">Multicriteria benefit-risk assessment using network meta-analysis</div></div><div class="host u-font-sans">J. Clin. Epidemiol., 65 (2012), pp. 394-403</div><div class="ReferenceLinks u-font-sans"><a class="anchor pdf link anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S0895435611002812/pdfft?md5=f8fe731b7f10771a16350a8a0cd0773b&amp;pid=1-s2.0-S0895435611002812-main.pdf" target="_blank" rel="nofollow" aria-describedby="ref-id-sref113"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a><a class="anchor link anchor-primary" href="/science/article/pii/S0895435611002812" aria-describedby="ref-id-sref113"><span class="anchor-text-container"><span class="anchor-text">View article</span></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84857646328&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref113"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Multicriteria%20benefit-risk%20assessment%20using%20network%20meta-analysis&amp;publication_year=2012&amp;author=G.%20van%20Valkenhoef&amp;author=T.%20Tervonen&amp;author=J.%20Zhao&amp;author=B.%20de%20Brock&amp;author=H.L.%20Hillege&amp;author=D.%20Postmus" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref113"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib114" id="ref-id-bib114" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">von Winterfeldt and Edwards, 1986</span></span></a></span><span class="reference" id="sref114"><div class="contribution"><div class="authors u-font-sans">D. von Winterfeldt, W. Edwards</div><div id="ref-id-sref114" class="title text-m">Decision Analysis and Behavioral Research</div></div><div class="host u-font-sans">Cambridge University Press, Cambridge (1986)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Decision%20Analysis%20and%20Behavioral%20Research&amp;publication_year=1986&amp;author=D.%20von%20Winterfeldt&amp;author=W.%20Edwards" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref114"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib115" id="ref-id-bib115" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Wagner et al., 2017</span></span></a></span><span class="reference" id="sref115"><div class="contribution"><div class="authors u-font-sans">M. Wagner, H. Khoury, L. Bennetts, P. Berto, J. Ehreth, X. Badia, <em> et al.</em></div><div id="ref-id-sref115" class="title text-m">Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: a multi-country study applying pragmatic MCDA</div></div><div class="host u-font-sans">BMC Canc., 17 (2017)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=Appraising%20the%20holistic%20value%20of%20Lenvatinib%20for%20radio-iodine%20refractory%20differentiated%20thyroid%20cancer%3A%20a%20multi-country%20study%20applying%20pragmatic%20MCDA&amp;publication_year=2017&amp;author=M.%20Wagner&amp;author=H.%20Khoury&amp;author=L.%20Bennetts&amp;author=P.%20Berto&amp;author=J.%20Ehreth&amp;author=X.%20Badia" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref115"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib116" id="ref-id-bib116" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">World Health Organisation Collaborating Centre, 2016</span></span></a></span><span class="reference" id="sref116"><div class="contribution"><div class="authors u-font-sans">World Health Organisation Collaborating Centre</div><div id="ref-id-sref116" class="title text-m">ATC/DDD Index 2016</div></div><div class="host u-font-sans">World Health Organisation Collaborating Centre (2016)</div><div class="ReferenceLinks u-font-sans"><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=ATCDDD%20Index%202016&amp;publication_year=2016&amp;author=World%20Health%20Organisation%20Collaborating%20Centre" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref116"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li><li><span class="label u-font-sans"><a class="anchor anchor-primary" href="#bbib117" id="ref-id-bib117" data-aa-button="sd:product:journal:article:location=references:type=anchor:name=citation-name"><span class="anchor-text-container"><span class="anchor-text">Wouters et al., 2015</span></span></a></span><span class="reference" id="sref117"><div class="contribution"><div class="authors u-font-sans">O.J. Wouters, H. Naci, N.J. Samani</div><div id="ref-id-sref117" class="title text-m">QALYs in cost-effectiveness analysis: an overview for cardiologists</div></div><div class="host u-font-sans">Heart (British Cardiac Society), 101 (2015), pp. 1868-1873</div><div class="ReferenceLinks u-font-sans"><span class="link lazy-third-party-pdf-link"><span></span></span><a class="anchor link anchor-primary" href="https://doi.org/10.1136/heartjnl-2015-308255" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref117"><span class="anchor-text-container"><span class="anchor-text">Crossref</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://www.scopus.com/inward/record.url?eid=2-s2.0-84948714642&amp;partnerID=10&amp;rel=R3.0.0" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref117"><span class="anchor-text-container"><span class="anchor-text">View in Scopus</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a><a class="anchor link anchor-primary" href="https://scholar.google.com/scholar_lookup?title=QALYs%20in%20cost-effectiveness%20analysis%3A%20an%20overview%20for%20cardiologists&amp;publication_year=2015&amp;author=O.J.%20Wouters&amp;author=H.%20Naci&amp;author=N.J.%20Samani" target="_blank" rel="noopener noreferrer" aria-describedby="ref-id-sref117"><span class="anchor-text-container"><span class="anchor-text">Google Scholar</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></span></li></ol></section></section></div><div id="section-cited-by"><section aria-label="Cited by" class="ListArticles preview"><div class="PageDivider"></div><header id="citing-articles-header"><h2 class="u-h4 u-margin-l-ver u-font-serif">Cited by (43)</h2></header><div aria-describedby="citing-articles-header"><div class="citing-articles u-margin-l-bottom"><ul><li class="ListArticleItem u-margin-l-bottom"><div class="sub-heading u-margin-xs-bottom"><h3 class="u-font-serif" id="citing-articles-article-0-title"><a class="anchor anchor-primary" href="/science/article/pii/S1098301522047386"><span class="anchor-text-container"><span class="anchor-text">The Use of Multicriteria Decision Analysis to Support Decision Making in Healthcare: An Updated Systematic Literature Review</span></span></a></h3><div>2023, Value in Health</div></div><div class="buttons"><button class="button-link button-link-primary button-link-icon-right" type="button" data-aa-button="sd:product:journal:article:location=citing-articles:type=view-details" aria-describedby="citing-articles-article-0-title" aria-controls="citing-articles-article-0" aria-expanded="false"><span class="button-link-text-container"><span class="button-link-text">Show abstract</span></span><svg focusable="false" viewBox="0 0 92 128" height="20" class="icon icon-navigate-down"><path d="M1 51l7-7 38 38 38-38 7 7-45 45z"></path></svg></button></div><div class="u-display-none" aria-hidden="true"><div class="abstract u-margin-xs-top u-margin-m-bottom u-font-serif" id="reference-abstract"><div class="u-margin-ver-m"><div class="u-margin-s-bottom" id="abspara0010">Multicriteria decision analysis (MCDA) is increasingly used for decision making in healthcare. However, its application in different decision-making contexts is still unclear. This study aimed to&nbsp;provide a comprehensive review of MCDA studies performed to inform decisions in healthcare and to summarize its application in different decision contexts.</div><div class="u-margin-s-bottom" id="abspara0020">We updated a systematic review conducted in 2013 by searching Embase, MEDLINE, and Google Scholar for MCDA studies in healthcare, published in English between August 2013 and November 2020. We also expanded the search by reviewing grey literature found via Trip Medical Database and Google, published between January 1990 and November 2020. A comprehensive template was developed to extract information about the decision context, criteria, methods, stakeholders involved, and sensitivity analyses conducted.</div><div class="u-margin-s-bottom" id="abspara0025">From the 4295 identified studies, 473 studies were eligible for full-text review after assessing titles and abstracts. Of those, 228 studies met the inclusion criteria and underwent data extraction. The use of MCDA continues to grow in healthcare literature, with most of the studies (49%) informing priority-setting decisions. Safety, cost, and quality of care delivery are the most frequently used criteria, although there are considerable differences across decision contexts. Almost half of the MCDA studies used the linear additive model whereas scales and the analytical hierarchy process were the most used techniques for scoring and weighting, respectively. Not all studies report on each one of the MCDA steps, consider axiomatic properties, or justify the methods used.</div><div class="u-margin-s-bottom" id="abspara0030">A guide on how to conduct and report MCDA that acknowledges the particularities of the different decision contexts and methods needs to be developed.</div></div></div></div></li><li class="ListArticleItem u-margin-l-bottom"><div class="sub-heading u-margin-xs-bottom"><h3 class="u-font-serif" id="citing-articles-article-1-title"><a class="anchor anchor-primary" href="/science/article/pii/S037722172200426X"><span class="anchor-text-container"><span class="anchor-text">Collaborative development of composite indices from qualitative value judgements: The EURO-HEALTHY Population Health Index model</span></span></a></h3><div>2023, European Journal of Operational Research</div></div><div class="buttons"><button class="button-link button-link-primary button-link-icon-right" type="button" data-aa-button="sd:product:journal:article:location=citing-articles:type=view-details" aria-describedby="citing-articles-article-1-title" aria-controls="citing-articles-article-1" aria-expanded="false"><span class="button-link-text-container"><span class="button-link-text">Show abstract</span></span><svg focusable="false" viewBox="0 0 92 128" height="20" class="icon icon-navigate-down"><path d="M1 51l7-7 38 38 38-38 7 7-45 45z"></path></svg></button></div><div class="u-display-none" aria-hidden="true"><div class="abstract u-margin-xs-top u-margin-m-bottom u-font-serif" id="reference-abstract"><div class="u-margin-ver-m"><div class="u-margin-s-bottom" id="spara015">Promoting participation and combining evidence with expert knowledge in constructing composite indices that can be meaningfully interpreted are key open challenges identified in performance measurement literature. To address them, this article proposes a sociotechnical decision-aid process, under a collaborative value-modelling framework, rooted in both process consultation and multicriteria value measurement principles. It consists of two phases (structuring and model building), each one developed in a sequence of non-face-to-face (Web-Delphi) and face-to-face (decision conferencing) group processes, designed to allow for increased participation. Performance indicators are selected and structured in a value-tree (phase one), upon which a group hierarchical additive value-function model is built (phase two), supported by the MACBETH multicriteria decision-support system. Collaborative questioning protocols allow to elicit and reconcile individual qualitative value judgements, in a Web-Delphi platform. The collective knowledge thus acquired is used in decision conferencing with a core group to define value functions and weights. Extensive sensitivity and robustness analyses serve to test the requisiteness of the model, giving rise to a shared structure of composite indices. The proposed approach was shaped within the EURO-HEALTHY project, to create a Population Health Index intended to be a tool enabling policymakers to analyse population health and related inequalities at the regional level across the European Union, and design improvement policies. Many stakeholders and experts from different intervention and knowledge areas, and located across Europe, participated in the different modelling activities, as detailed in this article. Research paths derived from learnings acquired are suggested to further improve process effectiveness and flexibility.</div></div></div></div></li><li class="ListArticleItem u-margin-l-bottom"><div class="sub-heading u-margin-xs-bottom"><h3 class="u-font-serif" id="citing-articles-article-2-title"><a class="anchor anchor-primary" href="https://doi.org/10.1186/s13561-021-00342-y" target="_blank"><span class="anchor-text-container"><span class="anchor-text">How innovation can be defined, evaluated and rewarded in health technology assessment</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></h3><div>2022, Health Economics Review</div></div><div class="buttons"></div><div class="u-display-none" aria-hidden="true"><div class="abstract u-margin-xs-top u-margin-m-bottom u-font-serif" id="reference-abstract"></div></div></li><li class="ListArticleItem u-margin-l-bottom"><div class="sub-heading u-margin-xs-bottom"><h3 class="u-font-serif" id="citing-articles-article-3-title"><a class="anchor anchor-primary" href="https://doi.org/10.2217/cer-2020-0273" target="_blank"><span class="anchor-text-container"><span class="anchor-text">Evidence-based public policy making for medicines across countries: Findings and implications for the future</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></h3><div>2021, Journal of Comparative Effectiveness Research</div></div><div class="buttons"></div><div class="u-display-none" aria-hidden="true"><div class="abstract u-margin-xs-top u-margin-m-bottom u-font-serif" id="reference-abstract"></div></div></li><li class="ListArticleItem u-margin-l-bottom"><div class="sub-heading u-margin-xs-bottom"><h3 class="u-font-serif" id="citing-articles-article-4-title"><a class="anchor anchor-primary" href="https://doi.org/10.1080/14737167.2021.1884546" target="_blank"><span class="anchor-text-container"><span class="anchor-text">Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></h3><div>2021, Expert Review of Pharmacoeconomics and Outcomes Research</div></div><div class="buttons"></div><div class="u-display-none" aria-hidden="true"><div class="abstract u-margin-xs-top u-margin-m-bottom u-font-serif" id="reference-abstract"></div></div></li><li class="ListArticleItem u-margin-l-bottom"><div class="sub-heading u-margin-xs-bottom"><h3 class="u-font-serif" id="citing-articles-article-5-title"><a class="anchor anchor-primary" href="https://doi.org/10.1371/journal.pone.0240584" target="_blank"><span class="anchor-text-container"><span class="anchor-text">Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></h3><div>2020, Plos One</div></div><div class="buttons"></div><div class="u-display-none" aria-hidden="true"><div class="abstract u-margin-xs-top u-margin-m-bottom u-font-serif" id="reference-abstract"></div></div></li></ul><a class="button-alternative button-alternative-secondary large-alternative button-alternative-icon-left" href="http://www.scopus.com/scopus/inward/citedby.url?partnerID=10&amp;rel=3.0.0&amp;eid=2-s2.0-85076690323&amp;md5=edb95189a9c07d76a938b421888e49c4" target="_blank" id="citing-articles-view-all-btn"><svg focusable="false" viewBox="0 0 54 128" height="20" class="icon icon-navigate-right"><path d="M1 99l38-38L1 23l7-7 45 45-45 45z"></path></svg><span class="button-alternative-text-container"><span class="button-alternative-text">View all citing articles on Scopus</span></span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></a></div></div></section></div><div class="Copyright"><span class="copyright-line">© 2019 The Authors. Published by Elsevier Ltd.</span></div></article><div class="u-display-block-from-md col-lg-6 col-md-8 pad-right u-padding-s-top"><aside class="RelatedContent u-clr-grey8" aria-label="Related content"><section class="RelatedContentPanel u-margin-s-bottom"><header id="recommended-articles-header" class="related-content-panel-header u-margin-s-bottom"><button class="button-link button-link-secondary related-content-panel-toggle is-up button-link-icon-right button-link-has-colored-icon" type="button" aria-expanded="true" data-aa-button="sd:product:journal:article:location=recommended-articles:type=close"><span class="button-link-text-container"><span class="button-link-text"><h2 class="section-title u-h4"><span class="related-content-panel-title-text">Recommended articles</span></h2></span></span><svg focusable="false" viewBox="0 0 92 128" height="20" class="icon icon-navigate-down"><path d="M1 51l7-7 38 38 38-38 7 7-45 45z"></path></svg></button></header><div class="" aria-hidden="false" aria-describedby="recommended-articles-header"><div id="recommended-articles" class="text-xs"><ul><li class="RelatedContentPanelItem u-display-block"><div class="sub-heading u-padding-xs-bottom"><h3 class="related-content-panel-list-entry-outline-padding text-s u-font-serif" id="recommended-articles-article0-title"><a class="anchor u-clamp-2-lines anchor-primary" href="/science/article/pii/S1098301516342218" title="Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs"><span class="anchor-text-container"><span class="anchor-text"><span>Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs</span></span></span></a></h3><div class="article-source u-clr-grey6"><div class="source">Value in Health, Volume 20, Issue 2, 2017, pp. 200-205</div></div><div class="authors"><span>Tanya G.K.</span> <span>Bentley</span>, …, <span>Michael S.</span> <span>Broder</span></div></div><div class="buttons"><a class="anchor anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S1098301516342218/pdfft?md5=646956b455a3dcbb640dc7d303d80cb7&amp;pid=1-s2.0-S1098301516342218-main.pdf" target="_blank" rel="nofollow" aria-describedby="recommended-articles-article0-title"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a></div></li><li class="RelatedContentPanelItem u-display-block"><div class="sub-heading u-padding-xs-bottom"><h3 class="related-content-panel-list-entry-outline-padding text-s u-font-serif" id="recommended-articles-article1-title"><a class="anchor u-clamp-2-lines anchor-primary" href="/science/article/pii/S2059702920324959" title="Comparing assessment frameworks for cancer drugs between Canada and Europe: What can we learn from the differences?"><span class="anchor-text-container"><span class="anchor-text"><span>Comparing assessment frameworks for cancer drugs between Canada and Europe: What can we learn from the differences?</span></span></span></a></h3><div class="article-source u-clr-grey6"><div class="source">ESMO Open, Volume 1, Issue 6, 2016, Article e000124</div></div><div class="authors"><span>Matthew C.</span> <span>Cheung</span>, …, <span>William K.</span> <span>Evans</span></div></div><div class="buttons"><a class="anchor anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S2059702920324959/pdfft?md5=68ad9436b5e82c18d2790159194ef77c&amp;pid=1-s2.0-S2059702920324959-main.pdf" target="_blank" rel="nofollow" aria-describedby="recommended-articles-article1-title"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a></div></li><li class="RelatedContentPanelItem u-display-block"><div class="sub-heading u-padding-xs-bottom"><h3 class="related-content-panel-list-entry-outline-padding text-s u-font-serif" id="recommended-articles-article2-title"><a class="anchor u-clamp-2-lines anchor-primary" href="/science/article/pii/S2211883717300461" title="Guidance for the development of a National HTA-strategy"><span class="anchor-text-container"><span class="anchor-text"><span>Guidance for the development of a National HTA-strategy</span></span></span></a></h3><div class="article-source u-clr-grey6"><div class="source">Health Policy and Technology, Volume 6, Issue 3, 2017, pp. 339-347</div></div><div class="authors"><span>Claudia</span> <span>Wild</span>, …, <span>Nikolaus</span> <span>Patera</span></div></div><div class="buttons"><a class="anchor anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S2211883717300461/pdfft?md5=6ba2f36e22956b75dec87ad5da4e5377&amp;pid=1-s2.0-S2211883717300461-main.pdf" target="_blank" rel="nofollow" aria-describedby="recommended-articles-article2-title"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a></div></li><li class="RelatedContentPanelItem u-display-none"><div class="sub-heading u-padding-xs-bottom"><h3 class="related-content-panel-list-entry-outline-padding text-s u-font-serif" id="recommended-articles-article3-title"><a class="anchor u-clamp-2-lines anchor-primary" href="/science/article/pii/S2211692317301674" title="A role for MCDA to navigate the trade-offs in the National Institute for Health and Care Excellence’s public health recommendations"><span class="anchor-text-container"><span class="anchor-text"><span>A role for MCDA to navigate the trade-offs in the National Institute for Health and Care Excellence’s public health recommendations</span></span></span></a></h3><div class="article-source u-clr-grey6"><div class="source">Operations Research for Health Care, Volume 23, 2019, Article 100179</div></div><div class="authors"><span>Brian P.</span> <span>Reddy</span>, …, <span>Michael P.</span> <span>Kelly</span></div></div><div class="buttons"><a class="anchor anchor-primary anchor-icon-left anchor-with-icon" href="/science/article/pii/S2211692317301674/pdfft?md5=22f212802dac3d6048b3f40bf11e2aab&amp;pid=1-s2.0-S2211692317301674-main.pdf" target="_blank" rel="nofollow" aria-describedby="recommended-articles-article3-title"><svg focusable="false" viewBox="0 0 35 32" height="20" class="icon icon-pdf-multicolor"><path d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="anchor-text-container"><span class="anchor-text">View PDF</span></span></a></div></li><li class="RelatedContentPanelItem u-display-none"><div class="sub-heading u-padding-xs-bottom"><h3 class="related-content-panel-list-entry-outline-padding text-s u-font-serif" id="recommended-articles-article4-title"><a class="anchor u-clamp-2-lines anchor-primary" href="/science/article/pii/S0168851018304408" title="Value assessment of disease-modifying therapies for Relapsing-Remitting Multiple Sclerosis: HTA evidence from seven OECD countries"><span class="anchor-text-container"><span class="anchor-text"><span>Value assessment of disease-modifying therapies for Relapsing-Remitting Multiple Sclerosis: HTA evidence from seven OECD countries</span></span></span></a></h3><div class="article-source u-clr-grey6"><div class="source">Health Policy, Volume 123, Issue 2, 2019, pp. 118-129</div></div><div class="authors"><span>Erica</span> <span>Visintin</span>, …, <span>Panos</span> <span>Kanavos</span></div></div><div class="buttons"></div></li><li class="RelatedContentPanelItem u-display-none"><div class="sub-heading u-padding-xs-bottom"><h3 class="related-content-panel-list-entry-outline-padding text-s u-font-serif" id="recommended-articles-article5-title"><a class="anchor u-clamp-2-lines anchor-primary" href="/science/article/pii/S0168851017300854" title="HTA and decision-making processes in Central, Eastern and South Eastern Europe: Results from a survey"><span class="anchor-text-container"><span class="anchor-text"><span>HTA and decision-making processes in Central, Eastern and South Eastern Europe: Results from a survey</span></span></span></a></h3><div class="article-source u-clr-grey6"><div class="source">Health Policy, Volume 123, Issue 2, 2019, pp. 182-190</div></div><div class="authors"><span>Leticia</span> <span>García-Mochón</span>, …, <span>Román</span> <span>Pérez Velasco</span></div></div><div class="buttons"></div></li></ul></div><button class="button-link more-recommendations-button u-margin-s-bottom button-link-primary button-link-icon-right" type="button"><span class="button-link-text-container"><span class="button-link-text">Show 3 more articles</span></span><svg focusable="false" viewBox="0 0 92 128" height="20" class="icon icon-navigate-down"><path d="M1 51l7-7 38 38 38-38 7 7-45 45z"></path></svg></button></div></section><section class="RelatedContentPanel u-margin-s-bottom"><header id="metrics-header" class="related-content-panel-header u-margin-s-bottom"><button class="button-link button-link-secondary related-content-panel-toggle is-up button-link-icon-right button-link-has-colored-icon" type="button" aria-expanded="true"><span class="button-link-text-container"><span class="button-link-text"><h2 class="section-title u-h4"><span class="related-content-panel-title-text">Article Metrics</span></h2></span></span><svg focusable="false" viewBox="0 0 92 128" height="20" class="icon icon-navigate-down"><path d="M1 51l7-7 38 38 38-38 7 7-45 45z"></path></svg></button></header><div class="" aria-hidden="false" aria-describedby="metrics-header"><div class="plumX-metrics"><h3 class="text-s metric-title metric-title-citations">Citations</h3><ul><li class="text-xs metrics"><span>Citation Indexes</span><span>43</span></li><li class="text-xs metrics"><span>Policy Citations</span><span>4</span></li></ul><h3 class="text-s metric-title metric-title-captures">Captures</h3><ul><li class="text-xs metrics"><span>Mendeley Readers</span><span>148</span></li></ul><h3 class="text-s metric-title metric-title-mentions">Mentions</h3><ul><li class="text-xs metrics"><span>News Mentions</span><span>5</span></li></ul><h3 class="text-s metric-title metric-title-social-media">Social Media</h3><ul><li class="text-xs metrics"><span>Shares, Likes &amp; Comments</span><span>8</span></li></ul><div class="metrics u-margin-m-top u-margin-s-bottom"><img src="https://cdn.plu.mx/3ba727faf225e19d2c759f6ebffc511d/plumx-logo.png" class="plumX-logo" alt="PlumX Metrics Logo"><a class="anchor text-xs anchor-primary" href="https://plu.mx/plum/a/?doi=10.1016%2Fj.socscimed.2019.112595&amp;theme=plum-sciencedirect-theme&amp;hideUsage=true" target="_blank"><span class="anchor-text-container"><span class="anchor-text">View details</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></div></div></div></section></aside></div></div></div></div><footer role="contentinfo" class="els-footer u-bg-white text-xs u-padding-s-hor u-padding-m-hor-from-sm u-padding-l-hor-from-md u-padding-l-ver u-margin-l-top u-margin-xl-top-from-sm u-margin-l-top-from-md"><div class="els-footer-elsevier u-margin-m-bottom u-margin-0-bottom-from-md u-margin-s-right u-margin-m-right-from-md u-margin-l-right-from-lg"><a class="anchor anchor-primary anchor-icon-left anchor-with-icon" href="https://www.elsevier.com/" target="_blank" aria-label="Elsevier home page (opens in a new tab)"><img class="footer-logo" src="https://sdfestaticassets-us-east-1.sciencedirectassets.com/shared-assets/47/images/elsevier-non-solus-new-with-wordmark.svg" alt="Elsevier logo with wordmark" height="64" width="58" loading="lazy"></a></div><div class="els-footer-content"><div class="u-remove-if-print"><ul class="els-footer-links u-margin-xs-bottom" style="list-style:none"><li><a class="anchor u-display-flex u-clr-grey8 u-margin-s-bottom u-margin-0-bottom-from-sm u-margin-m-right-from-sm u-margin-l-right-from-md anchor-primary anchor-small" href="https://www.elsevier.com/solutions/sciencedirect" target="_blank" id="els-footer-about-science-direct" rel="nofollow"><span class="anchor-text-container"><span class="anchor-text">About ScienceDirect</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></li><li><a class="anchor u-display-flex u-clr-grey8 u-margin-s-bottom u-margin-0-bottom-from-sm u-margin-m-right-from-sm u-margin-l-right-from-md anchor-primary anchor-small" href="/user/institution/login?targetURL=%2Fscience%2Farticle%2Fpii%2FS0277953619305908" id="els-footer-remote-access" rel="nofollow"><span class="anchor-text-container"><span class="anchor-text">Remote access</span></span></a></li><li><a class="anchor u-display-flex u-clr-grey8 u-margin-s-bottom u-margin-0-bottom-from-sm u-margin-m-right-from-sm u-margin-l-right-from-md anchor-primary anchor-small" href="https://www.elsmediakits.com" target="_blank" id="els-footer-advertise" rel="nofollow"><span class="anchor-text-container"><span class="anchor-text">Advertise</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></li><li><a class="anchor u-display-flex u-clr-grey8 u-margin-s-bottom u-margin-0-bottom-from-sm u-margin-m-right-from-sm u-margin-l-right-from-md anchor-primary anchor-small" href="https://service.elsevier.com/app/contact/supporthub/sciencedirect/" target="_blank" id="els-footer-contact-support" rel="nofollow"><span class="anchor-text-container"><span class="anchor-text">Contact and support</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></li><li><a class="anchor u-display-flex u-clr-grey8 u-margin-s-bottom u-margin-0-bottom-from-sm u-margin-m-right-from-sm u-margin-l-right-from-md anchor-primary anchor-small" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions" target="_blank" id="els-footer-terms-condition" rel="nofollow"><span class="anchor-text-container"><span class="anchor-text">Terms and conditions</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></li><li><a class="anchor u-display-flex u-clr-grey8 u-margin-s-bottom u-margin-0-bottom-from-sm u-margin-m-right-from-sm u-margin-l-right-from-md anchor-primary anchor-small" href="https://www.elsevier.com/legal/privacy-policy" target="_blank" id="els-footer-privacy-policy" rel="nofollow"><span class="anchor-text-container"><span class="anchor-text">Privacy policy</span><svg focusable="false" viewBox="0 0 8 8" height="20" aria-label="Opens in new window" class="icon icon-arrow-up-right-tiny arrow-external-link"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span></a></li></ul></div><p id="els-footer-cookie-message" class="u-remove-if-print">Cookies are used by this site. <!-- --> <button class="button-link ot-sdk-show-settings cookie-btn button-link-primary button-link-small" type="button" id="ot-sdk-btn">Cookie Settings</button></p><p id="els-footer-copyright">All content on this site: Copyright © <!-- -->2025<!-- --> Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.</p></div><div class="els-footer-relx u-margin-0-top u-margin-m-top-from-xs u-margin-0-top-from-md"><a class="anchor anchor-primary anchor-icon-left anchor-with-icon" href="https://www.relx.com/" target="_blank" aria-label="RELX home page (opens in a new tab)" id="els-footer-relx"><img class="" src="https://sdfestaticassets-us-east-1.sciencedirectassets.com/shared-assets/60/images/logo-relx-tm.svg" alt="RELX group home page" height="20" width="93" loading="lazy"></a></div></footer></div></div></div></div>
      <div id="floating-ui-node" class="floating-ui-node" data-sd-ui-floating-ui="true"></div>
      <iframe style="display: none" src="//acw.clinicalkey.com/SSOCore/update?acw=681b06f55c798046ab69b9920fff400384ebgxrqa%7C%24%7C1C6745D43BCBAF9A06AE3840493E39F5C9B42085E171313B70F03348F0E43FA6250A54675C94FCD9C857DC92233BF31BEB3C9BFFCFB27E583FBA44D1BD4E4F2EB0469A67597464825D387A21AFA2E514&amp;utt=6a64-e24302c57917b71a9c6-c338e6a124245881" tabindex="-1"></iframe><iframe style="display: none" src="//acw.scopus.com/SSOCore/update?acw=681b06f55c798046ab69b9920fff400384ebgxrqa%7C%24%7C1C6745D43BCBAF9A06AE3840493E39F5C9B42085E171313B70F03348F0E43FA6250A54675C94FCD9C857DC92233BF31BEB3C9BFFCFB27E583FBA44D1BD4E4F2EB0469A67597464825D387A21AFA2E514&amp;utt=6a64-e24302c57917b71a9c6-c338e6a124245881" tabindex="-1"></iframe><iframe style="display: none" src="//acw.sciencedirect.com/SSOCore/update?acw=681b06f55c798046ab69b9920fff400384ebgxrqa%7C%24%7C1C6745D43BCBAF9A06AE3840493E39F5C9B42085E171313B70F03348F0E43FA6250A54675C94FCD9C857DC92233BF31BEB3C9BFFCFB27E583FBA44D1BD4E4F2EB0469A67597464825D387A21AFA2E514&amp;utt=6a64-e24302c57917b71a9c6-c338e6a124245881" tabindex="-1"></iframe><iframe style="display: none" src="//acw.elsevier.com/SSOCore/update?acw=681b06f55c798046ab69b9920fff400384ebgxrqa%7C%24%7C1C6745D43BCBAF9A06AE3840493E39F5C9B42085E171313B70F03348F0E43FA6250A54675C94FCD9C857DC92233BF31BEB3C9BFFCFB27E583FBA44D1BD4E4F2EB0469A67597464825D387A21AFA2E514&amp;utt=6a64-e24302c57917b71a9c6-c338e6a124245881" tabindex="-1"></iframe>
      
      
<script type="text/javascript">
    window.pageData = {"content":[{"contentType":"JL","format":"MIME-XHTML","id":"sd:article:pii:S0277953619305908","type":"sd:article:JL:scope-full","detail":"sd:article:subtype:fla","publicationType":"journal","issn":"0277-9536","volumeNumber":"246","suppl":"C","provider":"elsevier","entitlementType":"openaccess"}],"page":{"businessUnit":"ELS:RP:ST","language":"en","name":"product:journal:article","noTracking":"false","productAppVersion":"full-direct","productName":"SD","type":"CP-CA","environment":"prod","loadTimestamp":1749597544023,"loadTime":"","testId":"sd:article-page:current-ui"},"visitor":{"accessType":"ae:ANON_GUEST","accountId":"ae:228598","accountName":"ae:ScienceDirect Guests","loginStatus":"anonymous","userId":"ae:12975512","ipAddress":"189.120.74.179","appSessionId":"fd08cf2b-4bf8-441d-95de-8224722d540a"}};
    window.pageData.page.loadTime = performance ? Math.round(performance.now()).toString() : '';

    try {
      appData.push({
      event: 'pageLoad',
      page: pageData.page,
      visitor: pageData.visitor,
      content: pageData.content
      })
    } catch(e) {
        console.warn("There was an error loading or running Adobe DTM: ", e);
    }
</script>
      <script nomodule="" src="https://sdfestaticassets-us-east-1.sciencedirectassets.com/shared-assets/73/js/core-js/3.20.2/core-js.es.minified.js" type="text/javascript"></script>
      <script src="https://sdfestaticassets-us-east-1.sciencedirectassets.com/shared-assets/108/js/react/18.3.1/react.production.min.js" type="text/javascript"></script>
      <script src="https://sdfestaticassets-us-east-1.sciencedirectassets.com/shared-assets/108/js/react-dom/18.3.1/react-dom.production.min.js" type="text/javascript"></script>
      <script async="" src="https://sdfestaticassets-us-east-1.sciencedirectassets.com/prod/0408e3544c5d8a31f29fd84f48c3b04cd8f090f1/arp.js" type="text/javascript"></script>
      <script type="text/javascript">
    const pendoData = {"visitor":{"pageName":"SD:product:journal:article","pageType":"CP-CA","pageProduct":"SD","pageLanguage":"en","pageEnvironment":"prod","accessType":"ae:ANON_GUEST","countryCode":"BR"},"account":{"id":"ae:228598","name":"ae:ScienceDirect Guests"},"events":{}};;
    pendoData.events = {
      ready: function () {
        pendo.addAltText();
      },
    };
    function runPendo(data, options) {
  const {
    firstDelay,
    maxRetries,
    urlPrefix,
    urlSuffix,
    apiKey
  } = options;
  (function (apiKey) {
    (function (p, e, n, d, o) {
      var v, w, x, y, z;
      o = p[d] = p[d] || {};
      o._q = [];
      v = ['initialize', 'identify', 'updateOptions', 'pageLoad'];
      for (w = 0, x = v.length; w < x; ++w) (function (m) {
        o[m] = o[m] || function () {
          o._q[m === v[0] ? 'unshift' : 'push']([m].concat([].slice.call(arguments, 0)));
        };
      })(v[w]);
      y = e.createElement(n);
      y.async = !0;
      y.src = urlPrefix + apiKey + urlSuffix;
      z = e.getElementsByTagName(n)[0];
      z.parentNode.insertBefore(y, z);
    })(window, document, 'script', 'pendo');
    pendo.addAltText = function () {
      var target = document.querySelector('body');
      var observer = new MutationObserver(function (mutations) {
        mutations.forEach(function (mutation) {
          if (mutation?.addedNodes?.length) {
            if (mutation.addedNodes[0]?.className?.includes("_pendo-badge")) {
              const badge = mutation.addedNodes[0];
              const altText = badge?.attributes['aria-label']?.value || 'Feedback';
              const pendoBadgeImage = pendo.dom(`#${badge?.attributes?.id.value} img`);
              if (pendoBadgeImage.length) {
                pendoBadgeImage[0]?.setAttribute('alt', altText);
              }
            }
          }
        });
      });
      var config = {
        attributeFilter: ['data-layout'],
        attributes: true,
        childList: true,
        characterData: true,
        subtree: false
      };
      observer.observe(target, config);
    };
  })(apiKey);
  (function watchAndSetPendo(nextDelay, retryAttempt) {
    if (data.visitor.id) {
      console.debug(`initializing pendo`);
      pendo.initialize(data);
    } else if (typeof pageDataTracker === 'object' && typeof pageDataTracker.getVisitorId === 'function' && pageDataTracker.getVisitorId()) {
      data.visitor.id = pageDataTracker.getVisitorId();
      console.debug(`initializing pendo`);
      pendo.initialize(data);
    } else {
      if (retryAttempt > 0) {
        return setTimeout(function () {
          watchAndSetPendo(nextDelay * 2, retryAttempt - 1);
        }, nextDelay);
      }
      pendo.initialize(data);
      console.debug(`gave up ... pendo initialized`);
    }
  })(firstDelay, maxRetries);
}
    window.addPendoScript = () => {
      runPendo(pendoData, {
        firstDelay: 100,
        maxRetries: 5,
        urlPrefix: 'https://cdn.pendo.io/agent/static/',
        urlSuffix: '/pendo.js',
        apiKey: 'd6c1d995-bc7e-4e53-77f1-2ea4ecbb9565',
      });
      window.addPendoScript = () => {};
    };
    addEventListener('load', () => window.addPendoScript());
  </script>
      <span id="pendo-answer-rating"></span>
      <script type="text/x-mathjax-config;executed=true">
        MathJax.Hub.Config({
          displayAlign: 'left',
          "fast-preview": {
            disabled: true
          },
          CommonHTML: { linebreaks: { automatic: true } },
          PreviewHTML: { linebreaks: { automatic: true } },
          'HTML-CSS': { linebreaks: { automatic: true } },
          SVG: {
            scale: 90,
            linebreaks: { automatic: true }
          }
        });
      </script>
      <script async="" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=MML_SVG" type="text/javascript"></script>
      <script async="" src="https://www.googletagservices.com/tag/js/gpt.js" type="text/javascript"></script>
      <script async="" src="https://scholar.google.com/scholar_js/casa.js" type="text/javascript"></script>
      <script data-cfasync="false">
      (function initOneTrust()  {
        const monitor = {
  init: () => {},
  loaded: () => {},
};
        function enableGroup(group) {
  document.querySelectorAll(`script[type*="ot-${group}"]`).forEach(script => {
    script.type = 'text/javascript';
    document.head.appendChild(script);
  });
}
        function runOneTrustCookies(doClear, monitor) {
  const oneTrustConsentSdkId = 'onetrust-consent-sdk';
  const emptyNodeSelectors = 'h3.ot-host-name, h4.ot-host-desc, button.ot-host-box';
  const ariaLabelledByButtonNodes = 'div.ot-accordion-layout > button';
  const ariaAttribute = 'aria-labelledby';
  function adjustOneTrustDOM() {
    const oneTrustRoot = document.getElementById('onetrust-consent-sdk');

    /* remove empty nodes */
    [...(oneTrustRoot?.querySelectorAll(emptyNodeSelectors) ?? [])].filter(e => e.textContent === '').forEach(e => e.remove());

    /* remove invalid aria-labelledby values */
    oneTrustRoot?.querySelectorAll(ariaLabelledByButtonNodes).forEach(e => {
      const presentIdValue = e.getAttribute(ariaAttribute)?.split(' ').filter(label => document.getElementById(label)).join(' ');
      if (presentIdValue) {
        e.setAttribute(ariaAttribute, presentIdValue);
      }
    });
  }
  function observeOneTrustLoaded(shouldSetOTDefaults, isConsentPresent) {
    const cb = (mutationList, observer) => {
      const oneTrustRoot = mutationList.filter(mutationRecord => mutationRecord.type === 'childList' && mutationRecord.addedNodes.length).map(mutationRecord => [...mutationRecord.addedNodes]).flat().find(e => e.id === oneTrustConsentSdkId);
      if (oneTrustRoot && typeof OneTrust !== 'undefined') {
        monitor.loaded(true);
        OneTrust.OnConsentChanged(() => {
          const perfAllowed = decodeURIComponent(document.cookie.match('(^| )OptanonConsent=([^;]+)')?.[2])?.match('groups=([0-9:0|1,?]+)&?')?.[1]?.match('2:([0|1])')[1] === '1';
          if (perfAllowed) {
            enableGroup('performance');
          }
        });
        if (!isConsentPresent && (shouldSetOTDefaults || OneTrust.GetDomainData().ConsentModel.Name === 'implied consent')) {
          OneTrust.UpdateConsent(`Category`, `1:1`);
          OneTrust.UpdateConsent(`Category`, `2:1`);
          OneTrust.UpdateConsent(`Category`, `3:1`);
          OneTrust.UpdateConsent(`Category`, `4:0`);
        }
        document.dispatchEvent(new CustomEvent('@sdtech/onetrust/loaded', {}));
        observer.disconnect();
        adjustOneTrustDOM();
      }
    };
    const observer = new MutationObserver(cb);
    observer.observe(document.querySelector('body'), {
      childList: true
    });
  }
  if (doClear) {
    document.cookie = 'OptanonAlertBoxClosed=; expires=Thu, 01 Jan 1970 00:00:00 UTC; samesite=lax; path=/';
  }
  const isConsentPresent = !!decodeURIComponent(document.cookie.match('(^| )OptanonConsent=([^;]+)')?.[2])?.match('groups=([0-9:0|1,?]+)&?')?.[1];
  const shouldSetOTDefaults = 'true' === 'false' && !document.cookie?.match('OptanonAlertBoxClosed=');
  if (shouldSetOTDefaults) {
    const date = new Date();
    date.setFullYear(date.getFullYear() + 1);
    document.cookie = `OptanonAlertBoxClosed=${new Date().toISOString()}; expires=${date.toUTCString()}; samesite=lax; path=/; domain=sciencedirect.com`;
  }
  observeOneTrustLoaded(shouldSetOTDefaults, isConsentPresent, monitor);
  window.addOTScript = () => {
    const otSDK = document.createElement('script');
    otSDK.setAttribute('data-cfasync', 'false');
    otSDK.setAttribute('src', 'https://cdn.cookielaw.org/scripttemplates/otSDKStub.js');
    otSDK.setAttribute('data-document-language', 'true');
    otSDK.setAttribute('data-domain-script', '865ea198-88cc-4e41-8952-1df75d554d02');
    window.addOTScript = () => {};
    document.head.appendChild(otSDK);
    monitor.init();
  };
  window.addEventListener('load', () => window.addOTScript());
}
        if (document.location.host.match(/.sciencedirect.com$/)) {
          runOneTrustCookies(true, monitor);
        }
        else {
          window.addEventListener('load', (event) => {
            enableGroup('performance');
          });
        }
      }());
    </script>
      
    <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94dc97683e934ed1',t:'MTc0OTU5NzU0NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe>
  <iframe id="ps_ljpxmu" src="https://service.seamlessaccess.org/ps/" style="display: none; position: absolute; top: -999px; left: -999px;"></iframe><div class="js-react-modal"></div><div class="js-react-modal"></div><div class="js-react-modal"></div><div class="js-react-modal"></div><div class="js-react-modal"></div><div class="js-react-modal"></div><div class="js-react-modal"></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-hide ot-fade-in" style="display: none;visibility: hidden;
                    opacity: 0;transition: visibility 0s 400ms, opacity 400ms linear;"></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region" style="display: none;visibility: hidden;
                    opacity: 0;transition: visibility 0s 400ms, opacity 400ms linear;"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler" ot-button-order="0" style="display: inline-block;">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Strictly Necessary Cookies - Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" checked="" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Performance Cookies - Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Targeting Cookies - Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><div id="ot-filter-list-header"></div><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler" ot-button-order="2">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite">Your Privacy [`dialog closed`]</span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div><script>
var pageDataTracker = {
    eventCookieName: 'eventTrack',
    debugCookie: 'els-aa-debugmode',
    debugCounter: 1,
    warnings: [],
    measures: {},
    timeoffset: 0

    ,trackPageLoad: function(data) {
        if (window.pageData && ((pageData.page && pageData.page.noTracking == 'true') || window.pageData_isLoaded)) {
            return false;
        }

        this.updatePageData(data);

        this.initWarnings();
        if(!(window.pageData && pageData.page && pageData.page.name)) {
            console.error('pageDataTracker.trackPageLoad() called without pageData.page.name being defined!');
            return;
        }

        this.processIdPlusData(window.pageData);

        if(window.pageData && pageData.page && !pageData.page.loadTime) {
          pageData.page.loadTime = performance ? Math.round((performance.now())).toString() : '';
        }

        if(window.pageData && pageData.page) {
            var localTime = new Date().getTime();
            if(pageData.page.loadTimestamp) {
                // calculate timeoffset
                var serverTime = parseInt(pageData.page.loadTimestamp);
                if(!isNaN(serverTime)) {
                    this.timeoffset = pageData.page.loadTimestamp - localTime;
                }
            } else {
                pageData.page.loadTimestamp = localTime;
            }
        }

        this.validateData(window.pageData);

        try {
            var cookieTest = 'aa-cookie-test';
            this.setCookie(cookieTest, cookieTest);
            if(this.getCookie(cookieTest) != cookieTest) {
                this.warnings.push('dtm5');
            }
            this.deleteCookie(cookieTest);
        } catch(e){
            this.warnings.push('dtm5');
        }

        this.registerCallbacks();
        this.setAnalyticsData();

        // handle any cookied event data
        this.getEvents();

        window.pageData_isLoaded = true;

        this.debugMessage('Init - trackPageLoad()', window.pageData);

        _satellite.track('eventDispatcher', JSON.stringify({
          eventName: 'newPage',
          eventData: {eventName: 'newPage'},
          pageData: window.pageData
        }));
    }

    ,trackEvent: function(event, data, callback) {
        if (window.pageData && pageData.page && pageData.page.noTracking == 'true') {
            return false;
        }
        
        if(!window.pageData_isLoaded) {
            if(this.isDebugEnabled()) {
                console.log('[AA] pageDataTracker.trackEvent() called without calling trackPageLoad() first.');
            }
            return false;
        }

        if (event) {
            this.initWarnings();
            if(event === 'newPage') {
                // auto fillings
                if(data && data.page && !data.page.loadTimestamp) {
                    data.page.loadTimestamp = ''+(new Date().getTime() + this.timeoffset);
                }
                this.processIdPlusData(data);
            }

            window.eventData = data ? data : {};
            window.eventData.eventName = event;
            if(!_satellite.getVar('blacklisted')) {
                this.handleEventData(event, data);
    
                if(event === 'newPage') {
                    this.validateData(window.pageData);
                }
                this.debugMessage('Event: ' + event, data);
    
                _satellite.track('eventDispatcher', JSON.stringify({
                  eventName: event,
                  eventData: window.eventData,
                  pageData: window.pageData
                }));
            } else {
                this.debugMessage('!! Blocked Event: ' + event, data);
            }
        }

        if (typeof(callback) == 'function') {
            callback.call();
        }
    }

    ,processIdPlusData: function(data) {
        if(data && data.visitor && data.visitor.idPlusData) {
            var idPlusFields = ['userId', 'accessType', 'accountId', 'accountName'];
            for(var i=0; i < idPlusFields.length; i++) {
                if(typeof data.visitor.idPlusData[idPlusFields[i]] !== 'undefined') {
                    data.visitor[idPlusFields[i]] = data.visitor.idPlusData[idPlusFields[i]];
                }
            }
            data.visitor.idPlusData = undefined;
        }
    }

    ,validateData: function(data) {
        if(!data) {
            this.warnings.push('dv0');
            return;
        }

        // top 5
        if(!(data.visitor && data.visitor.accessType)) {
            this.warnings.push('dv1');
        }
        if(data.visitor && (data.visitor.accountId || data.visitor.accountName)) {
            if(!data.visitor.accountName) {
                this.warnings.push('dv2');
            }
            if(!data.visitor.accountId) {
                this.warnings.push('dv3');
            }
        }
        if(!(data.page && data.page.productName)) {
            this.warnings.push('dv4');
        }
        if(!(data.page && data.page.businessUnit)) {
            this.warnings.push('dv5');
        }
        if(!(data.page && data.page.name)) {
            this.warnings.push('dv6');
        }

        // rp mandatory
        if(data.page && data.page.businessUnit && (data.page.businessUnit.toLowerCase().indexOf('els:rp:') !== -1 || data.page.businessUnit.toLowerCase().indexOf('els:rap:') !== -1)) {
            if(!(data.page && data.page.loadTimestamp)) {
                this.warnings.push('dv7');
            }
            if(!(data.page && data.page.loadTime)) {
                this.warnings.push('dv8');
            }
            if(!(data.visitor && data.visitor.ipAddress)) {
                this.warnings.push('dv9');
            }
            if(!(data.page && data.page.type)) {
                this.warnings.push('dv10');
            }
            if(!(data.page && data.page.language)) {
                this.warnings.push('dv11');
            }
        }

        // other
        if(data.page && data.page.environment) {
            var env = data.page.environment.toLowerCase();
            if(!(env === 'dev' || env === 'cert' || env === 'prod')) {
                this.warnings.push('dv12');
            }
        }
        if(data.content && data.content.constructor !== Array) {
            this.warnings.push('dv13');
        }

        if(data.visitor && data.visitor.accountId && data.visitor.accountId.indexOf(':') == -1) {
            this.warnings.push('dv14');
            data.visitor.accountId = "data violation"
        }
    }

    ,initWarnings: function() {
        this.warnings = [];
        try {
            var hdn = document.head.childNodes;
            var libf = false;
            for(var i=0; i<hdn.length; i++) {
                if(hdn[i].src && (hdn[i].src.indexOf('satelliteLib') !== -1 || hdn[i].src.indexOf('launch') !== -1)) {
                    libf = true;
                    break;
                }
            }
            if(!libf) {
                this.warnings.push('dtm1');
            }
        } catch(e) {}

        try {
            for (let element of document.querySelectorAll('*')) {
                // Check if the element has a src attribute and if it meets the criteria
                if (element.src && element.src.includes('assets.adobedtm.com') && element.src.includes('launch')) {
                    if (element.tagName.toLowerCase() !== 'script') {
                        this.warnings.push('dtm5');
                    }
                    if (!element.hasAttribute('async')) {
                        this.warnings.push('dtm4');
                    }
                }
            }
        } catch (e) { }
    }

    ,getMessages: function() {
        return ['v1'].concat(this.warnings).join('|');
    }
    ,addMessage: function(message) {
        this.warnings.push(message);
    }

    ,getPerformance: function() {
        var copy = {};
        for (var attr in this.measures) {
            if(this.measures.hasOwnProperty(attr)) {
                copy[attr] = this.measures[attr];
            }
        }

        this.measures = {};
        return copy;
    }

    ,dtmCodeDesc: {
        dtm1: 'satellite-lib must be placed in the <head> section',
        dtm2: 'trackPageLoad() must be placed and called before the closing </body> tag',
        dtm3: 'trackEvent() must be called at a stage where Document.readyState=complete (e.g. on the load event or a user event)',
        dtm4: 'Embed codes need to be loaded in async mode',
        dtm5: 'Embed codes not in type script',
        dv1: 'visitor.accessType not set but mandatory',
        dv2: 'visitor.accountName not set but mandatory',
        dv3: 'visitor.accountId not set but mandatory',
        dv4: 'page.productName not set but mandatory',
        dv5: 'page.businessUnit not set but mandatory',
        dv6: 'page.name not set but mandatory',
        dv7: 'page.loadTimestamp not set but mandatory',
        dv8: 'page.loadTime not set but mandatory',
        dv9: 'visitor.ipAddress not set but mandatory',
        dv10: 'page.type not set but mandatory',
        dv11: 'page.language not set but mandatory',
        dv12: 'page.environment must be set to \'prod\', \'cert\' or \'dev\'',
        dv13: 'content must be of type array of objects',
        dv14: 'account number must contain at least one \':\', e.g. \'ae:12345\''
    }

    ,debugMessage: function(event, data) {
        if(this.isDebugEnabled()) {
            console.log('[AA] --------- [' + (this.debugCounter++) + '] Web Analytics Data ---------');
            console.log('[AA] ' + event);
            console.groupCollapsed("[AA] AA Data: ");
            if(window.eventData) {
                console.log("[AA] eventData:\n" + JSON.stringify(window.eventData, true, 2));
            }
            if(window.pageData) {
                console.log("[AA] pageData:\n" + JSON.stringify(window.pageData, true, 2));
            }
            console.groupEnd();
            if(this.warnings.length > 0) {
                console.groupCollapsed("[AA] Warnings ("+this.warnings.length+"): ");
                for(var i=0; i<this.warnings.length; i++) {
                    var error = this.dtmCodeDesc[this.warnings[i]] ? this.dtmCodeDesc[this.warnings[i]] : 'Error Code: ' + this.warnings[i];
                    console.log('[AA] ' + error);
                }
                console.log('[AA] More can be found here: https://confluence.cbsels.com/display/AA/AA+Error+Catalog');
                console.groupEnd();
            }
            console.log("This mode can be disabled by calling 'pageDataTracker.disableDebug()'");
        }
    }

    ,getTrackingCode: function() {
      var campaign = _satellite.getVar('Campaign - ID');
      if(!campaign) {
        campaign = window.sessionStorage ? sessionStorage.getItem('dgcid') : '';
      }
      return campaign;
    }

    ,isDebugEnabled: function() {
        if(typeof this.debug === 'undefined') {
            this.debug = (document.cookie.indexOf(this.debugCookie) !== -1) || (window.pageData && pageData.page && pageData.page.environment && pageData.page.environment.toLowerCase() === 'dev');
            //this.debug = (document.cookie.indexOf(this.debugCookie) !== -1);
        }
        return this.debug;
    }

    ,enableDebug: function(expire) {
        if (typeof expire === 'undefined') {
            expire = 86400;
        }
        console.log('You just enabled debug mode for Adobe Analytics tracking. This mode will persist for 24h.');
        console.log("This mode can be disabled by calling 'pageDataTracker.disableDebug()'");
        this.setCookie(this.debugCookie, 'true', expire, document.location.hostname);
        this.debug = true;
    }

    ,disableDebug: function() {
        console.log('Debug mode is now disabled.');
        this.deleteCookie(this.debugCookie);
        this.debug = false;
    }

    ,setAnalyticsData: function() {
        if(!(window.pageData && pageData.page && pageData.page.productName && pageData.page.name)) {
            return;
        }
        pageData.page.analyticsPagename = pageData.page.productName + ':' + pageData.page.name;

        var pageEls = pageData.page.name.indexOf(':') > -1 ? pageData.page.name.split(':') : [pageData.page.name];
        pageData.page.sectionName = pageData.page.productName + ':' + pageEls[0];
    }

    ,getEvents: function() {
        pageData.savedEvents = {};
        pageData.eventList = [];

        var val = this.getCookie(this.eventCookieName);
        if (val) {
            pageData.savedEvents = val;
        }

        this.deleteCookie(this.eventCookieName);
    }

    ,updatePageData(data) {
        window.pageData = window.pageData || {};
        if (data && typeof(data) === 'object') {
            for (var x in data) {
                if(data.hasOwnProperty(x) && data[x] instanceof Array) {
                    pageData[x] = data[x];
                } else if(data.hasOwnProperty(x) && typeof(data[x]) === 'object') {
                    if(!pageData[x]) {
                        pageData[x] = {};
                    }
                    for (var y in data[x]) {
                        if(data[x].hasOwnProperty(y)) {
                            pageData[x][y] = data[x][y];
                        }
                    }
                }
            }
        }
    }

    ,handleEventData: function(event, data) {
        var val;
        switch(event) {
            case 'newPage':
                this.updatePageData(data);
                this.setAnalyticsData();
            case 'saveSearch':
            case 'searchResultsUpdated':
                if (data) {
                    // overwrite page-load object
                    if (data.search && typeof(data.search) == 'object') {
                        window.eventData.search.resultsPosition = '';
                        pageData.search = pageData.search || {};
                        var fields = ['advancedCriteria', 'criteria', 'currentPage', 'dataFormCriteria', 'facets', 'resultsByType', 'resultsPerPage', 'sortType', 'totalResults', 'type', 'database',
                        'suggestedClickPosition','suggestedLetterCount','suggestedResultCount', 'autoSuggestCategory', 'autoSuggestDetails','typedTerm','selectedTerm', 'channel',
                        'facetOperation', 'details'];
                        for (var i=0; i<fields.length; i++) {
                            if (data.search[fields[i]]) {
                                pageData.search[fields[i]] = data.search[fields[i]];
                            }
                        }
                    }
                }
                this.setAnalyticsData();
                break;
            case 'navigationClick':
                if (data && data.link) {
                    window.eventData.navigationLink = {
                        name: ((data.link.location || 'no location') + ':' + (data.link.name || 'no name'))
                    };
                }
                break;
            case 'autoSuggestClick':
                if (data && data.search) {
                    val = {
                        autoSuggestSearchData: (
                            'letterct:' + (data.search.suggestedLetterCount || 'none') +
                            '|resultct:' + (data.search.suggestedResultCount || 'none') +
                            '|clickpos:' + (data.search.suggestedClickPosition || 'none')
                        ).toLowerCase(),
                        autoSuggestSearchTerm: (data.search.typedTerm || ''),
                        autoSuggestTypedTerm: (data.search.typedTerm || ''),
                        autoSuggestSelectedTerm: (data.search.selectedTerm || ''),
                        autoSuggestCategory: (data.search.autoSuggestCategory || ''),
                        autoSuggestDetails: (data.search.autoSuggestDetails || '')
                    };
                }
                break;
            case 'linkOut':
                if (data && data.content && data.content.length > 0) {
                    window.eventData.linkOut = data.content[0].linkOut;
                    window.eventData.referringProduct = _satellite.getVar('Page - Product Name') + ':' + data.content[0].id;
                }
                break;
            case 'socialShare':
                if (data && data.social) {
                    window.eventData.sharePlatform = data.social.sharePlatform || '';
                }
                break;
            case 'contentInteraction':
                if (data && data.action) {
                    window.eventData.action.name = pageData.page.productName + ':' + data.action.name;
                }
                break;
            case 'searchWithinContent':
                if (data && data.search) {
                    window.pageData.search = window.pageData.search || {};
                    pageData.search.withinContentCriteria = data.search.withinContentCriteria;
                }
                break;
            case 'contentShare':
                if (data && data.content) {
                    window.eventData.sharePlatform = data.content[0].sharePlatform;
                }
                break;
            case 'contentLinkClick':
                if (data && data.link) {
                    window.eventData.action = { name: pageData.page.productName + ':' + (data.link.type || 'no link type') + ':' + (data.link.name || 'no link name') };
                }
                break;
            case 'contentWindowLoad':
            case 'contentTabClick':
                if (data && data.content) {
                    window.eventData.tabName = data.content[0].tabName || '';
                    window.eventData.windowName = data.content[0].windowName || '';
                }
                break;
            case 'userProfileUpdate':
                if (data && data.user) {
                    if (Object.prototype.toString.call(data.user) === "[object Array]") {
                        window.eventData.user = data.user[0];
                    }
                }
                break;
            case 'videoStart':
                if (data.video) {
                    data.video.length = parseFloat(data.video.length || '0');
                    data.video.position = parseFloat(data.video.position || '0');
                    s.Media.open(data.video.id, data.video.length, s.Media.playerName);
                    s.Media.play(data.video.id, data.video.position);
                }
                break;
            case 'videoPlay':
                if (data.video) {
                    data.video.position = parseFloat(data.video.position || '0');
                    s.Media.play(data.video.id, data.video.position);
                }
                break;
            case 'videoStop':
                if (data.video) {
                    data.video.position = parseFloat(data.video.position || '0');
                    s.Media.stop(data.video.id, data.video.position);
                }
                break;
            case 'videoComplete':
                if (data.video) {
                    data.video.position = parseFloat(data.video.position || '0');
                    s.Media.stop(data.video.id, data.video.position);
                    s.Media.close(data.video.id);
                }
                break;
            case 'addWebsiteExtension':
                if(data && data.page) {
                    val = {
                        wx: data.page.websiteExtension
                    }
                }
                break;
        }

        if (val) {
            this.setCookie(this.eventCookieName, val);
        }
    }

    ,registerCallbacks: function() {
        var self = this;
        if(window.usabilla_live) {
            window.usabilla_live('setEventCallback', function(category, action, label, value) {
                if(action == 'Campaign:Open') {
                    self.trackEvent('ctaImpression', {
                        cta: {
                            ids: ['usabillaid:' + label]
                        }
                    });
                } else if(action == 'Campaign:Success') {
                    self.trackEvent('ctaClick', {
                        cta: {
                            ids: ['usabillaid:' + label]
                        }
                    });
                }
            });
        }
    }

    ,getConsortiumAccountId: function() {
        var id = '';
        if (window.pageData && pageData.visitor && (pageData.visitor.consortiumId || pageData.visitor.accountId)) {
            id = (pageData.visitor.consortiumId || 'no consortium ID') + '|' + (pageData.visitor.accountId || 'no account ID');
        }

        return id;
    }

    ,getSearchClickPosition: function() {
        if (window.eventData && eventData.search && eventData.search.resultsPosition) {
            var pos = parseInt(eventData.search.resultsPosition), clickPos;
            if (!isNaN(pos)) {
                var page = pageData.search.currentPage ? parseInt(pageData.search.currentPage) : '', perPage = pageData.search.resultsPerPage ? parseInt(pageData.search.resultsPerPage) : '';
                if (!isNaN(page) && !isNaN(perPage)) {
                    clickPos = pos + ((page - 1) * perPage);
                }
            }
            return clickPos ? clickPos.toString() : eventData.search.resultsPosition;
        }
        return '';
    }

    ,getSearchFacets: function() {
        var facetList = '';
        if (window.pageData && pageData.search && pageData.search.facets) {
            if (typeof(pageData.search.facets) == 'object') {
                for (var i=0; i<pageData.search.facets.length; i++) {
                    var f = pageData.search.facets[i];
                    facetList += (facetList ? '|' : '') + f.name + '=' + f.values.join('^');
                }
            }
        }
        return facetList;
    }

    ,getSearchResultsByType: function() {
        var resultTypes = '';
        if (window.pageData && pageData.search && pageData.search.resultsByType) {
            for (var i=0; i<pageData.search.resultsByType.length; i++) {
                var r = pageData.search.resultsByType[i];
                resultTypes += (resultTypes ? '|' : '') + r.name + (r.results || r.values ? '=' + (r.results || r.values) : '');
            }
        }
        return resultTypes;
    }

    ,getJournalInfo: function() {
        var info = '';
        if (window.pageData && pageData.journal && (pageData.journal.name || pageData.journal.specialty || pageData.journal.section || pageData.journal.issn || pageData.journal.issueNumber || pageData.journal.volumeNumber || pageData.journal.family || pageData.journal.publisher)) {
            var journal = pageData.journal;
            info = (journal.name || 'no name') 
            + '|' + (journal.specialty || 'no specialty') 
            + '|' + (journal.section || 'no section') 
            + '|' + (journal.issn || 'no issn') 
            + '|' + (journal.issueNumber || 'no issue #') 
            + '|' + (journal.volumeNumber || 'no volume #')
            + '|' + (journal.family || 'no family')
            + '|' + (journal.publisher || 'no publisher');

        }
        return info;
    }

    ,getBibliographicInfo: function(doc) {
        if (!doc || !(doc.publisher || doc.indexTerms || doc.publicationType || doc.publicationRights || doc.volumeNumber || doc.issueNumber || doc.subjectAreas || doc.isbn)) {
            return '';
        }

        var terms = doc.indexTerms ? doc.indexTerms.split('+') : '';
        if (terms) {
            terms = terms.slice(0, 5).join('+');
            terms = terms.length > 100 ? terms.substring(0, 100) : terms;
        }

        var areas = doc.subjectAreas ? doc.subjectAreas.split('>') : '';
        if (areas) {
            areas = areas.slice(0, 5).join('>');
            areas = areas.length > 100 ? areas.substring(0, 100) : areas;
        }

        var biblio	= (doc.publisher || 'none')
            + '^' + (doc.publicationType || 'none')
            + '^' + (doc.publicationRights || 'none')
            + '^' + (terms || 'none')
            + '^' + (doc.volumeNumber || 'none')
            + '^' + (doc.issueNumber || 'none')
            + '^' + (areas || 'none')
            + '^' + (doc.isbn || 'none');

        return this.stripProductDelimiters(biblio).toLowerCase();
    }

    ,getContentItem: function() {
        var docs = window.eventData && eventData.content ? eventData.content : pageData.content;
        if (docs && docs.length > 0) {
            return docs[0];
        }
    }

    ,getFormattedDate: function(ts) {
        if (!ts) {
            return '';
        }

        var d = new Date(parseInt(ts) * 1000);

        // now do formatting
        var year = d.getFullYear()
            ,month = ((d.getMonth() + 1) < 10 ? '0' : '') + (d.getMonth() + 1)
            ,date = (d.getDate() < 10 ? '0' : '') + d.getDate()
            ,hours = d.getHours() > 12 ? d.getHours() - 12 : d.getHours()
            ,mins = (d.getMinutes() < 10 ? '0' : '') + d.getMinutes()
            ,ampm = d.getHours() > 12 ? 'pm' : 'am';

        hours = (hours < 10 ? '0' : '') + hours;
        return year + '-' + month + '-' + date;
    }

    ,getVisitorId: function() {
        var orgId = '4D6368F454EC41940A4C98A6@AdobeOrg';
        if(Visitor && Visitor.getInstance(orgId)) {
            return Visitor.getInstance(orgId).getMarketingCloudVisitorID();
        } else {
            return ''
        }
    }

    ,setProductsVariable: function() {
        var prodList = window.eventData && eventData.content ? eventData.content : pageData.content
            ,prods = [];
        if (prodList) {
            for (var i=0; i<prodList.length; i++) {
                if (prodList[i].id || prodList[i].type || prodList[i].publishDate || prodList[i].onlineDate) {
                    if (!prodList[i].id) {
                        prodList[i].id = 'no id';
                    }
                    var prodName = (pageData.page.productName || 'xx').toLowerCase();
                    if (prodList[i].id.indexOf(prodName + ':') != 0) {
                        prodList[i].id = prodName + ':' + prodList[i].id;
                    }
                    prodList[i].id = this.stripProductDelimiters(prodList[i].id);
                    var merch = [];
                    if (prodList[i].format) {
                        merch.push('evar17=' + this.stripProductDelimiters(prodList[i].format.toLowerCase()));
                    }
                    if (prodList[i].type) {
                        var type = prodList[i].type;
                        if (prodList[i].accessType) {
                            type += ':' + prodList[i].accessType;
                        }
                        merch.push('evar20=' + this.stripProductDelimiters(type.toLowerCase()));

                        if(type.indexOf(':manuscript') > 0) {
                            /*
                            var regex = /[a-z]+:manuscript:id:([a-z]+-[a-z]-[0-9]+-[0-9]+)/gmi;
                            var m = regex.exec(prodList[i].id);
                            if(m) {
                                merch.push('evar200=' + m[1]);
                            }
                            merch.push('evar200=' + prodList[i].id);
                            */
                            a = prodList[i].id.lastIndexOf(':');
                            if(a>0) {
                                merch.push('evar200=' + prodList[i].id.substring(a+1).toUpperCase());
                            }
                        } else if(type.indexOf(':submission') > 0) {
                            merch.push('evar200=' + prodList[i].id);
                        }
                    }
                    if(!prodList[i].title) {
                        prodList[i].title = prodList[i].name;
                    }
                    if (prodList[i].title) {
                        merch.push('evar75=' + this.stripProductDelimiters(prodList[i].title.toLowerCase()));
                    }
                    if (prodList[i].breadcrumb) {
                        merch.push('evar63=' + this.stripProductDelimiters(prodList[i].breadcrumb).toLowerCase());
                    }
                    var nowTs = new Date().getTime()/1000;
                    if (prodList[i].onlineDate && !isNaN(prodList[i].onlineDate)) {
                        if(prodList[i].onlineDate > 32503680000) {
                            prodList[i].onlineDate = prodList[i].onlineDate/1000;
                        }
                        merch.push('evar122=' + this.stripProductDelimiters(pageDataTracker.getFormattedDate(prodList[i].onlineDate)));
                        var onlineAge = Math.floor((nowTs - prodList[i].onlineDate) / 86400);
                        onlineAge = (onlineAge === 0) ? 'zero' : onlineAge;
                        merch.push('evar128=' + onlineAge);
                    }
                    if (prodList[i].publishDate && !isNaN(prodList[i].publishDate)) {
                        if(prodList[i].publishDate > 32503680000) {
                            prodList[i].publishDate = prodList[i].publishDate/1000;
                        }
                        merch.push('evar123=' + this.stripProductDelimiters(pageDataTracker.getFormattedDate(prodList[i].publishDate)));
                        var publishAge = Math.floor((nowTs - prodList[i].publishDate) / 86400);
                        publishAge = (publishAge === 0) ? 'zero' : publishAge;
                        merch.push('evar127=' + publishAge);
                    }
                    if (prodList[i].onlineDate && prodList[i].publishDate) {
                        merch.push('evar38=' + this.stripProductDelimiters(pageDataTracker.getFormattedDate(prodList[i].onlineDate) + '^' + pageDataTracker.getFormattedDate(prodList[i].publishDate)));
                    }
                    if (prodList[i].mapId) {
                        merch.push('evar70=' + this.stripProductDelimiters(prodList[i].mapId));
                    }
					if (prodList[i].relevancyScore) {
						merch.push('evar71=' + this.stripProductDelimiters(prodList[i].relevancyScore));
					}
                    if (prodList[i].status) {
                        merch.push('evar73=' + this.stripProductDelimiters(prodList[i].status));
                    }
                    if (prodList[i].previousStatus) {
                        merch.push('evar111=' + this.stripProductDelimiters(prodList[i].previousStatus));
                    }
                    if (prodList[i].entitlementType) {
                        merch.push('evar80=' + this.stripProductDelimiters(prodList[i].entitlementType));
                    }
                    if (prodList[i].recordType) {
                        merch.push('evar93=' + this.stripProductDelimiters(prodList[i].recordType));
                    }
                    if (prodList[i].exportType) {
                        merch.push('evar99=' + this.stripProductDelimiters(prodList[i].exportType));
                    }
                    if (prodList[i].importType) {
                        merch.push('evar142=' + this.stripProductDelimiters(prodList[i].importType));
                    }
                    if (prodList[i].section) {
                        merch.push('evar100=' + this.stripProductDelimiters(prodList[i].section));
                    }
                    if (prodList[i].detail) {
                        merch.push('evar104=' + this.stripProductDelimiters(prodList[i].detail.toLowerCase()));
                    } else if(prodList[i].details) {
                        merch.push('evar104=' + this.stripProductDelimiters(prodList[i].details.toLowerCase()));
                    }
                    if (prodList[i].position) {
                        merch.push('evar116=' + this.stripProductDelimiters(prodList[i].position));
                    }
                    if (prodList[i].publicationTitle) {
                        merch.push('evar129=' + this.stripProductDelimiters(prodList[i].publicationTitle));
                    }
                    if (prodList[i].specialIssueTitle) {
                        merch.push('evar130=' + this.stripProductDelimiters(prodList[i].specialIssueTitle));
                    }
                    if (prodList[i].specialIssueNumber) {
                        merch.push('evar131=' + this.stripProductDelimiters(prodList[i].specialIssueNumber));
                    }
                    if (prodList[i].referenceModuleTitle) {
                        merch.push('evar139=' + this.stripProductDelimiters(prodList[i].referenceModuleTitle));
                    }
                    if (prodList[i].referenceModuleISBN) {
                        merch.push('evar140=' + this.stripProductDelimiters(prodList[i].referenceModuleISBN));
                    }
                    if (prodList[i].volumeTitle) {
                        merch.push('evar132=' + this.stripProductDelimiters(prodList[i].volumeTitle));
                    }
                    if (prodList[i].publicationSection) {
                        merch.push('evar133=' + this.stripProductDelimiters(prodList[i].publicationSection));
                    }
                    if (prodList[i].publicationSpecialty) {
                        merch.push('evar134=' + this.stripProductDelimiters(prodList[i].publicationSpecialty));
                    }
                    if (prodList[i].issn) {
                        merch.push('evar135=' + this.stripProductDelimiters(prodList[i].issn));
                    }
                    if (prodList[i].id2) {
                        merch.push('evar159=' + this.stripProductDelimiters(prodList[i].id2));
                    }
                    if (prodList[i].id3) {
                        merch.push('evar160=' + this.stripProductDelimiters(prodList[i].id3));
                    }
                    if (prodList[i].provider) {
                        merch.push('evar164=' + this.stripProductDelimiters(prodList[i].provider));
                    }
                    if (prodList[i].citationStyle) {
                        merch.push('evar170=' + this.stripProductDelimiters(prodList[i].citationStyle));
                    }

                    var biblio = this.getBibliographicInfo(prodList[i]);
                    if (biblio) {
                        merch.push('evar28=' + biblio);
                    }

                    if (prodList[i].turnawayId) {
                        pageData.eventList.push('product turnaway');
                    }

                    var price = prodList[i].price || '', qty = prodList[i].quantity || '', evts = [];
                    if (price && qty) {
                        qty = parseInt(qty || '1');
                        price = parseFloat(price || '0');
                        price = (price * qty).toFixed(2);

                        if (window.eventData && eventData.eventName && eventData.eventName == 'cartAdd') {
                            evts.push('event20=' + price);
                        }
                    }

                    var type = window.pageData && pageData.page && pageData.page.type ? pageData.page.type : '', evt = window.eventData && eventData.eventName ? eventData.eventName : '';
                    if (type.match(/^CP\-/gi) !== null && (!evt || evt == 'newPage' || evt == 'contentView')) {
                        evts.push('event181=1');
                    }
                    if (evt == 'contentDownload' || type.match(/^CP\-DL/gi) !== null) {
                        evts.push('event182=1');
                    }
                    if (evt == 'contentDownloadRequest') {
                        evts.push('event319=1');
                    }
                    if (evt == 'contentExport') {
                        evts.push('event184=1');
                    }
                    if (this.eventFires('recommendationViews')) {
                        evts.push('event264=1');
                    }

                    if(prodList[i].datapoints) {
                        evts.push('event239=' + prodList[i].datapoints);
                    }
                    if(prodList[i].documents) {
                        evts.push('event240=' + prodList[i].documents);
                    }
                    if(prodList[i].size) {
                        evts.push('event335=' + prodList[i].size);
                        evts.push('event336=1')
                    }

                    if(evt == 'genAIContentUpdated') {
                        evts.push('event51=1');
                    }

                    prods.push([
                        ''					// empty category
                        ,prodList[i].id		// id
                        ,qty				// qty
                        ,price				// price
                        ,evts.join('|')		// events
                        ,merch.join('|')	// merchandising eVars
                    ].join(';'));
                }
            }
        }

        return prods.join(',');
    }
    ,eventFires: function(eventName) {
      var evt = window.eventData && eventData.eventName ? eventData.eventName : '';
      if(evt == eventName) {
        return true;
      }
      // initial pageload and new pages
      if((!window.eventData || evt == 'newPage') && window.pageData && window.pageData.trackEvents) {
        var tEvents = window.pageData.trackEvents;
        for(var i=0; i<tEvents.length; i++) {
          if(tEvents[i] == eventName) {
            return true;
          }
        }
      }
      return false;
    }

    ,md5: function(s){function L(k,d){return(k<<d)|(k>>>(32-d))}function K(G,k){var I,d,F,H,x;F=(G&2147483648);H=(k&2147483648);I=(G&1073741824);d=(k&1073741824);x=(G&1073741823)+(k&1073741823);if(I&d){return(x^2147483648^F^H)}if(I|d){if(x&1073741824){return(x^3221225472^F^H)}else{return(x^1073741824^F^H)}}else{return(x^F^H)}}function r(d,F,k){return(d&F)|((~d)&k)}function q(d,F,k){return(d&k)|(F&(~k))}function p(d,F,k){return(d^F^k)}function n(d,F,k){return(F^(d|(~k)))}function u(G,F,aa,Z,k,H,I){G=K(G,K(K(r(F,aa,Z),k),I));return K(L(G,H),F)}function f(G,F,aa,Z,k,H,I){G=K(G,K(K(q(F,aa,Z),k),I));return K(L(G,H),F)}function D(G,F,aa,Z,k,H,I){G=K(G,K(K(p(F,aa,Z),k),I));return K(L(G,H),F)}function t(G,F,aa,Z,k,H,I){G=K(G,K(K(n(F,aa,Z),k),I));return K(L(G,H),F)}function e(G){var Z;var F=G.length;var x=F+8;var k=(x-(x%64))/64;var I=(k+1)*16;var aa=Array(I-1);var d=0;var H=0;while(H<F){Z=(H-(H%4))/4;d=(H%4)*8;aa[Z]=(aa[Z]| (G.charCodeAt(H)<<d));H++}Z=(H-(H%4))/4;d=(H%4)*8;aa[Z]=aa[Z]|(128<<d);aa[I-2]=F<<3;aa[I-1]=F>>>29;return aa}function B(x){var k="",F="",G,d;for(d=0;d<=3;d++){G=(x>>>(d*8))&255;F="0"+G.toString(16);k=k+F.substr(F.length-2,2)}return k}function J(k){k=k.replace(/rn/g,"n");var d="";for(var F=0;F<k.length;F++){var x=k.charCodeAt(F);if(x<128){d+=String.fromCharCode(x)}else{if((x>127)&&(x<2048)){d+=String.fromCharCode((x>>6)|192);d+=String.fromCharCode((x&63)|128)}else{d+=String.fromCharCode((x>>12)|224);d+=String.fromCharCode(((x>>6)&63)|128);d+=String.fromCharCode((x&63)|128)}}}return d}var C=Array();var P,h,E,v,g,Y,X,W,V;var S=7,Q=12,N=17,M=22;var A=5,z=9,y=14,w=20;var o=4,m=11,l=16,j=23;var U=6,T=10,R=15,O=21;s=J(s);C=e(s);Y=1732584193;X=4023233417;W=2562383102;V=271733878;for(P=0;P<C.length;P+=16){h=Y;E=X;v=W;g=V;Y=u(Y,X,W,V,C[P+0],S,3614090360);V=u(V,Y,X,W,C[P+1],Q,3905402710);W=u(W,V,Y,X,C[P+2],N,606105819);X=u(X,W,V,Y,C[P+3],M,3250441966);Y=u(Y,X,W,V,C[P+4],S,4118548399);V=u(V,Y,X,W,C[P+5],Q,1200080426);W=u(W,V,Y,X,C[P+6],N,2821735955);X=u(X,W,V,Y,C[P+7],M,4249261313);Y=u(Y,X,W,V,C[P+8],S,1770035416);V=u(V,Y,X,W,C[P+9],Q,2336552879);W=u(W,V,Y,X,C[P+10],N,4294925233);X=u(X,W,V,Y,C[P+11],M,2304563134);Y=u(Y,X,W,V,C[P+12],S,1804603682);V=u(V,Y,X,W,C[P+13],Q,4254626195);W=u(W,V,Y,X,C[P+14],N,2792965006);X=u(X,W,V,Y,C[P+15],M,1236535329);Y=f(Y,X,W,V,C[P+1],A,4129170786);V=f(V,Y,X,W,C[P+6],z,3225465664);W=f(W,V,Y,X,C[P+11],y,643717713);X=f(X,W,V,Y,C[P+0],w,3921069994);Y=f(Y,X,W,V,C[P+5],A,3593408605);V=f(V,Y,X,W,C[P+10],z,38016083);W=f(W,V,Y,X,C[P+15],y,3634488961);X=f(X,W,V,Y,C[P+4],w,3889429448);Y=f(Y,X,W,V,C[P+9],A,568446438);V=f(V,Y,X,W,C[P+14],z,3275163606);W=f(W,V,Y,X,C[P+3],y,4107603335);X=f(X,W,V,Y,C[P+8],w,1163531501);Y=f(Y,X,W,V,C[P+13],A,2850285829);V=f(V,Y,X,W,C[P+2],z,4243563512);W=f(W,V,Y,X,C[P+7],y,1735328473);X=f(X,W,V,Y,C[P+12],w,2368359562);Y=D(Y,X,W,V,C[P+5],o,4294588738);V=D(V,Y,X,W,C[P+8],m,2272392833);W=D(W,V,Y,X,C[P+11],l,1839030562);X=D(X,W,V,Y,C[P+14],j,4259657740);Y=D(Y,X,W,V,C[P+1],o,2763975236);V=D(V,Y,X,W,C[P+4],m,1272893353);W=D(W,V,Y,X,C[P+7],l,4139469664);X=D(X,W,V,Y,C[P+10],j,3200236656);Y=D(Y,X,W,V,C[P+13],o,681279174);V=D(V,Y,X,W,C[P+0],m,3936430074);W=D(W,V,Y,X,C[P+3],l,3572445317);X=D(X,W,V,Y,C[P+6],j,76029189);Y=D(Y,X,W,V,C[P+9],o,3654602809);V=D(V,Y,X,W,C[P+12],m,3873151461);W=D(W,V,Y,X,C[P+15],l,530742520);X=D(X,W,V,Y,C[P+2],j,3299628645);Y=t(Y,X,W,V,C[P+0],U,4096336452);V=t(V,Y,X,W,C[P+7],T,1126891415);W=t(W,V,Y,X,C[P+14],R,2878612391);X=t(X,W,V,Y,C[P+5],O,4237533241);Y=t(Y,X,W,V,C[P+12],U,1700485571);V=t(V,Y,X,W,C[P+3],T,2399980690);W=t(W,V,Y,X,C[P+10],R,4293915773);X=t(X,W,V,Y,C[P+1],O,2240044497);Y=t(Y,X,W,V,C[P+8],U,1873313359);V=t(V,Y,X,W,C[P+15],T,4264355552);W=t(W,V,Y,X,C[P+6],R,2734768916);X=t(X,W,V,Y,C[P+13],O,1309151649);Y=t(Y,X,W,V,C[P+4],U,4149444226);V=t(V,Y,X,W,C[P+11],T,3174756917);W=t(W,V,Y,X,C[P+2],R,718787259);X=t(X,W,V,Y,C[P+9],O,3951481745);Y=K(Y,h);X=K(X,E);W=K(W,v);V=K(V,g)}var i=B(Y)+B(X)+B(W)+B(V);return i.toLowerCase()}
    ,stripProductDelimiters: function(val) {
        if (val) {
            return val.replace(/\;|\||\,/gi, '-');
        }
    }

    ,setCookie: function(name, value, seconds, domain) {
        domain = document.location.hostname;
        var expires = '';
        var expiresNow = '';
        var date = new Date();
        date.setTime(date.getTime() + (-1 * 1000));
        expiresNow = "; expires=" + date.toGMTString();

        if (typeof(seconds) != 'undefined') {
            date.setTime(date.getTime() + (seconds * 1000));
            expires = '; expires=' + date.toGMTString();
        }

        var type = typeof(value);
        type = type.toLowerCase();
        if (type != 'undefined' && type != 'string') {
            value = JSON.stringify(value);
        }

        // fix scoping issues
        // keep writing the old cookie, but make it expire
        document.cookie = name + '=' + value + expiresNow + '; path=/';

        // now just set the right one
        document.cookie = name + '=' + value + expires + '; path=/; domain=' + domain;
    }

    ,getCookie: function(name) {
        name = name + '=';
        var carray = document.cookie.split(';'), value;

        for (var i=0; i<carray.length; i++) {
            var c = carray[i];
            while (c.charAt(0) == ' ') {
                c = c.substring(1, c.length);
            }
            if (c.indexOf(name) == 0) {
                value = c.substring(name.length, c.length);
                try {
                    value = JSON.parse(value);
                } catch(ex) {}

                return value;
            }
        }

        return null;
    }

    ,deleteCookie: function(name) {
        this.setCookie(name, '', -1);
        this.setCookie(name, '', -1, document.location.hostname);
    }

    ,mapAdobeVars: function(s) {
        var vars = {
            pageName		: 'Page - Analytics Pagename'
            ,channel		: 'Page - Section Name'
            ,campaign		: 'Campaign - ID'
            ,currencyCode	: 'Page - Currency Code'
            ,purchaseID		: 'Order - ID'
            ,prop1			: 'Visitor - Account ID'
            ,prop2			: 'Page - Product Name'
            ,prop4			: 'Page - Type'
            ,prop6			: 'Search - Type'
            ,prop7			: 'Search - Facet List'
            ,prop8			: 'Search - Feature Used'
            ,prop12			: 'Visitor - User ID'
            ,prop13			: 'Search - Sort Type'
            ,prop14			: 'Page - Load Time'
            ,prop15         : 'Support - Topic Name'
            ,prop16			: 'Page - Business Unit'
            ,prop21			: 'Search - Criteria'
            ,prop24			: 'Page - Language'
            ,prop25			: 'Page - Product Feature'
            ,prop28         : 'Support - Search Criteria'
            ,prop30			: 'Visitor - IP Address'
            ,prop33         : 'Page - Product Application Version'
            ,prop34         : 'Page - Website Extensions'
            ,prop60			: 'Search - Data Form Criteria'
            ,prop63			: 'Page - Extended Page Name'
            ,prop65         : 'Page - Online State'
            ,prop67         : 'Research Networks'
            ,prop40: 'Page - UX Properties'

            ,eVar3			: 'Search - Total Results'
            ,eVar7			: 'Visitor - Account Name'
            ,eVar15			: 'Event - Search Results Click Position'
            ,eVar19			: 'Search - Advanced Criteria'
            ,eVar21			: 'Promo - Clicked ID'
            ,eVar22			: 'Page - Test ID'
            ,eVar47			: 'Page - Test Subject ID'
            ,eVar27			: 'Event - AutoSuggest Search Data'
            ,eVar157		: 'Event - AutoSuggest Search Typed Term'
            ,eVar156		: 'Event - AutoSuggest Search Selected Term'
            ,eVar162		: 'Event - AutoSuggest Search Category'
            ,eVar163		: 'Event - AutoSuggest Search Details'
            ,eVar33			: 'Visitor - Access Type'
            ,eVar34			: 'Order - Promo Code'
            ,eVar39			: 'Order - Payment Method'
            ,eVar41			: 'Visitor - Industry'
            ,eVar42			: 'Visitor - SIS ID'
            ,eVar43			: 'Page - Error Type'
            ,eVar44			: 'Event - Updated User Fields'
            ,eVar48			: 'Email - Recipient ID'
            ,eVar51			: 'Email - Message ID'
            ,eVar52			: 'Visitor - Department ID'
            ,eVar53			: 'Visitor - Department Name'
            ,eVar60			: 'Search - Within Content Criteria'
            ,eVar61			: 'Search - Within Results Criteria'
            ,eVar62			: 'Search - Result Types'
            ,eVar74			: 'Page - Journal Info'
            ,eVar59			: 'Page - Journal Publisher'
            ,eVar76			: 'Email - Broadlog ID'
            ,eVar78			: 'Visitor - Details'
            ,eVar80         : 'Visitor - Usage Path Info'
            ,eVar102		: 'Form - Name'
            ,eVar103        : 'Event - Conversion Driver'
            ,eVar105        : 'Search - Current Page'
            ,eVar106        : 'Visitor - App Session ID'
            ,eVar107        : 'Page - Secondary Product Name'
            ,eVar117        : 'Search - Database'
            ,eVar126        : 'Page - Environment'
            ,eVar141        : 'Search - Criteria Original'
            ,eVar143        : 'Page - Tabs'
            ,eVar161        : 'Search - Channel'
            ,eVar169        : 'Search - Facet Operation'
            ,eVar173        : 'Search - Details'
            ,eVar174        : 'Campaign - Spredfast ID'
            ,eVar175        : 'Visitor - TMX Device ID'
            ,eVar176        : 'Visitor - TMX Request ID'
            ,eVar148        : 'Visitor - Platform Name'
            ,eVar149        : 'Visitor - Platform ID'
            ,eVar152        : 'Visitor - Product ID'
            ,eVar153        : 'Visitor - Superaccount ID'
            ,eVar154        : 'Visitor - Superaccount Name'
            ,eVar177        : 'Page - Context Domain'
            ,eVar189    : 'Page - Experimentation User Id'
            ,eVar190    : 'Page - Identity User'
            ,eVar199    : 'Page - ID+ Parameters'

            ,list2			: 'Page - Widget Names'
            ,list3			: 'Promo - IDs'
        };

        for (var i in vars) {
            s[i] = s[i] ? s[i] : _satellite.getVar(vars[i]);
        }
    }
};

// async support fallback
(function(w) {
	var eventBuffer = [];
	if(w.appData) {
		if(Array.isArray(w.appData)) {
			eventBuffer = w.appData;
		} else {
			console.error('Elsevier DataLayer "window.appData" must be specified as array');
			return;
		}
    }

	w.appData = [];

	var oldPush = w.appData.push;

	var appDataPush = function() {
        oldPush.apply(w.appData, arguments);
        for(var i=0; i<arguments.length; i++) {
            var data = arguments[i];
            if(data.event) {
                if(data.event == 'pageLoad') {
                    w.pageDataTracker.trackPageLoad(data);
                } else {
                    w.pageDataTracker.trackEvent(data.event, data);
                }
            }
        }
	};

	w.appData.push = appDataPush;
	for(var i=0; i<eventBuffer.length; i++) {
	    var data = eventBuffer[i];
	    w.appData.push(data);
	}
})(window);

</script><script>_satellite["_runScript1"](function(event, target, Promise) {
_satellite.logger.log("eventDispatcher: clearing tracking state");try{s.events="",s.linkTrackVars="",s.linkTrackEvents=""}catch(e){_satellite.logger.log("eventDispatcher: s object - could not reset state.")}try{dispatcherData=JSON.parse(event.detail),window.ddqueue=window.ddqueue||[],window.ddqueue.push(dispatcherData),window.eventData=dispatcherData.eventData,window.pageData=dispatcherData.pageData,_satellite.track(dispatcherData.eventName)}catch(e){_satellite.logger.log("eventDispatcher: exception"),_satellite.logger.log(e)}
});</script><script>_satellite["_runScript2"](function(event, target, Promise) {
_satellite.logger.log("eventDispatcher: clearing tracking state");try{s.events="",s.linkTrackVars="",s.linkTrackEvents=""}catch(e){_satellite.logger.log("eventDispatcher: s object - could not reset state.")}try{dispatcherData=JSON.parse(event.detail),window.ddqueue=window.ddqueue||[],window.ddqueue.push(dispatcherData),window.eventData=dispatcherData.eventData,window.pageData=dispatcherData.pageData,_satellite.track(dispatcherData.eventName)}catch(e){_satellite.logger.log("eventDispatcher: exception"),_satellite.logger.log(e)}
});</script></body></html>